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aL1/ARL2 a-like subunit 1 of the nAChR from Schistocerca gregaria
ALS a-like subunit 1 of the nAChR from Drosophila melanogaster
AnTx anatoxin-a
ARD p-like subunit 1 of the nAChR from Drosophila melanogaster
ARL1 p-like subunit 1 of the nAChR from Schistocerca gregaria
Bmax maximal binding
ChAT Choline acetyltransferase
CIAP calf intestinal alkaline phosphatase
Da2/SAD a-like subunit 2 of the nAChR from Drosophila melanogaster






EPSP excitatory postsynaptic potential
GABA y-aminobutyric acid
GC gas chromatography






LGIC ligand gated ion channel
Lumigen PPD [4-methoxy-4-(3-phosphate-phenyl)-spiro(1 t2-dioxetane-3,2’adamantane)
disodium salt]
MAb monoclonal antibody
mAChR muscarinic Acetylcholine Receptor
MARA1 Manduca sexta Acetylcholine Receptor Alpha-like subunit 1
MARB1 Manduca sexta Acetylcholine Receptor Beta-like subunit 1
MBTA 4-(N-maleimido)-benzyltrimethylammonium
MLA methyllycaconitine











RACE rapid amplification of cDNA ends
SBD p-like subunit 2 of the nAChR from Drosophila melanogaster
SM storage medium for bacteriophage X (see Appendix 3)
SSC sodium chloride, sodium citrate solution (see Appendix 3)
TAE Tris Acetate EDTA solution (see Appendix 3)
Taq Thermus aquaticus





Manduca sexta is a nicotine insensitive insect, the larval form of which feeds on tobacco. 
It was postulated that the nicotine insensitivity may be due, in part, to a modified nicotinic 
acetylcholine receptor (nAChR) whose a subunit does not possess the amino acid 
residues necessary to bind nicotine. The aim of this study was to test this hypothesis.
A partial length genomic clone and a partial length cDNA clone were isolated using 
inverse PCR on circularised genomic DNA and cDNA respectively. Together with an 
overlapping partial length cDNA clone previously isolated (Clarke, 1991), they encode 
the complete coding sequence of an a-like subunit of nAChR which does not show any 
obvious candidate amino acids substituting for those residues known to take part in 
nicotine binding in vertebrates. This a-like subunit is named MARA1 for Manduca 
Acetylcholine Receptor Alpha-like subunit JL Further searches have not isolated other a- 
like subunits, suggesting that only one a-like subunit may exist in Manduca. Proof that 
MARA1 was nicotine sensitive would require functional analysis. Therefore, two- 
electrode voltage clamp recording on Xenopus oocytes expressing the mouse muscle 
nAChR was carried out with the intention of using this technique for a functional 
assessment of MARAI. However, this was not feasible because of the difficulty in 
obtaining a full-length clone either de novo or by ligation of the overlapping clones, 
possibly due to complex RNA secondary structure.
[125l]a-Bungarotoxin ([125l]a-btx) binding was performed to investigate the presence of 
nicotine binding sites. Specific [125l]a-btx binding was demonstrated in both Manduca 
larval and adult membranes, consistent with an a-btx sensitive nAChR. Inhibition of 
[125l]a-btx binding by cholinergic ligands suggested that the same [125l]a-btx binding site 
was present in larvae and adults. Furthermore, this [125l]a-btx binding site bound nicotine 
(K j values of 1.6|iM and 2^M for larvae and adults respectively) with similar affinity to 
nicotine-sensitive insects, indicating that a modified nAChR is unlikely to be the definitive 
mechanism in Manduca's nicotine insensitivity. This corroborates the sequence data 
from MARA1. [3H](±)Epibatidine binding on Manduca larval and adult membranes did 
not reveal the presence of an a-btx insensitive binding site, consistent with the isolation 
of only one a-like subunit from Manduca.
Sequence and binding data predict that there is not a modified nAChR in Manduca and 
therefore other mechanisms of protection against nicotine toxicity in Manduca must exist.
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1.1 Manduca sexta: a nicotine resistant insect
1.1.1 Nicotine as an insecticide
The insecticidal properties of the tobacco plant Nicotiana tabacum have been known for 
centuries. However, not until 1828, when nicotine, the active alkaloid was isolated 
(Jackson, 1941), did commercial preparations containing standard nicotine contents 
become available. At its peak in 1944, the equivalent of 1.2 million pounds of nicotine 
was used in agriculture in the USA (Metcalf, 1948). Today, nicotine has limited use as 
an insecticide compared with the inorganic insecticides such as arsenicals and fluorides 
and the synthetic organic insecticides such as chlorinated hydrocarbons and 
organophosphorus and carbamate acetylcholinesterase inhibitors. This is due to its high 
mammalian toxicity, its narrow insecticidal spectrum (only being effective against soft- 
bodied insects with piercing mouthparts such as aphids) and its short life span under 
field conditions. Nicotine does offer some advantage over these other insecticides by 
acting on a different target in the nervous system of insects, thus insect strains which 
develop resistance to, say, acetylcholinesterase inhibitors are unlikely to develop cross- 
resistance to nicotine (reviewed in M. Eldefrawi, 1985).
Acetylcholine (ACh) is the major excitatory neurotransmitter in the insect central nervous 
system (CNS), where it acts on acetylcholine receptors (AChRs) (reviewed in Colhoun, 
1963 and Sattelle, 1980). The insecticidal activity of nicotine is due to its interaction with 
AChRs and in particular with the nicotinic AChR (nAChR), as opposed to the muscarinic 
AChR (mAChR), G-protein coupled receptors that are discussed in section 1.2.1. In the 
vertebrate peripheral nervous system (PNS) and the insect CNS, binding of ACh to 
nAChRs causes a transient conformational change in the receptor which creates a 
temporary channel through the protein and provides an aqueous environment for the 
passage of the cations Na+ and K" across the membrane. The excitable cell membrane 
is consequently depolarised and an action potential elicited if a threshold level is 
reached, upon which activation is terminated and the receptor returned to its resting 
state. Under normal conditions, the ACh is rapidly degraded by membrane bound and 
soluble acetylcholinesterase (AChE), thus preventing re-activation of the receptor. 
Similarly, nicotine binds to nAChRs, activating ion channel opening and subsequently 
causing an influx of (predominantly) sodium ions. This depolarisation initiates multiple 
firing of action potentials and excitation. Eventually, the prolonged activation of the ion 
channels results in a depolarisation of the initiating membrane that is sufficiently large to 
inactivate a major proportion of the ion channels responsible for the action potential. 
Consequently, too few ion channels remain in the resting and thus activatable state to
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generate an action potential and the conduction of nerve impulses fails. This is known 
as a "depolarising block" (Lund, 1985) and is the fundamental mechanism behind the 
toxicity of many cholinergic drugs. The toxic effects of nicotine observed in animals are 
generally due to a "depolarising blockade" of the nAChRs in the PNS, especially those of 
the respiratory muscles which leads to respiratory paralysis. In insects however, nicotine 
exerts its toxic effects upon nAChRs in the CNS. This mechanism is not necessarily 
applicable to the mammalian CNS due to the presence of presynaptic nAChR (see 
section 1.2.6).
1.1.2 Manduca sexta
Tobacco presumably contains nicotine as a defence against predators (i.e. nicotine acts 
as an allelochemical). This results in repelling the majority of insects but conversely 
attracts those which are adapted to nicotine ingestion, one such example being the 
larvae of the tobacco homworm, Manduca sexta (Lepidoptera; Sphingidae), which feed 
by leaf chewing and can tolerate diets containing 1-1.5% (wet weight) nicotine (Parr and 
Thurston, 1972). Incredibly, these larvae are also able to tolerate alkaloid ingestion from 
other solanaceous plants, including tomato, deadly nightshade and jimson weed. Thus 
for those plants that are economically important, Manduca can be a considerable pest. 
Accordingly, larvae of Manduca have been the target for insecticides on agricultural 
crops. As with other lepidopterans the adult moth feeds on nutritious liquids such as 
nectar from live and decaying plants and thus is a lesser pest than the larvae. The 
stages of the Manduca lifecycle are shown in Figure 1.1.
Initially, it could be postulated that a lack of nAChRs causes the nicotine resistance seen 
in Manduca. However, there is substantial evidence to suggest that ACh acts as an 
excitatory neurotransmitter at synapses in the Manduca CNS, in particular at those 
sensory neurons in the antennae which make synapses in the antennal lobes of the 
developing adult (pupae) brain (see Hildebrand et al., 1980 for detailed explanation of 
brain structure). It has been shown that antennae incubated with [14C]choline can 
synthesize and store [14C]ACh whereas several other neurotransmitter candidates do not 
accumulate when supplied with the appropriate radiolabelled precursors. Also, antennae 
and antennal nerves contain endogenous ACh, while extracts of antennae contain 
choline acetyltransferase (ChAT) and acetylcholinesterase (AChE), the biosynthetic and 
degradative enzymes of ACh respectively. Furthermore, levels of ACh, ChAT and AChE 
all rise during development and reach a plateau when neurons become morphologically 
mature (Sanes and Hildebrand, 1976). Similar experiments following quantification of 
ACh, ChAT and AChE from postembryonic (larvae) to adult development have shown
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that variations in activity (particularly of ChAT) correlate with known developmental 
endocrine events and hence indicate cholinergic neurochemical differentiation (Prescott 
et al., 1977).
The presence of nAChRs has been suggested by an [125l]a-bungarotoxin ([125l]a-btx) 
binding activity (a snake venom which blocks nAChRs at the vertebrate neuromuscular 
junction; see section 1.2.2) which rises gradually during antennal lobe development, is 
specific to nervous tissue and can be blocked by cholinergic agents such as 
carbamylcholine, d-tubocurarine and nicotine. Moreover, this activity is not lost in lobes 
deafferented by amputation of developing antennae (Sanes et al., 1977). The [125l]a-btx 
binding sites have been located in condensed regions of the neuropile of antennal lobes, 
that are known to be rich in synapses (Hildebrand et al., 1979).
Therefore, it appears that the presence and storage of ACh, the presence of ChAT and 
its ability to synthesise ACh from its presursors and the presence of an inactivating 
enzyme, AChE, together with a putative nicotine binding site suggests that ACh exerts a 
functional role in the CNS of Manduca. Hence it can be assumed that nAChRs, or at 
least nicotinic-like AChRs exist in Manduca. Consequently, an absence of the nAChR 
cannot explain the nicotine insensitivity of Manduca larvae (and possibly adult) and other 
mechanisms that protect against the toxic effects of nicotine must be considered.
4
Figure 1.1. Stages of the Manduca sexta lifecycle. From top to bottom, eggs and 1st 
instar larva (bar = 2mm), 5th instar larva, pupa and adult (bars = 1cm).
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1.1.3 Protective mechanisms against nicotine in Manduca
Metaboiism and excretion in Manduca
Early studies by Self et al. (1964a) showed that Manduca larvae could ingest at least 
20mg of nicotine in 24 hours without showing signs of toxicity. This was attributed to the 
rapid excretion of unmetabolised nicotine as larvae were able to eliminate most of the 
ingested nicotine within 2 hours and no metabolites of nicotine, as determined by GC 
and paper chromatography, were found. A similar mechanism was found for two other 
lepidopterous, tobacco feeding insects, the tobacco budworm, Heliothis virescens and 
the cabbage looper, Trichoplusia ni (Self et al., 1964b). In contrast, the tobacco 
wireworm, Conoderus vespertinus (a coleopteran) and nymphs of the differential 
grasshopper, Melanoplus differential (an orthopteran), were able to rapidly excrete 
nicotine metabolites, principally in the form of cotinine. This theory of tolerance by rapid 
excretion was reinforced by the finding that larval Manduca Malpighian tubules could 
rapidly remove nicotine by an active transport system that eliminated nicotine at a rate of 
approximately 3nmol/min, whereas the adult Manduca Malpighian tubules could only 
excrete nicotine by passive transport at a rate of approximately 4pmol/min (Maddrell and 
Gardiner, 1976). It was also established that larvae of the cabbage white butterfly, Pieris 
brassicae (another lepidoteran), could actively transport nicotine at high rates. However, 
as Pieris brassicae larvae were readily killed by dietary nicotine (David and Gardiner, 
1953), high excretion rates alone could not account for Manduca larval adaptation to 
nicotine.
It has been shown that rapid metabolism followed by excretion are the major 
mechanisms for tolerance to chemicals such as xanthotoxin and a-terthienyl in some 
chemically resistant lepidopterans (Ivie et al., 1983; Iyengar et al., 1987). It is not so 
surprising, therefore, that the more modem techniques of mass spectrometry and NMR 
have revealed that the nicotine ingested by Manduca larvae is metabolised, 
predominantly to cotinine-N-oxide and partially to nicotine-1-N-oxide and cotinine 
(Snyder et al., 1994). Metabolism occurs via N-oxidation to nicotine-1-M-oxide; C5' 
oxidation to cotinine and cotinine-N-oxide is probably formed from the nicotine-1-N-oxide, 
as shown in Figure 1.2. Both cotinine-N-oxide and nicotine-1-N-oxide are more polar 
than nicotine and this aids their excretion. Some alkaloid sequestration occurred, as the 
level of alkaloids still increased in the haemolymph and larvae 'carcass' after they had 
stabilised in the digestive tract. It was suggested that the rapid metabolism and 
excretion of nicotine by Manduca larvae could serve as a protective mechanism for the 
pupal and adult stages, as internal alkaloid levels could be eliminated quickly as feeding 
ceased in preparation for pupation.
As an aside, the authors attributed the lack of metabolism seen in Manduca by Self et al. 
(1964a) to the analytical techniques used. It was suggested that thermal deoxygenation 
of cotinine-N-oxide and nicotine-1-N-oxide would cause these compounds to behave like 
cotinine and nicotine respectively on a GC column. Furthermore, the paper 





Figure 1.2. Metabolic products formed from the breakdown of nicotine in the midgut of 
Manduca larvae. Thick arrows represent major routes, dashed arrows represent minor routes. 
Redrawn from Snyder et al. (1994).
The changing pattern of metabolites in different regions of the larvae suggested that the 
dietary nicotine is able to induce its own metabolism, which was reversed on removal 
from a nicotine diet. A further study indicated that this induction of nicotine metabolism 
involved midgut microsomal cytochrome P-450 mono-oxygenases (Snyder et al., 1993). 
It was shown that at a low dietary nicotine concentration (0.1%) three of 12 midgut 
microsomal P-450 enzyme activities were induced whereas at higher concentrations of 
nicotine, similar to those found in tobacco (0.75%), nine of 12 enzyme activities were 
induced, suggesting that a subset of P-450 genes was differentially expressed at low 
doses. Moreover, the induction of cytochrome P-450 appeared to have a protective 
effect, as those larvae previously fed nicotine displayed significantly faster nicotine 
metabolism. Thus, it appears that in Manduca larvae the potential toxicant nicotine, from 
the host plant tobacco, is able to induce its own metabolism by cytochrome P-450 
enzymes. Interestingly, this also appears to be an adaptation to nicotine ingestion used 
by Heliothis (Rose et al., 1991) and by the southern armyworm, Spodoptera eridania
(Brattsten et al., 1977). Hence, this inducible system provides a means of defence 
against chemical stress.
Protective adaptations of the Manduca central nervous system 
Although metabolism and excretion appear to be means of achieving chronic tolerance 
to nicotine ingestion in Manduca, electrophysiological recordings on Manduca nerve cord 
have indicated that local protective mechanisms must exist within the CNS. Global 
recordings on intact nerve cords from larvae have shown that the 10mM concentration of 
nicotine necessary to evoke a response is two orders of magnitude higher than that 
needed for the cockroach, Periplaneta americana, indicating that the Manduca CNS is 
approximately 100-fold less sensitive to nicotine than a nicotine sensitive insect, 
Periplaneta (Morris, 1984). In contrast, the cholinergic agonists ACh, muscarine, lobeline 
and tetramethylammonium (TMA) evoked responses at lower concentrations than 
nicotine, suggesting that the CNS of Manduca was not intrinsically insensitive to 
cholinergic agents. Desheathing of the nerve cord, resulting in the removal of the 
perineurium, increased the sensitivity of the Manduca CNS to nicotine but did not make 
the tissue as responsive as the Periplaneta CNS.
More detailed studies using intracellular recording methods on an isolated, desheathed 
motoneuron (PPR) in Manduca larvae have reinforced this earlier finding (Trimmer and 
Weeks, 1989). The synapse studied is part of the pathway mediating reflexive 
withdrawal of the abdominal prolegs. In this pathway, the reflex is generated by tactile 
stimulation of mechanosensory hairs (the planta hairs) located on the top of each proleg. 
The resultant withdrawal is initiated by contraction of the principal planta retractor muscle 
(PPRM) that is innervated by the single motoneuron, PPR. It was demonstrated that 
electrical stimulation of PPR elicited a monosynaptic excitatory postsynaptic potential 
(EPSP) that was reversibly blocked by the cholinergic antagonists d-tubocurarine, 
atropine and mecamylamine indicating that the afferent-to-PPR synapse used ACh as a 
neurotransmitter and that functional nAChRs and mAChRs exist in the Manduca CNS. 
a-Btx suppressed the EPSP but only at micromolar concentrations. The authors have 
attributed this ineffective blocking ability to either an a-btx insensitive nAChR or the 
presence of a penetration barrier that was not permeable to a-btx. The EPSP was 
depolarised in response to nicotine but demonstrated 60-fold lower sensitivity when 
compared with literature data for the Periplaneta motoneurone, Df (David and Sattelle, 
1984). However, responses evoked from other cholinergic agonists did not show such a 
distinctive difference (Table 1.1), implying that the relative insensitivity to nicotine was 
due to a selective protective mechanism(s).
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Agonist Manducat Peripfaneta * Ratio
Nicotine 91 1.5 61
Carbachol 117 200 0.59
TMA 13800 950 14.5
Table 1.1. ED5o values (p.M; the concentration producing an half-maximal response) for 
cholinergic agonists on the PPR motoneuron from Manduca and the Df motoneuron from 
Periplaneta. *David and Sattelle, 1984 (Values estimated from the dose response curves shown 
in Figure 1 of this reference) tTrimmer and Weeks, 1989.
The inability of the Manduca CNS to respond to nicotine with the same degree as a 
nicotine sensitive insect indicates the existence of several mechanisms that play either a 
major or minor role in defending the CNS against the toxic effects of nicotine.
Metabolism in the central nervous system
Although the midgut appears to be the major site of nicotine metabolism in Manduca, 
Morris (1983a) has shown that the CNS can also metabolise nicotine. In insects, the 
nerve cord is highly heterogeneous, comprising neurons, glia, branches of the tracheal 
system and some adherent fat body cells. Of these, it was found that nicotine 
metabolism occurred in the axonal/glial and the cell body/neuropile/glial regions in 
addition to the trachea. Comparison with the the nicotine sensitive cockroach, 
Periplaneta, demonstrated that the CNS of both insects metabolised nicotine but the 
latter to a lesser extent. This has since been confirmed by Snyder et al. (1993) who 
demonstrated that nerve cords from Manduca larvae were able to metabolise nicotine to 
nicotine-1-N-oxide, probably by cytochrome P-450. Unlike midgut metabolism however, 
CNS metabolism was not inducible. Morris (1983a) postulated that a nicotine detoxifying 
mechanism could only protect the CNS if the rate of nicotine metabolism at least 
equalled the rate of penetration, otherwise equilibration of nicotine between the 
haemolymph and the extracellular space would happen. This would explain why the 
CNS connectives and the tracheal cells were able to metabolise nicotine: if nicotine were 
not detoxified, it would be free to diffuse from the CNS connectives and tracheal cells 
into the neuropile of the ganglion. It was speculated that the peripheral layers of the 
insect CNS play a detoxifying role similar to that of the vertebrate liver. This would be 
necessary as the insect gut is very permeable and consequently ingested food can enter 
the haemolymph of the general body cavity, a space adjacent to the blood-brain barrier,
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in contrast to the vertebrate system whereby ingested food passes via the hepatic portal 
system to the liver before meeting the blood-brain barrier.
Related studies have shown that clearance of nicotine and its metabolites from the CNS 
of Manduca is different from that of the nicotine sensitive Periplaneta (Morris, 1983b). In 
fact, the kinetics of nicotine and metabolite efflux in Manduca seem slower and less 
complicated than that of Periplaneta, indicating a greater ability in Manduca CNS to 
immobilise nicotine. In contrast, organic molecules such as leucine and sucrose show 
similar efflux patterns for both Manduca and Periplaneta nerve cords (Morris, 1983c), 
implying that only nicotine and its metabolites are handled differently in the two insect 
species studied.
Barriers to nicotine penetration
It is possible that the blood-brain barrier in Manduca could result in some resistance to 
nicotine: this would require prevention of the diffusion of nicotine in both its hydrophilic 
protonated form and its lipophilic unprotonated form. The lipophilic unprotonated form 
can cross membranes such as the ion barrier and blood-brain barrier but only the 
hydrophilic protonated form can interact with the nAChR (Yamamoto et al., 1995). 
However, lipophilic nicotine once through the blood-brain barrier can establish a new 
equilibrium, resulting in the presence of protonated nicotine at the synapse. In Manduca 
and Periplaneta, the blood-brain barrier is at the level of the perineurium (Lane et al.,
1977). Electron micrographs have shown that larval Manduca ganglia appear to be 
surrounded by basal cells of the perineurium which form an epithelium with very few cell 
to cell contacts thus minimising the overall area available for intercellular diffusion of 
protonated nicotine (Morris and Harrison, 1984). Hence, accessible sites for the 
intercellular diffusion of nicotine into the neuropile are distinctly limited, directly 
contrasting with the nicotine sensitive Periplaneta whose basal perineurial cell layer is 
much richer in cell to cell contacts (Lane et al., 1977). Transcellular penetration through 
the cytoplasm of unprotonated nicotine appears to be prevented by enzymatic 
metabolism by the CNS (see Metabolism in the CNS above) as ultrastructural 
examination shows the presence of smooth endoplasmic reticulum associated with 
cytochrome P-450 in the perineurium (Morris and Harrison, 1984).
The presence of a tracheo-glial barrier which could substitute for the blood-brain barrier 
in those regions penetrated by branches of the tracheal system has also been postulated 
(Lane et al., 1977; Morris and Harrison, 1984). It is thought that as the tracheal cells 
within the CNS contain smooth endoplasmic reticulum, they may also possess
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detoxifying cytochrome P-450 enzymes which prevent nicotine from harming the nervous 
system.
Selective transport
The inclusion of alkaloid pumps within the CNS, which would transfer nicotine out of the 
extracellular space adjacent to the nicotine receptive membrane and into the cytoplasm 
could also account for the nicotine insensitivity seen in Manduca. However, 
measurements of nicotine uptake have suggested that there is no difference between 
nicotine penetration of nerve cords for Manduca and the nicotine sensitive Periplaneta 
(Morris, 1983a). Furthermore, utilisation of a cationic alkaloid pump inhibitor, 
N'methylnicotinamide (NMN) did not decrease the rate of nicotine uptake in Manduca 
nerve cords. Global extracellular electrophysiological recordings on Manduca nerve 
cords demonstrated that simultaneous application of 10-fold excess NMN with 0.25mM 
nicotine evoked neural activity (Morris, 1984). However, this potentiating effect could be 
due to a synergistic action of NMN and nicotine at the nAChR. Moreover, Trimmer and 
Weeks (1989) have reported that electrophysiological recordings on an isolated 
motoneuron from Manduca show only a weak potentiation of the nicotinic response with 
application of NMN, its main effect being to increase the rate of response and to reduce 
the rate of recovery, suggesting that the presence of alkaloid pumps does not markedly 
contribute to the nicotine resistance of the motoneuron. In fact, the continued (although 
diminished) resistance to nicotine after NMN treatment and during the prepupal 
developmental stage when cationic pumps were inactive suggested that active exclusion 
was not the major defence mechanism against nicotine.
Receptor modification
The relative insensitivity seen toward nicotine by the CNS even after desheathing of the 
neuron suggests that the nicotine resistance may be conferred, at least in part, by a 
modified receptor. Morris (1984) and Trimmer and Weeks (1989) have both postulated 
that an alteration of the insect nAChR that is genetically based could be achieved by the 
production of a novel receptor which would give rise to the unusual pharmacological 
characteristics seen in Manduca neurons. Alternatively, post-translational modifications 
of an otherwise typical insect nAChR could result in the CNS nicotine insensitivity. Either 
way, modifications such as these may have arisen throughout evolution to accommodate 
an alkaloid-rich diet and now remain as an intrinsic attribute of Manduca.
Recently, studies on the mutant, dieldrin-resistant y-aminobutyric acid subtype A 
(GABAa) receptor, of the fruit fly, Drosophila melanogaster (RDL) have shown that a 
single naturally occurring amino acid substitution (A302S) in the proposed channel lining
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domain (ffrench-Constant et al., 1993a) confers resistance to the insecticides dieldrin (a 
cyclodiene) and picrotoxinin, both in heterologously expressed homomeric RDL GABAa 
receptors and in situ GABAa receptors of Drosophila (ffrench-Constant et al., 1993b; 
Zhang et al., 1994). It has been postulated that the change of a methyl group of the 
alanine side chain to an aliphatic hydroxyl group on the serine side chain results in an 
alteration of the binding site in the channel pore thus hindering ion channel block and/or 
the mechanism(s) whereby these insecticides reduce GABA induced responses. 
Furthermore, this mutation also reduces the potency of the structurally distinct 
phenylpyrazole insecticide, fipronil (Hosie et al., 1995). This suggests that the single 
amino acid substitution in this mutant GABAa receptor results in a non-selective 
mechanism for protection against various insecticides.
Notably, there is evidence to suggest that different subtypes of the nAChR exist in 
nicotine resistant and wild type Drosophila derived from the Hikone-R strain (Hall et al.,
1978). It was established that the nicotine resistant type HR created a shift in the 
isoelectric point of an a-btx binding component, indicating that the mutation affected 
receptor structure. Both the nicotine resistance factor and the pi were X-linked, 
suggesting that the HR locus encoded a structural polypeptide in the a-btx binding 
complex (Hall, 1980).
Hence, the existence of a modified insect nAChR where substitution of an amino acid 
that would typically be used in binding nicotine is replaced by an amino acid that is 
incapable of nicotine binding could result in the nicotine insensitivity found in Manduca. 
In the Drosophila cases outlined above, resistance is a developed ability within the 
Drosophila species to tolerate doses of toxicants which would prove lethal to most 
individuals in a normal population of the same Drosophila species (reviewed in 
Oppenoorth, 1985). Resistance to nicotine in Manduca larvae is somewhat different, 
being an intrinsic trait seen in all offspring (Trimmer and Weeks, 1989). Consequently, a 
modified nAChR that prevented the binding of nicotine and ultimately a "depolarising 
blockade" in Manduca larvae could be termed a natural mutant.
There have been no published studies indicating functional nAChRs by 
electrophysiological recordings on adult Manduca cholinoreceptive neurons. Given 
Maddrell and Gardiner's (1976) finding that protective transport mechanisms existed in 
the larval but not in the adult form of Manduca, both larval and adult forms should be 
examined for the presence of a modified nAChR.
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Summary
In summary, a number of protective mechanisms could account for the nicotine 
insensitivity seen in Manduca. These are listed in Table 1.2.
REGION MECHANISM
Midgut and digestive tract Rapid metabolism of nicotine* 
Excretion of nicotine metabolites*
CNS Metabolism of nicotine"
Barriers against nicotine penetration to the 
nAChR4
Selective transport0
nAChR Modified and unable to interact with 
nicotine0
Table 1.2. Potential protective mechanisms against nicotine in Manduca. * Snyder et al., 
1994; " Morris, 1983a, Snyder et al., 1993; 4 Morris and Harrison, 1984; ° Morris, 1984, Trimmer 
and Weeks, 1989.
The nAChR and the possibility of a mutated receptor in Manduca are considered in 
greater detail for the remainder of this chapter. Vertebrate nAChRs have been 
intensively studied and therefore are considered before the lesser known insect nAChRs.
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1.2 Vertebrate nAChRs
1.2.1 The Ligand Gated Ion Channel Family
AChRs are divided into two classes on the basis of their pharmacological properties: 
those activated by the mushroom alkaloid, muscarine are termed muscarinic AChRs 
(mAChRs) and those activated by the tobacco alkaloid, nicotine are termed nicotinic 
AChRs (nAChRs). Both types span the lipid membranes of nerve and muscle. However, 
mAChRs are metabotropic receptors, in which the binding of ACh causes mAChRs to 
interact with G proteins sequentially, modulating various effector molecules such as ion 
channels and enzymes and thus eliciting a response, while nAChRs are ligand gated ion 
channels (LGICs), receptors that contain an integral hydrophilic ion channel through 
which particular ions can traverse the membrane.
Several other neurotransmitter receptors belong to the LGIC family. In vertebrates, ACh, 
5HT3 and glutamate gate cation channels typically found at excitatory synapses whereas 
glycine and GABAa gate anion channels typically found at inhibitory synapses. Amino 
acid sequence analysis has determined that the ACh, 5HT3, GABAa and glycine 
receptors are homologous whereas excitatory glutamate receptors share no overall 
homology with the other neurotransmitter receptors but do between themselves, thus 
resulting in two families of LGICs. More recently, ATP has been found to gate excitatory 
ion channels (termed P2x receptors), thus resembling the ACh LGIC family functionally. 
However, sequence analysis predicts a structure resembling the family that form inwardly 
rectifying and pH-sensitive K+ channels and amiloride sensitive Na+ channels and 
therefore cannot be classified as belonging to either family (Brake et al., 1994). The 
nAChR is subdivided into muscle and neuronal type receptors which share some 
common structural and functional features.
1.2.2 Muscle-type nAChRs
Muscle-type receptors and in particular those of the electric ray, Torpedo are the 
prototype of LGICs. They are introduced here and discussed in greater detail in Chapter 
5, where muscle nAChRs from the mouse were expressed in Xenopus oocytes as a 
training exercise in two electrode voltage clamp recording.
Release of ACh into the synaptic cleft of the neuromuscular junction results in the 
activation of muscle-type nAChRs and muscle fibre contraction. Purification and 
characterisation of these muscle-type nAChRs was assisted by the finding that the
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muscle derived electroplax of the electric eel, Electrophorus, and the electric ray, 
Torpedo, were rich in nAChRs that were almost irreversibly bound by the Bungarus 
multicinctus snake venom toxin, a-bungarotoxin (a-btx), that could be radiolabelled to 
high specific activity (reviewed in Chiappinelli, 1993).
Analysis of the ~ 2 7 0  kDa purified receptor by denaturing polyacrylamide gel 
electrophoresis resulted in four bands, a ,  p ,  y  and 8 of apparent molecular weights 3 8 ,  
5 0 ,  5 9  and 6 4  kDa respectively, that were assembled into an heteromeric pentamer with 
a resulting stoichiometry of ( a ) 2 p y 5  (Lindstrom et al., 1 9 7 9 ) .  Each a  subunit housed one 
binding site for ACh, giving two ACh binding sites per receptor. Purified receptors, 
reconstituted in lipid bilayers resulted in functional ion channels (reviewed in McNamee 
and Ochoa, 1 9 8 2 ) ,  as did expression in Xenopus oocytes of the combination a p y S  
(Mishina et al., 1 9 8 4 ;  also see Chapter 5 ) .  Developmental changes affect the subunit 
composition of the muscle-type receptor with the y  subunit of the embryonic form being 
replaced by an e subunit in the adult form. This in turn alters the functional properties of 
the receptor (Mishina et al., 1 9 8 6 ) .
1.2.3 Conserved structural features of the nAChR
Microsequencing of the peptides revealed high homology between subunits from the 
same species (for Torpedo see Noda et al., 1982, 1983a,b) and of the same subunit 
between different species. Sequence data such as these has allowed the identification 
of the following conserved features for nAChR subunits:
• an extracellular N-terminal region which in the a subunit contains the agonist and 
competitive antagonist binding sites
• four hydrophobic regions designated as putative transmembrane domains (TM1-4) of 
which TM2 is proposed to line the ion channel and contain non-competitive antagonist 
binding sites
• a variable intracellular or cytoplasmic loop between TM3 and TM4, incorporating 
putative phosphorylation sites
• a short extracellular C-terminal domain.
All nAChR subunits are characterised by a conserved sequence in the N-terminal 
extracellular region corresponding to a cysteine loop from residues 1 2 8  to 1 4 2  in the 
Torpedo a  subunit (see Appendix 1 ) .  In addition, a  subunits are characterised by the 
presence of a pair of disulphide bridged cysteines at positions 1 9 2  and 1 9 3  (Torpedo 
numbering) in the extracellular region, a  Subunits are referred to as the major agonist
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binding subunit although adjacent non-a subunits are thought to play a part. These 
basic features are shown in a diagrammatic model of the nAChR, Figure 1.3. The 
contribution of various residues in particular subunits to the formation of the ACh binding 
site, the a-btx binding site and the ion channel is further discussed in section 1.2.7.
1.2.4 Neuronal-type nAChRs
Cloning of genes and cDNAs encoding neuronal nA ChRs
Within the last decade, rapid progress has been made in the isolation of neuronal 
nAChRs through the use of complementary DNA (cDNA) probes. There are two types 
of neuronal receptor subunits designated a  and p  (or non-a). In agreement with muscle- 
type receptor subunits, the a  subunits are defined by the presence of two contiguous 
cysteines located at positions 1 9 2  and 1 9 3  in Torpedo (see Appendix 1 ) .  Although 
neuronal non-a subunits are named p  subunits for clarity, this does not imply that they 
are necessarily equivalent to the muscle-type p  subunits. The majority of putative 
nAChR encoding genes have been isolated from chick and rat neural tissues. Currently, 
seven putative a  subunits ( a 2  -  a 8 )  and three putative p  subunits ( p 2  -  p 4 )  have been 
cloned from neurons (muscle type receptors are deemed to possess a 1  and p 1  
subunits), although a 8  has been isolated only from chick and a 6  only from rat (reviewed 
in Sargent, 1 9 9 3 ) .  A further subunit, a 9 ,  has been located in certain endocrine and 
sensory organ cells of the rat (Elgoyhen et al., 1 9 9 4 ) .  Table 1 . 3  reveals that overall 
amino acid homology between cDNAs encoding neuronal and muscle-type a  subunits 
from the same species is 3 5 - 5 5 % .  The same applies to p  subunits (Sargent, 1 9 9 3 ) .  
Currently, there is no agreement on the evolution of vertebrate neural and muscle 
subunits. Of the most recent studies, Ortells and Lunt ( 1 9 9 5 )  postulate that muscle a 1  
and non-a subunits have evolved from two different groups of neural a-like and non-a 
subunits, respectively whereas le Novere and Changeux ( 1 9 9 5 )  have speculated that the 
muscle a1 subunit evolved alongside the vertebrate neural receptors while the muscle 
non-a subunits were an independently evolving group. The homology increases on 
comparison of the transmembrane domains and parts of the extracellular region and 
decreases on comparison of the cytoplasmic loop between T M 3  and T M 4 ,  indicating 
variability specific to a particular subunit (Sargent, 1 9 9 3 ) .  Furthermore, high homology is 
obtained from comparison of corresponding sequences in chick and rat. The neuronal a  
subunits themselves subdivide into two or three classes depending on their ability to bind 
a-btx: a 7  and a 8  are highly homologous to each other but distinct from other, a-btx 
insensitive, neuronal subunits. The a 9  subunit is distinct not only from the a-btx
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insensitive subunits but also from a7 and a8 subunits (Schoepfer et al., 1990; Elgoyhen 
et al., 1994).
c<x1 ra1 ca2 ra2 ca3 rcx3 ca4 ra4 ca5 ra5 ra6 ca7 ra7 ca8 ra9
45 46
3649 44
100 75 39 3668












Table 1.3. Amino acid identities between cDNA encoding muscle and neuronal a subunits 
of chick (c) and rat (r). Identities calculated from an alignment of a subunits using the gcg 
program Distances (uncorrected) (Swofford and Olsen, 1990). SwissProt accession numbers 
were: Ca1 p09479; ra1 p25108; Ca2 p09480; ra2 p12389; Ca3 p09481; ra3 p094757; Ca4 p09482; 
ra4 p09483; Ca5 p26152; ra5 p20420; ra6 p43143; Ca7 p22770; ra7 q05941; ra9 p43144.
7.2.5 Confirmation of function in neuronal nAChRs
Confirmation that these genes encode functional nAChRs has been elicited from 
purification of brain nAChRs that are encoded by these genes, expression of functional 
nAChRs from combinations of these genes in non-neuronal cells and expression of 
these genes in autonomic neurons and in brain nuclei from which nicotinic responses 
have been obtained.
Purification of neuronal nAChRs
nAChRs were immunopurified from chick brain by affinity chromatography with a 
monoclonal antibody (MAb) to electric organ nAChR. This resulting preparation
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contained two bands, of 49 and 59 kDa, on a denaturing gel (Whiting and Lindstrom, 
1986a). Another MAb against this immunopurified material, immunoprecipitated a third 
band at 75 kDa, as well as the two previously isolated. Using MAbs, two types of nAChR 
were distinguished, one containing the 49 and 59 kDa peptides and the other containing 
the 49 and 75 kDa peptides (Whiting et al., 1987a; Whiting and Lindstrom, 1987a). 
Protein sequencing determined that the 75 kDa peptide corresponded to the sequence 
predicted for the a 4  subunit (Whiting et al., 1991) whilst the 49 kDa peptide 
corresponded to the sequence predicted for the 0 2  subunit (Schoepfer et al., 1988). It 
was thought that the 59 kDa peptide may contain both a 2  and trace amounts of a 3  
(discussed in Sargent, 1993). Therefore, chick brain appeared to comprise nAChRs 
composed of a 4 / 0 2  and a 2 / 0 2  subunits and maybe a 3 / 0 2  subunits. More recently, it was 
demonstrated that the MAb to electric organ nAChR recognised the a 5  subunit and could 
be assembled with a 4 ,  thus suggesting that some nAChRs in chick brain comprised a 4 ,  
a 5  and 0 2  subunits (Conroy et al., 1992).
Whiting and Lindstrom (1987b) also immunopurified nAChRs from rat brain using a MAb 
against the chick 49 kDa peptide. This resulted in two bands of 51 and 79 kDa which 
were found to correspond to the sequences predicted for 02 and a4 subunits 
respectively (Whiting etal., 1987b; Schoepfer et al., 1988).
Using subunit specific MAbs, it has been shown that chick ciliary ganglion neurons 
contain three nAChR subtypes. The first subtype contains a3, a5 and 04 subunits 
(Vernallis et al., 1993). About 20% of these type receptors also contain the 02 subunit, 
suggesting that neuronal nAChRs have the potential to be as complex as the muscle- 
type receptor. The final subtype contains the a7 gene product and does not appear to 
be associated with the subunits found in the two other subtypes of receptor (Conroy and 
Berg, 1995).
Finally, a-btx sensitive nAChRs have been purified from vertebrate brain using a-btx 
affinity columns and have revealed between one to five bands on denaturing gels in the 
range 45 to 72 kDa (Norman et al., 1982; Conti-Tronconi et al., 1985; Kemp et al., 1985; 
Whiting and Lindstrom, 1987b; Gotti et al., 1991), suggesting either the presence of an 
homomeric or an heteromeric receptor. Schoepfer et al. (1990) demonstrated that the 
majority of a-btx sensitive nAChRs in chick brain contained the a7 and/or a8 subunits 
(see Chapter 3, section 3.1.1).
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Functional expression of neuronal nAChR genes
Expression studies using Xenopus oocytes (see Chapter 5 for further explanation of this 
technique) have demonstrated that the genes thought to encode nAChRs do actually 
represent functional nAChRs. Boulter et al. (1987), Wada et al. (1988) and Deneris et al. 
(1989a) showed that oocytes expressing either cRNA encoding rat a 2 ,  a 3  or a 4  subunits 
in combination with cRNA encoding the rat p 2  subunit formed functional heteromeric 
receptors that were activated by ACh and nicotine. ACh evoked responses were not 
blocked by a-btx in all three combinations. In contrast, only a 3 / p 2  and a 4 / p 2  were 
blocked by neuronal bungarotoxin (n-btx). Alone, only injection of a 4  produced 
functional responses but these were only small depolarisations at high concentrations of 
ACh in one third of the trials. Similarly, ACh evoked currents were obtained from cDNAs 
encoding chick a 3 / p 2 ,  a 3 / p 4 ,  a 4 / p 2  and a 4 / p 4  subunit combinations (Couturier et al., 
1990a). Both a-btx and n-btx had little effect on the a 4 / p 2  combination, though other 
combinations were not tested (Ballivet et al., 1988; Bertrand et al., 1990). Moreover, no 
subunit alone produced functional responses (Couturier et al., 1990a).
Neither the rat a5 cRNA nor the chick a5 cDNA resulted in the formation of functional 
nAChRs when co-injected with cRNA encoding rat p2, p3 or p4 subunits (Boulter et al.,
1990) or cDNA encoding chick p2 or p4 subunits (Couturier et al., 1990a). Combinations 
of the rat a6 gene with various p subunits and the rat p3 gene with several a  subunits 
also did not result in functional nAChRs (Deneris et al., 1989b; Sargent, 1993). Recently 
however, it was established that chick a5 mRNA could form functional nAChRs when co­
injected with mRNA encoding the a4 and p2 subunits, producing responses that differed 
significantly from oocytes injected with just a4 and p2 mRNA (Ramirez-Latorre et al., 
1996). Interestingly, it has been suggested that the a5 subunit has been misnamed 
(Conroy et al., 1992). As a5 lacks one or two of the tyrosines thought to play a role in 
ligand binding: tyrosine 190 in chick and tyrosines 93 and 190 in rat (Couturier et al., 
1990a; Boulter et al., 1990 respectively; see section 1.2.7), it is possible that a5  
represents a p type and therefore structural subunit of the nAChR. However, it does 
contain the vicinal cysteines that define the a  subunit. This may set a precedent for 
Manduca, which quite possibly lacks the tyrosine residues similarly to the a5 subunit and 
therefore may not form a functional receptor.
Thus, it appears that some functional nAChRs are formed from the combination of 
specific a  and p subunits giving an a/p heteromeric receptor. However, this heteromeric 
model has been complicated by the demonstration of functional receptors from a  
subunits alone.
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Using Xenopus oocytes, it was shown that cDNA encoding the chick a 7  subunit alone, in 
the absence of any co-injected p subunit cDNA, led to the assembly of functional 
neuronal nAChRs (Couturier et al. 1990b). These were more sensitive to nicotine than 
ACh, desensitised very rapidly and showed significant voltage dependence at elevated 
membrane potentials. Furthermore, the a 7  channel was completely blocked by 
nanomolar concentrations of a-btx. Co-injection of cDNAs encoding a 7  with either p2, 
p3 or p4 subunits, did not result in functional responses differing from those obtained 
with a 7  alone, indicating that a 7  did not co-assemble with any of these subunits into a 
functional heteromeric nAChR. However, it was suggested that in vivo, the a 7  subunit 
was perhaps part of an heteromeric a-btx sensitive nAChR. This has also been 
indicated by pharmacological comparison using inhibition of radiolabelled a-btx binding 
between native a 7  containing nAChRs from chick brain and homomeric chick a 7  
nAChRs extracted from Xenopus oocytes (Anand et al., 1993). The slight differences in 
affinity for particular ligands (especially cytisine, a nicotinic agonist that differentiates 
between p subunits - see Functional diversity of expressed nAChRs below) suggested 
that the native a 7  nAChRs probably did not exist as homomers but were combined with 
other subunits.
The cDNA encoding another subunit, a 8  (Schoepfer et al., 1990) has also been shown to 
form functional homomeric nAChRs in Xenopus oocytes (Gotti et al., 1994). The 
channels were blocked by nanomolar concentrations of a-btx but unlike a 7  showed equal 
affinity for ACh and nicotine. Interestingly, co-injection of a 7  and a 8  in varying ratios, 
always resulted in responses typical of the a 7  subtype, although the a 7 / a 8  combination 
occurs in vivo (see above; Schoepfer et al., 1990; Gotti et al., 1994; Chapter 3, section 
3.1.1).
In contrast to a 7  and a 8  homomeric receptors, the cRNA encoding a9 receptors formed 
functional homomeric receptors that were activated by ACh but not by nicotine although 
nicotine reduced the currents evoked by ACh (Elgoyhen et al., 1994). In addition, co­
injection of a9 with either p2 or p4 did not result in the formation of channels that were 
activated by nicotine. However, both the nicotinic agonist, 1,1-dimethyl-4- 
phenylpiperazinium (DMPP) and the muscarinic agonist, oxotremorine M induced inward 
currents in a9 injected oocytes while ACh evoked responses were blocked by nanomolar 
concentrations of a-btx as well as d-tubocurarine (a nicotinic antagonist) and atropine (a 
muscarinic antagonist). Thus cRNA encoding the a9 subunit was able to form functional 
homomeric receptors with an unusual mixed nicotinic-muscarinic pharmacology.
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Functional diversity of expressed nAChRs
Pharmacological profiles of various subunit combinations demonstrated that particular 
sensitivities to agonists were peculiar to distinct combinations. Using combinations of 
cRNA encoding rat a 2 ,  a 3  and a 4  with p 2  and p 4 ,  Luetje and Patrick (1991) revealed 
that those combinations containing the p 2  subunit were almost completely unresponsive 
to cytisine compared with ACh whereas those combinations containing the p 4  subunit 
were more sensitive to cytisine than any other agonist tested. Moreover, Papke and 
Heinemann (1993) established that cytisine was a partial agonist at p 2  subunit containing 
receptors. For example, cytisine bound with high affinity to a 4 p 2  receptors but had low 
agonist efficacy being relatively ineffective at opening the ion channel. It is pertinent to 
suggest that a similar mechanism may exist in Manduca, where nicotine might bind to the 
nAChR with high affinity but has poor efficacy as an agonist, thus enabling Manduca to 
survive nicotine ingestion (see Chapter 3, section 3.5). Furthermore, replacing the a  
subunit combined with p 2  resulted in different orders of sensitivity to nicotine and ACh 
(Luetje and Patrick, 1991). Similarly, different sensitivities to ACh were found with chick 
combinations of a 3 ,  a 4 ,  p 2  and p 4  (Couturier et al., 1990a). Experiments with 
antagonists also demonstrated that the potency of n-btx and lophotoxin analog-1 
depended on which a  subunit was combined with rat p 2 ,  for example, a 3 / p 2  showed the 
greatest sensitivity to n-btx (Luetjie et al., 1990). Summarised, these results indicated 
that both a  and p  subunits contributed to the pharmacological diversity of neuronal 
nicotinic receptors. In addition, the distinctive agonist sensitivities could serve as a 
means of distinguishing different neuronal subtypes in vivo.
Subunit composition has been shown to affect single channel conductances. Papke et 
al. (1989) showed that different combinations of a 2 ,  a 3  or a 4  mRNA with p 2  mRNA 
resulted in receptors expressed in Xenopus oocytes with unique single channel 
properties. Two conductance states were observed for a 2 / p 2  and a 3 / p 2  indicating the 
presence of two distinct nAChR populations following the injection of a single a  subunit 
and a single p  subunit. Multiple conductance states were also observed in p 4  containing 
nAChRs which differed from those containing p 2  subunits (Papke and Heinemann,
1991).
This phenomenon may be due to either indiscriminate subunit assembly or different post 
translational modifications in the oocyte. In the former case this may be due to mixing in 
stoichiometry (for example 2 a 2 p ,  3 a 2 p ,  2 a 3 p ,  3 a 3 p )  or mixing in subunit arrangements 
around the ion channel (for example a p a p p  or a a p p p ) .  However, [^Sjmethionine 
labelling of mRNAs encoding a 4  and p 2  subunits gave a ratio of 1 : 1 . 4 6  implying a
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pentamer containing two a  and three p  subunits (Anand et al., 1 9 9 1 ) ,  as did channel 
conductance studies on putative ion channel mutated subunits (Cooper et al., 1 9 9 1 ) .  
Therefore, an a : p  stoichiometry of 2:3 is favoured as this correlates with a size (~300 
kDa) consistent with a pentameric structure, as shown in Figure 1.4.
Correlating subunit composition to native receptors
At present, there is little evidence to identify native nAChRs with those subunit 
combinations expressed in Xenopus oocytes. Only in the rat interpeduncular nucleus 
(IPN) where it is known that the genes encoding a 2 ,  a 3 ,  a4, a 5 ,  and p 2  are expressed, 
does the channel conductance of 35pS (Mulle et al., 1991) correspond to the largest 
conductance state obtained from the a 2 / p 2  combination in Xenopus oocytes (34pS; 
Papke et al., 1989), suggesting that a composition of a 2 / p 2  may form the main class of 
nAChRs on IPN neuronal cell bodies. However, comparison of agonist potency does not 
agree with this conclusion as cytisine and ACh are equally effective at eliciting responses 
on IPN neurons (Mulle et al., 1991) but not on p2 containing nAChRs expressed in 
Xenopus oocytes (Luetjie and Patrick, 1991).
1.2.6 Presynaptic nAChRs
Although nAChRs mediate fast excitatory transmission at the neuromuscular junction 
and in autonomic ganglia of the PNS, there is scant evidence for a similar role of 
nAChRs in the vertebrate CNS. It has been suggested that the majority of nAChRs in 
the CNS are presynaptic (residing at nerve terminals rather than cell bodies) and play a 
modulatory role in the brain (Sargent, 1 9 9 3 ;  Wonnacott, 1 9 9 6 ) .  Those presynaptic 
nAChR most extensively studied are found on striatal dopamine terminals. It has been 
demonstrated that nicotine at low concentrations (ECs0: submicromolar) elicited 
pHJdopamine release in superfused synaptosome preparations (Clarke and Reuben, 
1 9 9 6 ) .  Partial agonism by cytisine (see section 1 . 2 . 5 ,  Functional diversity of expressed 
nAChRs above) on the same preparation and lesion studies on dopaminergic terminals 
suggest that this presynaptic nAChR correlates with the a 4 / p 2  subunit combination 
(reviewed in Wonnacott, 1 9 9 6 ) .
Another example of presynaptic nAChRs transpires from the ability of low concentrations 
of nicotine (EC5o: 170nM) to enhance synaptic transmission of glutamate in the medial 
habenula (McGehee et al., 1995). The nicotinic response was blocked by a-btx, 
suggesting the involvement of the a7 subunit and this was confirmed by antisense 
knockdown experiments. Interestingly, nicotine was still able to enhance glutamate
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transmission (that was now insensitive to a-btx), suggesting the presence of an 
heteromeric a l  receptor (see section 1.2.5, Functional expression of neuronal nAChR 
genes).
1.2.7 Agonist and antagonist binding sites
Given the hypothesis that the nicotine insensitivity in Manduca is due to a naturally 
mutated receptor (see section 1.1.3, Receptor modification), it is important to discuss the 
structural features of the nAChR that may contribute to the nicotine binding site. 
Although the vertebrate nAChR (especially the Torpedo receptor) has been used for the 
analysis of residues important for binding agonists and lining the ion channel, a similar 
structure incorporating particular residues is presumed to exist for insect nAChRs.
Pharmacological characterisation of nAChRs in muscle and nerve tissue has resulted in 
the identification of pharmacologically discrete receptor populations. Three classes of 
ligands have been used (reviewed in Chiappinelli, 1993):
1) Agonists such as ACh, nicotine and epibatidine which elicit opening of the channel.
2) Competitive antagonists such as a-btx, d-tubocurarine and dihydro-p-erythroidine 
which prevent opening of the channel by binding to a site(s) overlapping the cholinergic 
binding site.
3) Non-competitive antagonists such as histrionicotoxin which either sterically block ion 
flux by binding to the ion channel or prevent channel opening by binding to regulatory 
sites distinct from the ACh binding site.
Localisation of binding sites
Of these ligands, radiolabelled nicotine and a-btx have been the most utilised in 
determining high affinity binding sites for different subtypes of native neuronal nAChRs 
(see Chapter 3). Mapping of high affinity binding sites in rat brain has determined that 
[3H]nicotine and [125l]a-btx sites are distinct from each other with [125l]a-btx sites being 
distributed most densely in the cerebral cortex, hypothalamus, hippocampus, inferior 
colliculus and in some nuclei of the brain stem whereas [3H]nicotine sites were mostly 
located in the thalamic nuclei (except posterior and intralaminar nuclei), interpeduncular 
nucleus, medial habenula and the superior colliculus while binding was also prominent in 
the substantia nigra pars compacta and ventral tegmental area, the molecular layer of 
the dentate gyrus, the presubiculum and the cerebral cortex (Clarke etal., 1985).
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The [3H]nicotine binding site locations correlate with those observed from 
immunostaining using MAbs against the p2 subunit (Swanson et al., 1987). In chick, 
MAbs against a7 and a8 subunits have shown different distributions of immunoreactivity 
compared with a MAb against the p2 subunit (Britto et al., 1992).
In addition, the pattern of gene expression for particular subunits has been useful in 
defining those populations of nAChRs on different neurons. In situ hybridisation assays 
have shown that each gene is expressed in a distinct pattern. For example, high levels 
of a7 transcripts have been located in the olfactory areas, the amygdala, the 
hippocampus, the hypothalamus and the cerebral cortex of the rat, areas that overlap 
with high affinity [125l]a-btx binding sites (Seguela et al., 1993), while rat a2 transcripts 
have limited distribution, primarily in the interpeduncular nucleus (Deneris et al., 1989a) 
where some of the [3H]nicotine sites are located.
Structural features of the nAChR
Given that the agonist binding sites and the ion channel are so topographically distinct, 
an allosteric mechanism of action which uses multiple interconvertible conformations 
(resting, active, intermediate and desensitised) has been proposed (Changeux et al., 
1984). As yet, how the binding of agonists activates ion channel opening has not been 
demonstrated. Recently however, electron images of postsynaptic membranes from 
Torpedo have delineated the structures for the open and closed channel forms of the 
receptor (Unwin, 1995). Briefly, it appears that the binding of ACh initiates small 
rotations of the subunits in the extracellular region, which elicit a change in configuration 
of the a-helices lining the ion channel, pulling away the ion channel gate and thus 
allowing ion flow through the pore.
This leads onto the importance of particular residues in forming attachment points for 
ligand binding and in forming the ion channel gate.
Structure of the ACh binding site
The topology of the ACh binding sites on Torpedo nAChR has been investigated using 
photoaffinity labelling probes. The interaction of these probes with the nAChR suggest 
that many residues of the a subunit contribute to the ACh binding site. Those residues 
of particular importance are shown in Figure 1.3.
Initial studies identified the disulphide linked vicinal cysteines at positions 192 and 193 
(Torpedo numbering), when reduced, as the site of incorporation of the affinity label 
MBTA (4-(N-maleimido)-benzyltrimethylammonium) (Kao et al., 1984). Further
investigation using the photoaffinity label DDF (p-(N,N-dimethylamino) 
benzenediazonium fluoroborate) which in the dark behaves as a reversible competitive 
antagonist of the nAChR but irreversibly blocks the binding of cholinergic ligands 
following irradiation at 295nm, has led to a three loop model of the agonist and 
competitive antagonist binding site (Dennis et al., 1986, 1988; Galzi et al., 1990). In this, 
DDF identifies the residues tryptophan 86 and tyrosine 93 in loop A, the residues 
tryptophan 149 and tyrosine 151 in loop B and the residues tyrosine 190, the vicinal 
cysteines 192 and 193 and tyrosine 198 in loop C. The three loop model is supported 
not only by the fact that, within these three loops DDF labelling is competitive with a-btx 
and carbamylcholine but also by the labelling of tyrosine 190 by an analog of the 
competitive antagonist, lophotoxin (Abramson et al., 1989) and by the equilibrium 
labelling of tyrosine 190, cysteine 192 and tyrosine 198 by [3H]nicotine, the latter residue 
being labelled the most predominantly (Middleton and Cohen, 1991).
The residues labelled by DDF are conserved at homologous positions in all known a 
subunits from muscle and neuronal nAChRs in all species examined to date, excluding 
the a5 subunit which lacks the residues tyrosine 93 and tyrosine 190 in rat (Boulter et al., 
1990) and tyrosine 190 in chick (Couturier et al., 1990a). Moreover, muscle type non-a 
subunits lack those amino acids labelled by DDF whereas neuronal p subunits contain 
tryptophan 149 and tyrosine 93, suggesting that these p subunits play a minor role in 
binding (reviewed in Devillers-Thiery et al., 1993). Thus in Manduca, it might be 
expected that one or more of these residues are altered, thus preventing agonist binding 
(see section 1.2.5, Functional expression of neuronal nAChR genes).
The cysteine loop
The cysteine residues 128 and 142 (Torpedo numbering) have been shown to form a 
disulphide bridge in the a subunit. This stretch of residues is commonly termed the 'cys 
loop' and occurs in a region that is highly conserved between the a, p, y and 8 subunits, 
suggesting that the cysteines at either end of the cys loop are disulphide cross-linked in 
each subunit (Kao and Karlin, 1986). Computer modelling has suggested that the cys 
loop forms a rigid amphiphilic p-hairpin that is a major determinant of the binding site 
(Cockcroft et al., 1990). It was postulated that the invariant aspartate at position 11 of 
the cys loop is the anionic site interacting with the positively charged amine group of 
agonists (i.e. the cationic headgroup); that the proline residue at position 9 induces the 
turn of the cys loop and interacts with the agonist at its electronegative centre and that 
differences in the type of residue at position 6 resulted in selective recognition of a 
particular agonist. However, there is no experimental evidence to support such claims
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Figure 1.3. Structure of the nAChR.
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although the cys loop has been implicated in the binding of allosteric effectors such as 
physostigmine (see Non-competitive agonists below; Chapter 2, section 2.5.3).
Functional appearance of the ACh binding site
The functional significance of the photoaffinity labelled residues has been investigated 
by site directed mutagenesis. In Torpedo nAChR, substitution of the vicinal cysteines at 
positions 192 and 193 with serines abolishes the response to ACh (Mishina et al., 1985), 
indicating that cysteines 192 and 193 are imperative for ACh binding.
In separate experiments, three aromatic residues in the chick a7 subunit, namely 
tyrosine 92, tryptophan 148 and tyrosine 187 corresponding to the Torpedo residues 
tyrosine 93, tryptophan 149 and tyrosine 190 that were labelled by DDF, were mutated to 
phenylalanine (Galzi et al., 1991). These substitutions caused a decrease in the 
apparent affinity for the agonists ACh and nicotine. The affinity for ACh was decreased 
10-fold by the mutations Y92F and Y187F and 100-fold by the mutation W148F, while 
the affinity for nicotine was decreased by different amounts: 2-fold for the mutations 
Y92F and Y187F and 300-fold for the mutation W148F, indicating that ACh and nicotine 
make different interactions with these three residues. In particular, tryptophan 148 
appears to be important for nicotine binding and it may be that this residue is missing in a 
modified receptor in Manduca. In addition, affinity for the competitive antagonist, 
dihydro-p-erythroidine was decreased by 4-fold for Y92F and Y187F and 30-fold for 
W148F and to a lesser extent for a-btx. Other properties investigated, such as the 
voltage dependency of the ion response were not changed, indicating that the mutations 
selectively affected the recognition of cholinergic ligands by the receptor protein.
Further studies where tyrosine 93, 190 and 198 in the mouse muscle a subunit have 
been individually replaced with serine show a much larger decrease in affinity for ACh 
compared with substitution by other aromatic amino acids (Aylwin and White, 1994). For 
example, the mutations Y198F and Y198W decreased affinity 5-fold whereas the 
mutation Y198S resulted in a 30-fold decrease in affinity, suggesting that at position 198, 
an interaction of the ligand with an aromatic side chain occurs. Moreover, experiments 
on the replacement of tryptophan 54 of the chick a7 receptor by phenylalanine, alanine 
or histidine residues have resulted in a progressive decrease in binding affinity and 
responses evoked by ACh and nicotine (Corringer et al., 1995). Approximately, a 2-fold, 
10-fold and 50-fold reduction in ECso values was seen on W54F, W54A and W54H 
mutations respectively, suggesting once again the importance of aromatic residues. 
That tryptophan 54 was not included in the three loop model, indicated that it formed a 
complementary component of the binding site.
27
That aromatic residues play an important role in agonist binding within the nAChR, is 
similar to the situation in AChE, where atomic resolution of the structure has shown that 
the substrate binding site is in an 'aromatic gorge' (Sussman et al., 1991). It has been 
proposed that the electronegative character of the photoaffinity labelled aromatic 
residues is sufficient to associate with the diffuse positive charge of the quaternary 
ammonium ions representing the cationic head of ACh (reviewed in Devillers-Thiery et 
al., 1993). Relating this to Manduca, it is conceivable that these important aromatic 
residues have been replaced with non-aromatic residues and therefore do not bind 
nicotine efficiently.
Contribution of non-a subunits to the ACh binding site
In muscle, each nAChR contains two a  subunits and therefore two ACh binding sites. 
For effective activation of the receptor, the co-operative binding of two molecules of ACh 
(one to each binding site) is required and a variety of evidence has indicated that these 
sites are not equivalent (reviewed in Devillers-Thiery et al., 1993) and that this was 
probably due to contributions to the binding site made by non-a subunits. Indeed, the y 
subunit was specifically photoaffinity labelled by DDF (Langenbuch-Cachat et al., 1988). 
Moreover, a  and y subunits and a  and 8 subunits were photoaffinity labelled with [3H]d- 
tubocurarine (Pederson and Cohen, 1990). The a-y subunit pair formed the high affinity 
d-tubocurarine binding site whilst the a-5 subunit pair formed the low affinity site. As the 
p1 subunit did not contribute to the binding site, it was suggested that the subunits were 
arranged in a rosette of ayaps enabling rotational pseudosymmetry around the channel 
pore, as shown in Figure 1.4.
MUSCLE NEURONAL NEURONAL
(<x1)2p iy 8  (<x)2(p)3 (<x7 )5
Figure 1.4. Proposed subunit arrangement around the ion channel for nAChRs expressed 
in Xenopus oocytes. Muscle arrangement:ayap8 (Pederson and Cohen, 1990); neuronal 
arrangement either heteromeric: apapp or homomeric: aaaaa (Sargent, 1993).
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It appears that the non-a subunits may help to create a negatively charged subsite of 
anionic residues which interact with the ligand. Czajkowski and Karlin (1991) 
demonstrated that the bifunctional affinity reagent, S-(2-[3H]-glycylaminoethyl) dithio-2- 
pyridine (containing sulphydryl and carboxyl interacting groups) labelled the negatively 
charged carboxyl groups from aspartate and glutamate residues specifically in a region 
in the Torpedo 8 subunit. Replacement in the 5  subunit of the aspartate and glutamate 
residues at positions 180 and 189 with asparagine and glutamine residues respectively 
resulted in a decrease in the apparent affinity for ACh (Czajkowski et al., 1993). As 
these residues were conserved in the y ,  5  and e  subunits of all species, but not in p  
subunits it was suggested that they formed a negative subsite at both the a-y and a - 5  
ACh binding sites.
On the other hand, there is abundant proof that the neuronal p2 and p4 subunits play a 
role in ligand binding as pharmacological profiles of combinations of subunits differ 
according to the p subunit used (Luetjie and Patrick, 1991; see section 1.2.5, Functional 
diversity of expressed nAChRs). Investigations with chimeric models composed of p2/p4 
hybrids coexpressed with a4 subunits in Xenopus oocytes showed that the p subunits 
agonist or competitive antagonist selectivity were due to interactions with the N-terminal 
domain, particularly residues 1 to 80 (Wheeler etal., 1993).
Non-competitive agonists
Physostigmine, an AChE inhibitor, has been shown to have both an agonistic and 
channel blocking effect on the nAChR (Shaw et al., 1985). Activation of the nAChR 
reconstituted in membrane vesicles by physostigmine was insensitive to a-btx but was 
inhibited by the physostigmine-competitive MAb, FK1 (Okonjo et al., 1991). Similarly, 
Storch et al. (1995) demonstrated that FK1 did not affect channel activation by ACh but 
did inhibit channel activation by physostigmine in PC 12 cells, suggesting that 
physostigmine acted via binding sites distinct from ACh. Using the dominant prototope 
of FK1, it was established that physostigmine bound to the residues 118-137 of the a 
subunit in Torpedo (Schroder et al., 1994), a region that contained lysine 125, the amino 
acid photoaffinity labelled by fHJphysostigmine (Schrattenholz et al., 1993), a residue 
not labelled by ACh binding site affinity labels. This region overlaps the cys loop (see 
section 1.2.7, The cysteine loop above). These data indicated that nAChR activation by 
a second pathway that may function physiologically as an allosteric control of receptor 
activity was possible.
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The a-Bungarotoxin binding site
a-Btx has been used as a major determinant in the classification of different nAChR 
subtypes as it is a potent antagonist of muscle a1 subunits (reviewed in Chiappinelli, 
1993) and neuronal a7 and a8 subunits as well as a9 subunits (Couturier et al., 1990b; 
Schoepfer et al., 1990; Elgoyhen et al., 1994). a-Btx with a molecular weight of ~8 kDa, 
is significantly larger than any of the agonists that activate the nAChR, therefore it would 
be expected that there is some overlap with the ACh binding site. The importance of the 
a subunit was initially established by demonstration of a-btx binding to a denatured a1 
subunit from Torpedo (Haggerty and Froehner, 1981). However, considering the 
selective nature of a-btx binding, the contribution of specific domains to formation of the 
a-btx binding site must be necessary.
Several regions of the a  subunit have been implicated in the binding site of a-btx. Using 
synthetic peptides, it has been established that the region a181-200 in Torpedo is 
imperative for a-btx binding (Conti-Tronconi et al., 1990). Homologous regions are found 
in muscle a1 from chick (positions 179-198) and neuronal a7 and a8 from chick 
(positions 181-200) which, as synthetic peptides, specifically bind a-btx with differing 
affinities (McLane et al., 1991a). Approximately the same segment (a183-204) was 
shown to bind a-btx in bacterial fusion proteins from a variety of organisms ranging from 
human to Drosophila (Ohana and Gershoni, 1990).
Reduction and alkylation of the peptides corresponding to the Torpedo a subunit 
sequence 181-200 from a variety of organisms has resulted in a reduction of a-btx 
binding activity, although oxidation of the same sequence has little effect (Conti-Tronconi 
et al,, 1990; McLane et al., 1991a,b). This has suggested that although oxidation of the 
adjacent cysteines to form a vicinal disulphide bond may not be critical for a-btx binding, 
one or both cysteines are involved in forming the interface of this region with a-btx as 
cysteine alkylation leads to reduced a-btx binding.
Other regions shown to complex with a-btx using synthetic peptides based on the 
Torpedo sequence include, a55-74 (Conti-Tronconi et al., 1990) and also regions a1-10, 
a32-41, a100-115 and a122-150 (Mulac-Jericevic and Atassi, 1987a,b), indicating that a 
complex interaction with several parts of the molecule takes place.
Detailed analysis has revealed that particular residues, distinct from those labelled by 
photoaffinity reagents delineating the agonist binding site are essential for a-btx 
interaction with the nAChR. Using site directed mutagenesis, Mishina et al. (1985)
demonstrated that the cysteine residues at a 1 2 8  and a 1 4 2  (in Torpedo) were crucial 
residues for a-btx binding. It appeared that these mutations affected the conformation of 
the a  subunit or its assembly with the other subunits as substantially smaller amounts of 
the a ,  y  and 5  subunits were recovered by electrophoretic analysis on the Xenopus 
oocytes expressing the mutants. Conti-Tronconi et al. ( 1 9 9 1 )  analysed the a 1 8 1 - 2 0 0  
region of Torpedo by employing non-conservative glycine substitutions to each residue 
within this peptide segment. It was found that valine 1 8 8 ,  tyrosine 1 8 9 ,  tyrosine 1 9 0 ,  
cysteines 1 9 2  and 1 9 3  and proline 1 9 4  were imperative for a-btx binding. To a lesser 
degree, the residues tryptophan 1 8 4 ,  lysine 1 8 5 ,  tryptophan 1 8 7 ,  aspartate 1 9 5 ,  
threonine 1 9 6 ,  proline 1 9 7  and tyrosine 1 9 8  appeared influential on a-btx binding. A  
similar investigation on the peptide 1 8 0 - 1 9 9  of the rat a 5  sequence indicated that lysine 
1 8 4 ,  arginine 1 8 7 ,  cysteine 1 9 1  and proline 1 9 5  were essential for binding of a-btx 
(McLane etal., 1991c).
Several organisms possess muscle type nAChRs that, although activated by cholinergic 
ligands, do not bind a-btx. Sequence analysis of the muscle a  subunit from a species of 
elapid snake resistant to a-btx revealed high homology with other muscle a  subunits. 
However, within the region of the ligand binding site, four major substitutions were found: 
at position 184 a tryptophan was replaced with a phenylalanine, at position 185 a lysine 
was replaced with a tryptophan, at position 187 a tryptophan was replaced with a serine 
and at position 194 a proline was replaced with a leucine (Neumann et al., 1989), as well 
as several other substitutions. Further analysis using single or multiple mutations in 
fragments of the a  subunit corresponding to the region 185-196 that were cloned and 
expressed in bacteria, have indicated that proline residues at positions 194 and 197 and 
aromatic amino acids at positions 187 and 189 of the a  subunit are required to confer a -  
btx sensitivity, as changes at these positions to non-proline and non-aromatic residues 
respectively result in a-btx resistance (Barchan etal., 1995; Kachalsky etal., 1995).
X-ray crystallographic analysis has revealed that a-btx (and also cobra-toxin, the 'long' 
toxins) comprises a globular head, the folding of which is determined by four disulphide 
bridges, and three loops hanging down from the head arranged side by side in a p-sheet 
configuration (Walkinshaw et al., 1980; Love and Stroud, 1986). It has been suggested 
that a large area of the a-btx molecule formed by three sequence segments, namely 
both sides of the central loop and the lower tip of the third loop are involved in nAChR 
interactions (Chatrenet et al., 1990). A correspondingly large area on the nAChR, 
formed by several residues within the sequence segments a181-200 and a55-74 could 
make contact with the a-btx molecule (Conti-Tronconi et al., 1991). Amalgamating the
data described here from various sources suggests that the residues forming attachment 
points with the toxin include tyrosine (or other aromatic residue) 189, cysteine 192 and 
193 and proline 194 and 197, as shown in Figure 1.5.
180 200
a-Btx sensitive a subunits
Torpedo a1 DYRGWKHWVYYTCCPDTPYLD
Chick a1 EARGWKHWVYYACCPDTPYLD
Chick a7 G IP G K R T E S FY E C C K E . PYPD
a-Btx insensitive a subunits
Chick a2 N A IG R YN SK K YD C C TE. IY P D
Snake a1 DYRGFWHSVNY SCCLDTPYLD
Mongoose a1 EARGWKHNVTYACCLTTHYLD
Figure 1.5. Sequence alignment of a180-200 from a-btx sensitive and a-btx insensitive 
subunits, indicating residues postulated to form interactions with a-btx (underlined, bold 
amino acids). Torpedo a1: Noda et al., 1982; Chick a1, a2: Nef et al., 1988; Chick a7: Couturier 
etal., 1990b; Schoepfer et al., 1990; Snake a1: Neumann etal., 1989; Mongoose a1: Barchan et 
al., 1992.
As discussed in section 1.1.2, Manduca brain appears to be rich in [125l]a-btx binding 
sites. Therefore, [125l]a-btx will prove a useful tool in defining the binding affinity of 
agonists for this site. This is the subject of Chapter 3.
The ion channel
The permeability response resulting from the activation of nAChRs can be inhibited by 
non-competitive blockers (NCBs) such as histrionicotoxin, chlorpromazine and QX222. 
They operate by entering the open channel and binding to a site located within it, 
consequently decreasing the amplitude of the ion flux. Accordingly, many NCBs are 
voltage dependent. Separate from the agonist binding site, there appear to be two 
classes of NCB binding site: an high affinity histrionicotoxin sensitive site within the ion 
channel and 10-30 low affinity, histrionicotoxin insensitive sites thought to be located at 
the lipid-protein interface (reviewed in Devillers-Thiery etal., 1993).
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Affinity labelling using [3H]chlorpromazine showed that it was incorporated into the four 
different subunits of Torpedo (Heidemann and Changeux, 1984) indicating that the high 
affinity binding site for the NCBs was located in the axis of pseudosymmetry of the 
molecule within the ion channel. Extensive photoaffinity labelling studies with 
[3H]chlorpromazine indicated that those residues labelled were common to the TM2 
(Giraudat et a/., 1986, 1987, 1989; Revah et a/., 1990) and thus a model of the ion 
channel was established. In this, TM2 segments of each subunit line the ion channel in a 
symmetrical arrangement with these segments probably forming an a helical structure. 
Site directed mutagenesis has confirmed that TM2 lines the ion channel. Homologous 
residues from each subunit, lining the ion channel lumen form five superimposed rings: 
the Threonine, Serine, equatorial Leucine, Valine and outer Leucine rings from N to C 
terminal ends of the TM2 segment (reviewed in Devillers-Thiery et a/., 1993). Additional 
rings of negatively charged residues (the Inner and Intermediate rings at the N-terminal 
end and the Outer ring at the synaptic cleft) are found at the extremes of the lumen 
(Imoto etal., 1988). These are shown in Figure 1.3.
Functional expression studies of nAChRs mutated at these rings suggest the presence 
of a stratified organisation within the ion channel (reviewed in Bertrand et al., 1993). 
Briefly, it appears that the Serine, equatorial Leucine, Valine and outer Leucine rings 
control ion channel gating whilst others such as the Threonine ring control ion size 
selectivity. Interestingly, mutations in the Serine ring alter monovalent cation selectivity 
whereas mutations in the outer Leucine ring modify monovalent versus divalent ion 
selection and mutations between the inner and intermediate rings of negatively charged 
residues control cation versus anion selectivity. This organisation indicates that ion 
channel access is highly regulated.
Phosphorylation of the nAChR
The phenomenon of desensitisation at the nAChR is well documented. However, its role 
is unclear as at the synapse, AChE will typically remove ACh at a rate sufficient to 
prevent induction of desensitisation. Therefore, desensitisation must be either 
physiologically important or the result of a mechanism in which the nAChR structure 
relaxes as the initial low affinity ACh binding becomes high affinity as the binding site 
refolds to accommodate the bound ligand (Stroud et al., 1990). It is possible that 
phosphorylation regulates the extent of desensitisation of the receptor. For example, 
phosphorylation of purified, reconstituted Torpedo nAChR by cAMP-dependent protein 
kinase was correlated with acceleration of the rapid phase of agonist induced 
desensitisation by an in vitro flux assay (Huganir et al., 1986). Furthermore, increasing 
the number of tyrosine residues phosphorylated by protein tyrosine kinase in purified
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nAChR reconstituted in lipid bilayers resulted in acceleration of the rate of 
desensitisation, indicating that the responsive state of the nAChR was regulated by the 
extent and type of phosphorylated residues (Hopfield et al., 1988). Indeed, it has been 
postulated that the nAChR autoregulates its own functional activity by a novel signal 
transduction pathway, whereby the nAChR is a substrate for an uncharacterised protein 
kinase in situ and that activity of this protein kinase is stimulated by calcium ions that 
permeate through the activated nAChR ion channel (Miles et al., 1994). More recently, 
site directed mutagenesis studies have shown that mutant receptors lacking 
phosphorylation sites are expressed and assembled normally but desensitise at a 
significantly slower rate than wild type nAChR (Hoffman et al., 1994). Interestingly, 
phosphorylation has also been implicated in subunit assembly (Green etal., 1991).
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1.3 Insect nAChRs
ACh is thought to be the major excitatory neurotransmitter in the CNS of insects due to 
the presence of components of cholinergic synapses such as the ACh synthesising 
enzyme, ChAT, the degrading enzyme, AChE and binding sites for the nicotinic 
cholinergic ligand, a-btx in a variety of insects, such as Manduca (see section 1.1.2; 
reviewed in Colhoun, 1963; Pichon and Manarache, 1985; Restifo and White, 1990). In 
contrast to vertebrates, insect neuromuscular transmission appears to be glutamatergic 
(Usherwood, 1980). Hence, there does not appear to be a synonymous muscle-type 
nAChR in insects. Information regarding insect nAChRs is scarce, those best
characterised being nAChRs from Drosophila, the two locust species, Schistocerca 
gregaria (desert locust) and Locusta migratoria (migratory locust) and the cockroach, 
Periplaneta.
1.3.1 Binding sites for nicotinic cholinergic ligands in the insect CNS 
Pharmacological characterisation
a-Btx, a potent antagonist of vertebrate neuromuscular and neuronal a7-a8 receptors, 
and also a9 receptors, has been a useful pharmacological tool in the study of putative 
nAChRs in insects. High affinity binding sites for [125l]a-btx, with a dissociation constant 
(Kd) in the range 0.1-2nM and an abundance (Bmax) of between 0.2 and 1.4 pmol/mg 
membrane protein have been identified by several groups using either centrifugal assays 
or filter binding assays on membrane extracts from Drosophila heads (Dudai, 1977, 
1978; Dudai and Amsterdam, 1977; Schmidt-Nielsen et al., 1977; Rudloff, 1978). A 
pharmacological profile typical for nAChRs is displayed by the binding of [125l]a-btx: it is 
specifically displaced with high affinity in pre-incubation experiments by other nicotinic 
ligands such as unlabelled ACh, nicotine, a-btx and d-tubocurarine and is less sensitive 
to muscarinic ligands such as atropine and quinuclidinyl benzilate (QNB) (see Schmidt- 
Nielsen et al., 1977 for examples of dose response curves). More recently, Scatchard 
analysis has demonstrated the presence of at least two different classes of high affinity 
[125l]a-btx binding sites in Drosophila head and embryonic membranes, with Kd values of 
-0.1 nM (class 1) and ~4nM (class 2) and maximal binding of -0.24 and -1.1 pmol/mg 
protein respectively (Schloss etal., 1988).
An a-btx binding component has also been demonstrated for several other insects. For 
Schistocerca, Kd values between 0.8 and 1.7nM, with a Bmax of 1.2pmol/mg have been 
obtained for [125l]a-btx binding (Filbin et al., 1983; MacAllan et al., 1988). Again, a
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pharmacological profile typical of an nAChR was seen, specific [125l]a-btx binding was 
displaced by unlabelled ACh, nicotine, a-btx and d-tubocurarine, as well as the extremely 
potent nicotinic agonist and antagonist, anatoxin-a and methyllycaconitine (MLA) 
respectively. A nicotinic profile was also seen for the closely related species, Locusta 
where unusually, nicotine displaced [125l]a-btx binding with considerably higher affinity 
than ACh (Breer, 1981). [125l]a-Btx binding sites exhibiting nicotinic pharmacology have 
also been reported for the house fly, Musca domestica (Harris et al., 1979; Mansour et 
al., 1980; Jones et al., 1981), the honey bee, Apis mellifera (Tomizawa et al., 1995a) as 
well as Periplaneta (Lummis and Sattelle, 1985) and Manduca (Sanes eta!., 1977). The 
latter two insects are interesting as they enable direct comparison between ligand 
binding studies and electrophysiological experiments on identifiable neurons, and 
therefore may show that a-btx is binding to a functional nAChR. It is notable that there 
have been few studies with other radioligands that show specific binding to the nAChR in 
insects. Most recently, Tomizawa et al. (1995a) demonstrated that [3H]phencyclidine 
(PCP) bound to Apis membranes at high and low affinity sites and demonstrated typical 
nicotinic pharmacology. It was suggested that these high and low affinity sites 
corresponded to the insect equivalent of the vertebrate NCB site on the ion channel and 
the ACh binding site respectively (see section 1.2.7).
Biochemical characterisation and reconstitution into lipid bilayers
Purification of the a-btx binding components from several insects has resulted in the 
isolation of a putative nAChR. Hall (1980) increased the purity of the a-btx binding 
component from Drosophila heads 1200-fold by passing Triton X-100 solubilised 
membrane extracts over a cobratoxin-Sepharose 4B affinity column, eluting the 
adsorbed material with carbamylcholine, re-applying to a second cobratoxin-Sephadex 
affinity column where contaminating material was removed by high salt solution before 
finally eluting with carbamylcholine. Treatment of Drosophila head membranes with 
sodium deoxycholate at pH9.0, followed by affinity chromatography was also successful 
(Rudloff et al., 1980). These solubilised a-btx binding complexes were demonstrated by 
gel filtration chromatography to have a molecular weight of 460,000 - 500,000 (Hall, 
1980; Rudloff et al., 1980; Schmidt-Glenewinkel et al., 1981) and by sucrose density 
gradients to have a molecular weight of 250,000-300,000 (Hall, 1980; Jimenez and 
Rudloff, 1980). The two different classes of a-btx binding sites could not be separated 
by sucrose density centrifugation, ion exchange chromatography or affinity 
chromatography on lentil-lectin agarose (Schloss et al., 1991). Four subunits have been 
identified on SDS-polyacrylamide gel electrophoresis, with molecular weights of 78, 64, 
57 and 48 kDa (Schmidt-Glenewinkel etal., 1981).
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Purification of membranes from Musca heads has identified two subunits of -40  and -20  
kDa (Osborne et al., 1982) whilst three subunits of 60, 41 and 25 kDa have been isolated 
from partially purified Schistocerca supraoesophageal ganglion membranes (Filbin et al., 
1983). In contrast an a-btx binding component from the related species, Locusta has 
been purified to homogeneity and migrates as a 250-300 kDa complex in native 
polyacrylamide gels and as a single 65 kDa band under denaturing conditions (Breer et 
al., 1985). The isolated protein was reconstituted in a planar lipid bilayer where it formed 
ion channels that were activated by cholinergic agonists and blocked by d-tubocurarine 
when subjected to patch-clamp analysis (Hanke and Breer, 1986), thus indicating that an 
a-btx sensitive protein from Locusta was a functional homomeric nAChR.
Autoradiographic localisation
Several autoradiographic studies using [125l]a-btx have been carried out on frozen 
sections of Drosophila. Given that in insect brain a distinction exists between the 
ganglion cell bodies which are located in the cortex at the periphery of the brain and the 
neuropile which houses the inner parts of the brain including the synapses that are 
axodendritic rather than axosomatic (Dudai and Amsterdam, 1977) it was important to 
discover that toxin binding was confined to the synaptic neuropile areas of the 
Drosophila CNS in adult heads (Dudai and Amsterdam, 1977; Schmidt-Nielsen et al., 
1977; Rudloff, 1978) and could be abolished by pre-incubation of sections with nicotine, 
d-tubocurarine or unlabelled a-btx, strongly implying that [125l]a-btx was labelling 
nAChRs. Rudloff (1978) also located [125l]a-btx binding to the neuropile in Drosophila 
larvae and pupae. Only the lamina of the optic lobes showed no detectable [125l]a-btx 
binding.
Autoradiographic localisation of [125l]a-btx on the sixth abdominal ganglion of Periplaneta 
again revealed dense binding in the central neuropile either side of the midline that could 
be completely removed by pre-incubation with nicotine or d-tubocurarine (Sattelle et al., 
1983). As this was the region of the ganglion where cereal afferent fibres made their 
synaptic contacts with the dendritic branches of the giant interneurons, it suggested that 
the toxin was labelling a nAChR. However, dense binding was also observed in the 
periphery of the ganglion, a non-synaptic region occupied by glial cells and neuronal cell 
bodies and was only partially removed on pre-treatment with d-tubocurarine indicating 
that some of this [125l]a-btx binding was non-specific.
Finally, [125l]a-btx binding to frozen sections of Manduca brain has been demonstrated 
(Hildebrand etal., 1979; see section 1.1.2). The anatomical organisation of the antennal
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lobes facilitates the histological distinction between synaptic regions, nonsynaptic 
regions and neuronal cell bodies. In each antennal lobe, sensory axons from the 
ipsilateral antennae enter the neuropile via the antennal nerve and end in the glomeruli. 
These glomeruli contain the primary afferent synapses and specialised cellular 
components associated with them. Hildebrand et al. (1979) showed that toxin binding 
was heavily concentrated in the glomeruli and therefore associated with putative 
nAChRs.
Electrophysiological characterisation
The presence of functional nAChRs on identified neurons in insects has been 
demonstrated by electrophysiological recordings from afferent terminals of sensory 
neurons that make synaptic contact with interneurons and motoneurons. Single 
afferents generate EPSPs on stimulation by mechanical or electrical means that can be 
modulated by application of drug.
Sattelle et al. (1983) have investigated synaptic transmission between cereal sensory 
neurons and the giant interneuron 2 (GI2) in the terminal (sixth) abdominal ganglion of 
Periplaneta. GI2 was a convenient preparation as it facilitated direct comparison of the 
pharmacology between synaptic and extrasynaptic nAChRs on the same neuron. It was 
demonstrated that nanomolar concentrations (50nM) of a-btx (comparatively close to the 
Kd of 5nM established from binding studies - see Lummis and Sattelle, 1985) irreversibly 
blocked the cereal afferent input to GI2. Furthermore, the time taken to block the EPSP 
was increased under conditions which either enhanced presynaptic release of ACh 
(increased frequency of stimulation or inclusion of 4-aminopyridine - a potassium channel 
blocker known to increase the duration of presynaptic action potential in Periplaneta 
(Hue et al., 1976)) or inhibited the hydrolysis of ACh within the synapse (inclusion of 
physostigmine, an AChE inhibitor). In contrast, application of QNB (a muscarinic agent) 
was ineffective at concentrations up to 1pM (compared with a Kd of 8nM in binding 
experiments - see Lummis and Sattelle, 1985). Similar results were shown with the cell 
body of GI2, it being sensitive to ionophoretically applied ACh and blocked by a-btx at 
lower concentrations than QNB. Thus it was established that both synaptic and 
extrasynaptic membranes of GI2 contained a-btx sensitive nAChRs.
Further nAChRs have been identified in Periplaneta on the fast coxal depressor 
motoneurone, Df which is located on the metathoracic ganglion. David and Sattelle 
(1984) obtained dose response curves for four ionophoretically applied agonists. 
Nicotine was the most effective, followed by ACh, carbamylcholine and TMA. The ACh 
depolarisation could be blocked by nanomolar concentrations of a-btx but only by high
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micromolar concentrations of QNB. Under voltage clamp conditions, it was established 
that a-btx block was voltage-independent compared with d-tubocurarine block which was 
voltage dependent.
The presence of nAChRs in the grasshopper, Schistocerca nitens has also been 
revealed (Goodman and Spitzer, 1979). Ionophoretic application of ACh onto the dorsal 
unpaired median (DUM) neurons resulted in depolarisation of the membrane that was 
abolished by removal of Na+ ions and reduced by d-tubocurarine. Nicotine also 
depolarised the membrane whereas a-btx failed to block the ACh response at 
micromolar concentrations, an observation also seen for DUM neurons of the 
metathoracic ganglion in Periplaneta (Harrow et al., 1982) indicating the presence of a- 
btx insensitive nAChRs. In this context, it is interesting that Lees et al. (1983) observed 
two populations of nAChRs in cultured neurons from the CNS of embryonic Periplaneta, 
the majority of which were sensitive to a-btx and a minority that were insensitive to a-btx.
Voltage clamp experiments on isolated, thoracic ganglion neuronal somata from Locusta 
indicate the presence of nAChRs due to a rapid depolarisation in response to ACh, 
nicotine, anabasine and TMA and inhibition by a-btx (Benson, 1992).
Electrophysiological characterisation of Drosophila has been limited. Recently, Albert 
and Lingle (1993) have shown that single channel recordings in cultured Drosophila 
neurons established the presence of nAChRs as ACh and nicotine both evoked 
responses that were blocked by a-btx.
Functional nAChRs have also been identified in Manduca using the planta hair afferent- 
to-motoneuron synapse (Trimmer and Weeks, 1989) as discussed in section 1.1.3.
1.3.2 Cloning of genes and cDNAs that encode insect nAChRs
nAChRs from vertebrates and invertebrates have the same topology and therefore the 
subunits that have been isolated from insects have been divided into a-like and p-like 
subunits: all contain the N-terminal extracellular region housing the cysteine loop, the 
four transmembrane domains, the cytoplasmic loop between TM3 and TM4 and the 
extracellular C-terminal tail but only the a-like subunits contain the vicinal cysteines.
The gene of the first a-like subunit ALS, from Drosophila was identified through cross­
hybridisation with a fragment of the chick a2 gene on a Drosophila genomic library and
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the corresponding cDNA was isolated by screening a Drosophila cDNA library with 
restriction fragments of the ALS gene (Bossy et al., 1988). Utilisation of probes from the 
ALS cDNA has isolated two further a-like subunit encoding genes, Drosophila a-like 
subunit 2, Da2 (Jonas et al., 1990) and Drosophila a-like subunit 3, Da3 (unpublished 
observations cited in Gundelfinger, 1992). The corresponding cDNA of Da2 has been 
isolated through the same means (Baumann et al., 1990) and also by probing a cDNA 
library with a mixture of synthetic oligonucleotides deduced from a highly conserved 
stretch of ten amino acids preceding TM4 (Sawruk et al., 1990a). The latter cDNA clone 
is commonly referred to as SAD, the second a-like subunit from Drosophila. The cDNA 
encoding the y subunit of the nAChR from Torpedo was used to isolate firstly the cDNA 
and secondly the gene for the first p-like subunit of the AChR, ARD, from Drosophila, 
(Hermans-Borgmeyer et al., 1986; Sawruk et al., 1988). The gene encoding the ARD 
subunit was also isolated at the same time by another group, again by cross- 
hybridisation with cDNA encoding the Torpedo y subunit and named the AChR64B 
protein (Wadsworth et al., 1988). The cDNA encoding a second £-like subunit from 
Drosophila (SBD; Sawruk et al., 1990b) was isolated in the same manner as adopted by 
Sawruk et al. (1990a).
An a-like and a p-like subunit have been isolated from Schistocerca gregaria. The gene 
encoding a p-like subunit was isolated by cross hybridisation with a chick p2 subunit 
(Marshall et al., 1988) and a restriction fragment of this clone was then used to isolate 
the cDNA encoding an a-like subunit, aL1 (the subunit is called ARL2) and a p-like 
subunit, ARL1 (Marshall et al., 1990). A further four a-like subunits and two p-like 
subunits have been isolated from Locusta (Hermsen et al., 1991) but as yet their 
sequences have not been published. Insect subunits whose cDNA sequences have 
been published are summarised in Table 1.4.
Hereinafter, the second a-like subunit from Drosophila is called Da2/SAD (except in 
alignments where it is termed SAD) and the a-like subunit from Schistocerca is called 
aL1 (except in alignments where it is termed ARL2).
Generally, the mRNAs encoding the subunits displayed in Table 1.3 are approximately 2- 
3kb. After cleavage from the putative signal peptide, the mature proteins comprise 493 








Table 1.4. Published insect cDNA sequences encoding nAChR subunits. ALS: Bossy et al., 
1988; Da2: Baumann et al., 1990, Sawruk et al., 1990a; ARD: Hermans-Borgmeyer et al., 1986, 
Wadsworth etal., 1988; SBD: Sawruk etal., 1990b; aL1: Marshall etal., 1990.
The subunits contain between one and three potential N-glycosylation sites. Of these, 
one at amino acid position 24 is conserved in all insect subunits. To date, this site is 
characteristic of all neuronal nAChRs and is missing from all muscle nAChRs and the a9 
subunit. Putative protein phosphorylation sites have been predicted in the cytoplasmic 
loop for all the Drosophila subunits. Sites for protein kinase A have been predicted for 
ALS and ARD; for protein kinase C have been predicted for ALS and Da2/SAD and for 
tyrosine protein kinase have been predicted for SBD, suggesting that phosphorylation of 
subunits may play a role in the regulation of insect nAChRs similar to that seen in 
vertebrates (reviewed in Gundelfinger and Hess, 1992). In Schistocerca, protein kinase 
C sites have been predicted in the cytoplasmic loop.
The insect subunits displayed in Table 1.4 share relatively high sequence identity with 
each other, as shown in Table 1.5. Da2/SAD and aL1 show the greatest overall identity, 
suggesting that they are orthologs, i.e. they have arisen from the same gene in different 
species (le Novere and Changeux, 1995). It can be seen that a-like subunits do not 
always have higher homology with other a-like subunits than p-like subunits and vice 
versa. For example, SBD has greater sequence identity with both Drosophila a-like 
subunits than ARD which has roughly equal identity with all subunits. Closer 
examination of the alignment shown in Figure 1.6 indicates that the sequence similarities 
are unevenly distributed along the protein. Highest similarity is seen in the extracellular 
region and the transmembrane domains whereas the cytoplasmic loop between TM3 and 
TM4 and the C-terminal tail show significantly lower sequence similarities between 
subunits. Interestingly, the sequence similarity of insect subunits is higher with 
vertebrate neuronal receptors than with those subunits expressed in vertebrate muscle 
(see alignment in Marshall etal., 1990).
41
1 50
Drosophila SAD MAPG TTRPRPIALLAHIWRH KPL LLLVLLLL ETVQANPDAKRLYDDLLSNYNRLIRPVSNNTDTVLVKLGLRLSQLIDLNLKDQILTTNVWLEHE
Schistocerca ARL2 .....................................MAAALP. . . PMLLLLLLLLLHHPAAANPDAKRLYDDLLSNYNRLIRPVSNNTDTVLVKLGLRLSQLIDLNLKDQILTTNVWLEHE
Drosophila SBD .....................................................................................APISFEANPDTKRLYDDLLSNYNRLIRPWNNTETLTVWLGLKLSQLIEVNLKNQVMTTNLWVKQR
Drosophila ALS ..............................................MGSVLFAAVFIALHFATGGL. ANPDAKRLYDDLLSNYNRLIRPVGNNSDRLTVKMGLRLSQLIDVNLKNQIMTTNVWVEQE
Drosophila ARD  MESS KSWLL SILVLVAFSLVSASEDEERLVRDLFRGYNKLIRPVQNMTQKVGVRFGLAFVQLINVNEKNQVMKSNVWLRLV
100 150
Drosophila SAD WQDHKFKWDPSEYGGVTELYVPSEHIWLPDIVLYNNADGEYWTTMTKAILHYTGKWWTPPAIFKSS EIDVRYFPFDQQT FMKFGSWTYDGDQIDLK
Schistocerca ARL2 WQDHKFRWDPAEYGGVTELYVPSEHIWLPDIVLYNNADGEYWTTMTKAVLHHTGKWWTPPAIFKSS EIDVRYFPFDQQT FMKFGSWTYDGDQIDLK
Drosophila SBD WFDYKLRWDPEEYGGVEQLYVPSEHIWVPDIVLYNNWDGNYEVTLMTKATLKYTGEVFWEPPAIYKSS EMNVEYFPYDEQI FMKFGSWTYNGAQVDLK
Drosophila ALS WNDYKLKWNPDDYGGVDTLHVPSEHIWHPDIVLYNNADGNYEVTIMTKAILHHTGKWWKPPAIYKSF EIDVEYFPFDEQT FMKFGSWTYDGYMVDLR
Drosophila ARD WYDYQLQWDEADYGGIGVLRLPPDKVWKPDIVLFNNADGNYEVRYKSNVLIYPTGEVLWVPPAIYQSS TIDVTYFPFDQQT IMKFGSWTFNGDQVSLA
200 250
Drosophila SAD HISQKNDKDNKVEIGIDLREYYPSVEWDILGVPAERHEKYYP AEPYPDIFFNITLRRKTLFYTVNLIIP VGISYLSVLVFYLPADSGEKIAL IS IL
Schistocerca ARL2 HINQKYD.DNKVKVGIDLREYYPSVEWDILGVPAERHEKYYP AEPYPDIFFNITLRRKTLFYTVNLIVP VGISYLSVLVFYLPADSGEKIAL IS IL
Drosophila SBD HLDQIPGSNL.VQVGIDLTEFYLSVEWDILEVPATKNEEYYPDTLEPFSDITFKLTMRRKTLFYTVNLIVP VALTFLTVLVFYLPSDSGEKVTL IS IL
Drosophila ALS HLKQTADSDN. IEVGIDLQDYYISVEWDIMRVPAVRNEKFYS EEPYLDIVFNLTLRRKTLFYTVNLIIP VGISFLSVLVFYLPSDSGEKISL IS IL
Drosophila ARD LYNNKN...................FVDLSDYWKSGTWDIIEVPAYLNVYEGDSNHPTETDITFYIIIRRKTLFYTVNLILPTVLISFL VLVFYLPAEAGEKVTLGISIL
300 350
Drosophila SAD LSQTMFFLLISEIIPSTSLALPLLGKYLLFTMLLVGLSWITIIILNIHYRKPSTHKMRPWIRSFFIKRLPKLLLM.RVPKDLLRDLAANKI. . . NYGLK
Schistocerca ARL2 LSQTMFFLLISE11PST SLALPLLGKYLLFTMVLVGLS WITIMVLNVHYRKPS THKMAPWVRKVFIRRLPKLLLM. RVPEQLLADLASKRLLRHAHNSK
Drosophila SBD VSLTVFFLLLAEIIPPTSLAVPLLGKYLLFTMILVSLSVWTTV VLNIHFRSPSTHNMSRLVRKLFLHFMPKLMMMRRTQ........................................YTLP
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Figure 1.6. Alignment of insect a-like and p-like subunits of the nAChR. Alignment constructed using the gcg program Pileup (Feng and Doolittle, 
1987; Higgins and Sharp, 1989) after extracting amino acid sequences from the Genbank and EMBL databases.
D a2/S A D aL1 SBD ALS ARD
Da2/SAD 100 82 56 55 43
aL1 100 57 56 43
SBD 100 59 45
A LS 100 42
ARD 100
Table 1.5. Amino acid identities between cDNA encoding insect a-like and p-like subunits.
Identity calculated using the gcg program Distances (uncorrected) (Swofford and Olsen, 1990) 
from an alignment of these subunits. SwissProt accession numbers: Da2/SAD p17644; aL1 
p23414; SBD p25162; ALS p09478; ARD p04755.
Of the genes encoding insect subunits, Da2/SAD is 5.5kb (Jonas et al., 1990), ARD is 
over 7kb (Sawruk et al., 1988) whilst ALS exceeds 54kb (Bossy et al., 1988). 
Comparison with the known structures of vertebrate neuronal and muscle genes 
emphasises the closer relationship between insect subunits and vertebrate neuronal 
subunits than vertebrate muscle subunits. After exclusion of genes encoding the 
vertebrate neuronal a7 (Couturier et al., 1990b) and a9 subunits (Elgoyhen et al., 1994) 
which differ markedly from the other neuronal subunits and the muscle subunits, the 
remaining vertebrate neuronal genes a2  - a5  have the same exon/intron organisation 
(Nef et al., 1988; Boulter et al., 1990; Couturier et al., 1990a), containing five introns 
within the protein coding region. Vertebrate muscle genes have all these introns and 
between three and six additional ones (Noda et al., 1983a,b; Nef et al., 1984; Buonanno 
et al., 1989). The Drosophila genes have three (Da2/SAD) or four (ALS and ARD) of 
these common introns, in addition to one (ARD) or three (Da2/SAD and ALS) others, all 
of which differ from those in genes expressed in vertebrate muscle (reviewed in 
Gundelfinger, 1992; Gundelfinger and Hess, 1992). Comparison of the Drosophila a-like 
subunits with the neuronal a2 - a5  subunits shows that for these genes, the sequences 
corresponding to the first three transmembrane domains are part of the same exon, in 
contrast to those genes encoding the muscle subunits which are split into two or three 
exons. The intron/exon boundaries are summarised in Figure 1.7. Interestingly, the 
genes encoding ALS, Da2/SAD and SBD have been mapped by in situ hybridisation to 
the same chromosomal band in the 96A region of the 3R Drosophila chromosome, 
suggesting that these genes have arisen by gene duplication and might form a gene 
cluster (Bossy et al., 1988; Jonas et al., 1990; Sawruk et al., 1990b). In comparison,
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ARD has been located in the 64B region of the 3L Drosophila chromosome (Sawruk et 
al., 1988; Wadsworth et al., 1988). The cluster of genes encoding ALS, Da2/SAD and 
SBD is similar to that seen for the rat and chick a3, a5 and p4 encoding genes (Boulter 
et al., 1990; Couturier et al., 1990a), which also form a gene cluster spanning 60kb in rat 
and 28kb in chick.
SP S S  TM1TM2TM3 TM4
▲ a a A  A A AAA A  A AAA AAA A A A A A  A  A
ALS o o o o Q o o
SAD 0 0 o 0 0  o
ARD o o o o o
neuronal
a2,3,4,5 p4 o o o o o
neuronal a7 o o o o o o o o o
neuronal a9 o o o o
muscle a 1 o o o o o o o o
muscle p1 o o o 0  o o o o o o
muscle y5e o o o o o o o o o o o
Figure 1.7. Comparison of intron positions for genes encoding Drosophila a-like and p-like 
subunits and vertebrate neuronal and muscle subunits. Arrowheads indicate intron positions 
on diagram of generic subunit (not to scale). Introns are indicated by circles. Abbreviations: SP, 
signal peptide; TM1-4, transmembrane regions 1-4, S-S, disulphide bridge representing cys loop. 
Adapted from Gundelfinger, 1992 using data from Nef et al., 1984; Bossy et al., 1988; Nef et al., 
1988; Sawruk et al., 1988; Buonanno et al., 1989; Couturier et al., 1990a,b; Jonas et al., 1990; 
Elgoyhen etal., 1994.
Fragments of genes encoding nAChR subunits have been isolated from a variety of 
insects, using PCR with degenerate primers to the extracellular region (shortly before the 
vicinal cysteines) and the beginning of TM3, based on the gene sequences encoding 
ALS, Da2/SAD and aL1 subunits (Sgard etal., 1993). At the amino acid sequence level, 
these fragments were clearly ALS-like or Da2/SAD-like, indicating that other insect 
species possessed genes encoding nAChR subunits similar to those of Drosophila. Of 
the insects tested, only the peach potato aphid, Myzus persicae appeared to have gene
45
fragments encoding both subunits. Gene fragments isolated from the lepidopteran 
species used (Chilo suppressalis: the asiatic rice borer, Heliothis virescens: the tobacco 
budworm and Spodoptera frugiperda: the fall armyworm) were all closer to the ALS 
sequence than the Da2/SAD sequence. The greatest homology was seen between 
Heliothis virescens and Spodoptera frugiperda, the two most closely related species. 
Both these insects possessed an intron within this gene fragment that was absent in 
Chilo suppressalis. Manduca was not used in this study.
1.3.3 Functional analysis of cloned genes and cDNAs
Although the homology between the cloned genes and cDNAs in insects and vertebrates 
suggests that they form nAChR subunits, only their assembly into receptors identified at 
the physiological and pharmacological level (see section 1.3.1) indicates their ability to 
form functional nAChRs. For insect nAChRs this has taken the form of 
immunoprecipitation of [125l]a-btx binding sites and expression in Xenopus oocytes.
Immunoprecipitation of [125l]a-Bungarotoxin binding sites
Bacterial fusion proteins have been used as antigens for the production of antisera 
against the Drosophila subunits, ALS and ARD. Antibodies against the cytoplasmic loop, 
which appears to be the most variable region of the nAChR subunits and hence specific 
for each subunit have been extremely useful in correlating cloned genes with [125l]a-btx 
binding sites representing physiological nAChRs. Antisera against bacterially expressed 
fusion proteins that included the extracellular region (amino acids 65-212) and the 
cytoplasmic loop (amino acids 305-444) of ARD were used in immunoprecipitation 
experiments against [125l]a-btx binding sites (Schloss et al., 1988). The antisera 
precipitated between 20 and 30% of all the [125l]a-btx binding sites in the Drosophila 
head solubilised membranes, suggesting that ARD antisera may bind exclusively to high 
affinity class 1 [125l]a-btx binding sites which represent ~25% of the total toxin binding 
components. This was confirmed by Scatchard analysis which revealed that only class 1 
binding sites (rather than class 2; see section 1.3.1) were removed specifically by ARD 
antibodies. Accounting for the facts that the ARD sequence did not contain the two 
vicinal cysteines nor did the ARD antisera actually interfere with toxin binding to 
Drosophila membranes, it was suggested that ARD was a structural subunit of the class 
1 a-btx binding nAChR in Drosophila.
Bacterial fusion proteins containing the ALS extracellular regions corresponding to amino 
acids 192-212 and 135-224 were shown to bind [125l]a-btx but with a lower affinity than
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that of native class 1 binding sites (Ohana and Gershoni, 1990; Schloss et al., 1991). 
Antisera against a fusion protein of the cytoplasmic loop of ALS (amino acids 327-463) 
immunoprecipitated between 20 and 30% of the [125l]a-btx binding sites from Drosophila 
head solubilised membranes, suggesting that ALS was associated with the class 1 high 
affinity [125l]a-btx binding sites, also recognised by ARD-specific antisera (Schloss et al., 
1991). Combining equal amounts of ALS and ARD specific antisera again precipitated 
20-30% of the [125l]a-btx binding sites, confirming that ALS and ARD antisera recognise 
the same high affinity [125l]a-btx binding site. These results suggested that ALS and ARD 
were subunits of the same heteromeric nAChR with ALS as a ligand binding subunit and 
ARD as a structural subunit.
Although these immunoprecipitation experiments have established the existence of ALS 
and ARD in the same receptor complex, they do not preclude the possibility of further 
subunits in the receptor. More comprehensive studies encompassing the range of 
Drosophila subunits (see section 1.3.2) are needed to account for the remaining a-btx 
binding sites. Given that this is a difficult technique to interpret, additional information 
may not make the situation any clearer.
Expression in Xenopus oocytes
Sawruk et al. (1990a) demonstrated that Da2/SAD cRNA, expressed in Xenopus oocytes 
formed cation channels that were gated by nicotine and thus was able to form an 
homomeric receptor. However, the nicotine concentrations required to elicit responses 
were high (half maximal responses were seen at 10-15mM agonist rather than 
micromolar concentrations observed for example in the homomeric chick and rat a7 
receptors; Couturier et al., 1990b, Seguela et al., 1993) and both lOO^M d-tubocurarine 
and 1p,M a-btx failed to block the responses, suggesting the formation of a rather 
unphysiological receptor that might require other subunits for correct formation and 
physiological function. Co-expression of Da2/SAD with ARD did not alter these unusual 
properties indicating either that ARD was not the appropriate subunit or that other 
subunits in addition to ARD were necessary.
Further evidence to support the existence of functional homomeric receptors that 
operated under physiological conditions was gained with the expression of aL1 cRNA 
and cDNA (Marshall et al., 1990; Amar et al., 1995). However, the data from these two 
studies cannot be easily compared as in Marshall’s report, the responses measured were 
membrane potentials whereas in Amar’s report the responses measured were membrane 
currents under voltage clamp. This may explain the differences seen in response to
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nicotine when aL1 alone was expressed in Xenopus oocytes. In each case, functional 
ion channels were formed that were gated by nicotine, but at micromolar concentrations 
according to Marshall et al. and at millimolar concentrations (EC50: 0.83mM) according to 
Amar et al. Nicotine evoked currents were blocked by the nicotinic antagonists a-btx and 
n-btx (each at 0 . 1  ^ M), in addition to a more unusual blockade by bicuculline and 
strychnine (Marshall et al., 1990) and by MLA (0.1 pM; Amar et al., 1995). These 
pharmacological characteristics were all consistent with data from insect neuronal 
recordings in situ (Sattelle et al., 1983; Benson, 1988; Pinnock et al., 1988; Chiappinelli 
et al., 1989 and Buckingham et al., 1994). It was therefore concluded that the aL1 cDNA 
encoded a subunit of a locust a-btx sensitive functional receptor. It is notable that the a- 
btx core binding site (see section 1.2.7) is perfectly conserved between aL1 and 
Da2/SAD.
Preliminary experiments on the expression of ALS and ARD in Xenopus oocytes 
demonstrated that alone, neither could generate nicotine-evoked responses but that 
together a functional heteromeric receptor was formed (discussed in Schloss et al., 
1991). More recently, Bertrand et al. (1994) have reported that ALS alone and in 
combination with ARD failed to reconstitute functional nAChRs when expressed in 
Xenopus oocytes. In contrast, co-expression of ALS with the chick p2 subunit did 
produce functional nAChRs. The resulting ACh evoked currents were large, with a 
maximum amplitude of 2pA whereas at the same concentration, nicotine evoked currents 
were ~20% smaller. Dose response curves gave an EC50of 0.18^M for ACh and 1.3|xM 
for nicotine. Furthermore, ACh evoked currents were blocked by 100nM a-btx. The 
same workers also found that Da2/SAD did not form functional nAChRs in Xenopus 
oocytes either alone or in combination with ARD or with ALS and ARD but when co­
expressed with the chick p2 subunit reconstituted functional nAChRs. Similarly to 
ALS/p2, ACh evoked responses were larger than nicotine evoked responses, however 
lower affinities were demonstrated with an EC5o of 35jiM for ACh and 7.4|iM for nicotine. 
In contrast to ALS/p2, ACh evoked responses were not blocked by 100nM a-btx and 
desensitised faster. These results indicated that ligand binding and desensitisation 
properties were due to the a-like subunit, as the same p subunit was used in both cases. 
As functional expression was only demonstrated with inclusion of the p subunit, it was 
also suggested that ALS and Da2/SAD formed heteromeric receptors rather than the 
homomeric receptor previously described for Da2/SAD (Sawruk et al., 1990). This 
discrepancy was attributed to the use of physiological concentrations of ACh in this study 
rather than the high concentrations used previously. Finally, the fact that co-expression 
of each a-like subunit with ARD failed to reconstitute functional nAChRs but their
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association was known in vivo (Schloss et al., 1991; Schuster et al., 1993) and that the 
ARD subunit was significantly expressed in the oocytes as demonstrated by 
immunocytochemistry localisation (Bertrand et al., 1994) implied that additional structural 
subunits were needed for a functional receptor.
It is also possible that the aL1 subunit is heteromeric in the native receptor. Although it 
is capable of forming functional homomeric ion channels, it may need additional 
structural subunits for responses to be evoked at physiological concentrations (Amar et 
al., 1995). A similar suggestion was made for the chick a7 receptor (Couturier et al., 
1990b; see section 1.2.5, Functional expression of neuronal nAChR genes). Given that 
the same subunit can form either homomeric or heteromeric receptors in different hands, 
it is important to point out that expression in Xenopus oocytes is not a straightforward 
technique and its success depends on many factors. These are discussed in Chapter 5.
For simplicity, the results of expression are summarised in Table 1.6.
Currents evoked by 
ACh?
Currents evoked by 
nicotine ?
Currents blocked by 
a-btx ?
ALS* NO NO NO
SAD* YES YES NO
aL1 ♦ YES YES YES
ARD ND ND ND
ALS/ARD* NO NO NO
SAD/ARD** NO NO NO
ALS/SAD/ARD* NO NO NO
ALS/p2* YES YES YES
SAD/p2* YES YES NO
Table 1.6. Expression of insect subunits in Xenopus oocytes. ND, not determined. "Bertrand 
etal., 1994; "Sawruk et al., 1990a; ♦Marshall etal., 1990, Amar et al., 1995.
Localisation by immunohistochemical studies
The distribution of ALS and ARD in Drosophila has been studied by Schuster et al. 
(1993). Using subunit specific antibodies targeted to the cytoplasmic loop between TM3 
and TM4, co-localisation in many areas of the neuropile (with the exception of only ARD 
immunoreactivity in the lamina of the optic lobe) was demonstrated. During embryonic
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development, ARD immunoreactivity was first detected in ~10 hour embryos whereas 
both subunits were detected in the CNS of late embryos, the three larval stages and all 
prepupal and pupal stages. In larvae and adults, immunoreactivity to both ALS and ARD 
was heavily concentrated in the synaptic regions while embryos and pupae also 
exhibited strong immunoreactivity in the cortical cell bodies. It was suggested that, as 
these developmental periods coincided with accumulation of ARD transcripts, cell body 
staining could reflect newly synthesised and assembled receptors whilst functional, 
heteromeric ALS and ARD containing receptors could be intended for synapses.
In contrast to adult Drosophila, a polyclonal antibody raised against the purified, 
homomeric a-btx binding protein from Locusta (Breer at al., 1985) demonstrated 
immunoreactivity in both synaptic and cell body membranes of the neuropile in the CNS 
of the adult Schistocerca (Leitch et al., 1993), as well as in particular glial cells. Analysis 
of the distribution of immunoreactivity to the same antibody in developing Schistocerca 
showed that labelling first appeared between 30 to 35% development on axonal 
outgrowths from differentiated neurons which at 40 to 45% development appeared in the 
cytoplasm of neuronal cell bodies. By 50% development when the developing neuropile 
was enclosed this labelling was uniform but soon after areas representing the location of 
future tracts and commissures were unlabelled. The adult pattern of immunoreactivity 
was first observed at 75% development when synaptic neuropile regions were stained 
but tracts and commissures were not, suggesting that at early stages of development 
nAChR-like antigenic sites were evenly distributed but were later concentrated to the 
synaptic regions (Watkins etal., 1995).
Temporal and spatial localisation
Genes and cDNAs that encode functional nAChRs would be expressed specifically in the 
nervous system and this has been demonstrated for several nAChR genes from 
Drosophila. During development, the expression of putative nAChR genes appears to 
be highly regulated. Transcripts from genes encoding ALS, Da2/SAD, ARD and SBD 
have been detected on Northern blots of developmental stages of Drosophila, beginning 
with mid-late aged embryos to adult flies. Levels of ARD, Da2/SAD and SBD were 
particularly high in late embryogenesis and in late pupae but had decreased by the early 
adult stage and were only detected at very low levels in larvae and late adults (Hermans- 
Borgmeyer et al., 1986; Wadsworth et al., 1988; Sawruk et al., 1990a,b). In contrast, the 
level of ALS transcript remained at elevated levels in larvae (Bossy et al., 1988). The 
periods of high expression of the ARD transcripts corresponded to periods of terminal 
neuronal differentiation and synapse formation in the CNS, suggesting that they were of 
neuronal origin (Hermans-Borgmeyer et al., 1986). This was also implied from in situ
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hybridisation which showed that trancripts from the ARD, Da2/SAD and SBD Drosophila 
putative nAChR genes were expressed throughout the CNS but not in non-CNS regions 
(Wadsworth et al., 1988; Sawruk et al., 1990a,b). Comprehensive studies for ARD 
transcripts showed that transcripts were first detected in neuronal cell bodies of 10-12 
hour embryos corresponding to condensation of the ventral nerve cord. Transcript levels 
increased during late embryogenesis in all parts of the CNS and then decreased in 
larvae before rising again in both the cortical regions of the brain and in the thoracic 
ganglion of the pupae. In adult flies, ARD transcripts were expressed in all cortical 
regions of the neuropile except the lamina of the optic lobes (Wadsworth et al., 1988).
Of other insects investigated, Hermsen et al. (1991) have shown that transcription of 
Locusta nAChR subunits (sequences unpublished) begins during late embryonic 
development.
1.4 Summary
The wealth of evidence described here strongly suggests the presence of excitatory 
nicotinic cholinergic receptors within the insect CNS. Moreover, it is clear that an 
heterogeneity of subtypes exists, apparent at the pharmacological, physiological and 
molecular level. However, this does not preclude the existence of an homomeric 
receptor, postulated to be the structure of an ancestral ligand gated ion channel (Lunt, 
1986).
There is abundant evidence to support cholinergic transmission in Manduca. The 
possibility of nicotine resistance in Manduca as a result of a 'mutated* nAChR will only be 
solved through pharmacological characterisation of binding sites on brain membranes 
and isolation of genes and/or cDNAs encoding putative nicotine resistant nAChRs and 
their subsequent expression in a functional system. Consequently, the aims of this study 
were to isolate a gene(s) or cDNA(s) encoding a putative a-like nAChR subunit(s) (i.e. 
those subunits generally thought to bind nicotine in vertebrates and other invertebrates) 
and correlate the sequence(s) obtained with pharmacological profiles from radioligand 
binding studies on Manduca adults and larvae. The results obtained may help to 
establish the true cause of Manducas nicotine insensitivity and may give further insight 
into the nicotine binding site of the nAChR.
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CHAPTER 2 
Molecular characterisation of an a-like 




Morris (1984) and Trimmer and Weeks (1989) have postulated that the reduced nicotine 
sensitivity seen in Manduca larvae could reflect, in part, an altered nAChR, making it a 
natural, nicotine-insensitive, mutant receptor. A plausible explanation of the nicotine 
insensitivity is a mutation resulting in an alteration of a key amino acid in the binding site 
on the extracellular region of the a-like subunit (reviewed in Devillers-Thiery et al., 1993; 
further discussion in Chapter 1, sections 1.1.3 and 1.2.7) relative to the a-like subunits of 
other nicotine sensitive insects.
A partial length cDNA encoding an a-like subunit, named MARA1 (for Manduca 
Acetylcholine Receptor Alpha-like subunit V) had been cloned previously from a cDNA 
library prepared from developing (9-12 day old) adult brains (Clarke, 1991) by cross­
hybridisation with the a-like subunit of the nAChR from the locust, Schistocerca gregaria, 
aL1 (Marshall etal., 1990).
The sequence, hereinafter called fragment c, contained the cys loop common to all 
subunits of the nAChR, the two vicinal cysteines indicative of an a-subunit, the four 
putative transmembrane domains (TM1-4), the intracellular loop between TM3 and TM4 
and part of the N-terminal extracellular region. Fragment c lacked some 5' sequence of 
the coding region, equivalent to approximately 90 N-terminal amino acids (from 
comparison with other insect a-like subunits; see sequence alignment, Figure 2.36) and 
any 5' untranslated sequence. Fragment c is shown in Appendix 2, part a.
In order to test the hypothesis that the reduced nicotine sensitivity seen in Manduca is 
due to a naturally mutated nAChR, and assuming that MARA1 contains the necessary 
altered amino acid residue(s) of this mutated nAChR, it was necessary to isolate the 
missing N-terminal fragment of MARA1 and find or construct a full-length clone of 
MARA1 before investigating its nicotine sensitivity in an expression system.
This chapter therefore, delineates the steps taken to determine the full coding sequence 
and the attempts made to isolate a full-length clone of MARA1. Several techniques were 
used, including cDNA library screening and a variety of PCR based strategies and these 
are discussed briefly below.
cDNA libraries are widely used as molecular tools for finding particular cDNA clones. 
They are easier to manipulate than genomic libraries, as in theory, a cDNA clone is more
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amenable to Identification than the equivalent gene. As cDNA clones are representative 
of the mRNA in the original preparation, a cDNA library from adult Manduca brain should 
contain a proportion of clones representing nAChRs and ideally that of MARA1.
PCR based strategies offer an efficient alternative to time consuming library screens and 
are useful in cases where the gene or cDNA of interest is expressed at low levels or if a 
limited amount of material is available because the DNA is amplified through the PCR. 
The inverse PCR technique is beneficial in obtaining the 5’ ends of cDNA or genes as it 
relies on the digestion and circularisation of the genetic material such that the primers 
used in amplification effectively synthesise nucleotides from the inside to the outside of 
the known sequence (Towner and Gartner, 1992). A further alternative is to use RACE 
PCR (rapid amplification of cDNA ends; Frohman et al., 1988) or modifications thereof. 
In this technique, either an homopolymeric tail or an oligonucleotide of known sequence 
is ligated to the cDNA. Primers designed to the 5’ end of the homopolymeric tail or the 
oligonucleotide and the 3’ end of the cDNA are then used to amplify the cDNA.
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2.2 Materials
Molecular biology grade chemicals were obtained from Fisons Scientific Equipment, 
Loughborough, U.K. Bacteriological culture media and Tris-satu rated 
phenol:chloroform:isoamyl alcohol were obtained from the Sigma-Aldrich Chemical 
Company Ltd., Poole, U.K. Water saturated phenol was from Rathburn Chemicals Ltd., 
Walkerbum, U.K. Absolute ethanol was obtained from Hayman Ltd., Witham, U.K. 
Ultrapure Sequagel™ Sequencing Systems acrylamide solutions were obtained from 
National Diagnostics, Hull, U.K. Falcon plasticware was supplied by Becton Dickinson 
and Company, Plymouth, U.K. and Nunc plasticware by Life Technologies, Glasgow, 
U.K. Whatman 3MM Chromatography Paper was from Whatman International Ltd., 
Maidstone, U.K.
Restriction and modifying enzymes were purchased from New England Biolabs, Hitchin, 
U.K. or from the Promega Corporation, Southampton, U.K. with the exception of T4 DNA 
Ligase and Superscript™ II RNase H- Reverse Transcriptase which were purchased from 
GibcoBRL, Paisley, U.K. and Expand™ Long Template PCR System and RNase Inhibitor 
from Boehringer Mannheim U.K., Lewes, U.K.
Ultrapure dNTP sets, T7QuickPrime™ Kits and MicroSpin™ columns were obtained from 
Pharmacia Biotech, St. Albans, U.K. Wizard™ Minipreps DNA Purification System Kits 
were purchased from Promega and Sequenase™ Version 2.0 DNA Sequencing Kits 
(United States Biochemical) from Amersham International Pic., Little Chalfont, U.K. 
Geneclean® II Kits (Bio101 Inc.) and Kodak X-Omat LS™ film were from Anachem, 
Luton, U.K. High Pure PCR Product Purification Kits, positively charged nylon 
membranes and the non-radioactive DIG System Labelling and Detection Kits were 
purchased from Boehringer Mannheim. Dynabeads® mRNA Purification Kits were 
supplied by Dynal®, Wirral, U.K. The GeneAmp® Thermostable rTth Reverse 
Transcriptase RNA PCR Kit was purchased from Perkin Elmer Ltd., Warrington, U.K. 
Radioisotopes were from NEN-Dupont (U.K.) Ltd., Stevenage, U.K.
Oligonucleotides were synthesised either in house, by R&D Systems Europe Ltd., 
Abingdon, U.K. or by Perkin Elmer Ltd.
A customised cDNA library in the vector AZapll, was made by Clontech Laboratories Inc., 
(Cambridge Bioscience), Cambridge, U.K., using Manduca heads from the pupal stage, 
dissected by Professor S.E. Reynolds. A partial cDNA of an a-like subunit of the nAChR
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from Manduca (MARA1) in the vector pBluescript was kindly donated by B. Clarke (Shell 
Research Ltd., Sittingbourne, U.K.). Manduca eggs were supplied by the University of 




2.3.1 Techniques used in nucleic acid preparation and synthesis 
Calcium chloride competent cells
A 5ml culture of either E. coli XL-1 blue cells or DH5a cells in 2YT (see Appendix 3) was 
incubated with shaking at 37°C overnight. 2 0 0 pJ of overnight culture was added to 50ml 
2YT and incubated with shaking at 37°C until an A550 of 0.3 was reached. The cells were 
placed on ice for 5min, centrifuged in a Sorvall SS34 rotor at 1090g, 4°C for 5min and 
the pellet resuspended in 2 0 ml 1 0 0 mM CaCb. After a further 2 0 min on ice, the cells 
were centrifuged as above and the pellet resuspended in 2 ml 1 0 0 mM CaCI2.
Transformation
DNA (50-1 OOng) was added to 200pl competent cells and incubated on ice for 40min. 
The cells were heat shocked at 42°C for 90s, 1ml 2YT was added and the cells 
incubated at 37°C for 40min before being plated onto 2YT agar plates containing 
ampicillin at 100ng/ml for transformant selection. Plates were then incubated at 37°C 
overnight.
a-Compiementation
Transformed competent cells which utilised the replacement of the lacZ gene with foreign 
DNA were selected for on 2YT ampicillin plates supplemented with the chromogenic 
substrate 5-bromo-4-chloro-3-indolyl-p-D-galactoside (X-gal) and the inducer 
isopropylthio-p-D-galactoside (IPTG) as described in Sambrook etal. (1989).
Storage of bacterial cultures
Bacterial cultures were stored indefinitely at -20°C with the addition of 15% (v/v) sterile 
glycerol, as described in Sambrook etal. (1989).
Plasmid DNA preparation 
‘Mini’ scale
5ml of 2YT media containing ampicillin at 100ng/ml was inoculated with either a single 
colony of transformed cells or 5pl of a glycerol stock and incubated with shaking at 37°C 
overnight. Plasmid DNA was subsequently prepared using the Promega Wizard™ 
Minipreps DNA Purification System as described in the manufacturer’s protocol.
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*Midi’ scale
50ml of 2YT media containing ampicillin at 100ng/ml was inoculated with 200jlxI of 
glycerol stock and incubated with shaking at 37°C overnight. Cells were harvested by 
centrifugation in a Sorvall SS34 rotor at 7720g for 5min. The pellet was resuspended in 
4ml of pre-lysis buffer (50mM glucose, 10mM EDTA, 25mM Tris-CI, pH8.0) and the cells 
lysed with 4ml of alkaline lysis solution (0.2M NaOH, 1% (w/v) SDS). The alkali was 
neutralised by the addition of 4ml of neutralising solution (3M sodium acetate, pH4.8) 
and the mixture centrifuged in a Sorvall SS34 rotor at 17400g for 5min.
The supernatant was mixed with an equal volume of isopropanol and centrifuged at 
17400g for 5min. The pellet was resuspended in 500^1 of sterile water in a 
microcentrifuge tube and the alkaline lysis and neutralisation steps repeated using 250pl 
volumes in order to eliminate any remaining cellular DNA. The pellet obtained after a 
second isopropanol precipitation was resuspended in 500pl of sterile water and 
incubated for 5min with an equal volume of 6 M LiCI in order to precipitate RNA. After 
centrifuging at high speed for 2min the DNA in the supernatant was ethanol precipitated 
and the subsequent pellet resuspended in 400pl of TE, pH7.8 (see Appendix 3). RNA 
was digested by the addition of DNase-free RNase to a concentration of 100pg/ml and 
incubation at 37°C for 30min. The reaction was stopped by the addition of 20|il 10% 
(w/v) SDS and incubation at 75°C for 10min. The remaining RNA was then precipitated 
by incubation at room temperature with 6 M LiCI for 15min and pelleted by centrifugation 
at high speed. DNA in the supernatant was ethanol precipitated and the subsequent 
pellet resuspended in sterile water before extraction of protein once with 
phenol:chloroform:isoamyl alcohol (25:24:1) and twice with chloroform:isoamyl alcohol 
(24:1). After a final ethanol precipitation, the DNA pellet was resuspended in 100^1 
sterile water.
Genomic DNA preparation
Genomic DNA was prepared according to the method of Herrmann and Frischauf (1987). 
Manduca eggs were ground to a powder in liquid nitrogen and dispersed in 9 ml TEN9 
buffer (50mM Tris-CI, pH9.0, 100mM EDTA, 200mM NaCI) containing 100|ig/ml DNase- 
free RNase A. The solution was rocked at room temperature for 10min, 0.5ml 20% (w/v) 
SDS was added and rocked for a further 10min, followed by the addition of 0.5ml 
proteinase K (10mg/ml in sterile water). The solution was incubated at 55°C with shaking 
overnight. Equilibrated phenol (pH8.0; 10ml) was added and the solution rocked at room 
temperature for 2.5h. After centrifugation in a Sorvall SS34 rotor at 1090g, 25°C for 
10min, the aqueous layer was removed and respun in a Sorvall SS34 rotor at 9770g,
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25°C for 30min. The supernatant was dialysed against 11 of TE, pH7.8 at room 
temperature for 4h, then against 21 TE, pH7.8 at 4°C overnight. The DNA was 
precipitated with 0.1 volumes of 3M sodium acetate, pH5.5 and 0.8 volumes isopropanol. 
The solution was mixed gently and the DNA spooled out on a glass rod, washed with 
70% (v/v) ethanol and dissolved in 0.5ml TE at 4°C over a week on a rotating wheel.
Total RNA isolation
Total RNA was isolated from day 2-3 Manduca eggs using the guanidinium thiocyanate- 
phenol-chloroform extraction method (Chomczynski and Sacchi, 1987). Eggs (1g) were 
frozen and ground to a powder in liquid nitrogen, dispersed in 1 0 ml denaturing solution 
(4M guanidinium thiocyanate, 25mM sodium citrate, pH7.0, 0.5% (v/v) sarkosyl, 0.1M 2- 
mercaptoethanol), homogenised and transferred to a 30ml Corex tube. In succession, 
1ml 2M sodium acetate pH4.0, 10ml water saturated phenol and 2ml chloroform:isoamyl 
alcohol (49:1) were added to the homogenate, mixed thoroughly and the suspension 
cooled on ice for 15min. After centrifugation in a Sorvall SS34 rotor at 121 OOg at 4°C for 
2 0 min, the aqueous phase was removed, mixed with 1 0 ml isopropanol and precipitated 
at -20°C for 2h. The RNA was centrifuged as above and the pellet resuspended in 3ml 
denaturing solution. The RNA was re-precipitated with 3ml isopropanol at -20°C 
overnight. The RNA was centrifuged as above, resuspended in 10ml RNase free 75% 
(v/v) ethanol, sedimented and dried. The RNA was dissolved in 1ml RNase free 0.5% 
(w/v) SDS for 10min.
Poly [A+] RNA isolation
Poly [A+] RNA was selected using Dynabeads® oligo (dT) 25 (Dynal®). These are 
uniform, superparamagnetic polystyrene beads with a 2 .8 p,m diameter which have chains 
of deoxythymidylate, 25 nucleotides long, covalently attached to the surface of the beads 
via a 5' linker group.
An aliquot of total RNA (75pg) was heated to 65°C for 2min. 200^1 (1mg) of 
resuspended Dynabeads® oligo (dT) 25 was added to a microcentrifuge tube and 
separated from the supernatant using the Dynal MPC®-E-1 magnetic separator. The 
supernatant was removed and the beads washed with 200^1 2x binding buffer (20mM 
Tris-CI pH7.5, 1M LiCI, 2mM EDTA). The washed beads were then resuspended in 
100pl 2x binding buffer. The heated total RNA was added to the beads, mixed and left 
to hybridise at room temperature for 5min. The supernatant was removed using the 
magnet and the beads washed twice with 200pl washing buffer (10mM Tris-CI pH7.5, 
150mM LiCI, 1mM EDTA). The beads were resuspended in 16pl elution buffer (2mM
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EDTA, pH7.5), heated to 65°C for 2min and placed on the magnet. The eluted RNA was 
transferred to a new microcentrifuge tube and used directly for cDNA synthesis.
First strand cDNA synthesis
To 16fxl poly [A+] RNA was added 1 (xl oligo dT linker primer (RoRi(dT)17; sequence 5' 
G ACTACGTTAG CAT CTAG AATT CTCG AGTi 7 3'). This mixture was heated to 65°C for 
2-10min and then chilled on ice before the addition of 6 fil 5x 1st strand buffer (250mM 
Tris-CI, pH8.3, 375mM KCI, 15mM MgCI2), 3pl 0.1M DTT and 2|nl 10mM dNTPs. After 
equilibration at 37°C for 2min, 1 jj,I RNase inhibitor (40Units) and 1pl Superscript™ II 
RNase H- Reverse Transcriptase (200Units) was added, mixed gently and incubated at 
37°C for 1h.
In order to assess the size of the first strand cDNA, 1 fxl [a-32P]dCTP was added to 0.1 
volumes of the total reaction volume and incubated at 37°C for 1 h.
Second strand cDNA synthesis and circu/arisation
40(xl 5x second strand buffer (100mM Tris-CI, pH7.5, 25mM MgCI2, 50mM (NH4)2S 04, 
250^ig/ml BSA), 3|j.l 10mM dNTPs, 131.2fxl sterile water, 0.8|il RNase H (2Units/ i^l) and 
5pl DNA Polymerase I (10Units/jxl) was added to 20|xl first strand cDNA. The contents of 
the tube were mixed and incubated at 16°C for 2.5h. cDNA was extracted once with an 
equal volume of phenol:chloroform (1 :1 ) and once with an equal volume of chloroform, 
ethanol precipitated at -20°C overnight, sedimented at high speed for 1 h, washed with 
75% (v/v) ethanol, dried and resuspended in 38.5|al TE, pH8.0.
Double stranded cDNA was made blunt ended by the addition of 5pl T4 DNA 
Polymerase buffer (330mM Tris acetate, pH7.9, 660mM sodium acetate, 100mM 
magnesium acetate, 5mM DTT, 1 mg/ml BSA), 3\i\ 2mM dNTPs and 3.5^1 T4 DNA 
Polymerase (2.9Units/pJ) and incubated at 37°C for 30min. Sterile water was added to 
give a total volume of 10Ojxl and DNA extracted once with an equal volume of 
phenol:chloroform (1:1) and once with an equal volume of chloroform. DNA was ethanol 
precipitated at -20°C for 1h. After centrifugation as above, the pellet was washed with 
75% (v/v) ethanol, dried and resuspended in 792^1 sterile water.
The blunt ended cDNA was circularised with 200jxl 5x T4 DNA Ligase buffer (250mM 
Tris-CI, pH7.6, 50mM MgCI2, 25% (w/v) PEG8000, 5mM ATP, 5mM DTT) and 8 pil T4 
DNA Ligase (5Units/jnl) in a total volume of 1ml. The ligation was incubated at 16°C for
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60h. The circularised DNA was ethanol precipitated at -20°C overnight and sedimented 
as above, washed, dried and resuspended in 50pl sterile water.
Single stranded cDNA preparation
Total RNA, poly [A+] RNA and first strand cDNA were prepared from Manduca eggs as 
above. To prevent adherence of the single stranded cDNA, all plastic and glassware 
was siliconised. The RNA strand of the RNA-cDNA hybrid was hydrolysed by incubation 
of the RNA-cDNA hybrid with an equal volume of 0.3M NaOH at 37°C for 2h and 
neutralised by dropwise addition of 1M HCI; the excess oligonucleotide, RoRi(dT)i7 
removed by passage through a Sephacryl HR S-400 spin column and the single 
stranded cDNA purified once by phenol extraction and once by chloroform extraction.
2.3.2 Techniques used in the purification of nucleic acids 
Extraction of nucleic acids with phenol:chloroform
Purification of nucleic acids by phenol:chloroform extraction was routinely performed as 
described in Sambrook etal. (1989).
Concentration of nucleic acids by ethanol precipitation
Nucleic acids were concentrated by precipitation with 0.1 volumes 3M sodium acetate, 
pH4.8 and 2.5 volumes absolute ethanol at -70°C for 20min or -20°C overnight, 
centrifuged at high speed for 20min, washed in 70% (v/v) ethanol and resuspended in 
sterile water.
Purification of DNA from agarose gels
Bands of DNA were excised from agarose gels and purified using a Geneclean® II kit 
(Bio101, Inc.) as described in the manufacturer’s protocol.
Removal of short fragments of DNA
Fragments of DNA less than 100bp in size, were removed after enzymatic reactions, if 
necessary, using the High Pure PCR Product Purification Kit (Boehringer Mannheim) as 
described in the manufacturer’s protocol.
2.3.3 Techniques used in the analysis of nucleic acids 
Estimation of concentration of nucleic acid
The concentration of nucleic acid was calculated from readings of the absorbance at 
260nm on a Perkin Elmer UV/VIS Lambda 11 Spectrometer. For double-stranded DNA,
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at 260nm, 10D = 50pg/ml; for single stranded DNA and RNA, at 260nm, 10D = 40pg/ml 
and for single stranded oligonucleotides, at 260nm, 10D = 20pg/ml (Sambrook et al., 
1989). Contamination with protein was calculated using the ratio: absorbance at 260nm / 
absorbance at 280nm.
Agarose gel electrophoresis
Agarose gel electrophoresis was performed as described in Sambrook et al. (1989). 
DNA samples for agarose and low gelling temperature agarose contained 0.16 volumes 
of 6x loading buffer (0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol FF, 15% 
(w/v) Ficoll). These were loaded onto 1x TAE (see Appendix 3) gels of varying 
percentage agarose, containing 0.5pg/ml ethidium bromide. Gels were photographed 
under U.V. light using a Polaroid camera with yellow filter and Polaroid 667 black and 
white ISO 3000/36° film.
Radiolabelled cDNA samples for alkaline agarose gels contained 0.16 volumes of 6x 
alkaline loading buffer (300mM NaOH, 6mM EDTA, 18% (w/v) Ficoll, 0.15% (w/v) 
bromophenol blue, 0.25% (w/v) xylene cyanol FF). These were loaded onto 1% (w/v) 
agarose gels containing 50mM NaOH, 1mM EDTA, pH8.0. Gels were dried and 
autoradiographed at room temperature with Kodak X-Omat LS™ film.
Denaturing gels
All solutions were treated with 0.1% (v/v) DEPC at room temperature overnight and 
subsequently autoclaved to destroy RNase. RNA samples were denatured at 55°C for 
1min in 1x formaldehyde buffer (40mM MOPS, 10mM sodium acetate, 1mM EDTA, 
pH8.0), 2.2M formaldehyde, 50% (v/v) formamide, then mixed with loading buffer (50% 
(v/v) glycerol, 1mM EDTA, pH8.0, 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene 
cyanol FF) and loaded on 1% (w/v) agarose gels containing 1x formaldehyde running 
buffer and 2.2M formaldehyde. Gels were run at 90mV for 3h.
Sequencing
DNA was sequenced using the dideoxynucleotide chain termination method of Sanger et 
al. (1977), using T7 DNA Polymerase in a Sequenase™ Version 2.0 DNA Sequencing Kit 
(United States Biochemical/Amersham). Samples were electrophoresed on a 6% (w/v) 
acrylamide sequencing gel, for 2-4h at 30mA, 40W. Gels were fixed in 10% (v/v) 
methanol, 10% (v/v) acetic acid, dried and exposed to Kodak X-Omat LS™ film at room 
temperature overnight. A number of PCR products were sequenced directly on a Perkin 
Elmer ABI PRISM™ 377 DNA Sequencer.
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2.3.4 Techniques used in the manipulation of nucleic acids
Restriction digests 
Plasmid DNA digests
Plasmid DNA (up to 1pg) in sterile water, 0.1 volumes of the appropriate 10x reaction 
buffer and 1Unit/(|ng DNA) of the relevant restriction enzyme were mixed gently and 
incubated under optimal conditions of time and temperature (generally 37°C overnight). 
If necessary, 0.01 volumes of 100x BSA (10mg/ml) was also added to the digest. The 
digest was stopped by the addition of EDTA to 5mM and/or heat inactivation of the 
restriction enzyme (generally 75°C for 20min). DNA needing double digestion under 
incompatible conditions was digested with one restriction enzyme, the restriction enzyme 
inactivated, the DNA ethanol precipitated and then re-digested with the second restriction 
enzyme.
Genomic DNA digests
Genomic DNA (30pg), sterile water and 0.1 volumes of the appropriate 10x reaction 
buffer were incubated at 4°C for 4h. Restriction enzyme (30Units) was added, stirred 
gently and incubated at 37°C for 15min. Another 30Units of restriction enzyme was 
added, stirred and incubated at 37°C overnight. RNase (10Units) was also added to 
digest any remaining RNA.
Ligations
Ligations using T4 DNA Ligase
Ligations were performed with varying vectorinsert ratios (generally a 3-fold molar 
excess of vector, a 3-fold molar excess of insert and equal amounts of vector and insert). 
An optimal amount of vector (250ng), the corresponding amount of insert, 0.2 volumes 
5x T4 DNA Ligase buffer (250mM Tris-CI, pH7.6, 50mM MgCI2, 25% (w/v) PEG8000, 
5mM ATP, 5mM DTT) and 5Units T4 DNA Ligase were mixed in a minimal volume.
Blunt end ligations were incubated at room temperature overnight whereas sticky end 
ligations were incubated at 16°C overnight. Ligations were diluted 5-fold in sterile water 
before adding to competent cells.
Ligations using T4 RNA ligase
Ligation of oligonucleotide to single stranded cDNA was achieved by incubation of 1- 
2pmol of a 5' phosphorylated, 3' blocked oligonucleotide and an aliquot of purified single 
stranded cDNA with 0.1 volumes of 10x T4 RNA Ligase buffer (500mM Tris-CI, pH7.5,
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100mM MgCI2l 10mM hexamine cobalt chloride), 25% (w/v) PEG8000, 20|iM ATP, 
10(xg/ml BSA and 20Units T4 RNA Ligase at 22°C for 18h.
Basic polymerase chain reactions (PCR)
PCR amplification of receptor plasmid DNA and cDNA fragments was performed using 
oligonucleotide primers designed to specific sequences within the receptor. PCR was 
performed in a 50pl total volume, containing 0.1 volumes 10x reaction buffer (500mM 
KCI, 100mM Tris-CI, pH9.0, 1% (v/v) triton X-100), 1.5-4mM MgCI2, 0.2mM dNTPs, 1pM 
each primer and approximately 100ng DNA template. If necessary, magnesium titrations 
were performed in order to achieve the optimal amount of specific product.
Using a Perkin Elmer Cetus DNA Thermal Cycler, the template was denatured at 95- 
96°C for 5min (an hotstart reaction), 2.5Units of Taq DNA Polymerase (Promega) was 
added and generally 30-40 cycles of denaturation at 95°C for 1 min, annealing at 37-65°C 
for 1min and extension at 72°C for 1-2min commenced. The cycles were followed by a 
final extension of 72°C for 10min. Exact conditions were dependent on the annealing 
temperature and GC content of primer pairs (see calculation of annealing temperature in 
Appendix 2, part d) and the length of the template.
In some cases, the proof reading enzyme, VentR® DNA Polymerase (New England 
Biolabs) was used. Conditions were similar but used 10x reaction buffer containing 
100mM KCI, 200mM Tris-CI, pH8 .8 , 100mM (NH4)2S 04, 20mM MgS04, 1% (v/v) Triton X- 
100.
PCR amplification of genomic DNA utilised the long template DNA polymerase system 
called Expand™ (Boehringer Mannheim). Genomic DNA (250ng), 0.1 volumes of 10x 
reaction buffer (buffer 1: 500mM Tris-CI, pH9.2, 160mM (NH4)2S 0 4, 17.5mM MgCI2; 
buffer 2: 500mM Tris-CI pH9.2, 160mM (NH4)2S 04, 22.5mM MgCI2; buffer 3: 500mM Tris- 
CI, pH9.2, 160mM (NH4)2S 04, 22.5mM MgCI2, 20% (v/v) DMSO, 1% (v/v) Tween 20), 
350^iM or 500|nM dNTPs for buffer 1 or buffers 2 and 3 respectively, 300nM sense primer 
and 300nM antisense primer and 2.5Units Expand™ were incubated at 94°C for 2min 
and then subjected to 1 0  cycles of 94°C for 10s, 55°C for 30s and 6 8 °C for 1 2 min, 
followed by 2 0  cycles of the same conditions but with an extra 2 0 s for each extension 




Primers incorporating unique restriction sites resulted in PCR products that were 
digested with the appropriate restriction enzyme, re-purified and ligated into digested 
pBluescript.
PCR primers that were unable to incorporate restriction sites resulted in PCR products 
that were phosphorylated and ligated into a blunt ended, dephosphorylated vector. 
Amplified DNA was phosphorylated with the addition of 0.1 volumes 10x buffer (300mM 
Tris-CI, pH7.8, 100mM MgCI2, 100mM DTT, 5mM ATP), 0.2mM dNTPs, Klenow (5Units) 
and T4 Polynucleotide Kinase (10Units), with incubation at room temperature for 2h. 
The enzymes were heat inactivated at 70°C for 10min and the DNA extracted once with 
an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) and once with an equal 
volume of chloroform:isoamyl alcohol (24:1). The DNA was ethanol precipitated and 
resuspended in sterile water.
Vector (pBluescript) was digested with EcoRV at 37°C for 2h. Following heat inactivation 
of the enzyme at 75°C for 20min, the digested vector was dephosphorylated with 6pl calf 
intestinal alkaline phosphatase (CIAP, 1 Unit/jxl) in 10x CIAP buffer (500mM NaCI, 
100mM Tris-CI, pH7.9, 100mM MgCI2> 10mM DTT) with incubation at 50°C for 1h. The 
enzyme was inactivated with EDTA to 5mM and heat at 75°C for 10min. The DNA was 
extracted once with an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) and 
once with an equal volume of chloroform:isoamyl alcohol (24:1), ethanol precipitated and 
resuspended in sterile water.
Vector and insert were mixed in varying ratios as described under Ligations using T4 
DNA ligase.
2.3.5 Techniques used in radioactive hybridisation 
Southern blots
DNA gels were rinsed in distilled water, incubated at room temperature with shaking for 
30min in denaturation solution (1.5M NaCI, 0.5M NaOH), rinsed again in distilled water 
and incubated twice at room temperature with shaking for 15min each in neutralisation 
solution (1.5M NaCI, 0.5M Tris-CI, pH7.2, 1mM EDTA) before being transferred to 
positively charged nylon membrane.
The gel was placed on a Whatman® 3MM filter paper wick soaked in 10x SSC (see 
Appendix 3) and each side edged with parafilm to stop horizontal diffusion. Nylon
membrane was placed on the gel, covered with Whatman® 3MM filter paper and paper 
towels and a heavy weight placed on top to allow transfer overnight.
DNA was fixed on the nylon membrane by baking at 80°C for 2h.
Radiolabelling of probes
Radiolabelled DNA probes were prepared using the T7QuickPrime™ Kit (Pharmacia) 
according to the manufacturer’s protocol. Denatured DNA (50ng) was incubated with 
reaction mix, 50[xCi [a-32P]dCTP (specific activity 3000Ci/mmol; 10mCi/ml) and 4-8Units 
T7 DNA Polymerase at 37°C for 30min.
Purification of radiolabelled probes
Unincorporated radiolabel was removed from radiolabelled probes using MicroSpin™ 
columns (Pharmacia), generally of Sephacryl S-200 HR type, according to the 
manufacturer’s protocol.
Hybridisation
Blots were soaked in 2x SSC at room temperature with shaking for 5min. Blots were 
prehybridised in hybridisation solution (50% (v/v) formamide, 6 x SSC, 0.5% (w/v) SDS, 
0.2% (w/v) sodium pyrophosphate, 5x Denhardt's solution (see Appendix 3), 0.1 mg/ml 
denatured, sonicated, purified salmon sperm DNA) at 42°C, with shaking overnight. 
Purified, labelled probe was added to the blot in fresh hybridisation solution and 
hybridised with shaking at 42°C overnight. Blots were generally washed once in 2 x SSC, 
0.5% (w/v) SDS at room temperature for 5min, once in 2x SSC, 0.1% (w/v) SDS at room 
temperature for 15min and twice in 0.1x SSC, 0.5% (w/v) SDS at 37°C for 30min, 
although the exact stringency of washing was varied according to the level of 
background noise for each blot. Blots were exposed to Kodak X-Omat LS™ film with 
intensifying screens at -70°C overnight or longer.
Stripping the blot of radiolabelled probe
After each hybridisation, the blot was stripped of probe by incubation with shaking in 
0.2M NaOH at room temperature for 20min, followed by incubation with shaking in 
neutralisation solution (0.2M Tris-CI, pH7.8, 0.1x SSC, 0.1% (w/v) SDS), at 42°C for 2x 
15min.
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2.3.6 Techniques used in non-radioactive hybridisation for screening of a cDNA 
library
Plating out
E. coli XL-1 blue host cells were grown with shaking at 37°C overnight in NZY (see 
Appendix 3) supplemented with 1M MgS04 and 20% (w/v) maltose. The cells were spun 
down and resuspended in 10mM MgS04 to give an A6oo of 0.5.
Serial dilutions of the library in the bacteriophage vector, AZapll, were prepared in SM 
buffer (see Appendix 3). XL-1 blue cells (200pJ) were mixed with dilutions of the library 
(100^1) and incubated at 37°C for 30min. Controls contained XL-1 blue cells and SM 
buffer. The library was spread onto warm 1.5% (w/v) NZY agar plates (large BioAssay 
dishes of dimensions 250x250mm) using 0.7% (w/v) NZY top agarose containing the 
infected host cells at a density of 150,000 pfu/plate. Plates were incubated at 37°C. 
Sequential screens were plated at a density of 500 pfu/plate (90mm culture plates) using 
bacteriophage X eluted into SM buffer from plaques yielding a positive signal in the 
previous screen.
Plaque lifts
Duplicate plaque lifts, orientated by needle holes, were taken for each plate, the first for 
1min and the second for 5min. The DNA was denatured in 1.5M NaCI, 0.5M NaOH for 
5min and then neutralised in 0.5M Tris-CI, pH7.4, 1.5M NaCI for 5min. The filters were 
washed in 2x SSC and fixed by baking at 80°C for 2h.
Probe preparation 
Oligonucleotide 3 'tailing
Oligonucleotides were labelled with Digoxigenin (DIG) -11-dUTP using a 3' tailing 
reaction. Oligonucleotide (5|nM), was incubated with 1x reaction buffer (0.2M potassium 
cacodylate, 25mM Tris-CI, pH6.6, 0.25mg/ml BSA), 5mM CoCI2, 0.05mM DIG-11-dUTP, 
0.5mM dATP and 2.5Units/pl Terminal Transferase at 37°C for 15min. Glycogen 
(0.02mg) and EDTA to 10mM were added and the labelled oligonucleotide precipitated 
with 0.1 volumes 4M LiCI and 3 volumes absolute ethanol at -70°C for 30min. Labelled 
oligonucleotide was centrifuged at high speed for 15min, washed with 70% (v/v) ethanol, 
dried and resuspended in 20|xl sterile water.
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Random prime labelling
DNA was labelled with DIG-11-dUTP using the random prime reaction. DNA (~150fig/ml) 
was incubated with 1x hexanucleotide mixture (6.25 A26o units/ml random 
hexanucleotides, 50mM Tris-CI, pH7.2, 10mM MgCI2, 0.1 mM Dithioerythritol, 0.2mg/ml 
BSA), 1x dNTP labelling mixture (0.1 mM dATP, 0.1 mM dCTP, 0.1 mM dGTP, 0.065mM 
dTTP, 0.035mM DIG-11-dUTP, pH7.5), and 100Units/ml Klenow at 37°C for at least 1h. 
EDTA to 10mM was added and the labelled DNA precipitated as for oligonucleotide 3’ 
tailing.
Hybridisation
Filters were prehybridised in hybridisation solution (5x SSC, 1% (w/v) blocking agent, 
0.1% (w/v) N-lauroylsarcosine, 0.02% (w/v) SDS) with shaking for 2h at 45°C or 68°C for 
oligonucleotide or random primed probe respectively. Oligonucleotide probes were 
diluted to 1pmol/ml in hybridisation solution with the addition of 100pg/ml poly(A). Filters 
probed with labelled oligonucleotides were hybridised at 45°C for 3h. Random primed 
probes were diluted to 5ng/ml in hybridisation solution. Filters probed with random prime 
labelled DNA were hybridised at 68°C overnight.
Washing
Washing of the filters was carried out twice in 2x SSC, 0.1% (w/v) SDS at room 
temperature for 5min each and twice in 0.1x SSC, 0.1% (w/v) SDS at the temperature of 
the hybridisation for 15min each.
Detection
Colourimetric detection using nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl 
phosphate (X-phosphate) was carried out on oligonucleotide probed filters and random 
primed fragment c probed filters. All incubations were at room temperature with shaking. 
Filters were equilibrated in buffer 1 (100mM maleic acid, 150mM NaCI, pH7.5) for 1min 
and then blocked by shaking in buffer 2 (1% (w/v) blocking reagent in buffer 1) for 30min. 
Filters were incubated in Anti-DIG-alkaline phosphatase (150mll/ml) for 30min and 
unbound antibody removed by washing twice in buffer 1, for 15min each. After 
equilibration of the filters in buffer 3 (100mM Tris-CI, pH9.5, 100mM NaCI, 50mM MgCI2) 
for 2min, colour substrate (0.3mg/ml NBT and 0.17 mg/ml X-phosphate) was added and 
the filters incubated in the dark overnight. The reaction was stopped by washing the 
filters in buffer 1.
Chemiluminescent detection using Lumigen™ PPD [4-methoxy-4-(3-phosphate-phenyl)- 
spiro(1,2-dioxetane-3,2'-adamantane) disodium salt] was performed on oligonucleotide
probed filters and random primed DNA probed filters. Filters were incubated as above 
except Lumigen™ PPD (0.235mM) was substituted for colour substrate. Following a 
5min incubation in Lumigen™ PPD, the filters were incubated at 37°C for 15min and 
exposed to Kodak X-Omat LS™ film at room temperature for 15min to overnight.
After detection, duplicated positive signals that corresponded to plaques, were picked 
from the corresponding plate and eluted into SM buffer.
2.3.7 Oligonucleotides
In house synthesis and deprotection of oligonucleotides
Oligonucleotides were synthesised on an Applied Biosystems 381A DNA Synthesiser 
using chemicals supplied by Cruachem, Glasgow, U.K. Oligonucleotides were 
deprotected with ammonia solution of Analar grade at 55°C for 6h. The ammonia was 
neutralised with glacial acetic acid and the oligonucleotide precipitated with absolute 
ethanol. The precipitated oligonucleotide was spun, washed, dried and resuspended in 
1ml sterile water. The absorbance at 260nm was taken and the oligonucleotide diluted 
to a working stock solution of 20fiM.
Radiolabelling of oligonucleotides
Oligonucleotides at 2\M  were radiolabelled with 5pCi [y-32P]ATP (specific activity 
3000Ci/mmol; 10mCi/ml) and 10Units T4 Polynucleotide Kinase in 0.1 volumes of 10x 
buffer (300mM Tris-CI, pH7.8, 100mM MgCI2, 100mM DTT, 5mM ATP) at 37°C for 30min. 
The enzyme was inactivated with EDTA, pH8.0 to 5mM and 1 volume of sequencing stop 
dye (95% (v/v) formamide, 20mM EDTA, 0.05% (w/v) xylene cyanol FF) was added. The 
radiolabelled oligonucleotide was heated at 80°C for 3min and electrophoresed on a 12% 
(w/v) acrylamide sequencing gel for 1h at 30mA, 40W. The gel was immediately 
exposed to Kodak X-Omat LS™ film at room temperature for 15-30min.
69
2.4 Results
2.4.1 Screening of the cDNA library
The first step in isolating both the missing N-terminus and a full-length clone of MARA1 
and/or identifying any other a-like subunits, was a library screen using a cDNA library 
made from pupal Manduca brain.
2.4.1.11nitial characterisation of the cDNA library
PCR on the Manduca library
In order to confirm the presence of an a-like subunit of the Manduca nAChR in the 
library, specific primers were designed from regions of the sequence from fragment c. 
The primer sense 1, with the sequence 5' AACAATGCTGACGGCAACTTT 3' was 
designed to the predicted extracellular region (nucleotide positions 79-99 on fragment c) 
and the primer antisense 1, with the sequence 5' GGACAGCGATACCTTCTC 3' was 
designed to the putative second transmembrane domain (nucleotide positions 544-561 
on fragment c) as shown in Appendix 2 parts a and c. These sequences were used as 
comparison with other insect a-like sequences (see alignment, Figure 2.36) indicated a 
high degree of homology between a-like subunits for these particular regions. Thus it 
was assumed, that if MARA1 was not found, another a-like subunit might be present. 
PCR as described in section 2.3.4, resulted in the amplification of a fragment of 
approximately the expected size of 483bp (Figure 2.1), suggesting that an a-like subunit 
of the nAChR probably corresponding to the sequence of MARA1 was present in the 
library.
Calculating the library titre
In order to determine the density of plaques needed for screening, the library titre was 
measured by plating out the library, as described in section 2.3.6. The titre of the cDNA 
library was calculated to be 5.76 x 109 pfu/ml.
Determining the range of insert size
In order to assess the range of insert size, plaques were picked at random and used in 
PCR with the pBluescript primers T3 (sense) and T7 (antisense) (sequences: 5' 
ATTAACCCTCACTAAAG 3' and 5' AATACGACTCACTATAG 3' respectively). PCR 
resulted in insert sizes ranging from 500bp to 2000bp as shown in Figure 2.2, indicating 
the presence of relatively large cDNA clones in the library.
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2.4.1.2 Results of the cDNA library screen
Identification of positive plaques
The Digoxigenin (DIG) non-radioactive method was used to screen the Manduca cDNA 
library, in order to find a full-length cDNA encoding MARA1. Primers specific to the 
MARA1 sequence (sense 1 at nucleotide positions 79-99 of fragment c and antisense 1 
at positions 544-561 of fragment c; see Appendix 2, parts a and c) were labelled with 
DIG-11-dUTP by the 3' tailing technique. The efficiency of labelling was checked by 
colour detection and this revealed detection at 4fmol/pl. Consequently, both primers 
were used in separate solutions for hybridisation to plaque lifts. Colourimetric detection 
was applied to the lifts using NBT and X-phosphate. The primary screen resulted in a 
number of positive signals, of which only one was present in duplicate. The plaques 
were picked from the corresponding region on the plate and taken through a secondary 
screen which did not result in any positive signals.
The partial length cDNA, fragment c, was labelled with DIG-11-dUTP using the random 
prime technique. The efficiency of labelling was checked by colour detection. Fragment 
c was detected at a concentration of 25pg/pl. The library was screened again using the 
random primed fragment c and colour detection but did not result in any positive signals.
The labelling efficiency of the random primed fragment c was then assessed by 
chemiluminescent detection and fragment c was detected at a concentration of 
0.002pg/|uJ. The library screen was repeated again. A total of 900,000 plaques were 
screened using random primed fragment c and chemiluminescent detection. Several 
plaques corresponding to positive signals were picked from the primary screen, however 
these positive signals were not in duplicate. Sequential screens did not result in any 
duplicated signals.
Approximately 1.5 million plaques were screened in total and no duplicated positives 
were found. A control using fragment c dotted onto a membrane was successful, thus 
indicating that a technically correct labelling and detection procedure was being applied. 
A number of variables, such as altering the hybridisation temperature and also the 
stringency during washing were altered but these did not affect the outcome.
Nested PCR on the Manduca cDNA library
In order to facilitate finding the full-length cDNA, nested PCR on the library was 
performed. For the missing N-terminus to be amplified, primary and secondary reactions
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utilised primers designed from fragment c and from the library vector AZapll, as shown in 
Figure 2.3.
Figure 2.3. Nested PCR on Manduca 
cDNA library. (Not to scale).
1. Primary round of amplification with outer 
primers (1) designed from XZapll (sense) and 
fragment c (antisense 1, see Appendix 2), 
using 35 cycles of 95°C for 1min, 45°C for 
1 min and 72°C for 2min.
2. Product diluted 1 in 100 in sterile water.
3. Secondary round of amplification with inner 
pair of primers (2) designed from AZapll 
(sense T3) and fragment c (antisense 2, see 
Appendix 2), using 35 cycles of 95°C for 1min, 
55°C for 1min and 72°C for 2min.
The outer pair of primers designed from AZapll (sense), with the sequence 5' 
AACAGCTATGACCATG 3', and fragment c (antisense 1 at nucleotide positions 544-561 
of fragment c; see Appendix 2, parts a and c) with the sequence 5’ 
GGACAGCGATACCTTCTC 3’ were used in a primary amplification, the product from 
which was diluted 1 in 100 in sterile water and subjected to a secondary amplification 
with the inner pair of primers, from XZapW, T3 (sense) with the sequence 5’ 
ATTAACCCTCACTAAAG 3’ and from fragment c (antisense 2 at positions 313-336 of 
fragment c; see Appendix 2, parts a and c) with the sequence 5' 
AAACTCGGAGAGGTCGACGCCCAA 3'. Amplification of the missing N-terminus from 
the cDNA library resulted in a fragment of approximately 600bp that was smaller than the 
band of approximately 700bp (calculated size: 697bp) for the positive control, fragment c 
in the primary round and in a fragment of approximately 400bp (calculated size: 421 bp) 
in the secondary round which was the same size as the band for the positive control, 
fragment c (Figure 2.4). Although, this cDNA was not sequenced, the results suggested 
that the library contained only truncated cDNA encoding a partial length a-like subunit 
corresponding to MARA1 and consequently was of no use.
As the library screen did not result in additional sequence information, methods based on 












Figure 2.1. PCR on the Manduca cDNA library to 
confirm the presence of an a-like subunit in the 
library. cDNA, PCR reaction mix (as described in section 2.3.4) 
and primers (described in section 2.4.1.1) were incubated at 
95°C for 5min, 2.5Units of Taq DNA Polymerase was added and 
the mix subjected to 35 cycles of 95°C for 1min, 48°C for 1min 
and 72°C for 2min. Products were analysed on a 1% (w/v) 
agarose gel. Lane 1, 100bp ladder (sizes in bp); lane 2, library 
cDNA amplified with both sense and antisense primers; lane 3, 
negative control of library cDNA amplified with sense primer only; 
lane 4, negative control of library cDNA amplified with antisense 
primer only; lane 5, positive control of fragment c amplified with 
both sense and antisense primers. Lane 2 shows faint band of ~ 
500bp corresponding to band amplified in positive control.
Figure 2.2. PCR on
randomly picked plaques 
from the library screen to 
determine range of insert 
size. Plaques, PCR reaction 
mix (as described in section 
2.3.4) and primers (described in 
section 2.4.1.1) were incubated 
at 95°C for 5min, 2.5Units of 
Taq DNA Polymerase was
added and the mix subjected to 
30 cycles of 95°C for 1 min, 55°C 
for 1min and 72°C for 1min. 
Products were analysed on a 
1% (w/v) agarose gel. Lanes 1- 
10 show PCR products ranging 
from 500bp to 2000bp; lanes 
11-13, negative controls; lane 14, positive control of fragment c in pBluescript, expected size of band
~1600bp which was not revealed on the gel; lane 15, X DNA digested with Pstt (sizes in bp).
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Figure 2.4. Nested PCR on the Manduca 
cDNA library. The primary round of 
amplification with outer primers designed from 
XZapll (sense) and fragment c (antisense 1, see 
Appendix 2), used 35 cycles of 95°C for 1min, 45°C 
for 1min and 72°C for 2min. The resulting PCR 
product was diluted 1 in 100 in sterile water and 
used in a secondary round of amplification. The 
secondary round of amplification with inner pair of 
primers designed from XZapll (sense T3) and 
fragment c (antisense 2, see Appendix 2), used 35 
cycles of 95°C for 1min, 55°C for 1min and 72°C for 
2min. Products were analysed on a 1% (w/v) 
agarose gel. Lanes 1 and 2, positive controls 
using fragment c in outer and inner rounds of 
amplification; lanes 3 and 4 library cDNA amplified 
with both sense and antisense primers in outer and 
inner rounds of amplification; lanes 5-9, negative 
controls (5, no cDNA; 6-9, either sense or 
antisense primer with library cDNA only, outer 
followed by inner rounds of amplification); lane 10, 
100bp ladder (sizes in bp). Lane 3 (experimental) shows band ~100bp smaller than that from positive control 





2.4.2 Inverse PCR on double stranded, circularised cDNA
A PCR based strategy which used inverse PCR on double stranded, circularised cDNA 
(Towner and Gartner, 1992) was attempted. This involved the isolation of total RNA and 
poly [A+] RNA from Manduca, the latter subsequently being used for the synthesis of first 
strand cDNA. This in turn, was used to synthesise double stranded cDNA which was 
circularised and used as a template in inverse PCR. This inverse PCR strategy is shown 
in Figure 2.5. RNA was isolated from day 2-3 eggs, as transcription levels of nAChRs in 
insects are particularly high in late embryos and in late pupae, i.e. during periods of 
terminal differentiation and synapse formation in the CNS (Sanes et al., 1977; 
Hildebrand et al., 1979; Hermans-Borgmeyer et al., 1986). Also, eggs were used rather
Figure 2.5. Inverse PCR on double 
stranded, circularised cDNA 
(adapted from Towner and Gartner, 
1992). (Not to scale).
1.Guanidinium thiocyanate phenol 
chloroform extraction of total RNA (see 
section 2.3.1).
2. Dynabead® extraction of poly [A+] RNA 
(see section 2.3.1).
3. 1st strand cDNA synthesis using 
Superscript™ II RNase H- RT (see section
2.3.1).
4. 2nd strand cDNA synthesis using DNA 
Polymerase I; RNA degradation using 
RNase H (see section 2.3.1).
5. Formation of blunt ends using T4 DNA 
Polymerase; circularisation using T4 DNA 
Ligase (see section 2.3.1).
6. Inverse PCR using primer sense 2 (see 
Appendix 2) to 3’ end and primer
antisense 3 (see Appendix 2) to 5’ end. cDNA, PCR reaction mix (see section 2.3.4) and primers were 
incubated at 95°C for 5min, 2.5Units of Taq DNA Polymerase added and 30 cycles of 95°C for 1min, 55°C 
for 1min and 72°C for 1min were completed.
For inverse PCR, a sense primer was designed from the 3' end of fragment c shortly 
before the poly [A+] tail (sense 2 at nucleotide positions 1601-1624 of fragment c; see
than pupae due to ease of collection.
MANDUCA  EGGS 
TOTAL RNA 5’
POLY [A+] RNA 5’ A„ 3’
1st STRAND CDNA 3’
A„ 3’
T17GAG...CAG 5’












Appendix 2, parts a and c) and an antisense primer was designed from the 5' sequence 
of fragment c shortly before the N-terminus (antisense 3 at nucleotide positions 67-90 of 
fragment c; see Appendix 2, parts a and c). The primer sequences were, sense 2, 5' 
ACGAAATAAAATGATCGTTTGTAT 3' and antisense 3, 5'
GTCAGCATTGTTGTAAAGCACGAT 3'.
2.4.2.1 Analysis of preparative steps and inverse PCR products
The total RNA isolated was analysed on a denaturing gel (see section 2.3.3) which 
revealed one bright band of rRNA (RNA markers indicated that the Manduca rRNA was 
between 1.35 and 2.37 kb) as normally found in Manduca (Fujiwara et al., 1995; A.Wang 
- personal communication). The concentration of total RNA was 1.5mg/ml, with an 
A260/A280 of 1-85.
Analysis of first strand synthesis by incorporation of radiolabel showed first strand cDNA 
ranging in size from 500bp to 7kb (Figure 2.6).
Analysis of the inverse PCR by agarose gel electrophoresis and ethidium bromide 
staining (see section 2.3.3) did not reveal any bands of the anticipated size (300bp) as 
estimated from comparison of fragment c with full-length a-like subunits from other 
insects (see alignment, Figure 2.36). In an attempt to isolate the 5' end, a slice of the gel 
that would contain DNA products ranging in size from 200-400bp was excised from the 
gel. This DNA was purified with Geneclean® II and ethanol precipitated at -20°C 
overnight as described in section 2.3.2. After resuspending the DNA in 10pl sterile 
water, the DNA was re-amplified in a PCR using the same sense and antisense primers 
but with 40 cycles. This resulted in a band of DNA of approximately 200bp as shown in 
Figure 2.7 which was excised, purified and subcloned into pBluescript for sequencing, as 
described in section 2.3.4.
2A.2.2 Sequencing analysis of inverse PCR product
The nucleotide and corresponding amino acid sequence results for the inverse PCR 
product are shown in Figure 2.8. Analysis of the sequence data using the gcg program 
Fasta (Pearson and Lipman, 1988) showed high sequence identity between the inverse 
PCR product and insect a-like subunits of the nAChR (Figure 2.9) indicating that the 
inverse PCR product was an a-like subunit of the nAChR. Hereinafter, this inverse PCR 
product is called fragment b.
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1 2
Figure 2.6. Analysis of first strand cDNA synthesised from RNA isolated from Manduca 
eggs. 1pl [a-32P]dCTP was added to 0.1 volumes of the total 1st strand cDNA reaction volume 
and incubated at 37°C for 1h. The cDNA was run on an alkaline agarose gel and exposed to 
Kodak X-Omat LS™ film. Lane 1, X DNA digested with H/ndlll (sizes in bp); lane 2, 1st strand 
cDNA ranging in size from 500bp to 7kb.
Figure 2.7. Inverse PCR on double stranded, circularised cDNA. cDNA, PCR reaction mix 
(as described in section 2.3.4) and primers sense 2 and antisense 3 (see Appendix 2) were 
incubated at 95°C for 5min, 2.5Units of Taq DNA Polymerase added and 40 cycles of 95°C for 
1min, 55°C for 1min and 72°C for 1min were completed. Products were analysed on a 1% (w/v) 
agarose gel. Lane 1, X DNA digested with Psfl (sizes in bp); lane 2, double stranded, circularised 
cDNA amplified with both primers, lanes 3-5, negative controls (3, no cDNA; 4 and 5, one primer 
only). Lane 2 shows band of ~200bp.
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1 ACGAAATAAAATGATCGTTTGTATAATATTGCAAATTCGAATTTGCGTGAATCGAAAAT.A 60
61 CGA GCGA GCT GAG C CAGCT CAT C GAC GT GAAT CT CAAGAAT CAAAT AAT GAC AAC CAAT C 120
37 L S Q L I D V N L K N Q I M T T N L  54
121 TATGGGTGGAACAGAGCTGGTACGACTACAAGCTTTCGTGGGAGCCGCGCGAGTACGGCG 180
55 W V E Q S W Y D Y K L S W  E P R E Y G G 74
181 GCGTGGAAATGCTGCACGTGCCTTCCGACCACATCTGGCGGCCCGACATCGTGCTTTACA 240
75 V E M L H V P S D H I W R  P D I V L Y N 94
241 ACAATGCTGA 250
95 N A D 97
Figure 2.8. Nucleotide and amino acid sequence of fragment b. Amino acids that are 
underlined represent overlap with fragment c. PCR artifact in italics (see text).
Fragment b is 250bp in length. The first 24bp of fragment b denote the sequence for the 
primer sense 2, however, the following 44bp appear to be a PCR artifact. Logically, any 
sequence appearing after the sense primer should be poly [A] tail, as the poly [A] tail 
signal cleavage site, AATAAA is present 20 nucleotides upstream from the poly [A] tail in 
fragment c (see Appendix 2). Possibly, this sequence is due to mis-ligation of the blunt 
ended double stranded cDNA during circularisation. The coding sequence representing 
the a-like subunit is 182bp (61 amino acid residues) long, of which 93bp (31 amino acid 
residues) are novel data as fragment b overlaps with fragment c, the original partial 
length sequence by 89bp (30 amino acid residues). This expansive overlap supports the 
assumption that fragment b and fragment c are part of the same a-like subunit, namely 
MARA1. Furthermore, this strongly suggests that this a-like subunit of the nAChR in 
Manduca is found in both the embryonic and pupal stages, justifying the decision to use 
material from Manduca eggs (the embryonic stage) for the inverse PCR strategy whilst 
material from the pupal stage had been used to isolate fragment c and was used in the 
library screen above. Additional sequencing (throughout regions of the sequence only 
discernable as compressions on a sequencing gel) replaced the initial amino acid residue 
in fragment c, an arginine (Clarke, 1991), with a glutamate.
Despite sequencing five more clones in both directions, no further 5' sequence could be 
isolated. Although some of the missing N-terminus of MARA1 had been found, an 
estimated 171-231 bp (or 57-77 amino acid residues) by comparison with Drosophila and 
Schistocerca a-like subunits remained elusive (see alignment, Figure 2.36).
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1)S. gregaria mRNA for neuronal nicotinic acetylcholine receptor 
(aLl/ARL2)
ACCESSION NUMBER X55439 
74.7% identity in 182 bp overlap
40 50 60 70 80 90
frag b GAATTTGCGTGAATCGAAAATACGAGCGAGCTGAGCCAGCTCATCGACGTGAATCTCAAG
I I I  I I I I I I I I I I I I I I I I I I I I I I
ARL2 GACACGGTGCTCGTCAAGCTGGGCCTGCGCCTGTCGCAGCTCATCGACCTGAATCTGAAG 
170 180 190 200 210 220
100 110 120 130 140 150
frag b AATCAAATAATGACAACCAATCTATGGGTGGAACAGAGCTGGTACGACTACAAGCTTTCG
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
ARL2 GATCAGATCCTTACCACCAACGTCTGGTTGGAGCACGAATGGCAGGACCACAAGTTCCGA 
230 240 250 260 270 280
160 170 180 190 200 210
frag b TGGGAGCCGCGCGAGTACGGCGGCGTGGAAATGCTGCACGTGCCTTCCGACCACATCTGG
I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I
ARL2 TGGGACCCGGCGGAGTACGGAGGCGTGACGGAGCTGTACGTCCCTTCGGAGCACATCTGG 
290 300 310 320 330 340
220 230 240 250
frag b CGGCCCGACATCGTGCTTTACAACAATGCTGA 
I I I I I I  I I I  I I I I  I I  I I I I I I I I I I I I I 
ARL2 CTGCCCGACATCGTCCTGTACAACAACGCTGACGGCGAGTACGTGGTCACGACCATGACT 
350 360 370 380 390 400
2)D.melanogaster Dalpha2 mRNA for nicotinic acetylcholine receptor 
(Da2/SAD)
ACCESSION NUMBER X52274
72.7% identity in 183 bp overlap
40 50 60 70 80 90
frag b CGAATTTGCGTGAATCGAAAATACGAGCGAGCTGAGCCAGCTCATCGACGTGAATCTCAA
I I I  I I I  I I I I I I I I I I I I I I I I I I 
SAD GGACACGGTGTTGGTCAAATTGGGCCTACGGCTCTCCCAACTCATCGATTTGAATCTCAA 
700 710 720 730 740 750
100 110 120 130 140 150
frag b GAAT CAAAT AAT GACAACCAAT CTAT GGGT GGAACAGAGCT GGTACGACTACAAGCTTT C 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I 
SAD AGAT CAAATT CTAACCACCAACGT GT GGCT GGAGCAC GAAT GGCAGGAT CATAAATT CAA 
760 770 780 790 800 810
160 170 180 190 200 210
frag b GTGGGAGCCGCGCGAGTACGGCGGCGTGGAAATGCTGCACGTGCCTTCCGACCACATCTG
I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I 
SAD GT GGGATCCCTCGGAGTAT GGCGGCGT CACAGAGCTTTAT GT GCCATCCGAGCACAT CTG
820 830 840 850 860 870
Figure 2.9. Alignment of part of fragment b with part of the sequences encoding aL1 
(ARL2) from Schistocerca and Da2/SAD from Drosophila. These two sequences represent the 
highest nucleotide identities obtained from searching the Genbank and EMBL databases using the 
gcg program Fasta (Pearson and Lipman, 1988).
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2.4.3 Ligation anchored PCR
A second PCR based method utilising a modification of the RACE method (rapid 
amplification of cDNA ends; see section 2.1; Frohman et al., 1988) and termed ligation 
anchored PCR was attempted. In this a single stranded oligonucleotide (the anchor) was 
ligated to the 3' end of the first strand cDNA, with T4 RNA Ligase. A ligation anchored 
PCR based on a combination of methods adapted from Tessier et al. (1986), Edwards et
al. (1991) and Troutt et al. (1992) was used. The ligation anchored PCR strategy is
shown in Figure 2.10.
Figure 2.10. Ligation anchored PCR 
on first strand cDNA. (Not to scale).
1.Guanidinium thiocyanate phenol 
chloroform extraction of total RNA (see 
section 2.3.1).
2. Dynabead® extraction of poly [A+] RNA 
(see section 2.3.1).
3. 1st strand cDNA synthesis using 
Superscript™ II RNase H- RT (see section
2.3.1).
4. Degradation of RNA with NaOH; removal 
of excess oligo(dT) with Sephacryl spin 
column (see section 2.3.1).
5. Ligation of anchor oligonucleotide to 
single stranded cDNA using T4 RNA Ligase 
(see section 2.3.4).
6. PCR using sense primer specific to 
anchor and primer antisense 4 specific to 
fragments b and c (see Appendix 2). cDNA, 
PCR reaction mix (see section 2.3.4) and 
primers were incubated at 95°C for 5min,
2.5Units of Taq DNA Polymerase added and 40 cycles of 95°C for 1min, 55°C for 1min and 72°C for 1min 
were completed.
The anchor oligonucleotide was designed to incorporate a T3 promoter sequence for
direct in vitro transcription of the PCR product and the restriction sites Not\ and EcoRI for
easy cloning of the PCR product. The anchor oligonucleotide sequence (5' 
TTTAGTGAGGGTTAATAAGCGGCCGCACGTGAATTCGTACCTAC 3’) was analysed for 
homology with other sequences using the Genbank and EMBL databases on the gcg 
program Fasta (Pearson and Lipman, 1988), it being imperative to avoid sequences that 
might anneal with the cDNA. The anchor oligonucleotide was synthesised with a
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POLY [A+] RNA 6’ ------------------------------------------- A„ 3’
3 I
5---------------------------------------------A„ 3'
1st STRAND cDNA 3’ ------------------------------------------- T17GAG...CAG 5’
4
SINGLE STRANDED
cDNA * ’ --------------------------------------------- T17GAG...CAG 5'
5
LIGATION
3’ HjN----------- P 04 S' 3’ --------------------------------------------- T17GAG...CAG 5’
PCR
sense antisense
phosphoramidite group blocking the 3' end and checked by radiolabelling. After HPLC 
purification, 100pmol of anchor oligonucleotide was phosphorylated by incubation with 
0.1 volumes of 10x T4 Polynucleotide Kinase buffer, 1mM ATP and 20Units T4 
Polynucleotide Kinase at 37°C for 30min, in order for the anchor oligonucleotide to be 
ligated to the single stranded cDNA as described in sections 2.3.1 and 2.3.4.
PCR on the ligated anchor oligonucleotide and the single stranded cDNA used a sense 
primer to the anchor oligonucleotide (5' GCGGCCGCTTATTAACCCTCACTAAA 3') and 
the primer antisense 4 (5' TGTCATTATTTGATTCTTGAGATTCAC 3'; nucleotide 
positions 226-228+340-363 of fragment a, see Appendix 2, parts b and c) or the same 
sense primer and antisense 3 (5’ GTCAGCATTGTTGTAAAGCACGAT 3’; nucleotide 
positions 67-90 on fragment c, see Appendix 2, parts a and c).
Agarose gel analysis of the PCR products, as shown in Figure 2.11 did not result in any 
bands of the appropriate size, i.e. approximately 242-302bp for the anchor sense primer 
and antisense 4 primer and approximately 380-440bp for the anchor sense primer and 
antisense 3 primer, by comparison with sequence data from other insect a-like subunits 
(see alignment, Figure 2.36).
Following the dearth of sequence data obtained using PCR methods involving the 
synthesis of cDNA, an approach utilising genomic DNA was attempted.
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Figure 2.11. Ligation anchored PCR. PCR using sense primer specific to anchor and primer 
antisense 4 specific to fragments b and c (see Appendix 2). cDNA, PCR reaction mix (see section 
2.3.4) and primers were incubated at 95°C for 5min, 2.5Units of Taq DNA Polymerase added and 
40 cycles of 95°C for 1min, 55°C for 1min and 72°C for 1min were completed. Lane 1, ligation mix 
amplified with both sense and antisense primer; lanes 2, 3 and 4, negative controls (no cDNA, one 
primer only); lane 5, 100bp ladder (sizes in bp). No bands in lane 1 are visible.
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2.4 4 Inverse PCR on circularised, genomic DNA
An inverse PCR strategy on genomic DNA was attempted using a method adapted from 
Forster et al. (1994). This is shown in Figure 2.12. Succinctly, genomic DNA was 
digested with restriction enzymes that had only one restriction site in the N-terminal of 
fragments b and c. DNA fragments which hybridised to a partial fragment from the 5' 
end of fragment c, indicating restriction sites in the genomic DNA within a relatively short 
distance of the current 5' end (i.e. within 3kb), were circularised by self ligation and used 


















Figure 2.12. Inverse PCR on genomic 
DNA. (Not to scale).
1. Preparation of genomic DNA (see section 
2.3.1).
2. Genomic DNA digested with HincU 
restriction enzyme (see section 2.3.4).
3. Circularisation using T4 DNA Ligase.
4. Inverse PCR using primer sense 4 to 
sequence shortly before unique HincH 
restriction site and primer antisense 3 to 5’ 
end of fragment c (see Appendix 2). 
Genomic DNA (2pl), PCR reaction mix (see 
section 2.3.4) and primers were incubated 
at 95°C for 5min, 2.5Units of Taq DNA 
Polymerase added and 35 cycles of 95°C 
for 1min, 55°C for 1min and 72°C for 1min 
were completed.
unknown a-like subunit 
genomic sequence
2.4.4.1 Analysis of the genomic DNA
The genomic DNA was analysed on a 0.5% (w/v) agarose gel with a 1% (w/v) support 
and the A 26o/A28o taken. The genomic DNA concentration was calculated to be 0.5pg/pl.
Restriction digests on the genomic DNA using a number of enzymes that cut near to the 
N-terminal of fragments b and c were performed in order to deduce which enzyme would 
be most appropriate for the subsequent digestion and circularisation of the genomic 
DNA. The enzymes Seal, Bg/ll, XhoW, HincU and Xba\ were used. Control digests using
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rat genomic DNA were included. Samples were ethanol precipitated and resuspended in 
20pl sterile water. The digests were analysed on a large 0.6% (w/v) agarose gel, as 
shown in Figure 2.13, the DNA denatured and transferred to positively charged nylon 
membrane by Southern blotting as described in section 2.3.5. The probe (a partial 
length fragment from the 5' end of fragment c, excised from fragment c at the unique 
XbaI restriction site) was prepared and labelled with [a-32P]dCTP and the blot 
prehybridised, hybridised, washed and exposed to film as described in section 2.3.5.
Bands between 2kb and 6kb were observed in lanes with Manduca genomic DNA 
digested with Bgl\\, XhoW, HincW and Xba\ as shown in Figure 2.14. Generally, this 
indicated restriction sites within approximately 4kb of the 5' end of fragments b and c. 
For the rat genomic DNA control, only DNA digested with H/ndlll produced an obvious 
band.
2A.4.2 Inverse PCR on digested, circularised genomic DNA
Each of the successful enzymes (40Units) were used in repeat digestions of genomic 
DNA (20pg), as above. The digested DNA was ethanol precipitated and the washed, 
dried DNA resuspended in 792pl sterile water. The digested genomic DNA was 
circularised as described in section 2.3.1, Second strand cDNA synthesis and 
circularisation.
The primer antisense 3, (at nucleotide positions 67-90 of fragment c; see Appendix 2, 
parts a and c) which had been previously designed to the 5' end of fragment c (sequence 
5’ GTCAGCATTGTTGTAAAGCACGAT 3’) and a different sense primer for each 
digestion, corresponding to a sequence shortly before the unique restriction site were 
used in inverse PCR on the genomic DNA. These were for Xba I, sense 3 (sequence 5' 
AAGTTCTACACGTGCTGCGAC 3'; at nucleotide positions 388-408 of fragment c; see 
Appendix 2, parts a and c), for HincW, sense 4 (sequence 5' 
GTGCGAGGCACCAACGTCGTG 3'; at nucleotide positions 289-309 of fragment c; see 
Appendix 2, parts a and c) and for Xho\\/Bgl\\ sense 5 (sequence 5' 
AAGTTTGGCTCGTGGACCTAC 3'; at nucleotide positions 232-253 of fragment c; see 
Appendix 2, parts a and c). PCR resulted in bands on an agarose gel for the Xba I and 
HincW circularisations of approximately 200bp and 600bp respectively (the result using 
HincW is shown in Figure 2.15). The bands were excised, purified and subcloned into 





Figure 2.13. Genomic DNA digests. Genomic DNA 
from Manduca was digested with restriction enzymes 
and the products analysed on a 0.6% (w/v) agarose 
gel. Lane 1, X DNA digested with H/ndlll (sizes in bp), 
lanes 2-6, Manduca genomic DNA digested with Seal, 
BglW, XhoW, HincW and Xba\ respectively, lanes 7-9, rat 
genomic DNA digested with H/ndlll, EcoRI and Psfl 
respectively.
WELLS
2 3 4 5 6
2322
2027
Figure 2.14. Southern blot of 
Manduca genomic DNA. Genomic 
DNA digests were run on an agarose 
gel, Southern blotted and the blot 
hybridised with a radiolabelled probe of 
fragment c (see text). Lane 1, X DNA 
digested with H/ndlll (sizes in bp), lanes 
2-6, Manduca genomic DNA digested 
with Sea I, BglW, XhoW, HincW and Xba\ 
respectively, lanes 7-9, rat genomic 
DNA digested with H/ndlll, EcoRI and 
Pst\ respectively. Bands between 2kb 
and 6kb shown in lanes with Manduca 
genomic DNA digested with BglW, 
XhoW, HincW and Xbal.
Figure 2.15. PCR on HincW digested and circularised 
genomic DNA from Manduca. Genomic DNA, PCR reaction 
mix (see section 2.3.4) and primers (see section 2.4.4.2) were 
incubated at 95°C for 5min, 2.5Units of Taq DNA Polymerase 
added and 35 cycles of 95°C for 1min, 55°C for 1min and 72°C 
for 1min were completed. Lanel, 100bp ladder (sizes in bp), 
lane 2, genomic DNA amplified with sense and antisense 
primers, lanes 3 and 4, negative controls, genomic DNA 




The PCR product resulting from inverse PCR on HincW digested and circularised 
genomic DNA resulted in the following nucleotide and amino acid sequence (Figure 
2.16). Analysis using the gcg program Fasta (Pearson and Lipman, 1988) showed 
identity with a-like subunits of the nAChR (Figure 2.17). Hereinafter, this sequence is 
called fragment a.
1 GTGCGAGGCCCAACGTGTGGAGTTGGGCGTCAACTCATGCGGAGTGTGACAAAATATTAC 60 
-21 M R S V T K Y Y  -14
61 TTACATGGTGTTGTTTTGTTTGCGACAGGATGTGCCGGCAACCCCGACGCGAAGCGGCTG 120 
-13 L H G V V L  F A T G C A G N  P D A K R L  7
121 TACGACGATCTGCTCAGCAATTACAACAAGTTGGTGCGGCCTGTACTCAACGTCAGCGAC 180 
8 Y D D L L S N Y N K L V R P V L N V S D  27
181 GCGCTCACCGTGCGCATCAAGCTCAAGCTGAGCCAGCTCATCGACGTGGTCAGCCGCCTT 240 
2 8 A L T V R I K L K L S Q L I D V  43
241 TAA CA CAAAAACGTCACAA TCACTAGTTCTTA CAA TA TCA TA CTGGAA TCGTTGCAA TAA 300
301 TAA TAGCAA TAGTTTAACATTGTAA TA TAA TTGTTGCAGAAT CT CAAGAAT CAAATAAT G 360 
44 N L K N Q I M  50
361 ACAACCAATCTATGGGTGGAACAGGTTAGTCTCATTGTGTATGTGTTTGCACGATTATTG 420 
5 1 T T N L W V E Q  58
421 CAAGTTTGCATACAGTTTTTCTAGTAGCTATTGTGTTATTCGCAGAGCTGGTACGACTAC 480 
59 S W Y D Y 63
481 AAGCTTTCGTGGGAGCCGCGCGAGTACGGCGGCGTGGAAATGCTGCACGTGCCTTCCGAC 540 
64 K L S W E P R E Y G G V E M L H V P S D  83
541 CACAT CTGGCGGCCC GACAT C GT G C T T TACAACAAT G CT GAC 582
84 H I W R P D I V L Y N N A D  97
Figure 2.16. Nucleotide and amino acid sequence of fragment a. Intronic sequences are 
shown in italics. Sequence which overlaps with fragment c is underlined.
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1 )D. melanogaster mRNA for nicotinic acetylcholine receptor alpha­
like subunit (ALS)
ACCESSION NUMBER X07194
64.0% identity in 150 bp overlap
50 60 70 80 90 100
frag a ACAAAATATTACTTACATGGTGTTGTTTTGTTTGCGACAGGATGTGCCGGCAACCCCGAC
I I I I I I I I I I I I I I I I I I I
ALS CTATTCGCAGCTGTATTCATAGCATTACACTTTGCCACCGGCGGCCTGGCCAACCCAGAT 
1300 1310 1320 1330 1340 1350
110 120 130 140 150 160
frag a GCGAAGCGGCTGTACGACGATCTGCTCAGCAATTACAACAAGTTGGTGCGGCCTGTACTC
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
ALS GCGAAGCGACTCTACGACGACCTGCTGAGCAACTACAATCGCCTCATCCGACCCGTGGGC 
1360 1370 1380 1390 1400 1410
170 180 190 200 210 220
frag a AACGTCAGCGACGCGCTCACCGTGCGCATCAAGCTCAAGCTGAGCCAGCTCATCGACGTG 
I I I  I I I I  I I I I I I I I II II II I I I I I I I I I I I I I I
ALS AACAACTCGGACCGTCTCACCGTCAAGATGGGTCTGCGCCTCTCCCAGCTGATCGATGTG 
1420 1430 1440 1450 1460 1470
2)S. gregaria mRNA for neuronal nicotinic acetylcholine receptor 
(aLl/ARL2)
ACCESSION NUMBER X55439
77.2% identity in 114 bp overlap
440 450 460 470 480 490
frag a TTCTAGTAGCTATTGTGTTATTCGCAGAGCTGGTACGACTACAAGCTTTCGTGGGAGCCG
I I I  I I I I  I I I I I I I I I I I I I I
ARL2 CTTACCACCAACGTCTGGTTGGAGCACGAATGGCAGGACCACAAGTTCCGATGGGACCCG 
240 250 260 270 280 290
ARL2
Figure 2.17. Alignment of part of fragment a with part of the sequences encoding ALS from 
Drosophila and aL1 (ARL2) from Schistocerca. These two sequences represent the highest 
nucleotide identities obtained from searching the Genbank and EMBL databases using the gcg 
program Fasta (Pearson and Lipman, 1988).
Fragment a is 582bp in length. Of this, 90bp (30 amino acid residues) overlaps with 
fragment c and contained within it, is the entire sequence of fragment b. As the 
overlapping sequences are identical, it suggests that fragments a, b and c are from the
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same a-like subunit, which appears to be found in both embryonic and pupal stages of 
the life cycle.
Fragment a represents the complete coding sequence missing from fragment c. 
Interestingly, it comprises 3 exons and 2 introns. The 3 exons are 192, 45 and 117bp in 
length and are separated by extremely short intronic sequences of 111 and 81 bp. In 
each case, there appears to be a donor consensus sequence of GGTNAG and an 
acceptor consensus sequence of TT/CGCAGA where “N” represents any nucleotide. 
This is in agreement with invertebrate consensus sequences described by Senapathy et 
al. (1990). The positions of the introns correspond to the first two introns of ALS (Bossy 
et al., 1988) and the first intron of Da2/SAD (Jonas et al., 1990) (see Figure 1.7). There 
are 36 nucleotides prior to the presumed initiation codon, which may represent 5' 
untranslated sequence when converted to cDNA. However, as there appears to be no 
sequence corresponding to a TATA box in fragment a, the transcription start site cannot 
be located. The presumed initial coding sequence represents a signal peptide sequence 
of 20-21 amino acid residues. Analysis using the program Sigseq, based on von 
Heijne's rules (1983, 1986), gives two alternatives for the signal peptide cleavage site. 
The one with the highest probability is the sequence CA/GNPD, where T  represents the 
site of cleavage. Slightly less likely (but corresponding to those signal peptide cleavage 
sites predicted for other insect a-like subunits) is the sequence CAG/NPD. Accordingly, 
the nomenclature used in numbering amino acid residues in fragments a and b 
corresponds to that found in other insect a-like subunits, i.e. amino acid residue number 
1 is the asparagine after the predicted signal peptide cleavage site CAG/NPD.
2.4.5 Attempts to obtain a full-length MARA1
2.4.5.1 Preliminary observations
For the synthesis of a de novo copy of the full-length MARA1 or the construction of a 
hybrid from the fragments obtained, it was necessary to confirm that fragments a, b and 
c were all part of the same a-like subunit, i.e. MARA1. Given that there is 100% 
nucleotide and amino acid identity in the overlapping regions between fragment a, b and 




The palindromic sequences of restriction enzymes known as rare cutters arise so 
infrequently, that they could, in theory, result in the entire genomic clone of MARA1, 
which all the fragments would recognise.
Therefore, genomic DNA was digested with the restriction enzymes Not\, Bg/I, EcoR\ and 
Sad, the samples precipitated and run on a 0.6% (w/v) agarose gel and transferred to 
nylon membrane by Southern blotting, as described in section 2.3.5. Fragments a, b and 
c were excised from pBluescript at appropriate restriction sites, purified using 
Geneclean® II and used sequentially as radiolabelled probes for hybridisation to the 
Southern blot, using techniques described in section 2.3.5.
As seen in Figure 2.18, parts a, b and c, the pattern of bands observed for each 
autoradiograph, corresponding to the digested genomic DNA probed with each 
radiolabelled fragment was almost identical. Comparison with the original photograph of 
the gel (not shown) gave the following identical bands for each autoradiograph: For DNA 
digested with Bg/I, bands were evident at approximately 10kb and 8 kb; for DNA digested 
with EcoRI, bands appeared at approximately 12kb and 10kb and for DNA digested with 
Sacl there was one band between 6 and 7kb. Fragment b and c probes also resulted in 
a band at approximately 3kb for DNA digested with EcoRI. Furthermore, a band of size 
greater than 12kb was observed for DNA digested with Eg/I and probed with fragment b.
The genomic DNA could accommodate a number of nAChR a-like subunits and/or p-like 
subunits, thus differences in the pattern of bands arising on the autoradiographs would 
be dependent on the degree of homology between these hypothetical a-like or p-like 
subunits and MARAI. Other possible explanations for different band patterning include 
intronic restriction enzyme sites, by their very nature not present in the cDNA, and 
alternative splicing of the gene encoding the nAChR.
Overall, the pattern of bands for each fragment is so similar that it makes it unlikely that 
the fragments are derived from different a-like subunits. Comparisons of the sequence 
data from each fragment shows that the overlapping amino acid and more importantly, 
nucleotide sequences are identical. As fragments a and b overlap fragment c by 90bp 
and as fragment b is entirely contained within fragment a, the two anomalous bands may 
be due to experimental error. This spurious result may not be gene specific hybridisation 




Figure 2.18. Autoradiographs from the 
hybridisation of Southern blot of digested 
genomic DNA with each fragment encoding 
the a-like subunit of the nAChR in Manduca.
a) blot probed with fragment a; b) blot probed 
with fragment b and c) blot probed with fragment 
c. See text for experimental details. Lane 1, X 
DNA digested with H/ndlll (sizes in bp); lane 2, 
DNA digested with A/ofl; lane 3, DNA digested 
with Bg/ll; lane 4, DNA digested with EcoRI; lane 
5, DNA digested with Sacl; lane 6, 1kb ladder 
(sizes in bp). Similar banding patterns are 
shown for each fragment.
b)
1 2 3 4 5 6
<*
PCR analysis
PCR was used to splice by overlap extension (Horton et al., 1993) fragments a and c, to 
show that the overlapping sequence was real. PCR on fragments a and c used the 
primer sense 6 to fragment a (sequence: 5' A AG AAT CAAATAAT G AC AACC 3' at 
nucleotide positions 346-366 of fragment a; see Appendix 2, parts b and c), upstream of 
the overlapping region and the primer antisense 1 to fragment c (sequence: 5' 
GGACAGCGATACCTTCTC 3' at nucleotide positions 544-561 of fragment c; see 
Appendix 2, parts a and c), downstream of the overlapping region. PCR resulted in a 
product, shown in Figure 2.19, of approximately 700bp (size expected 708bp).
Direct sequencing of the PCR product using an automated Perkin Elmer ABI PRISM™ 
377 DNA Sequencer gave the following sequence, Figure 2.20, hereinafter called 
fragment d.
1 TGGGTGGAACAGGTTAGTCTCATTGTGTATGTGTTTGCACGATTATTGCAAGTTTGCATA 60 
55 W V E Q 58
61 CAGTTTTTCTAGTAGCTATTGTGTTATTCGCAGAGCTGGTACGACTACAAGCTTTCGTGG 120 
59 S W Y D Y K L S W  67
121 GAGCCGCGCGAGTACGGCGGCGTGGAAATGCTGCACGTGCCTTCCGACCACATCTGGCGG 180 
68 E P R E Y G G V E M L H V P S D H I W R  87
181 CCCGATATCGTGCTTTACAACAATGCTGACGGCAACTTTGAGGTGACGCTGGCGACTAAG 240 
88 P D I V L Y N N A D  G N F E V T L A T K  107
241 GCGACGCTCAATTACACCGGCCGAGTGGAGTGGCGTCCGCCCGCCATCTACAAGTCCTCG 300 
108 A T L N Y T G R V E W R P P A I Y K S S  127
301 TGCGAGATCGACGTAGAGTACTTTCCATTCGACCAGCAGACGTGCGTCATGAAGTTTGGC 360 
128 C E I D V E Y F P F D Q Q T C V M K F G  147
361 TCGTGGACCTACGACGGGTTTCAGGTAGATCTGCGACATATCGATGAAGTGCGAGGCACC 420 
148 S W T Y D G F Q V D L R H I  D E V R G T  167
421 AACGTCGTGGAGTTGGGCGTCGACCTCTCCGAGTTTTACACCTCTGTCGAGTGGGACATC 480 
168 N V V E L G V D L S E F Y T S V E W D I  187
481 CTGGAGGTGCCCGCCGTCCGAAATGAAAAGTTCTACACGTGCTGCGACGAGCCCTATCTA 540 
188 L E V P A V R N E K F Y T C C D E P Y L  207
541 GATATAACTTTCAACATCACGATGCGCCGCAAAACACTCTTCTACACCGTTAATCTGATC 600 
208 D I T F N I T M R R K T L F Y T V N L I  227
601 ATTCCGTGCATGGGAATATCGTTCCTGACG 630
228 I P C M G I S F L T  237
Figure 2.20. Nucleotide and amino acid sequence of fragment d. Amino acids that are 
underlined represent overlap between fragments a and c.
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Figure 2.19. PCR to splice together fragments a and c. DNA, PCR reaction mix (see section 
2.3.4) and primers (see section 2.4.5.1) were incubated at 95°C for 5min, 2.5Units of Tag DNA 
Polymerase was added and 40 cycles of 95°C for 1min, 37°C for 1min and 72°C for 1min were 
completed. Lane 1, X DNA digested with Psfl (sizes in bp); lane 2, fragments a and c amplified 
with both primers; lanes 3 and 4, negative controls, fragments a and c amplified with one primer 
only. A band of ~700bp shown in lane 2.
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Fragment d represents the overlapping sequence of fragments a and c, in addition to the 
sequences directly downstream and upstream of the sense and antisense primers 
respectively. Fragment d is 630bp in length, 90bp of which corresponds to the 
overlapping sequence, 120bp of which corresponds to solely fragment a sequence and 
420bp of which corresponds to solely fragment c sequence.
As fragments from different subunits would not be expected to anneal to form a stable 
product, this hybrid of fragments a and c, produced by PCR, implies that fragments a 
and c are of the same subunit gene.
2.4.S.2 Searching for the full-iength clone
An embryonic developmental profile
In order to facilitate the finding of a full-length clone, a preliminary study on the 
developmental profile of the a-subunit of the nAChR in Manduca eggs was carried out. 
In theory, a semi-quantitative PCR to amplify a short fragment of the a-subunit should 
indicate the day at which the amount of nAChR mRNAs are at their highest, thus giving 
the greatest chance of obtaining a full-length clone.
Total RNA and poly [A+] RNA were isolated from day 0 ,1 ,2 , 3, and 4 Manduca eggs as 
described in section 2.3.1. First strand cDNA was synthesised as previously but using a 
ramped reverse transcription protocol of 37°C for 30min, 42°C for 30min and 50°C for 
30min, as it was thought that elevated temperatures may alleviate problems caused by 
any secondary structure in the mRNA and thus result in full-length cDNA rather than 
truncated versions. Analysis of radiolabelled first strand cDNA on an alkaline agarose 
gel and subsequent autoradiography revealed cDNA up to 4kb in length. Estimation by 
eye suggested less synthesis of the cDNA from day 0 mRNA compared with days 1-4 
(data not shown).
Nested PCR on the first strand cDNA was performed using an outer pair (sequences: 
sense 7, 5’ CTCGATACGTTCAGCATATGCGTG 3' at nucleotide positions 673-696 of 
fragment c, see Appendix 2, parts a and c; antisense 5, 5'
GGCCGTGTACGCTATCTCCGACAG 3' at nucleotide positions 1334-1357 of fragment 
c, see Appendix 2, parts a and c) and inner pair (sequences: sense 8, 5' 
AGTCGCTTCGCAGGACTGGTGACC 3’ at nucleotide positions 835-858 of fragment c, 
see Appendix 2, parts a and c; antisense 6, 5’ CAGGAATGGTCTGTCGAGTACCAT 3' at 
nucleotide positions 1117-1140 of fragment c, see Appendix 2, parts a and c) of primers 
to the C-terminal region of MARAI. A first round PCR with the outer pair of primers
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resulted in a PCR product of approximately 600bp (expected size 591 bp) for the positive 
control of fragment c only (Figure 2.21). A second round hotstart PCR with the inner pair 
of primers and a 1 in 100 dilution of the first round product, using the same cycling 
conditions resulted in a PCR product of approximately 300bp (expected size 347bp) for 
both the positive control of fragment c and for first strand cDNA from each day. Visual 
analysis indicated that the quantity of PCR product made with day 4 eggs was far less 
than that for days 0-3, which showed a similar level of product (Figure 2.21). This finding 
was confirmed through Southern blot analysis, using a probe constructed from the C- 
terminal sequence of fragment c (Figure 2.22). Consequently first strand cDNA from 
days 2 and 3 was used to search for the full-length MARA1.
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Figure 2.21. Nested PCR on first strand cDNA. The first round of amplification (1°) used 40 
cycles of 95°C for 1min, 50°C for 1min and 72°C for 1min, after the initial 5min at 95°C and 
addition of Taq DNA Polymerase to the cDNA, PCR reaction mix and primers. The second round 
of amplification (2°) used a 1 in 100 dilution of the first round product, and the same cycling 
conditions. PCR products were analysed on 1 % (w/v) agarose gel. Lanes 1 and 2; day 0, lanes 3 
and 4, day 1; lanes 5 and 6, day 2; lanes 7 and 8, day 3; lanes 9 and 10, day 4; lanes 11 and 12, 
positive control using fragment c. In each doublet of lanes, the first of that day represents the 1° 
round and the second represents the 2° round. Lane 13, k DNA digested with H/ndlll (sizes in bp). 
Bands of -300 bp shown for each 2° round.
1 2 3 4 5 6 7 8 9  10 1112 13
Figure 2.22. Autoradiograph of Southern blot of nested PCR on first strand cDNA. PCR
products in gel were transferred to nylon membrane by Southern blotting and the blot hybridised 
with a probe constructed from fragment c, as described in section 2.3.5. Lanes 1 and 2, day 0; 
lanes 3 and 4, day 1; lanes 5 and 6, day 2; lanes 7 and 8, day 3; lanes 9 and 10, day 4; lanes 11 
and 12, positive control using fragment c. In each doublet of lanes, the first of that day represents 
the 1° round and the second represents the 2° round. Lane 13, k DNA digested with H/ndlll. 
Bands of -300 bp shown for each 2° round (by measurement from analytical gel, Figure 2.21).
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Searching for a de novo copy
Specific primers to the N-terminal end of fragment a and the C-terminal end of fragment 
c, incorporating different and non-compatible restriction enzyme sites, were used in PCR 
reactions with the proofreading VentR® DNA Polymerase (Mattila et al., 1991). These 
were the primers, sense 9 and 10 incorporating a BamH\ site (sequences: 5' 
CGCGGATCCGTGCGAGGCCCAACGTGTG 3' at nucleotide positions 1-19 of fragment 
a, see Appendix 2, parts b and c; 5' CGCGGATCCATGCGGAGTGTGACA 3' at 
nucleotide positions 37-51 of fragment a, see Appendix 2, parts a and c; respectively) 
and antisense primer 7 incorporating either an Apal or Xho\ site (sequences: 5' 
GCACGGGCCCATACAAACGATCATTTTATTTCGTC 3'; 5'
CCCGCTCGAGATACAAACGATCAI I I lATTTCGTC 3' both at nucleotide positions 
1600-1624 of fragment c and only differing in restriction site, see Appendix 2, parts a and 
c respectively). Standard PCR conditions, increasing the annealing temperature, using a 
second round - effectively doubling the number of cycles, and including formamide in the 
reaction mixture (Sarkar et al., 1990), all failed to produce a full-length clone. The 
smears present on the analytical gel shown in Figure 2.23 suggested a lack of template 
cDNA of the appropriate size.
In addition, Expand™ (Boehringer Mannheim) - a long template DNA Polymerase system 
and GeneAmp® (Perkin Elmer) - a thermostable Reverse Transcriptase that operates at 
70°C and also functions as a DNA Polymerase for PCR (Myers and Gelfand, 1991) were 
used for reverse transcription and PCR according to the manufacturer’s protocols. 
Neither were successful in producing a full-length clone of MARA1.
The lack of a full-length clone from cDNA suggests that in each case the reverse 
transcript for MARA1 was truncated. In addition, an excessive number of cycles was 
necessary to isolate an internal fragment of MARA1. Generally, 1pg of poly [A+] RNA 
contains ~5x107 copies of each low abundance transcript. PCR works well with as little 
as 103 templates in the starting mixture suggesting that the mRNA for MARA1 is in very 
low abundance (Frohman, 1993).
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Figure 2.23. PCR on first strand cDNA using primers specific to the extreme ends of 
sequence encoding the MARA1 subunit. cDNA, PCR reaction mix (see section 2.3.4) and 
primers (see text: Searching for a de novo copy) were incubated at 96°C for 5min, 2.5Units of 
Vent DNA Polymerase was added and 40 cycles of 95°C for 1min, 45°C for 1min and 72°C for 
2min were completed. PCR products were analysed on an agarose gel. Lane 1, 100bp ladder 
(sizes in bp); lane 2 and 3, representative smears, suggesting lack of template DNA from days 2 
and 3 cDNA respectively using primers sense 9 and antisense 7.
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Ligation of fragments a and c
The ligation of fragments a and c was also attempted. Following the successful isolation 
of fragment d using splicing by overlap extension, the same technique was applied to the 
whole fragments (Figure 2.24), using the specific primers to the N-terminal end of 
fragment a and the C-terminal end of fragment c described above.
Figure 2.24. Splicing by the overlap 
extension PCR method.
(Not to scale).
Primary PCR: Fragment a amplified with 
sense 9 (nucleotide positions 1-19 of 
fragment a) and antisense 8 (nucleotide 
positions 55-75 of fragment c), 
incorporating BamHI and EcoRV sites 
respectively. Fragment c amplified with 
sense 11 (nucleotide positions 55-75 of 
fragment c) and antisense 7 (nucleotide 
positions 1600-1624 of fragment c), 
incorporating EcoRV and either Apa\ or 
Xho\ respectively (see Appendix 2). 
Secondary PCR: Fragments a and c 
spliced together using sense 9 and 
antisense 7.
Resulting PCR product subcloned into 
pBluescript using restriction sites at either 
end of PCR product.
Despite alterations in the cycling conditions, the full-length clone was not amplified. 
Given that this technique produces a shorter overlapping fragment, (fragment d, Figure 
2.20) it seems strange that a longer overlapping fragment cannot be produced. This 
may be due to the disparities in size difference between the two fragments. Fragment c 
is approximately 3x larger than fragment a and this may create an unstable hybrid which 
is not readily amplified to produce a full-length fragment but is amplified for a shorter, 
more stable product.
The megaprimer technique, Figure 2.25 was also used. Here, fragment c is amplified by 
a sense megaprimer, namely fragment a, and antisense primer 7, specific to the C- 































overlapping fragment c, however, this was not the case. Again, this may be due to the 






















Figure 2.25. Splicing by the 
megaprimer PCR method.
(Not to scale)
Primary PCR: Fragment a amplified with 
sense 9 (nucleotide positions 1-19 of 
fragment a) and antisense 8 (nucleotide 
positions 55-75 of fragment c).
Secondary PCR: Fragment c amplified 
with fragment a (the megaprimer) and 
antisense 7 (nucleotide positions 1600- 
1624 of fragment c).
Resulting PCR product subcloned into 
pBluescript using restriction sites at either 
end of PCR product.
pBluescript SK
A final attempt to splice the two fragments together by engineering a mismatch EcoRV 
restriction site into the C-terminal end of fragment a and the N-terminal end of fragment c 
(Figure 2.26) (sense 11, sequence: 5' TGGCGGCCCGATATCGTGCTT 3'; antisense 8, 
sequence: 5' AAGCACGATATCGGGCCGCCA 3' at nucleotide positions 55-75 of 
fragment c, i.e. within overlap of fragments a and c, see Appendix 2, parts a and c; note 
incorporation of EcoRV restriction site into primers, i.e. MARA1 sequence, starting at 































Figure 2.26. Splicing by engineered 
restriction sites.
(Not to scale).
Fragment a amplified with sense 9 and 
antisense 8. Fragment c amplified with 
sense 11 and antisense 7 (see text for primer 
details).
Fragment a ligated into pBluescript using 
restriction sites at either end of PCR product. 
Fragment c ligated into the fragment a 
containing pBluescript using restriction sites 
at either end of PCR product, the N-terminal 
one corresponding to that of the C-terminal 
of fragment a.
Fragment a was amplified with a BamHI site at the N-terminal end (as above) and with a 
mismatch EcoRV site at the C-terminal end by PCR and subcloned into pBluescript at 
the corresponding restriction sites. Fragment c was amplified with a mismatch EcoRV 
site at the N-terminal end and either an Apa\ or Xho\ site at the C-terminal end (as 
above) and subcloned into pBluescript containing fragment a at the corresponding 
restriction sites. This technique however resulted in a fragment that was composed of 
fragment a ligated to only part of fragment c, thus giving another partial length fragment 
but not the full-length clone.
Searching for a genomic clone
Given the lack of a full-length clone from cDNA, attempts to isolate the genomic clone 
were made. This utilised PCR with the long template DNA polymerase system called 
Expand™ (see section 2.3.4). As the size of the genomic clone could not be estimated, 
three buffers supplied with the enzyme, giving various reaction conditions were used. 
The primers sense 9 incorporating a BamHI restriction site (sequence 5’ 
CGCGGATCCGTGCGAGGCCCAACGTGTG 3’ at nucleotide positions 1-19 of fragment 
a) and antisense 7 incorporating an Apal restriction site (sequence 5’
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GCACGGGCCCATACAAACGATCATTTTATTTCGTC 3’ at nucleotide positions 1600- 
1624 of fragment c) were used. Controls using single primers were also carried out.
Expand™ PCR resulted in a doublet of PCR products, the upper band approximately 6kb 
and the lower band approximately 5kb (Figure 2.27) which were not observed in the 
single primer controls. The PCR product was purified and approximately the first 700bp 
were sequenced on an automated Perkin Elmer ABI PRISM™ 377 DNA Sequencer. The 
sequence is shown in Figure 2.28. Sequencing ambiguities and analysis of the 
sequence using the gcg program Fasta (Pearson and Lipman, 1988), suggested that the 
purified product was not an a-like subunit of the nAChR (Figure 2.29).
1 TTTTGTGCGAGGcagGCGCCGTTTCaGAAaTACGACCTTTCGGGCCGAGg 50
51 GAACTAgCAAAcGGCTTCCCcATTTTCCATCTaATGaAaAtgCGGtcGAG 100













Figure 2.28. Partial nucleotide sequence of the genomic PCR product. Lower case letters 
represent unclear sequence while the letter N, represents any nucleotide.
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Figure 2.27. PCR on genomic DNA using primers specific to extreme ends of the sequence 
encoding MARA1. Genomic DNA, PCR reaction mix containing buffer 1 (see section 2.3.4) and 
Expand™ long template DNA Polymerase were incubated at 94°C for 2min and then subjected to 
10 cycles of 94°C for 10s, 55°C for 30s and 68°C for 12min, followed by 20 cycles of the same 
conditions but with an extra 20s for each extension step of each cycle. Any PCR products were 
subjected to a final extension of 68°C for 7min. Lane 1, A. DNA digested with Psfl (sizes in bp); 
lane 2, genomic DNA amplified with sense 9 and antisense 7, showing a doublet of PCR products 
at ~5000bp.
1) H. sapiens DMA, DMB, HLA-Zl, IPP2, LMP2, TAPI, LMP7, TAP2, DOB, 
DQB2
ACCESSION NUMBER X87344
61.3% identity in 106 bp overlap
130 140 150 160 170 179
gen. se T T GT AC GT C C C T AC AT CAT C T AC AC AT GT T C C CAT C AC GT T AC C GT AT C T— CCCTCTAA
I I I I  I I I I I I I I I I I I I I
hsevxnh AAAGAAGGGGAC AC AC GC C T C T T C C AC C C GC T CAT GC T GT T AC T GC AT C T GAT CAT C T C C 
134000 134010 134020 134030 134040 134050
180 190 200 210 220 230
gen. s e ATTCACGTCTGGTCGT- -ACTCCGCCT----- AGGGAGT GGC C C GAT AT C T GGA- GAAA
I I I I I  I I I I  I I I  I I I I I I I  I I I I I I I I I I I I
hsevmh GTGC-CGTGTCCTTGTTCACTTAGCCTGTGTTGAGTGTTTGTCTCCATTTCCAAATGCAA 
134060 134070 134080 134090 134100 134110
240 250 260 270 280 290
gen. se T AAAAC AT C T GGGAAAAC AGT GAAT AT GT T C T T C AT AAC C AC GAGT T TAT T C GGT AC T T T
I I I I I I I I I I I I I I I I
hsevmh T AAAAC AT C T GGGAAAGAC T AAGGT AGGT GT GGGC AGGAAGAAGGGAGGAAGT T AGAC C C 
134120 134130 134140 134150 134160 134170
2)Marchantia polymorpha mitochondrion, complete genome 
ACCESSION NUMBER M68929
68.2% identity in 44 bp overlap
99 89 79 69 59 50
gen.se TGTGATACTCGACCGCATTTTCATTAGATGGAAAATGGGGAA— GCCGTTTGCTAGTTCC
I I I I I I I I I I I I I I I I I I I I
mpomtc AT GT GAC AGAT AGAT GGAT AT AT AGAAAAAGAAAAT GAGC GAC C GGGGGAGGC T AGT T C C 
42370 42380 42390 42400 42410 42420
49 39 29 19 9
gen. se CTCGGCCCGAAAGGTCGTATTTCTGAAACGGCGCCTGCCTCGCACAAAA 
I I I I I I I I I I
mpomtc C GGGGAC C GAAAT GC GCAAC GGT GAC GAAT TAT C GCAAAT GT GAC GGAGATAGCAGGAAA 
42430 42440 42450 42460 42470 42480
3)D. melanogaster bithorax complex (BX-C), complete sequence 
ACCESSION NUMBER U31961
63.3% identity in 90 bp overlap
100 110 120 130 140 150
gen. se GC GGT C GAGT AT C AC AC C T GGGT C TAT T C C T T GT AC G- T C C C T AC AT CAT C T AC AC AT GT
II I I I  I I I I I II I I I I I I I I I
dm3196 C C T CAT TAT C GC CAT AT C T T GT GGC AC AAT T T T AAC GAT C C C AAAAT T A AC AC AT GT
117030 117040 117050 117060 117070 117080
160 170 180 190 200 210
gen.se TCCCATCACGTTACCGTATCTCCCTCTAAATTCACGTCTGGTCGTACTCCGCCTAGGGAG 
I I I  I I I I I I I I I I  I I I I I  I I I I I I  I I I I I  I I  I I I I I
dm3196 T C C GC T AAC GT T AAC AGAT T T C AGGC— AATACCCCT TC-TCCTCCCTCTGGGGAG
117090 117100 117110 117120 117130
220 230 240 250 260 270
gen. s e T GGC C C GAT AT C T GGAGAAAT AAAAC AT C T GGGAAAAC AGT GAAT AT GT T C T T CAT AAC C
dm3196 CTCCATCGGGAAATTTATGAAGCGGTTCGGTACGTTTTCTGTCCCGCCTAAAATGCATTG 
117140 117150 117160 117170 117180 117190
Figure 2.29. Alignment of part of genomic DNA PCR product with non-nAChR sequences.
Sequences shown represent the three highest nucleotide identities obtained from searching the 
Genbank and EMBL databases using the gcg program Fasta (Pearson and Lipman, 1988).
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2.4.6 Searching for other a-like subunits
The presence of 3 a-like subunits of the nAChR in Drosophila (ALS, Da2/SAD and Da3, 
Bossy et al., 1988; Baumann et al., 1990, Jonas et al., 1990, Sawruk et al., 1990a; 
unpublished observations cited in Gundelfinger, 1992, respectively) suggests the 
likelihood of more than one a-like subunit in Manduca. Consequently, degenerate 
primers based on those used by Sgard et al. (1993) were used in PCR on first strand 
cDNA in an attempt to isolate partial length fragments of other a-like subunits.
Sequences of the degenerate primers were sense: 5'
TACTAC/TA/CC/T CA/T C/GC/T GT C/GG AA/GTGGG ACAT 3' and antisense: 5’
GAAC/GAGC/TAGA/GTAC/TTTG/TCCC/GAGC/TAGCGG 3' giving degeneracy of 256- 
fold and 128-fold respectively. The positions of these primers are indicated on fragment 
c of Appendix 2, although the sequences of ALS, Da2/SAD and aL1 were used to design 
the primers.
A positive control using fragment c resulted in a PCR product of approximately 300bp, 
close to the expected size of 332bp. However, not until the second round of conditions 
did PCR products for the first strand cDNA experimental, corresponding to the same 
size seen in the positive control become visible when viewed on an agarose gel (figure 
2.30). The PCR products were transferred to nylon membrane by Southern blotting and 
hybridised with radiolabelled fragment c as described in section 2.3.5. The 
autoradiograph obtained, Figure 2.31, showed hybridisation to the positive control from 
both rounds of PCR. Bands corresponding to PCR products from the second round of 
PCR, for day 2 and 3 eggs were observed. However, the band produced from 
hybridisation of the probe to day 2 cDNA was much fainter than the band for day 3. 
Furthermore, both bands appeared with far less intensity than the positive controls. The 
intensity of hybridised label observed on the autoradiograph does not correlate with the 
intensity of the bands seen on the agarose gel, Figure 2.30. If there was only one a-like 
subunit in the first strand cDNA corresponding to MARA1, i.e. the same sequence as 
fragment c, bands of similar intensities would be expected. Therefore, this anomaly 
suggests that there is more than one a-like subunit present in Manduca, resulting in 
bands of similar size with these degenerate primers. This is in keeping with the results 
observed with Sgard et al. (1993) who have suggested the presence of both ALS-like 
and Da2/SAD-like subunits for Myzus persicae, as PCR results in one band that on 
sequencing, appears to consist of two subunits with degenerate primers at the same 
locations as those used in this study.
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Figure 2.30. Amplification of further 
putative a-like subunits of the nAChR 
by PCR on first strand cDNA. PCR used 
first strand cDNA from days 2 and 3 Manduca 
eggs. cDNA, PCR reaction mix and primers 
were incubated at 96°C for 5min, 2.5Units of 
Taq DNA Polymerase was added and 40 cycles 
95°C for 1min, 40°C for 1min and 72°C for 2min 
were completed. The PCR products from each 
day were diluted (1 in 50) and secondary 
rounds of PCR with the same cycling conditions 
except for an increased annealing temperature 
of 48°C were completed. PCR products were 
1636 analysed on an agarose gel. Lanes 1 and 2,
amplification of cDNA from day 2; lanes 3 and 
1018 4, amplification of cDNA from day 3; lanes 5
and 6, positive control, amplification with 
fragment c. For each doublet, the first lane 
506 represents the primary round and the second
lane represents the secondary round. Lane 7, 
blank lane; lane 8, X DNA digested with H/ndlll 
(sizes in bp). Bands of ~300bp shown in lanes 
2, 4, 5 and 6.
Figure 2.31. Autoradiograph of Southern blot 
of PCR with degenerate primers on cDNA.
PCR products in gel were transferred to nylon 
membrane by Southern blotting and the blot hybridised 
with a probe constructed from fragment c, as described 
in section 2.3.5. Lanes 1 and 2, amplification of cDNA 
from day 2; lanes 3 and 4, amplification of cDNA from 
day 3; lanes 5 and 6, positive control, amplification with 
fragment c. For each doublet, the first lane represents 
the primary round and the second lane represents the 
secondary round. Bands corresponding to PCR 
products from the second round of PCR, for day 2 and 
3 eggs shown, in addition to bands from the positive 
control, fragment c.
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Attempts to sequence the PCR products resulted in ambiguous sequence data (Figure 
2.32) that did not correlate well with any other sequences in the Genbank and EMBL 
databases (Figure 2.33). As these degenerate primers were designed to sequences 
upstream of the internal primers used in the developmental study, it is possible that the 






251 ANAT C CCACAAACGCAGGGT CNT GT CCCACT CCAC GCAGANATANT AA 298
Figure 2.32. Nucleotide sequence of PCR product obtained with degenerate primers on 
first strand cDNA. The letter N, represents any nucleotide.
1)C. reinhardtii Cblp gene for a G protein beta subunit 
ACCESSION NUMBER X53574
72.1% identity in 136 bp overlap
289 279 269
exp TTANTATNTCTGCGTGG— AGTGGGACANGACCC
I I : I I I  I I I  I I I I I I I : I I I I 
crgplp AGGACGTGGTCATCTCCTCCGATGGCCAGTTCTGCCTGACTGGCTCGTGGGACGGCACCC 
670 680 690 700 710 720
259 249 239 229 219 209
exp TGCGTTTGTGGGATNTCGCCGCCGGAAAGACCACCAGGCGTTTCGAAGACCATACTAAGG
I II I I I I I I I I I : I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
crgplp TGCGTCTGTGGGACCTGAACACCGGCACCACCACCCGCCGCTTCGTGGGCCACACCAAGG 
730 740 750 760 770 780
199 189 179 169 159 149
exp ATGTGCTCTCCGTGGCATTCTCAGTGGACAACCGTCAAATTGTGTGTGGCTCCCGTGACA
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I 
crgplp ATGTGCTGTCCGTGGCTTTCTCGGTGGACAACCGCCAGGTGGGGCGGCAAGGCCAAGGCG 
790 800 810 820 830 840
139 129 119 109 99 89
exp AGACCAT CAAACT GNGGAACANT CT GGC CGAGT GCAAGNACACNAT C CAGGAT GAT GGCC
crgplp AAGGAGGGGGGAGGTCGGCAGGCGGGGTAGCGCGTGGATGCCCGGCGGAGGAAACCACCG 
850 860 870 880 890 900
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2)N.crassa cpc-2 gene 
ACCESSION NUMBER X81875
68.9% identity in 286 bp overlap
289 279 269
exp TTANTATNTCTGCGTGGAGTGGGACANGACCCTGCG
I : I I I I I I I I I I I I I I : I I I I I I II
nccpc2 AGGTGATCTCTTCCGACGGTGCCTACGCCCTCTCTGCCT— CGTGGGACAAGACCCTCCG 
2320 2330 2340 2350 2360 2370
259 249 239 229 219 209
exp TTTGTGGGATNTCGCCGCCGGAAAGACCACCAGGCGTTTCGAAGACCATACTAAGGATGT
1111111:1 I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I
nccpc2 TCTCTGGGAGCTTTCCACCGGCACCACCACCCGCCGTTTCGTCGGCCACACCAACGACGT 
2380 2390 2400 2410 2420 2430
199 189 179 169 159 149
exp GCTCTCCGTGGCATTCTCAGTGGACAACCGTCAAATTGTGTGTGGCTCCCGTGACAAGAC
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II
nccpc2 TCTCTCCGTCTCTTTCTCCGCCGACAACCGCCAGATCGTCTCCGGTTCCCGCGATCGTAC 
2440 2450 2460 2470 2480 2490
139 129 119 109 99 89
exp CAT CAAACTGNGGAACANT CTGGCCGAGT GCAAGNACACNATCCAGGAT GAT GGCCACAG
I I I I I I l l h l l l l l l :  II I II I I I I I I : I I I : I I I II  I I I I I I I I
nccpc2 CATCAAGCTGTGGAACACCCTCGGTGACTGCAAGTTCACCATCACCGAGAAGGGCCACAC 





I I I I I I I I I II
nccpc2 CGGCTGGGACAAGCTCGTCAAGGTATGTTGTATAACCTGCTTTACTCCCCCCCCAAAAAA 
2620 2630 2640 2650 2660 2670
Figure 2.33. Alignment of PCR product obtained with degenerate primers on cDNA with 
non-nAChR sequences. Sequences shown represent the two highest nucleotide identities 
obtained from searching the EMBL database using the gcg program Fasta (Pearson and Lipman, 
1988). Exp = experimental.
In summary, PCR on circularised genomic DNA and circularised cDNA has resulted in 
the isolation of two fragments, encoding the missing N-terminus or part of the missing N- 
terminus, (a and b respectively), from fragment c. Together, the fragments represent an 
a-like subunit of the nAChR from Manduca. The sequence includes some 5' 
untranslated region, the complete deduced coding region with putative signal sequence 
peptide and the complete 3' untranslated region. The sequence of the a-like subunit, 
named MARA1, is shown in Figure 2.34. Features that are indicative of an a-like subunit 
of the nAChR are highlighted and are discussed in section 2.5.
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1 GTGCGAGGCCCAACGTGTGGAGTTGGGCGTCAACTCATGCGGAGTGTGACAAAATATTACTTACATGGTGTTGTT 7 5
- 2 1  M R S V T K Y Y L H G V V  - 9
7 6 TTGTTTGCGACAGGATGTGCCGGCAACCCCGACGCGAAGCGGCTGTACGACGATCTGCTCAGCAATTACAACAAG 150
- 8  L F A T G C A G N P D A K R L Y D D L L S N Y N K  17
151 TTGGTGCGGCCTGTACTCAACGTCAGCGACGCGCTCACCGTGCGCATCAAGCTCAAGCTGAGCCAGCTCATCGAC 225
18 L V R P V L N V S D A L T V R I K L K L S Q L I D  42
2 2 6  GTGAATCTCAAGAATCAAATAATGACAACCAATCTATGGGTGGAACAGAGCTGGTACGACTACAAGCTTTCGTGG 300
43 V N L K N Q I M T T N L W V E Q S W Y D Y K L S W  67
301 GAGCCGCGCGAGTACGGCGGCGTGGAAATGCTGCACGTGCCTTCCGACCACATCTGGCGGCCCGACATCGTGCTT 375
68 E P R E Y G G V E M L H V P S D H I W R P D I V L  92
3 7 6  TACAACAATGCTGACGGCAACTTTGAGGTGACGCTGGCGACTAAGGCGACGCTCAATTACACCGGCCGAGTGGAG 4 50
93 Y N N A D G N  F E V T L A T K A T L N Y T G R V E  117
4 51 TGGCGTCCGCCCGCCATCTACAAGTCCTCGTGCGAGATCGACGTAGAGTACTTTCCATTCGACCAGCAGACGTGC 525
118 W R P P A I Y K S S C E I D V E Y F P F D Q Q T C  142
5 2 6  GTCATGAAGTTTGGCTCGTGGACCTACGACGGGTTTCAGGTAGATCTGCGACATATCGATGAAGTGCGAGGCACC 600
143  V M K F G S W T Y D G F Q V D L R H I  D E V R G T  167
601 AACGTCGTGGAGTTGGGCGTCGACCTCTCCGAGTTTTACACCTCTGTCGAGTGGGACATCCTGGAGGTGCCCGCC 67 5
168 N V V E L G V D L S E F Y T S V E W D I L E V P A  192
67 6 GTCCGAAATGAAAAGTTCTACACGTGCTGCGACGAGCCCTATCTAGATATAACTTTCAACATCACGATGCGCCGC 7 50
19 3  V R N E K F Y T C C D E  P Y L D I T  F N I T M R R  217
7 51 AAAACACTCTTCTACACCGTTAATCTGATCATTCCGTGCATGGGAATATCGTTCCTGACGGTCCTGGTATTTTAC 825
218  K T L F Y T V N L I I  P C M G I S F L T V L V F Y  242
826 TTGCCTTCGGACAGTGGCGAGAAGGTATCGCTGTCCATATCGATCCTACTGTCGCTCACCGTGTTCTTCCTGCTG 900
2 4 3  L P S D S G E K  V S L S I S I L L S L T V F F L L  267
901 TTGGCCGAGATCATTCCACCGACTTCGCTGGTGGTGCCACTGCTTGGCAAGTTTGTTCTCTTCACCATGATCCTC 97 5
268  L___ A E l i  P P T S L V V P L L G K  F V L F T M I L  292
976 GATACGTTCAGCATATGCGTGACTGTGGTGGTATTGAATGTGCACTTCCGCTCGCCACAGACGCACACAATGTCG 1050
29 3  D T  F S I C V T V V V L  N V H F R S P Q T H T M S  317
1051  CCGTGGGTGCGGCGCGTGTTCATCCACGTGCTGCCGCGGCTCCTGGTCATGCGCCGCCCGCACTACCGACTCGAC 1125
318  P W V R R V F I  H V L P R L L V M R R  P H Y  R L D  342
11 26  CCGCACCGCAGTCGCTTCGCAGGACTGGTGACCGGCGCTGGCGAGACCACACTATGGGACGAGGGCTCGCCGGGC 1200
3 4 3  P H R S R  F A G L V T G A G E T T L W D E G S  P G  3 67
12 01  GTGCCGGCTCCGCCCCGTCCGCCGCCCTGCGCACCCCCGCTGGCGCCCTGCGCCGCCTGCGCGCCCGCTGAGGCG 1275
368 V P A P P R P P P C A P P L A P C A A C A P A E A  392
1 2 76  CCGGCGCTCTGCGACGCGCTGCGCCGGTGGCACCGGTGTCCCGAGCTACAT AAGGCTATTGACGGCATCAATT AT 13 50
393  P A L C D A L R R W H R C P E L H K A I  D G I N Y  417
1351  ATTGCCGACCAAACTAGGAAAGAGGAAGAGTCCACT AGGGTGAAAGAGGACTGGAAGTACGTAGCGATGGT ACTC 14 25
418 I A D Q T R K E E E S T R V K E D W K Y V A M V L  442
1 4 2 6  GACAGACCATTCCTGTGGAT ATTCACGCT AGCGGTGGTGGTGGGCTCGGCGGGCATCATCCTGCAGGCGCCGACG 1500
4 43 D R P F L W I  F T L A V V V G S A G I  I L  Q A P T 4 67
1501  CTGTACGACGAGCGCGCGCCCATCGACGTGCGCCTGTCGGAGAT AGCGTACACGGCCGCCAAGCCGCGCCCACCG 1575
468 L Y D E R A P I  D V R L S E I A Y T A A K P R P P  4 92
157 6 CCGCCACGCTGAGCGGGTCTCGCGTCACGTGCTACGTGTCACGCGTGACGCGTCACGCATCACGCGTCACGCGTC 1650
4 93 P P R 4 95
1651  GGCGTCTCTCGACGGGCTCCAGTGATTCTCGCTCGTATTTTCGATTCACGCAAATTCGAATTTGCAATATTGTAC 1725
1 7 2 6  AT AGTATACAT AATT ATT AT AGTTTATACAAAGAAACACCGCGATCGATTCTAAGTCGAATTTCTTTTGAT AGAG 1800
1801  ACGAAATAAAATGATCGTTTGTAT 1824
Figure 2.34. Nucleotide and amino acid sequence of MARA1. By analogy with other insect a- 
like subunits (Gundelfinger, 1992), putative transmembrane domains (underlined amino acids), the 
cys loop (italicised amino acids) and the vicinal cysteines (bold C) are shown. Predicted N- 




A number of molecular biology techniques were used to determine the complete coding 
sequence of an a-like subunit of the nAChR from Manduca.
The cDNA library screen did not result in a full-length MARA1 clone and thus did not 
contribute to the sequence data despite the screening of approximately 1.5 million 
clones. As a cDNA library is representative of the mRNA present in the original 
preparation, this suggests that either
1) the cDNA is of inferior quality as a result of either degradation of RNA before or after 
isolation; poor quality reverse transcriptase and inappropriate reaction conditions in first 
strand cDNA synthesis or badly controlled second strand cDNA synthesis.
2) The cDNA for MARA1 was in such low abundance that the likelihood of finding the 
full-length clone was statistically very low.
or 3) The library screen was in some way at fault.
In order to determine the quality of the manufacturer's cDNA, the library could be 
screened for an ubiquitous DNA such as actin. If this was found in a truncated form, it 
would indicate that in general the cDNAs in the library would not contain the entire 
nucleotide sequence of the corresponding mRNA. As the information about the 
preparation of the customised library is limited, any of the reasons given in 1) above 
could be at fault. Indeed, the presence of truncated cDNA probably encoding an a-like 
subunit of the nAChR in the library was confirmed with nested PCR (see Figure 2.4).
The quality of the library screen could be assessed using a more rigorous MARA1 
control, which was not contemplated for reasons of time and cost. This would entail 
subcloning fragment c into the same vector as the library, i.e. XZapll (which itself would 
involve combining the insert with left and right arms of the XZapll to get a recombinant 
phage and then in vitro packaging of the recombinant phage into mature phage particles) 
and then plating out as before so that every screening step could be compared to that 
used for the library. However, the excessive cost and time which would be spent on this 
experiment did not justify its role as a control.
Inverse PCR on double stranded, circularised cDNA was successful in that more DNA 
sequence data was obtained from the missing N-terminal end of fragment c. The 
predicted amino acid sequence now appeared to be lacking only the extreme N-terminal
amino acids (approximately 57-77 residues by comparison with other insect a-like 
subunits, see alignment, Figure 2.36). Ligation anchored PCR failed to add any further 
sequence data while inverse PCR on genomic DNA resulted in a DNA sequence that 
encodes the missing N-terminus from fragment c.
Common to both cDNA requiring PCR strategies is the synthesis of first strand cDNA. 
cDNA clones are sometimes truncated, containing only 3' untranslated and varying 
amounts of the protein coding sequence. This is due to the lack of generation of full- 
length cDNA strands during the reverse transcription reaction. As poly [A+] RNA instead 
of total RNA was used in both cases, contamination by non-specific products is 
improbable. Plausibly, the reverse transcriptase dissociated from the poly [A+] RNA at 
GC rich regions denoting areas of complex secondary structure, resulting in truncated 
cDNAs, which, by their very nature were not amplified in the PCR.
It is apparent that as the same antisense primer (antisense 3) was used in both cases 
and resulted in fragment b for the inverse PCR strategy, the lack of results in the ligation 
anchored PCR strategy must be due to either a different factor or a combination of 
factors.
Comparison of the sequence of the anchor oligonucleotide with other sequences in the 
Genbank and EMBL databases using the gcg program Fasta (Pearson and Lipman, 
1988) indicated little potential for the anchor oligonucleotide to anneal non-specifically to 
the cDNA, as the sequences extracted from the database were mainly from plants. Also, 
radiolabelling of the HPLC purified anchor oligonucleotide, followed by gel 
electrophoresis and autoradiography did not reveal any degradation of the 
oligonucleotide. Therefore, it was doubtful that synthesis of the anchor oligonucleotide 
was the problem.
The ligation reaction is dependent on the first strand cDNA having hydroxyl groups at 
both termini, leaving only the 3' end available for ligation, and on the 3' block of the 
anchor oligonucleotide, leaving only the 5' end available for ligation. As these pre­
requisites were adhered to, and as the reaction conditions were set according to studies 
developed by Tessier et al. (1986), this leaves the effect of acceptordonor ratio, i.e. the 
ratio of anchor oligonucleotide to single stranded cDNA. For ligation of 
oligodeoxyribonucleotides, Tessier etal. reported that a ratio of one molecule of donor to 
one molecule of acceptor only resulted in 3% ligation efficiency, but increasing the 
amount of acceptor to 5 molecules resulted in 17% ligation efficiency. As the amount of
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cDNA in the ligation reaction was estimated, it is possible that the amount of cDNA 
present never reached the threshold level that was critical for ligation.
Searching fora full-length MARA1 clone
The 90bp overlap between fragments a and c implies that they are from the same a-like 
subunit. This was confirmed using restriction digest analysis on Manduca genomic DNA, 
which gave a similar pattern of bands for each fragment, and by PCR that spliced part of 
each of the two fragments together by overlap extension.
Three approaches were applied to the construction of a full-length clone of MARA1. The 
first involved the attempted formation of a de novo copy of a full-length clone using the 
sequence information gained from fragments a and c to design specific primers to the 5' 
and 3' ends of the subunit, while the second involved the utilisation of an engineered 
restriction site to ligate fragments a and c together. The final approach searched for a 
genomic clone.
There were several advantages to making a de novo copy of the full-length cDNA clone. 
Firstly, ligation of the two fragments would lead to an hybrid molecule composed of 
genomic DNA and cDNA, with only the first part of the extracellular region containing 
introns - in contrast a de novo copy would comprise entirely cDNA. Secondly, as no 
convenient restriction sites were available for the ligation of the two fragments in their 
overlapping regions, the introduction of a novel restriction site by PCR would be 
necessary, making the ligation approach more difficult. Moreover, this could lead to the 
introduction of more mutations (in addition to the engineered restriction site) in the 
sequence due to the increase in error rate inherent with an increase in cycles of PCR. 
This would necessitate the sequencing of numerous clones to identify one without 
mutations (reviewed in Frohman, 1993). Contrastingly, PCR under inefficient but low 
error rate conditions using a minimum number of cycles and specific primers designed to 
the extreme N- and C-terminals of MARA1 could amplify a new cDNA likely to be free of 
mutations (Eckert and Kunkel, 1990). Thirdly, although unlikely, it could be possible to 
join two fragments that are never found together in vivo, if alternate promoters, splicing, 
polyadenylation signal sequences or highly homologous subunits resulted in multiple 5' 
and 3' ends - using specific primers to the extreme N- and C-terminals of MARA1 would 
confirm that the resulting amplified cDNA represents an mRNA that is present in the 
starting population (Ragsdale et a/., 1989). Finally, a de novo copy of a cDNA clone 
would facilitate injection of the subunit into Xenopus oocytes as the DNA could be 
injected directly or transcribed into cRNA, an option not available when using genomic
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DNA which has to be injected into the nucleus of the oocyte. A full-length MARA1 clone 
was neither found de novo nor constructed from its constituent fragments.
2.5.2 Possible causes for the lack of a full-length MARA1
The extreme difficulty in isolating a full-length cDNA clone of MARA1 indicates either a 
very rare message or a large degree of RNA secondary structure. Interestingly, similar 
problems have been found with the isolation of a putative p-like subunit encoding an 
nAChR from Manduca, MARB1 {Manduca Acetylcholine Receptor Beta-like subunit 1; 
J.Eastlake, University of Bath) which is also incomplete at the N-terminus.
Considering that ACh is the major neurotransmitter in the insect CNS (Colhoun, 1963; 
reviewed in Sattelle, 1980), and that nicotinic AChRs are known to be more abundant 
than muscarinic AChRs in the insect CNS (reviewed in Breer and Sattelle, 1987), a 
particularly rare message encoding an a-like subunit of the nAChR in Manduca seems 
unlikely. Nevertheless, an excessive number of PCR cycles (over 40) were necessary to 
isolate an internal fragment of MARA1. Amplification of the appropriate product normally 
requires cDNA in very low quantities, suggesting that the mRNA for MARA1 is very rare. 
Interestingly, the search for a full-length muscarinic AChR using cDNA from Manduca 
has also been fruitless: only two partial length fragments have been isolated from 
genomic DNA - the remainder of the sequence and the full-length clone have not been 
forthcoming (A.Wang, personal communication), indicating that it too is in extremely low 
abundance.
The question of secondary structure has been addressed using a variety of methods. In 
attempts to destroy the putative secondary structure by heat, the incubation temperature 
of the reverse transcription reaction was increased from a single hour at 37°C to a 
ramped protocol using temperatures of 37°C, 42°C and 50°C for 30min each. In addition, 
a thermostable Reverse Transcriptase that operated at temperatures of 70°C was used. 
Neither of these procedures solved the problem. The addition of methylmercury 
hydroxide (Payvar and Schimke, 1979) which is known to disrupt secondary structure 
was considered, but discounted as being too dangerous.
The gcg program mfold based on the method of Zuker (1989) was used to predict 
optimal and suboptimal RNA folding. Only the extracellular region of MARA1 was 
considered as a) this is the region in which all cDNA transcripts appear to be truncated 
and b) the program uses a ‘combinatorial’ method which forms structures by combining
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all potential helices in all possible ways, such that the computation time increases with 
the length of the sequence.
For MARA1, optimal and suboptimal secondary structures were predicted, as 
uncertainties in the folding model and the folding energies do not necessarily result in 
correct folding for the optimal structure.
The optimal structure obtained, Figure 2.35 uses an energy minimum of -159.1 kcal/mol. 
A suboptimal structure with an energy of -158.6 kcal/mol differs only in its representation 
of the extreme N-terminal nucleotides, equivalent to the amino acids asparagine 1 to 
threonine 106. In both structures, base pairing is extensive (as seen by the long stems) 
and hairpin loops are small, suggesting a highly folded region of the molecule.
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Figure 2.35. Optimal RNA secondary structure prediction for the extracellular region of 
MARA1. Structure predicted using the gcg program mfold (Zuker, 1989).
The 5’ end of fragment c is at nucleotide position 301 (indicated on Figure 2.35). The 
mRNA sequence upstream of nucleotide 301 represents the extreme N-terminus and 
shows very tight folding, due to closely spaced hairpin loops. Moreover, the mRNA in the 
extracellular region comprising nucleotides 100-301 is GC rich: guanine and cytisine 
nucleotides represent 53% of the total nucleotides within this region. Thus, this analysis 
helps explain the difficulties incurred in isolating the N-terminus of MARA1.
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In contrast, the same analysis of the extracellular region of Drosophila ALS shows 
relatively larger hairpin loops in both optimal and suboptimal structures. For the optimal 
structures, a maximum of 8 nucleotides in an hairpin loop is seen in MARA1, compared 
with a maximum of 25 in ALS, suggesting that the extracellular region of ALS is less 
tightly folded.
2.5.3 Analysis of the MARA1 sequence
To facilitate comparison, an amino acid alignment between Manduca MARA1 and the 
insect a-like subunits from Drosophila (ALS and Da2/SAD, the latter referred to as SAD 
on alignment) and Schistocerca (aL1 but referred to as ARL2 on alignment) is shown in 
Figure 2.36.
For MARA1, the 5' untranslated sequence of 36 nucleotides is part of a 5' leader 
sequence of unknown size. In Drosophila, these 5' leader sequences vary in length from 
1282 nucleotides in ALS (Bossy et ai, 1988) to only 343 nucleotides in Da2/SAD 
(Sawruk et a i, 1990a). Comparison with Schistocerca aL1 is not possible as only a 
partial length leader sequence of 20 nucleotides has been reported (Marshall et ai, 
1990). These observations suggest that MARA1 may be missing a substantial number 
of nucleotides from its 5' leader sequence. Moreover, the genomic sequence of 
fragment a (Figure 2.16) does not contain any nucleotides resembling a TATA box, that 
would help locate the transcription start site.
The open reading frame of 1548 nucleotides encodes 516 amino acids, the first 21 of 
which have the features of a putative signal peptide, being particularly hydrophobic (11 
out of 21 residues). The first residue of the mature protein is probably asparagine 1 
(nucleotide position 100) as this conforms to von Heijne's rules (1983, 1986) and is 
consistent with predicted signal cleavage sites for other insect a-like subunits of the 
nAChR.
By analogy with other insect a-like subunits (Figure 2.36), the first 219 residues of the N- 
terminus represent the predicted extracellular region of the a-like subunit. The sequence 
CEIDVEYFPFDQQTC at positions 128 to 142 corresponds to the cys loop - a structural 
motif present in all subunits of the nAChR and the two cysteines at positions 201 and 
202 correspond to the vicinal cysteines definitive of a-subunits. As these vicinal 
cysteines are found at positions 192 and 193 in Torpedo (the prototype of the nAChR; 
Noda et a i, 1982; see Appendix 1), but at positions 201 and 202 in insects studied to
113
date, due to a nine residue insertion from positions 164 to 172 inclusive, MARA1 is 
designated an a-like subunit of the nAChR. The cys loop has been indicated in the 
assembly of the subunits of the nAChR: it has been demonstrated that cysteine 128 and 
142 form a disulphide bridge in each subunit to maintain the correct conformation of the 
extracellular region of the nAChR (Mishina et a/., 1985). Although computer modelling 
studies suggest that the cys loop may be a major determinant of agonist binding 
(Cockcroft et al., 1990), there appears to be little experimental evidence to support this 
hypothesis. In contrast, the vicinal cysteines are well documented as part of the agonist 
binding site (reviewed in Devillers-Thiery et al., 1993) and will be discussed further (see 
Agonist and antagonist binding).
Analysis of the mature protein using the gcg program Motifs gave potential N- 
glycosylation sites (Pless and Lennarz, 1977). Glycosylation of an asparagine residue 
appears to be the only post translational modification that affects ligand binding, as 
shown for the a-btx binding site in Torpedo (Mishina et al., 1985). As protein folding 
plays an important role in the regulation of N-glycosylation, it is likely that only the 
extracellular region contains N-glycosylation sites. Potential N-glycosylation sites 
(corresponding to the consensus pattern of (N) X (T,S) where “X” represents any amino 
acid) in the extracellular region of MARA1 are found at amino acid positions 24, 111 and 
212. The first and last are also predicted for ALS (Bossy eta!., 1988), Da2/SAD (Sawruk 
et al., 1990a) and aL1 (Marshall et al., 1990). The site at position 111, although not 
present in the other insect a-like subunits, is present at equivalent positions in chick a7 
and a8 subunits (Couturier et al., 1990b; Schoepfer e ta i, 1990).
Following the extracellular region are three putative transmembrane domains (TM1-3), a 
putative intracellular loop and a fourth putative transmembrane domain (TM4) before the 
C-terminus (by analogy with other insect a-like subunits; see Figure 2.36 and 
Gundelfinger, 1992).
The transmembrane domains are predominantly hydrophobic and exhibit high homology 
with other insect a-like subunits (for example, 96%, 92% and 88% for TM1 with ALS, 
Da2/SAD and aL1 respectively). By analogy with other nAChR subunits, it is predicted 
that TM2 lines the ion channel. Comparison with Torpedo subunits (see Figure 1.3; 
Noda et al., 1983b; Devillers-Thiery et al., 1993) indicates the presence of essential 
residues that putatively form the superimposed rings within the ion channel (see section 
1.2.7). Negatively charged, aspartate and glutamate residues are present in the inner, 
intermediate and outer rings, consistent with subunits of the nAChR from Torpedo (Noda
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et al., 1983b) and may be involved in ion selectivity (reviewed in Bertrand et al., 1993). 
Serine and leucine residues corresponding to the serine and leucine rings are also 
present, however a serine residue is present in the threonine ring, contrasting with the a 
and y subunits of Torpedo but consistent with the p and 5 subunits of Torpedo (Noda et 
al., 1983b). Serine and leucine rings control ion channel gating whereas the threonine 
ring helps control ion size selectivity. Interestingly, analysis of the sequence encoding 
the putative TM2 from MARB1 shows that it contains a threonine residue at the site of 
the threonine ring and it is therefore possible that the p-like subunit in Manduca controls 
ion size selectivity.
The intracellular loop, thought to be the cytoplasmic region of the subunit, shows 
pronounced variability. Most striking, is the shortness of the intracellular loop in MARA1 
compared with other a-like subunits from insects - it is 140 amino acids in length and 
therefore 47 residues shorter than ALS, 40 residues shorter than Da2/SAD and 41 
residues shorter than aL1.
Analysis of the mature protein using the gcg program Motifs gave potential 
phosphorylation sites within the intracellular loop. Phosphorylation does not appear to 
affect ligand binding although it has been demonstrated to be involved in receptor 
desensitisation and subunit assembly (reviewed in Huganir and Greengard, 1990; Green 
et al., 1991). There are several potential phosphorylation sites in the cytoplasmic loop. 
Potential tyrosine phosphorylation sites are found at amino acid positions 417 and 437, 
neither of which are predicted for the other insect a-like subunits. These fit the 
consensus pattern of (R,K) X {2,3} (D,E) X {2,3} Y, where “X” represents any amino acid 
(Patschinsky et al., 1982). Potential protein kinase c phosphorylation sites are found at 
amino acid positions 422 and 428 but not in the other insect a-like subunits. These fit 
the consensus pattern of (S,T) X (R,K), where “X” represents any amino acid (Kishimoto 
et al., 1985; Woodget et al., 1986). However, it is known that the presence of additional 
basic residues at the N or C terminal of the target amino acid increases the maximal 
velocity of the phosphorylation reaction (Woodget et al., 1986) and instead these target 
positions are both close to several acidic glutamate residues, suggesting that they may 
not be true phosphorylation sites. Interestingly, Green et al. (1991) demonstrated that 
phosphorylation of unassembled y subunits led to an increase in assembly of all four 
subunits in cell lines expressing Torpedo nAChRs. As the y subunit is generally 
considered to play a more structural role than the a subunit which is predominantly ligand 
binding, phosphorylation of the a-like subunit in MARA1 may be concerned with 
desensitisation rather than subunit assembly.
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The coding region is stopped by the codon TGA and a 3' untranslated region of 240 
nucleotides follows which contains the putative polyadenylation consensus signal 
AATAAA, 14 nucleotides upstream of the polyadenylate tail.
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Schistocerca ARL2 ............... MAAALP. . . PMLLLLLLLLLHHPAAANPDAKRLYDDLLSNYNRLIRPVSNNTDTVLVKLGLRLSQLIDLNLKDQILTTNVWLEHE
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Figure 2.36. Alignment of insect a-like subunits. Constructed using the gcg program Pileup (Feng and Doolittle, 1987; Higgins and Sharp, 1989) with sequences 
extracted from the Genbank and EMBL databases. SwissProt accession numbers: SAD: p17644; ARL2: p23414; ALS: p09478.
Homology with other a-like subunits
DNA sequence identity between MARA1 and other insect a-like subunit genes was 
analysed for the coding region using the gcg program Distances (Swofford and Olsen, 
1990), using an observed number of substitutions per 100 nucleotides. The following % 
identities were obtained:
D a2/SAD aL1 A LS MARA1
D a2/SAD 100 72 62 59
aL1 100 63 62
ALS 100 64
MARA1 100
Genbank accession numbers used were: Da2/SAD: x52274; aL1: x55439; ALS: x07194.
Complete amino acid sequence identity between MARA1 and other insect a-like subunits 
was calculated with the gcg program Distances (Swofford and Olsen, 1990), using an 
observed number of substitutions per 100 amino acids. The following % identities were 
obtained:
Da2/SAD aL1 ALS MARA1
Da2/SAD 100 82 56 54
aL1 100 57 56
ALS 100 62
MARA1 100
SwissProt accession numbers were: Da2/SAD: p17644; aL1: p23414; ALS: p09478.
Both nucleotide and amino acid identities show the same pattern between the a-like 
subunits. Thus, MARA1 shares the highest identity with ALS from Drosophila, followed 
by aL1 from Schistocerca, and then by D a2/SAD  from Drosophila. D a2/SAD and aL1 
share much greater identity than Da2/SAD and ALS, implying that they are the 
homologous a-like subunits of different species.
This is further emphasised by a basic phylogenetic tree, Figure 2.37, constructed using 
the gcg program GrowTree (Swofford and Olsen, 1990). In order to construct a valid 
tree, the observed distances used to calculate % amino acid identity quoted above were 
corrected for multiple substitutions using the Kimura protein method (Kimura, 1983).
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This is necessary as the probability that more than one substitution occurred at a single 
site increases as the time since the sequences diverged increases, resulting in an 
underestimation of the true distance between all but very closely related sequences.
Figure 2.37. Phylogenetic tree of insect a-like subunits. Constructed using the gcg program 
GrowTree (Swofford and Olsen, 1990).
a L 1 SAD
ALS
MARA1
The tree shows that Da2/SAD and aL1 are the least divergent of the four subunits 
(shown by short vertical lines). MARA1 is the least divergent sequence from ALS but the 
most divergent sequence of the four subunits (i.e. it has the longest vertical line). It is 
known that Drosophila (Diptera) and Schistocerca (Orthoptera) are only distantly related 
in terms of evolution, whereas Manduca (Lepidoptera) and Drosophila are very closely 
related, being members of the division Panorpida (Kristensen, 1981). Therefore, it is 
rather surprising that Da2/SAD and aL1 show such high homology but that MARA1 and 
the Drosophila a-like subunits do not. However, a recent evolutionary study on the 
nAChR (le Novere and Changeux, 1995) suggests that the duplication between ALS and 
the pair, Da2/SAD and aL1 is older than the divergence of Orthoptera and Diptera 
(~300MYA), if it is assumed that Da2/SAD and aL1 are orthologs, i.e. they have arisen 
from the ‘same’ gene in different species. This helps to explain the remarkable similarity 
between Da2/SAD and aL1. Furthermore, it can be predicted that the ortholog of ALS 
also exists in Schistocerca.
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Although, the Lepidoptera were not included in the study, but assuming that the same 
case applies whereby duplication of the subunits of the nAChR occurred before 
divergence of the Lepidoptera and Diptera, it could be predicted that the orthologs of 
ALS and Dcx2/SAD exist in Manduca. Given that the amino acid identity between 
Da2/SAD and aL1 is 82% and that Drosophila and Manduca are more closely related 
than Drosophila and Schistocerca, it would be expected that an ortholog of ALS or 
Da2/SAD would have similarly high identity. However, MARA1 has only 62% amino acid 
identity with ALS and only slightly less with Da2/SAD (54%), suggesting that although 
closely related, it is not the ortholog of either a-like subunit. Furthermore, no other a-like 
subunits in Manduca have been found despite intensive searching. This suggests that 
only one a-like subunit of the nAChR is present in Manduca and therefore that orthologs 
of the Drosophila and Schistocerca a-like subunits do not exist in Manduca.
Homomeric versus heteromeric receptors
It has been demonstrated that insect a-like subunits can form both homo- and 
heteromeric nAChR in vitro. Breer et al. (1985) isolated an homomeric nAChR from 
Locusta migratoria. Reconstitution of this protein in a planar lipid bilayer (Hanke and 
Breer, 1986) demonstrated that cholinergic agonists activated functional ion channels.
Sawruk et al. (1990a) demonstrated that Da2/SAD cRNA elicited agonist evoked 
currents when expressed in Xenopus oocytes and subjected to voltage clamp recording. 
High concentrations of ACh produced small inward currents of 10-50nA, while nicotine 
was able to produce larger currents (~150nA at 20mM) in a concentration dependent 
manner, giving an EC50 value of 10mM.
aL1 has also been shown to form homomeric nAChRs in the Xenopus oocyte expression 
system (Marshall etal., 1990; Amar et al., 1995). Nicotine produced small currents (20- 
120nA) in a concentration dependent manner, giving an EC50 value of 0.83mM (Amar et 
al., 1995). Importantly, these nicotine-evoked currents were blocked by the cholinergic 
antagonists, a-btx and MLA, demonstrating that aL1, as an homomer produced a 
functional nAChR (Amaretal., 1995).
However, for both Da2/SAD and aL1, it is suggested that the atypical size of currents 
and the high E C 50 values for nicotine (considering that both insects are nicotine 
sensitive) reflect the absence of additional subunits necessary for in vivo function in the 
insect. Co-injection of Da2/SAD with the Drosophila p-like subunit, ARD produced no 
significant changes in the response profile though, indicating that it was either unlikely to
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be the other subunit expressed with Da2/SAD or that yet another subunit was necessary 
for more typical expression (Sawruk et al., 1990a).
In both these cases, it may be that small currents are only produced due to inefficient 
assembly of invertebrate proteins by a vertebrate expression system. This quandary 
could be solved using an invertebrate expression system such as baculovirus (for an 
example of the expression of Drosophila GABA receptors see Lee et al., 1993) or the 
Drosophila S2 cell line (Millar et al., 1994).
Bertrand et al., 1994, demonstrated that neither ALS nor Da2/SAD formed functional 
receptors as homomers (the latter contrasting to data from Sawruk et al., 1990a) but 
would function when co-expressed with the chick p2 subunit (but not with ARD). The two 
Drosophila subunits gave different characteristics, EC50 values for ACh being 0.18pM 
and 35pM and for nicotine being 1.3*iM and 7.4pM for ALS and Da2/SAD respectively. 
ALS/p2 was blocked by a-btx whereas Da2/SAD/p2 was not blocked by a-btx. Thus the 
Drosophila subunits ALS and Da2/SAD do respond to physiological concentrations of 
cholinergic agonists when co-expressed with an appropriate p-subunit. This suggests 
that although Da2/SAD can undoubtedly function as an homomer, it functions better as 
an heteromer, which may be its native state.
Given that MARA1 has the greatest sequence homology with ALS and that it appears to 
be more closely related evolutionary to ALS rather than Da2/SAD or aL1, it may be 
expected that it forms part of an heteromeric nAChR. For this to occur, p-like subunits 
would have to exist in the Manduca nervous system. Indeed, a partial length cDNA 
encoding a putative p-like subunit has been isolated from Manduca (MARB1) in this 
laboratory (J. Eastlake and A. Wolstenholme, unpublished data) indicating that 
heteromeric receptors for Manduca must exist. To determine whether MARA1 and 
MARB1 can function as subunits in the same nAChR though, will require the generation 
of full-length cDNAs.
The existence of more than one Drosophila a-like and p-like subunit of the nAChR form a 
precedent for other insects. Currently, three a-like subunits and two p-like subunits have 
been found in Drosophila and one of each has been isolated from Schistocerca. 
Moreover, Hermsen et al. (1991) have reported the isolation of four a-like subunits and 
two p-like subunits from another member of the Orthoptera, Locusta migratoria which 
they suggest form heteromeric nAChRs. However, the experiments reported in this 
study provide no evidence for the existence of additional subunits in Manduca.
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Agonist and antagonist binding
The agonist binding site is a pre-requisite for a functional nAChR. Affinity labelling and 
site directed mutagenesis experiments have resulted in the identification of residues 
required for ligand binding. The photoactivatable cholinergic ligand, p-N,N- 
dimethylaminobenzene diazonium fluoroborate (DDF) labels amino acids from three 
different regions of the N-terminal extracellular region in Torpedo (Dennis et al., 1986, 
1988; Galzi etal., 1990), suggesting a multiple loop model for cholinergic binding. These 
are residues tryptophan 86 and tyrosine 93, tryptophan 149 and tyrosine 151, and 
tyrosine 190, cysteine 192, cysteine 193 and tyrosine 198 (see Appendix 1 and Figure 
1.3) which in MARA1 correspond to residues tryptophan 86, tyrosine 93, tryptophan 149, 
tyrosine 151, tyrosine 199, cysteine 201, cysteine 202 and tyrosine 206 (see Figure 
2.34). It is thought that the tyrosines, which show electronegativity attract the quaternary 
ammonium of ACh.
Site directed mutagenesis of the a subunit of the nAChR and subsequent expression in 
Xenopus oocytes has shown that mutation of cysteine 192 and cysteine 193 in Torpedo 
results in the total loss of ACh evoked responses compared with the wild type receptor. 
In addition there is a marked decrease in the apparent binding affinity for ACh (Mishina 
et al., 1985). This indicates that cysteines 192 and 193 are imperative for ACh binding 
and activation of the receptor. Further experiments using the chick a7 receptor (Galzi et 
al., 1991) have demonstrated that tyrosine 92, tryptophan 148 and tyrosine 187 (in 
Manduca, corresponding residues are tyrosine 93, tryptophan 149 and tyrosine 199), 
when mutated to phenylalanine, give a 10-fold (Y92F, Y187F) or 100-fold (W148F) 
reduction in apparent ACh affinity whereas they give a 2-fold (Y92F, Y187F) or 300-fold 
(W148F) reduction in apparent nicotine affinity. Therefore, although all these residues 
are necessary for agonist binding, the two agonists ACh and nicotine do not establish the 
same interactions with these three residues. It appears that tryptophan 148 is essential 
for nicotine binding while tyrosine 92 and tyrosine 187 are less crucial. Given these 
findings, if MARA1 were truly resistant to nicotine and thus gave a different agonist 
profile to that of nicotine sensitive receptors, it might be expected that at least one of 
these residues would be replaced with a residue unable to form the correct bonds with 
nicotine but not necessary or still able to form the correct bonds with ACh. In this 
respect, tryptophan 148 seems an ideal candidate. More recently, replacement of 
tryptophan 54 of the chick a7 receptor (corresponding to tryptophan 55 in Manduca) by a 
phenylalanine, alanine or histidine residue has been shown to cause a progressive 
decrease in binding affinity and in responses for ACh and nicotine (Corringer et al., 
1995). Taking nicotine for example, the EC5o of the wild type receptor was 4.3|iM,
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whereas mutations gave EC50 values of 7.1\M  for W54F, 45pM for W54A and 200^iM for 
W54H. The authors suggested that tryptophan 54 was part of a ‘complementary 
component’ of the a7  binding site, as opposed to the three loop ‘principal component’ 
and was equivalent to the non-a contribution from 8  and y subunits in the muscle 
receptor (see Chapter 1, section 1.2.7). Analysis of the extracellular region of MARA1, 
however, reveals that all these residues are present, as shown in Figure 2.38.
Clarke (1991) speculated that glutamate 133 within the cys loop of MARA1 may 
contribute toward Manduca's nicotine insensitivity. This is based on the ligand binding 
model of Cockcroft et al. (1990) which proposes that the cys loop of the ligand gated ion 
channel superfamily determines their ligand specificity. However, it should be 
emphasised that there is no experimental data to support this model. As all nAChR 
subunits contain this cys loop whereas the a subunit is considered the major ligand 
binding subunit, it seems unlikely that it plays a predominant role in ligand binding. 
Interestingly however, the cys loop has been implicated in the binding of allosteric 
effectors of the nAChR such as physostigmine, which activates the nAChR at low 
concentrations and blocks the open ion channel at high concentrations (see Chapter 1, 
section 1.2.7). Activation of the nAChR by physostigmine was not blocked by a-btx, in 
contrast to the physostigmine-competitive antibody FK1 (Okonjo etal., 1991), suggesting 
that physostigmine was binding to a site distinct from ACh. Mapping of the dominant 
prototope of the FK1 antibody established that physostigmine bound to the sequence 
a118-137 of Torpedo (Schroder et al., 1994). This region included lysine 125, the amino 
acid photoaffinity labelled by tritiated physostigmine (Schrattenholz et al., 1993) and 
overlapped with the cys loop.
The key residue that defines specificity in Cockcroft and colleagues’ computer generated 
model is threonine 133 which is found through a1 to a6  and a9 subunits. However, in a7 
and a 8 , subunits known to bind nicotine, this residue is an arginine. Comparison of 
insect receptor sequences shows that in Da2/SAD and aL1 it is an arginine whereas in 
MARA1 and ALS it is a glutamate. If this hypothesis is correct, it begs the question is 
ALS nicotine sensitive? Although expression of ALS alone has shown no ACh or 
nicotine evoked responses (Bertrand etal., 1994), co-expression with a chick p2 subunit 
has shown sensitivity to low concentrations of nicotine (EC50: 1.3pM). Furthermore, the 
ALS clone was isolated from a nicotine sensitive strain of Drosophila. Therefore, it 
appears unlikely, that this residue is a candidate amino acid for nicotine insensitivity in 
Manduca. Thus, it seems that MARA1 does not contain any obvious candidate residues 
pertaining to nicotine insensitivity, suggesting one or more of the following: a) that the
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nicotine insensitivity seen in Manduca is not due to an altered residue(s) within the 
agonist binding site; b) that there is a mutated subunit but MARA1 is not it (unlikely as 
this study presents no evidence of other a-like subunits); or c) that other subunits make 
contributions to binding in such a way that there is a reduced sensitivity to binding of 
nicotine. The latter point is the focus of the next chapter, where it will be discussed 
further.
-21 MRSVTKYYLH GWLFATGCA GNPDAKRLYD DLLSNYNKLV 19
20 RPVLNVSDAL TVRIKLKLSQ LIDVNLKNQI MTTNLWVEQS 59
60 WYDYKLSWEP REYGGVEMLH VPSDHIJ7RPD IVLYNNADGN 99
100 FEVTLATKAT LNYTGRVEWR PPAIYKSSCE IDVEYFPFDQ 139
140 QTCVMKFGSJT TYDGFQVDLR HIDEVRGTNV VELGVDLSEF 179
180 YTSVEWDILE VPAVRNEKFY TCCDEPYLDI TFNITMRRK 218
Figure 2.38. Residues in the extracellular region of MARA1, potentially involved in ligand 
binding. Bold, italicised residues in Torpedo were labelled by DDF (Dennis et al., 1986, 1988; 
Galzi et al., 1990); bold underlined residues mutated to phenylalanine produced decrease in 
binding affinity for ACh and nicotine in the chick a7 receptor (Galzi et al., 1991).
The residues involved in binding of the antagonist, a-btx, are somewhat disputed. Being 
a large molecule (8kd) it is thought that a-btx binding results in a large conformational 
change of the receptor (McCarthy and Stroud, 1989). Indeed, Mishina et al. (1985) 
demonstrated that mutation of cysteine 128 and cysteine 142 in Torpedo, thus abolishing 
their disulphide linkage and the conformation of the subunit and perhaps intersubunit 
assembly, resulted in no a-btx binding. Furthermore, removal of the putative 
glycosylation site at asparagine 141 in Torpedo prevented a-btx binding, showing that 
the N-glycosylation site was essential for correct conformation of the nAChR.
It is generally agreed that a-btx binds in the region immediately prior to and after the 
vicinal cysteines. Evidence from experiments using muscle nAChRs from a-btx resistant 
species such as snake and mongoose (Barchan et al., 1995; Kachalsky et al., 1995) 
suggests two subsites at the a-btx binding site: an aromatic subsite at Torpedo positions 
187 and 189 before the vicinal cysteines and a proline subsite at Torpedo positions 194 
and 197 after the vicinal cysteines. The neuronal nAChRs that bind a-btx (a7 and a8 on 
alignment, Figure 2.39) have two close proline residues separated by a tyrosine residue, 
three residues downstream from the vicinal cysteines. Those that do not bind a-btx have
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either one or no proline residues in this region. Kachalsky et al. (1995) proposes that the 
two spaced proline residues can form a loop at the ligand binding site which could be 
important for binding of a-btx. The proline subsite appears to be critical for a-btx binding 
whilst the aromatic subsite appears to determine the degree of binding or resistance to 
a-btx.
Comparison with insect a-like subunits creates an even more confusing picture, as 
shown in the alignment of this region, Figure 2.39.
Figure 2.39. Alignment of potential a-btx binding site. Drosophila SAD: Sawruk et al., 1990a; 
Schistocerca aL1: Marshall etal., 1990; Drosophila ALS: Bossy et al., 1988; Chick a7: Couturier et 
al., 1990b; Schoepfer etal., 1990; Chick a8: Schoepfer etal., 1990; Chick a1, a2: Nef et al., 1988.
As expected, the neuronal a-btx binding subunits a7 and a8 possess the proline subsite, 
albeit downstream from that for muscle a1 (muscle at positions 194 and 197) whereas 
the neuronal non-a-btx binding a2 does not. Both Da2/SAD and aL1 have the proline 
subsite suggesting that they can bind a-btx whereas ALS and MARA1 only possess one 
proline residue implying that they should be a-btx resistant. Excepting a1 (which has 
two) and a2 (which has none), all subunits have one aromatic residue in the aromatic 
subsite.
Contradicting this hypothesis is the evidence that bacterial fusion proteins containing the 
potential ligand binding site of ALS were shown to bind iodinated a-btx with a Kd of 
1.7pM (Ohana and Gershoni, 1990) whereas a-btx failed to block nicotine-evoked 
currents in Xenopus oocytes expressing Da2/SAD (Sawruk et al., 1990a). However, this 
failure of a-btx to block currents was attributed by the authors to almost instantaneous 
dissociation of the a-btx in the presence of excess competing ligand. On the other hand, 



















heteromeric receptors; Bertrand et al., 1994) substantiated the experimental data 
obtained from Ohana and Gershoni (1990) and Sawruk et al. (1990a). To confuse 
matters further, nicotine-evoked currents of aL1 were blocked by a-btx (Marshall et al., 
1990; Amar etal., 1995).
It is therefore apparent that the residues used in binding of a-btx to insect subunits 
cannot be surmised by simple comparison with vertebrates. It is likely that the tertiary 
and quaternary structures play a large role in the binding of this toxin (Chatrenet et al., 
1990).
In order to determine the ability of nAChRs to bind nicotine in Manduca, an investigation 
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3.1 Introduction
Recent developments in molecular biology techniques have led to the cloning of 
numerous nAChR subunits, with similar but distinct sequences (see Chapter 1, section
1.2.4). Consequently, the need to distinguish between receptor subtypes in the nervous 
system has never been so great. Fortunately, this has been aided by the utilisation of 
specific ligands (generally natural toxins) which interact with the different receptor 
subtypes to give a range of binding affinities and selectivities giving a pharmacological 
profile typical for each receptor subtype. Functional expression, such as that using two 
electrode voltage clamp recording from receptors expressed in Xenopus oocytes aims to 
impart a particular pharmacological characterisation for each individual receptor subtype 
(see Chapter 1, section 1.2.5). However, this is far more difficult in the intact nervous 
system, given the potential for heterogeneity and the possibility that the subunit 
combinations that are being expressed in the oocytes are not representative of the native 
nAChR.
3.1.1 The relationship between radiolabelied binding sites and cioned subunits
Targeting of particular receptors in intact nervous tissue has generally employed specific 
radioligands. For nAChRs to be radiolabelled by a cholinergic ligand, they must be able 
to bind the same unlabelled ligand with high affinity.
fHJNIcotine
Nicotine, by definition interacts with all nAChRs but only those that bind nicotine with 
nanomolar affinity are labelled with [3H]nicotine. This property has been used to great 
advantage in numerous studies of the vertebrate brain nAChRs which have shown that 
[3H](-)nicotine binds to a single binding site that is both saturable and labelled with high 
affinity (Marks et a/., 1986; Lippiello et ai., 1987; Martino-Barrows and Kellar, 1987). 
Furthermore, the binding site shows 30 to 50-fold selectivity for the (-) stereoisomer 
compared with the (+) stereoisomer (Martino-Barrows and Kellar, 1987). Despite the 
potential for diversity, the radiolabelied agonists [3H]nicotine, [3H]acetylcholine, N- 
[3H]methylcarbamylcholine and ^HJcytisine have virtually identical pharmacological 
characteristics and regional distribution in rat brain (Marks et al., 1986; Martino-Barrows 
and Kellar, 1987; Anderson and Americ, 1994), suggesting that they all label the same 
neuronal nAChR subtype.
Immunopurification of nAChRs from rat brain using a monoclonal antibody (MAb) 
directed against the chick p2 subunit, resulted in the isolation of two subunits, namely a4
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and p2 (Whiting and Lindstrom, 1987b; see Chapter 1, section 1.2.5). 
Immunoprecipitation of detergent solubilised rat brain extracts using MAbs specific for 
either of these subunits removed over 90% of the high affinity fHJnicotine binding sites 
from solution, implying that the fHJnicotine binding site was found on receptors 
comprising a4 and p2 subunits (Whiting and Lindstrom, 1986b). This was confirmed by 
Flores et al. (1992) who demonstrated that the high affinity ^HJcytisine binding sites in 
rat brain extracts were removed by antisera to a4 and p2 subunits (reviewed in Sargent, 
1993).
Significantly, the newly marketed radioligand [3H](±)epibatidine putatively binds to a3 
subunits (McKay et al., 1994; Houghtling et al., 1995) as well as a4 subunits because of 
its higher affinity and thus widens the scope of pharmacological investigation for 
neuronal subunits.
[125l]a-Bungarotoxin
In contrast, the radioligand [125l]a-bungarotoxin ([125l]a-btx) does not appear to bind to the 
same site (Clarke et al., 1985), prefering the muscle nAChR and certain a-btx sensitive 
neuronal nAChRs. Indeed, for some time, it was considered that only the muscle type 
nAChR bound a-btx, such that these neuronal sites were termed a-Bungarotoxin Binding 
Proteins (a-BgtBPs) 1 and 2 (Schoepfer et al., 1990).
However, the available evidence strongly suggests that these neuronal a-btx binding 
sites correlate with a7 subunits in chick and possibly also a8 subunits in chick. 
Couturier et al. (1990b) demonstrated that a bacterial fusion protein incorporating the 
predicted agonist and toxin binding sites of the a7 subunit bound [125l]a-btx and 
Schoepfer et al. (1990) showed that MAbs against recombinant peptide fragments from 
variable regions of chick a7 and a8 identified bands of affinity purified a-BgtBP on 
Western blots. Moreover, it was demonstrated that nAChRs containing a7 subunits were 
the predominant a-BgtBPs in the chick brain as anti-a7 MAbs recognised at least 90% of 
the a-BgtBPs in depletion and immunoprecipitation assays. Interestingly, anti-a8 MAbs 
recognised ~15% of the [125l]a-BgtBPs in depletion assays, all of which were recognised 
by anti-a7 MAbs, suggesting that two different a subunits could be present in the same 
nAChR (reviewed in Clarke, 1992; see Chapter 1, section 1.2.5). More recently, 
Elgoyhen etal. (1994) have demonstrated that the a9 subunit displays high affinity for a- 
btx, however as this was not located in the central nervous system (see section 3.1.2, 
mixed nAChRs) it is unlikely that it accounts for any remaining a-BgtBPs.
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3.1.2 AChRs in insects
Nicotinic AChRs
As discussed in Chapter 1 (sections 1.1.2 and 1.3.1), radioligand binding on the nervous 
system tissues of a variety of insects has demonstrated the existence of an a-btx binding 
component that exhibits the properties of an AChR. Evidence of an a-btx binding site in 
Manduca was first presented by Sanes et al. (1977) who showed that a-btx binding 
activity increased throughout metamorphosis, was specific to nervous tissue and was 
blocked by the cholinergic agents carbamylcholine, d-tubocurarine and nicotine. Its 
pharmacological profile was such as to be considered an AChR. This was supported by 
further evidence demonstrating that the a-btx binding sites were localised in the 
glomeruli of the antennal lobes which contain all of the ultrastructurally known synapses 
(Hildebrand etal., 1979; see Chapter 1, section 1.1.2). Binding studies performed using 
Drosophila melanogaster (Schmidt-Nielsen et al., 1977; Dudai, 1978; Rudloff, 1978; 
Schloss et al., 1988) and Musca domestica (Mansour et al., 1980; Cattell et al., 1980a) 
further defined this a-btx binding component as a nicotinic AChR with pharmacological 
characteristics close to those found in vertebrates. It is tempting to draw correlations 
between vertebrate and insect pharmacology. Given that in vertebrates, a7 subunit- 
containing receptors bind a-btx, it could be very tentatively suggested that an a7-like 
subunit nAChR exists in insects. As yet, various interpretations of molecular and 
pharmacological data remain inconclusive.
Mixed AChRs
There is little evidence in the literature to suggest that an equivalent site to the vertebrate 
[3H]nicotine / [3H]acetylcholine site exists in insects. Instead, a putative mixed AChR 
displaying both nicotinic and muscarinic pharmacological characteristics has been 
proposed. Initially, Eldefrawi and O'Brien (1970) discovered that binding of 
[3H]muscarone (an AChR agonist effective on both nicotinic and muscarinic synapses) in 
Musca was inhibited by both nicotinic and muscarinic ligands. Since then, this putative 
mixed receptor has been purified and extensively characterised using the radiolabels 
fHJacetylcholine, [3H]decamethonium and [3H]nicotine (Cattell et al., 1980b; Mansour et 
al., 1980). This receptor does not bind a-btx but nicotine and muscarine inhibit, for 
example, ^HJdecamethonium binding with very similar IC50 values (6.5pM and 4pM 
respectively). Furthermore, this putative receptor can be solubilised without the use of 
detergents and is 50-fold and 1000-fold more concentrated than the nicotinic and 
muscarinic receptors of Musca respectively (Eldefrawi et al., 1982). Given that there is 
no functional electrophysiological data from Musca neurons, proving the existence of a
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mixed receptor, there is some speculation over the origin and physiological role of these 
mixed receptors in Musca. However, a similar putative receptor has been isolated from 
nerve cord extracts of the cockroaches, Gromphadorhina portentosa and Periplaneta 
americana (Aziz and Eldefrawi, 1973). More recently, a vertebrate subunit designated 
a9, has been identified that also has unusual mixed nicotinic-muscarinic pharmacology 
(Elgoyhen et al., 1994). When the a9  subunit was expressed either alone or in 
conjunction with p2 or p4 subunits in Xenopus oocytes it was not activated by either 
nicotine or muscarine, the definitive agonists of the nAChR and mAChR respectively. 
However, currents were elicited from a9 injected oocytes by the nicotinic agonist 1,1- 
dimethyl-4-phenylpiperazinium (DMPP) and the muscarinic agonist oxotremorine-M. In 
situ hybridisation demonstrated that a9 subunits were not found in the central nervous 
system, rather they were located in the pars tuberalis of the hypophysis, the nasal 
epithelium, the hair cells of the cochlea and the skeletal muscle of the tongue. How this 
finding reflects on the insect mixed receptor is unclear.
Muscarinic AChRs
Muscarinic AChRs have also been found in membrane extracts of nervous tissue from 
insects using the radiolabel pHjquinuclidinyl benzilate ([3H]QNB). Unlike vertebrates, in 
insects, muscarinic receptors appear to be fewer in quantity than nicotinic receptors (Bmax 
of 65fmol/mg protein for ^HJQNB binding compared with a Bmax of 300-800fmol/mg 
protein for [125l]a-btx binding in Drosophila; Dudai, 1978; Haim etal., 1979). Two putative 
mAChRs in Manduca have been recently characterised using the inhibition of pHjQNB 
binding. The high affinity site has a Bmax of 23fmol/mg protein whereas the low affinity 
site has a Bmax of ~800fmol/mg protein (Trimmer et al., 1993).
Manduca AChRs
Interestingly, Sanes et al. (1977) suggested that the a-btx binding component 
investigated in their study of Manduca was of the mixed nicotinic-muscarinic subtype, as 
it was sensitive to both nicotine and atropine. However, full dose response curves were 
not obtained, the one concentration of competing ligand was high (200pM) and a crude 
membrane preparation was used. As it was shown in Musca that the mixed receptor did 
not bind a-btx (see mixed AChRs above) it seems unlikely that this is the case in 
Manduca. This is further discussed in section 3.5.
Functional analysis of putative receptors on the motoneurone PPR of Manduca 
suggested the presence of both nicotinic and muscarinic AChRs (see Chapter 1, section 
1.1.3; Trimmer and Weeks, 1989). As with an earlier study completed by Morris (1984),
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it was suggested that the nAChRs tested were relatively insensitive to nicotine and that 
this may be due to a modified nAChR in Manduca (see Chapters 1 and 4 for a more 
extensive discussion).
Therefore the aim of this study (Chapter 3) is to provide a pharmacological profile of the 
nAChR in Manduca by employing the specific binding of the radioligands [125l]a-btx and 
[3H](±)epibatidine and their inhibition by assorted ligands. Most importantly, the 
endogenous ligand ACh and the definitive ligand nicotine are investigated. In addition, 
another alkaloid found in tobacco, anabasine, a cholinergic insecticide, imidacloprid and 
the highly potent frog toxin epibatidine are used. a-Btx and methyllycaconitine (MLA), a 
selective a7 inhibitor, are included as the antagonists in the study. The effects of 
muscarinic agents and acetylcholinesterase (AChE) inhibitors are also determined. 
Comparison of adults and larvae is made as it would be expected that larvae would show 
greater discrimination for nicotine binding than adults if Trimmer and Weeks’ (1989) 
observations hold for binding experiments (see Chapter 1, section 1.1.3).
3.1.3 Characteristics of specific binding
In a radioligand binding assay, two types of binding site are available to which the 
radioligand can bind. These are specific sites and non-specific sites. In the case of a 
selective and highly potent ligand such as [125l]a-btx on a-btx sensitive nAChRs, most of 
the binding will be to specific sites. However, the following criteria (Satelle, 1985) must 
be met in order to conclude that specific rather than non-specific binding is taking place:
1) The specific binding should saturate with increasing concentrations of radiolabel, 
showing that there is a finite number of receptor sites.
2) Ligands with the same receptor binding site specificity as the radiolabel should 
displace binding of the radiolabel at pharmacologically effective concentrations whilst 
those ligands that have a different receptor binding site specificity should be ineffective.
3) The saturating, specific binding should be located at tissue regions known to contain 
the receptors.
Although not a criterion, it is also necessary to select conditions whereby specific binding 
increases linearly with increasing tissue concentration. In this study, points 1 and 2 are 
studied. Hildebrand et al. (1979) have previously addressed point 3. For a detailed
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explanation of receptor-ligand interactions refer to Bylund and Yamamura (1990). 
Binding studies were carried out in collaboration with Robert Lind (University of Bath).
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3.2 Materials
Manduca were obtained from the University of Bath Manduca colony, where they were 
reared in a controlled environment room at 25 ± 0.5°C, 50 ± 10% relative humidity, with a 
light, dark cycle of 17 : 7hours. Larvae were raised on an artificial diet (Bell and 
Joachim, 1976) comprising wheatgerm, casein, sucrose, yeast, salts, vitamins and 
preservatives, bound together with agar in water (J. Gillespie, 1995). Manduca were 
precisely staged and dissected by Professor Stuart Reynolds and Audrey Brown.
a-Btx and (t)epibatidine dihydrochloride were supplied by Research Biochemicals 
International (RBI) and distributed by Semat, St. Albans, U.K. [125l]a-Btx (specific activity: 
~750Ci/mmol) was prepared by Dr. Adrian Rogers (University of Bath). 
[3H](±)Epibatidine (specific activity: 57Ci/mmol; 1mCi/ml) was supplied by NEN-DuPont 
(U.K.) Ltd., Stevenage, U.K.
ACh bromide, (±)anabasine (neonicotine) and (-)nicotine hydrogen di (+) tartrate, were 
obtained from the Sigma-Aldrich Chemical Company Ltd. (Sigma), Poole, U.K. 
Imidacloprid was a gift from Zeneca Agrochemicals, Jealott's Hill Research Station, U.K. 
MLA citrate was obtained from RBI.
The muscarinic ligands, atropine, (±)muscarine chloride and oxotremorine were 
purchased from Sigma, as were the acetylcholinesterase inhibitors, BW284c51 (1,5 bis(4 
allyl dimethylammoniumphenyl)pentan3one dibromide), neostigmine bromide, 
physostigmine (eserine) and THA (9 amino 1,2,3,4 tetrahydroacridine hydrochloride).
The protease inhibitors, leupeptin, pepstatin A and PMSF 
(phenylmethylsulphonylfluoride) were from Sigma, as were BSA fraction V and PEI 
(polyethylenimine). GF/C filters were obtained from Whatman International Ltd., 
Maidstone, U.K. The Bio-Rad protein assay was supplied by Bio-Rad Laboratories Ltd., 
Hemel Hempstead, U.K. All other chemicals were from Fisons Scientific Equipment, 
Loughborough, U.K.
All drugs used in binding assays were made as 10mM stock solutions in incubation 





The protocols used were based on the Drosophila particulate membrane preparation of 
Schmidt-Nielsen etal. (1977).
Preparation of adult P2 membranes
Manduca pharate adults were killed by decapitation. Brains (protocerebrum and optic 
lobes) were dissected and either used immediately or frozen in liquid nitrogen and stored 
at -70°C.
Solutions were kept on ice throughout and all equipment was cooled to 4°C before use. 
Generally, adult preparations used approximately 250 brains. Brains were homogenised 
manually in an homogeniser (glass mortar, PTFE pestle) containing (7%(w/v)) isolation 
buffer (0.32M sucrose, lOO^M EDTA, pH7.2) supplemented with the protease inhibitors 
leupeptin (1^M), pepstatin A (V M ) and PMSF (200pM). The homogenate was 
centrifuged at low speed for 15min and the resulting supernatant (S1) split between 
microcentrifuge tubes and centrifuged at 15000g for 30min. Pellets (P2) were combined 
and resuspended in incubation buffer (0.05M Tris-CI, 0.12M NaCI, 100pM EDTA, 0.25% 
(w/v) BSA, pH7.4) to a concentration of 10 brains/ml. The P2 membrane preparation 
was stored in aliquots (1ml) at -20°C.
Preparation of larval P2 membranes
First instar larvae were collected within one day of hatching from eggs, frozen in liquid 
nitrogen and stored at -70°C until required.
Solutions were kept on ice throughout and all equipment was cooled to 4°C before use. 
Whole larvae (approximately 10g per preparation) were homogenised in a rotary 
homogeniser (glass mortar, PTFE pestle) by repeated up and down strokes at 
approximately 3000rpm, using supplemented isolation buffer (66% (w/v)) as for adults. 
The homogenate was centrifuged at low speed for 15min. The resulting supernatant 
(S1) was filtered through nylon cloth and the filtrate split into microtubes and centrifuged 
as for adults. Pellets (P2) were combined and resuspended in incubation buffer to a 
concentration of 0.8g larvae/ml. P2 pellets were stored in 1ml aliquots at -20°C.
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3.3.2 Protein determination
The concentration of protein in each preparation was measured using the Bio-Rad 
Protein Assay based on the Bradford dye binding procedure (Bradford, 1976). Standard 
curves were constructed using BSA over the range 5-20pg/ml. Duplicates (total volume: 
800pl) of adult or larval P2 membranes in incubation buffer were serially diluted in water 
between the range 1:200 to 1:3200. Dye reagent concentrate (200pl) was added to 
each sample, mixed thoroughly and the colour left to develop over 10min. Water 
controls, treated with dye reagent concentrate were used as zero absorbance blanks. 
The absorbancies at 595nm were measured on a Perkin Elmer UVA/IS Lambda 11 
spectrometer. The BSA standard curves obtained were used to determine protein 
concentrations of the membrane preparations, taking into account the BSA (2.5mg/ml) 
contained in the incubation buffer.
3.3.3 f^lJa-Bungarotoxin GF/C filter binding assays
The following experiments were based on these three principles behind the experimental 
measure of specific binding.
1) Total binding of radioligand to all available sites was determined by incubation of 
membranes with radioligand.
2) Non-specific binding of the radioligand was determined by displacement of total 
binding by excess unlabelled ligand that competes for the same binding site.
3) Specific binding of the radioligand was calculated as the difference between total and 
non-specific binding.
The protocol followed was based on that by Schmidt-Nielsen et al. (1977). Assays were 
carried out as duplicate determinations at room temperature, using incubation buffer (as 
previously) and P2 membranes (23pg for adults; 93pg for larvae) in a total volume of 
200pl. Total binding was determined by the addition of [125l]a-btx to a final concentration 
of 1nM in adult assays or 5nM in larval assays and non-specific binding was determined 
in the presence of excess unlabelled a-btx (final concentration of 1 pM for adults or 5(iM 
for larvae). Controls without P2 membranes were also included. Samples were mixed 
thoroughly and incubated at room temperature for 60min.
Incubation buffer (3ml) was added to each sample and bound and free ligand separated 
by rapid filtration through GF/C filters (pre-soaked overnight in 0.3% (v/v) PEI) on a 
Millipore vacuum manifold. Sample tubes were rinsed once in incubation buffer and the 
filters washed twice with 5ml incubation buffer within 30s. Bound radiolabel on the filters
136
was counted on a Packard Cobra II gamma counter. Specific binding was calculated by 
subtracting non-specific binding from total binding. To ascertain total levels of 
radioactivity, a count of [125l]a-btx corresponding to the total amount of radioligand used 
in an individual sample was taken for each experiment.
3.3.3.1 Protein dependence of [125l]a-bungarotoxin binding
The dependence of [125l]a-btx binding on protein concentration was investigated for both 
adult and larval P2 membranes. P2 membranes were diluted in incubation buffer to give 
different protein concentrations and total and non-specific binding determined as above. 
Specific binding was calculated as the difference between total and non-specific binding.
3.3.3.2 Time and temperature dependence of [125i]a-bungarotoxin binding
To establish appropriate reaction conditions, the rate of [125l]a-btx binding to P2 
membranes was measured for adults over 3h, at room temperature (25°C) and at 37°C. 
Specific binding was determined for each time point as the difference in total and non­
specific binding as described above.
3.3.3.3 Saturation binding
The saturability of [125l]a-btx binding sites on P2 membranes from both adults and larvae 
was investigated. Concentration ranges for [125l]a-btx of 0.1-30nM and 0.5-30nM were 
used for adults and larvae P2 membranes respectively. Total and non-specific binding 
was determined for each [125l]a-btx concentration as described above and the resultant 
specific binding isotherm used to derive Bmax and Kd values (see section 3.3.5).
3.3.3.4 f 2Sl]a-Bungarotoxin competition binding assays
A variety of cholinergic ligands were used in competition binding assays, to adult and 
larval P2 membranes. Drugs, over an appropriate concentration range, generally nM to 
mM, were pre-incubated with P2 membranes in incubation buffer, at room temperature 
for 10min, before addition of [125l]a-btx, and incubation of samples as described above. 
Total and non-specific binding were determined as above. The resultant specific binding 
was used to calculate the IC5o and Kj value for each drug (see section 3.3.5).
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Pre-incubation of (-)nicotine
To detect the existence of substantial nicotine breakdown by metabolic enzymes in the 
P2 membrane preparations, the first (-)nicotine competition binding assay with [125l]a-btx 
was carried out using pre-incubation times of 0, 10 and 60min. The zero time point was 
incubated at 4°C, whereas 10 and 60min pre-incubation samples were incubated at room 
temperature. Specific binding was determined as the difference in total and non-specific 
binding as described above.
3.3.4 fH](±)Epibatidine binding assays
[3H](±)Epibatidine binding assays were carried out as duplicate determinations at room 
temperature, using incubation buffer (as previously) and P2 membranes (23|xg for adults; 
93^g for larvae) in a total volume of 200|il. Total binding was determined by the addition 
of [3H](±)epibatidine to a final concentration of 1 or 10nM while a-btx and (-) nicotine 
were used at high concentrations to assess specific [3H](±)epibatidine binding to adult 
and larval membranes. a-Btx (1pM for adults, 5^M for larvae) and (-)nicotine (1mM for 
adults and larvae) were pre-incubated with P2 membranes in incubation buffer, at room 
temperature for 10min, prior to addition of 1 or 10nM [3H](±)epibatidine and incubation of 
samples. Controls without P2 membranes were also included. Samples were mixed 
thoroughly and incubated at room temperature for 60min. Bound radioligand on the 
filters was counted in 5ml Optiphase 'Safe' scintillant using a Packard Tricarb 1600 TR 
scintillation spectrometer (counting efficiency 40%). Controls without membrane and 
total radioactivity counts were taken.
3.3.5 Data analysis
The parameters Bmax (the maximum number of binding sites) and Kd (the dissociation 
constant for the equilibrium binding of the radiolabel) were determined from [125l]a-btx 
saturation binding. Saturation data and also protein dependence and time course assay 
data were fitted to first order linear regression plots or rectangular hyperbolas using 
equation (1):
y  =  (B max.x ) /(K d + x ) (1 )
where y = amount of radioligand bound and x = protein or radioligand concentration. 
B max and Kd were derived from the curve fit of the specific binding isotherm.
Saturation data was transformed using equation (2):
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B/F = (-1/Kd)B + Bmax/Kd (2)
where B = bound radiolabel and F = free radiolabel, to produce a Scatchard plot 
(bound/free radiolabel versus bound radiolabel) indicative of a single or multiple binding 
site(s) model.
The parameters, IC5o (the concentration of the competing drug that inhibits 50% of the 
specific binding) and Kj (the affinity of the inhibitor for the receptor) were determined from 
competition binding assays. IC5o values were derived for each experiment by fitting to 
the Hill equation (3):
B = 100%/(1+([ligand]/ICso)nH) (3)
where B = % bound radiolabel, [ligand] = concentration of displacing ligand and nH = Hill 
number.
Each IC 50 value was used to calculate the Kj value by the method of Cheng and Prusoff 
(1973) (4):
Kj= IC5o/(1+([radioligand]/Kd)) (4)
where [radioligand] = concentration of radioligand.
For each concentration of drug, the mean ± range from two or mean ± sem from at least 
three experiments were plotted and fitted to a single binding site model, using the non­




3.4.1 Optimisation of [125i]a-bungarotoxin binding
Preliminary experiments were earned out on [125l]a-btx binding to membrane preparations 
in order to establish appropriate reaction conditions.
Membrane preparations
Initial preparations of adult membranes demonstrated that dissected brain tissue resulted 
in a more purified preparation than dissected whole head tissue. Consequently, brains 
of adults were used for binding assays. Conversely, dissections of larval fifth instar 
nerve cords proved exceedingly time consuming and resulted in such little tissue that 
binding assays had to be performed on whole first instar larvae.
Comparison of [125l]a-btx binding assays on both fresh and frozen brain tissue indicated 
that the freezing process did not impair binding; this allowed for large membrane 
preparations from the collection of adult and larval tissue. Binding to the S2 supernatant 
in comparison with the P2 pellet established that the pellet gave a greater difference 
between specific [125l]a-btx binding and non-specific [125l]a-btx binding than the 
supernatant.
( 12Sl]a-Bungarotoxin binding
Initial assays were earned out as triplicate determinations, however, due to the paucity of 
tissue these were later performed as duplicate determinations.
Separation of bound and free radiolabel was completed as quickly as possible in order to 
prevent dissociation of the receptor-radioligand complex. Non-specific binding to 
membranes and GF/C filters was minimised by washing with copious amounts of 
incubation buffer containing BSA. In addition, GF/C filters were pre-treated with PEI to 
reduce non-specific binding (Bruns et al., 1983).
Protein dependence of f 25i]a-bungarotoxin binding
The protein dependence of [125l]a-btx binding was determined in order to select a protein 
concentration which gave both a good signal to noise ratio and was proportional to the 
specific [125l]a-btx binding (i.e. on the linear part of the curve). The effect of altering the 
protein concentration and thus receptor concentration on the binding of [125l]a-btx varied 
between adults and larvae, as shown in Figure 3.1. For both adults and larvae, total 
binding increased linearly with increasing protein concentration. Non-specific binding to
140
adult membranes was very low (reaching approximately 3000cpm at 45pg/assay 
compared with approximately 26000cpm for total binding at the same protein 
concentration, in the example shown), demonstrating only a minor linear increase with 
increasing protein concentration. In contrast, non-specific binding to larval membranes 
was very high - being close to 50% of the total counts bound and increased steeply with 
increasing protein concentration. Consequently, this resulted in a different profile for the 
specific binding for each type of membrane preparation. Specific binding for adults 
emulated total binding, showing a steep linear increase with increasing protein 
concentration. Specific and non-specific binding could be distinguished easily at a 
protein concentration of 23pg/assay and accordingly this protein concentration was 
selected for subsequent binding assays. Specific binding for larvae however, was linear 
over the range 0-100pg protein/assay and then levelled off. At ~150pg protein/assay 
specific binding counts were exceeded by those for non-specific binding. Hence, a 
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Figure 3.1. Protein dependence of [125l]a-btx binding to P2 membranes. [125l]a-Btx was 
incubated for 1h with increasing protein concentration in the presence and absence of unlabelled 
a-btx as described in section 3.3.3.1. Bound and free [125l]a-btx were separated by vacuum 
filtration on GF/C filters, a) Data from adult P2 membranes, b) Data from larval P2 membranes. 
Points represent mean ± range for duplicate counts of one experiment. Total [125l]a-btx bound (•)  
and non-specific [125l]a-btx bound (■) were used to calculate specific [125l]a-btx bound (♦).
141
Time and temperature dependence of [125l]a-bungarotoxin binding
The effect of incubation time and temperature on [125l]a-btx binding to adult membranes, 
(Figure 3.2), was investigated to show that the reaction had reached a steady state. 
Incubation at room temperature (25°C) and 37°C revealed almost identical binding 
curves, indicating that incubation at room temperature was an appropriate choice for 
subsequent assays. An approximate JV2 was derived from the rectangular hyperbolic 
curve fit of specific [125l]a-btx binding: at room temperature T1/2 was 11min whereas at 
37°C T 1/2 was 13min. Steady state was reached within 60min. In contrast, previous 
experiments on Manduca membranes had demonstrated that the a-btx binding reaction 
took 16h to reach steady state (Sanes et al., 1977).
3.4.2 Saturation binding of [125l]a-bungarotoxin binding
The effect of increasing the [125l]a-btx concentration on specific binding to P2 
membranes from both adults and larvae is shown in Figure 3.3.
Total and specific binding data were fitted to a rectangular hyperbola whilst non-specific 
binding data was fitted to a first order linear regression. For adults, subtraction of linear 
non-specific binding from saturating total binding resulted in specific binding that was 
almost completely saturated at 30nM. Scatchard analysis of the specific binding (inset) 
was linear suggesting a single a-btx binding site. From the curve fit, the apparent Bmax 
was 815fmol/mg protein and the apparent Kd was 6.5nM (Table 3.1). For larvae, the 
difference between very high linear non-specific binding and only slightly higher total 
binding resulted in low specific binding that was saturating at 15nM. A linear Scatchard 
plot of the specific binding (inset) was obtained suggesting a single class of a-btx binding 
site. Curve fit data for the experiment shown, gave an apparent Bmax of 138fmol/mg 
protein and an apparent Kd of 7.4nM (Table 3.1).







Table 3.1. Parameters for saturation binding from adult and larval P2 membranes. *adults, 
data are for one experiment performed in duplicate; "larvae, data are the mean ± range of two 
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Figure 3.2. Time and temperature 
dependence of [125l]a-btx binding.
Adult P2 membranes were incubated 
with [125l]a-btx at room temperature 
(• )  and at 37°C (■) and for increasing 
time periods in the presence and 
absence of excess unlabelled a-btx, 
as described in section 3.3.3.2. 
Bound and free [125l]a-btx were 
separated by vacuum filtration on 
GF/C filters. Specific [125l]a-btx 
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Figure 3.3. Saturable [125l]a-btx binding to P2 membranes from a) adults and b) larvae. P2
membranes were incubated with increasing concentrations of [125l]a-btx for 1 h in the presence and 
absence of unlabelled a-btx, as described in section 3.3.3.3. Bound and free [125l]a-btx were 
separated by vacuum filtration on GF/C filters. Specific [125l]a-btx binding data was fitted to a 
rectangular hyperbola and used to calculate the maximum number of binding sites, Bmax and the 
dissociation constant, Kd. Scatchard plots (insets) show linearity, indicating one class of [125l]a-btx 
binding site.
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3.4.3 [125l]a-Bungarotoxin competition binding
The effect of pre-incubation of P2 membranes with a variety of unlabelled cholinergic 
ligands was investigated in order to assess the different ligands for their potencies at the 
[125l]a-btx binding site. Unlabelled a-btx completely displaced [125l]a-btx with high affinity 
in both adult and larval membranes (Figure 3.4). The data were used to generate IC5o 
values, which were converted to Kj values using the Cheng-Prusoff equation (see section
3.3.5). Mean data were fitted to the Hill equation. Displacement of a radioligand by the 
same unlabelled ligand should result in identical Kd and Kj values, as under these 
conditions they are the same measurement. For adult membranes, a Kj value of 1.3nM 
was close to the Kd value of 6.5nM. For larval membranes, a slightly lower affinity giving 
a Kj value of 9.7nM was also close to the Kd value of 7.6nM (see Table 3.1). The Hill 
numbers of -0 .9  and -0 .7  for adults and larvae respectively (see Table 3.6), were close 
to unity, indicating a single binding site consistent with the saturation data.
Assessment of (-)nicotine pre-incubation time on the inhibition of [125l]a- 
bungarotoxin
(-)Nicotine was pre-incubated with adult membranes at times of 10 and 60min and 
compared with displacement using no pre-incubation, to assess for nicotine breakdown 
by putative metabolic enzymes present in the CNS of Manduca (Morris, 1983a). Figure
3.5 shows data for one experiment at each of these three time points. Kj values were 
calculated for each set of data and are shown in Table 3.2.
Omin, 4°0 10min, rt 60min, rt
Kt (fiM) 0.75 1.05 2.80
Table 3.2. Effect of nicotine pre-incubation time on the displacement of [125l]a-btx binding 
as measured by Kj values.
Nicotine was able to displace [125l]a-btx with micromolar affinity. The KjS were very 
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Figure 3.4. Competition binding assay of a-btx at the [125l}a-btx binding site in a) adults and
b) larvae. Increasing concentrations of a-btx ( • )  were pre-incubated with P2 membranes for 
10min before incubation with [125l]a-btx for 1h, as described in section 3.3.3.4. Total and non­
specific [125l]a-btx binding were determined by the incubation of P2 membranes and [125l]a-btx 
binding in the absence and presence of excess unlabelled a-btx respectively. Bound and free 
[125l]a-btx were separated by vacuum filtration on GF/C filters. Points represent specific [125l]a-btx 
binding for the mean ± sem for 3 independent assays. IC50 values obtained for each set of data 
were used to calculate the inhibition constant, Kj. Mean data were fitted to the Hill equation.
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Figure 3.5. Effect of pre-incubation on
the inhibition of specific [12Sl]a-btx
binding by (-)nicotine. Adult P2
membranes and increasing concentrations
of (-)nicotine were pre-incubated for 0 (•),
10 (■) and 60 (♦ )  min before addition of
1nM [125l]a-btx for 1h, as described in
section 3.3.3.4. Total and non-specific
binding were determined by the absence
and presence of excess unlabelled a-btx
respectively. Bound and free [125l]a-btx
were separated by vacuum filtration on
GF/C fitters. Data were fitted to the Hill 
equation.
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Assessment of inhibition by acetylcholinesterase inhibitors
It was imperative to supplement ACh assays with AChE inhibitors, thus preventing 
breakdown of ACh from the AChE present in the membrane preparations. A preliminary 
experiment evaluated several AChE inhibitors for their lack of ability in binding to the a- 
btx binding site, at a concentration (10pM) high enough to stop degradation of ACh. The 
effect of the AChE inhibitors, BW284c51, neostigmine, physostigmine and THA on 
displacement of [125l]a-btx is shown in Figure 3.6. Specific binding (%) of [125l]a-btx is 
shown in Table 3.3.






Table 3.3. Inhibition of [125l]a-btx binding by acetylcholinesterase inhibitors.
Figure 3.6. Inhibition of specific [125l]a- 
btx binding by acetylcholinesterase 
inhibitors. Adult P2 membranes were pre- 
incubated with the acetylcholinesterase 
inhibitors BW284c51 (1), neostigmine (2), 
physostigmine (3) and THA (4) (all at 10|j.M) 
for 10min before incubation with [125l]a-btx 
for 1h as described in section 3.3.3.4. Total 
and non-specific binding were determined 
by incubation of P2 membranes and [125l]a- 
btx for 1h in the absence and presence of 
excess unlabelled a-btx respectively. 
Acetylcholinesterase inhibitor (io^M ) Bound and free [125l]a-btx were separated
by vacuum filtration on GF/C filters.
At a concentration of 10pM (high enough to inhibit AChE in P2 membranes thus 
preventing ACh breakdown) the rank order of potency was physostigmine > THA > 
BW284c51 > neostigmine. Thus, neostigmine was used in further ACh competition 
binding assays to inhibit AChE, as this drug appeared to have the least ability to bind to 






Inhibition by nicotinic ligands
The effects of inhibition of [125l]a-btx binding by a number of nicotinic ligands is shown in 
Figure 3.7. The data obtained from adult membranes are much clearer than that from 
larval membranes, the displacement curves being more defined and the error bars much 
smaller. This is probably due to the increased purity of the P2 preparation obtained from 
adults and the resulting low non-specific binding in comparison with that from larvae. 
Unlabelled ligands did not always result in 100% inhibition of [125l]a-btx binding (0% 
specific binding) as the concentrations of unlabelled ligand necessary to reach this 
inhibition were too high.
The data were used to generate IC50 values, which, for comparison with other insects, 
were converted to Kj values using the Cheng-Prusoff equation as in section 3.3.5. a-Btx 
is also included for direct comparison. The IC50 value, Kj value and potency relative to 















ct-Btx 1.6 ±0.2x 10'y1.3 ±0.1 xiO 43077 1.7 ±0.7x10^ 9.7 ± 3.8 x 10'y 824
(3) (3)
ACh 6.4 ± 1.4 x 10'55.6 ± 1.2 x 10'5 1 1.3 ± 0.5 x 10’58.0 ±3.2x10'® 1
(3) (3)
(±)Anabasine 4.2 ±0 .4x1  O'53.6 ±0.3x1 O'5 1.5 2.8 ± 1.6 x 10'41.6 ± 0.9 x 10-4 0.05
(3) (3)
(i)Epibatidine 9.6 ±3 .4x1 O'78.4 ±2.9x1 O'7 67 1.1 ± 0.6 x 10'66.7 ±3.5x1 O'7 12
(3) (2)
Imidacloprid 1.9 ±0.6x10^ 1.7 ± 0.5 x 10-6 33 3.5 ± 2.3 x 10*62.1 ± 1.4 x 10'6 4
(3) (2)
MLA 1.5 x 10‘1° 1.2x1 O'10 466667 5.2 ±3.1 x 10‘93.1 ± 1.8 x 10'9 2580
(1) (3)
(-)Nicotine 2.3 ±0 .5x1  O'62.0 ±0.4x1 O’6 28 2.6 ± 1.4 x 10'6 1.6 ± 0.8 x 10‘6 5
(4) (4)
Table 3.4. Parameters for the inhibition of specific [125l]a-btx binding by cholinergic 
ligands. Values derived as described in section 3.3.5, for the mean ± sem for 3 to 4 or mean ± 
range for 2 independent assays (except MLA, adults), where numbers in parentheses represent the 
number of assays. "adults, Kj calculated assuming Kd of 6.5nM for [125l]a-btx binding and an 
[125l]a-btx concentration of 1nM, "larvae, Kj calculated assuming Kd of 7.6nM for [125l]a-btx 
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Figure 3.7. Competition binding assays of cholinergic ligands at the [125l]a-btx binding site 
in a) adults and b) larvae. Increasing concentrations of ACh (•), (±)anabasine (■), 
(±)epibatidine ( ), imidacloprid (•), MLA (■) and (-)nicotine (♦ )  were pre-incubated with P2 
membranes for 10min before incubation with [125l]a-btx for 1h, as described in section 3.3.3.4. 
Total and non-specific [125l]a-btx binding were determined by the incubation of P2 membranes and 
[125l]a-btx binding in the absence and presence of excess unlabelled a-btx respectively. Bound 
and free [125l]a-btx were separated by vacuum filtration on GF/C filters. Points represent specific 
[125l]a-btx binding for the mean ± sem for 3 to 4 or mean ± range for 2 independent assays 
(except MLA, adults, n=1). IC50 values obtained for each set of data were used to calculate the 
inhibition constant, Kit for each drug. Mean data were fitted to the Hill equation.
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For adults, the endogenous ligand, ACh, was the least potent at inhibiting [125l]a-btx 
binding, with a Kj of 56^M. Marginally greater potency was displayed by (±)anabasine, 
with a Kj of 36pM. In larvae however, ACh demonstrated greater potency than 
(±)anabasine (Kj values of 8.0|xM and 160^iM respectively). (-)Nicotine and imidacloprid 
exhibited similar potency of inhibition, approximately 30-fold greater than ACh for adults 
and approximately 4-fold greater than ACh for larvae (Table 3.4). (±)Epibatidine was 
approximately twice as effective as nicotine and imidacloprid. Greatest potency of all 
was exhibited by the two cholinergic antagonists tested, a-btx and MLA. For adults, a- 
btx (Kj 1.3nM) was approximately 40000-fold more potent than ACh and MLA (Kj0.12nM) 
was approximately 460000-foid more potent than ACh. Kj values for larvae were lower 
being 9.7nM for a-btx and 3nM for MLA, however, these were still 800-fold and 2500-fold 
more potent than ACh.
Therefore, rank orders of potency were: 
for adults,
MLA > a-btx > (±)epibatidine > imidacloprid = (-)nicotine > (±)anabasine = ACh 
and for larvae,
MLA > a-btx > (±)epibatidine > imidacloprid = (-)nicotine > ACh > (±)anabasine.
The greatest discrimination between adults and larvae does not appear to be with (-) 
nicotine, as has been hypothesed (see Chapter 1, section 1.1.3 and section 3.1.2). 
Accordingly the Kj values for each drug between adults and larvae were tested for 
statistical significance using a paired Student's t-test. At the 5% probability level, using 
the null hypothesis that the two Kj values from adults and larvae were not statistically 
different (i.e. P > 0.05), it was found that Kj values between adults and larvae were 
statistically different for the ligands ACh and (±)epibatidine only. P values are shown in 
Table 3.5. As the data for MLA in adults was from one experiment only, statistical 
significance between adults and larvae could not be tested.
Table 3.5. Statistical significance of Kj values 
for cholinergic ligands between adults and 











The a-btx binding data generated a dose response curve that was steeper than those for 
the other ligands (see Figures 3.4 and 3.7) and this was reflected in the Hill numbers 
(nH) obtained, as shown in Table 3.6. For adults, the a-btx Hill number is close to unity 
as opposed to those for the other ligands which are closer to 0.4. For larvae, the a-btx 





a-Btx 0.92 ± 0.08 (3) 0.68 ±0.11 (3)
ACh 0.43 ± 0.03 (3) 0.23 ± 0.05 (3)
(±)Anabasine 0.52 ± 0.05 (3) 0.13 ±0.06 (3)
(±)Epibatidine 0.46 ± 0.09 (3) 0.26 ± 0.04 (2)
Imidacloprid 0.44 ± 0.02 (3) 0.13 ±0.08 (2)
MLA 0.33 (1) 0.24 ± 0.02 (3)
(-)Nicotine 0.39 ± 0.03 (4) 0.28 ± 0.03 (4)
Table 3.6. Hill numbers (nH) derived from inhibition of specific [125l]a-btx binding by 
cholinergic ligands in adults and larvae. Values are the mean ± sem for 3 to 4 or mean ± 
range for 2 independent assays (except MLA, adults) where numbers in parentheses represent the 
number of assays.
Inhibition by muscarinic ligands
The inhibition of [125l]a-btx binding by muscarinic ligands is shown in Figure 3.8. At a 
concentration of 100|iM, the muscarinic antagonist atropine inhibited specific binding of 
[125l]a-btx more in adults than in larvae (67% compared with 61%). In contrast, the 
definitive muscarinic agonist muscarine showed -27%  inhibition for adults but -66%  
inhibition in larvae. The same pattern was observed for oxotremorine (45% inhibition for 




I 70 H 
*- 
o




IS 30 - 
o> c
■9 20 -
—  10  -
to
Ligand (100^M)
Figure 3.8. Inhibition of specific 
[125l]a-btx binding by muscarinic 
ligands for adults (1-3) and for 
larvae (4-6). P2 membranes were pre- 
incubated with the muscarinic ligands 
atropine (1 and 4), muscarine (2 and 5) 
and oxotremorine (3 and 6) for 10min 
before incubation with [125l]a-btx for 
1 h, as described in section 3.3.3.4. 
Total and non-specific [125l]a-btx 
binding were determined by the 
absence and presence of excess 
unlabelled a-btx respectively. Bound 
and free [125l]a-btx were separated by 
vacuum filtration on GF/C filters.
3.4.4 l3H](±)Epibatidine competition binding
[3H](±)Epibatidine binding to adult and larval membranes is shown in Figure 3.9. Almost 
the same profile is seen between adults and larvae. As expected, the number of counts 
bound increased from 1nM to 10nM [3H](±)epibatidine. However, in all cases, the total 
binding counts and those obtained with excess unlabelled (-)nicotine or a-btx were very 
similar. Statistical analysis using a paired Student's t-test shows that, with the exception 
of 1nM [3H](±)epibatidine and 1mM nicotine for larvae where P = 0.045, there is no 
statistical difference between total binding and displacement binding with either 1mM (-) 
nicotine or 1pM or 5pM a-btx (for adults and larvae respectively) (P > 0.05). Controls 
without P2 membranes showed slightly lower counts for 1nM [3H](±)epibatidine but varied 
for 10nM epibatidine.
Previously, comparison of the total counts of [125l]a-btx in a sample, with the total [125l]a- 
btx counts bound to P2 membranes, had indicated that a maximum of 4% of the total 
[125l]a-btx counts bound to the membranes. If the same applied to [3H](±)epibatidine, 
total counts bound for 1nM [3H](±)epibatidine using adults should have been ~370cpm, 
as opposed to the 25cpm recorded in the experiment. Furthermore, statistical analysis 
using a paired Student’s t-test indicated that a difference of 13cpm between total and 
non-specific binding (i.e. specific binding) was necessary for statistical significance (P < 
0.05). This was equivalent to 0.28fmol of binding sites. Assuming that 1mM nicotine 
was in excess and acted as a non-specific ligand, specific binding was 0.36fmol/mg.
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This suggests that the number of binding sites were not below the limit of detection of 
the assay. The combination of these factors suggest therefore, that there is not a 
[3H](±)epibatidine binding site in Manduca membranes, and that the binding detected is 
non-specific binding.
a) b)
Figure 3.9. Inhibition of [3H](±)epibatidine binding by excess (-)nicotine and a-btx in a) 
adult and b) larval membranes. P2 membranes were pre-incubated with excess unlabelled (-) 
nicotine or a-btx for 10min before incubation with [3H](±)epibatidine for 1 h, as described in section 
3.3.4. Total [3H](±)epibatidine bound was determined by incubation of P2 membranes and 
[3H](±)epibatidine for 1h. Bound and free [3H](±)epibatidine were separated by vacuum filtration 
on GF/C filters. Total bound: 1nM [3H](±)epibatidine (1); non-specific bound: 1nM 
[3H](±)epibatidine with 1mM nicotine (2); non-specific bound: 1nM [3H](±)epibatidine with 1pM (in 
adults) or 5pM (in larvae) a-btx (3); control: 1nM [3H](±)epibatidine without membrane preparation 
(4); Total bound: 10nM [3H](±)epibatidine (5); non-specific bound: 10nM [3H](±)epibatidine with 
1mM nicotine (6); non-specific bound: 10nM [3H](±)epibatidine with 1pM (in adults) or 5jiM (in 
larvae) a-btx (7) and control: 10nM [3H](±)epibatidine without membrane preparation. Bars are 
mean ± range of 2 assays.
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3.5 Discussion
[125l]a-Btx displayed saturable and high affinity binding to Manduca tissue consistent with 
the presence of a-btx sensitive AChRs and thus agreed with previous evidence from 
Manduca presented by Sanes etal. (1977) and Hildebrand et al. (1979).
Saturability of a-Btx binding sites
The number of a-btx binding sites increased ~7-fold from larvae to adults, as seen in 
Table 3.7. Comparison with other insects (Table 3.7) shows that Manduca larvae have 
fewer binding sites than Apis (Tomizawa et al., 1995a) while both larvae and adults have 
fewer binding sites than Schistocerca (MacAllan et al., 1988). As association and 
dissociation rates were not measured, the apparent KdS were estimated from the 
concentrations of free toxin required for half saturation. Kd values for Manduca were 
close to those of Apis (Tomizawa et al., 1995a) but higher than that from Schistocerca 
(MacAllan et al., 1988). Scatchard analysis revealed one binding site, unlike the most 
recent Scatchard analysis on Drosophila which revealed two binding sites with Bmax 
values of 240fmol/mg protein and 1080fmol/mg protein and Kd values of -0.1 nM and 






Bmax (fmol/mg 815 119 451 1200
protein)
Kd (nM) 6.5 7.6 7.5 0.8
Table 3.7. Comparison of Bmax and Kd for Manduca, Apis (Tomizawa et al., 1995a) and 
Schistocerca (MacAllan etal., 1988).
Metabolism of nicotine by the central nervous system in Manduca
Morris (1983a) established that the CNS of Manduca contained a local detoxification 
system, thus enabling it to tolerate nicotine (see Chapter 1, section 1.1.3). Therefore, it 
can be hypothesised that the presence of metabolic enzymes such as cytochrome P450 
results in the breakdown of nicotine before interaction with nAChRs results in 
desensitisation and death. To assess the possibility of nicotine breakdown and its 
subsequent effects on the inhibition of specific [125l]a-btx binding, three experiments were 
performed using various pre-incubation times. If metabolism by CNS detoxifying 
enzymes played a major role in nicotine insensitivity, a clearly defined pattern in which
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the longer the total incubation time of nicotine with membrane preparation, the greater 
the breakdown of nicotine and the lower the affinity for binding to the a-btx binding site 
would be expected. However, the results obtained (Figure 3.5) suggest that the pre­
incubation of nicotine has little effect on the inhibition of [125l]a-btx binding over the 1h 
incubation period used. Admittedly, the binding affinity of nicotine for the a-btx site 
decreases slightly with an increase in pre-incubation time (Table 3.2). There is 
approximately a 3-fold difference between no pre-incubation at 4°C (plus 60min 
incubation) and 60min pre-incubation at room temperature (plus 60min incubation), 
though the difference with 10min pre-incubation at room temperature (plus 60min 
incubation) of approximately 1.5-fold is much less marked. This suggests that there is 
some possibility of nicotine metabolism by the membrane preparation but at the 10min 
pre-incubation period (plus 60min incubation) used subsequently, there is not sufficient 
breakdown to make nicotine binding any different from other cholinergic ligand binding. 
It is therefore significant that Moms (1983a) observed more than half the nicotine taken 
up at the concentration of 10"4 M was metabolised within 5min, which clearly is not the 
case if measurement is taken as the inhibition of [125l]a-btx binding.
If nicotine metabolism by the CNS of Manduca did play a major role in preventing the 
binding of nicotine to nAChRs in Manduca, hence reducing Manduca’s nicotine 
sensitivity, the dose response curves shown would be expected to show a distinct shift to 
the right and this has not happened. It is always possible that the enzymes responsible 
for the nicotine metabolism were destroyed or washed out during the preparation of the 
membranes for some inexplicable reason or that rapid metabolism of nicotine occurred in 
which the resulting breakdown product displaced the specific binding of radiolabelled a- 
btx with similar affinities at each pre-incubation time.
Although the structures of nicotine and nicotine-1-N-oxide (the nicotine metabolite found 
in the CNS; Snyder etal., 1993; see Chapter 1, section 1.1.3) are similar, the process of 
metabolising a potentially toxic compound (nicotine) into another compound that had 
high affinity for the same target and hence also toxic, seems extremely maladaptive. 
However, if nicotine is toxic and the metabolic product is not, similar nicotine binding 
affinities to other nicotine sensitive insects would not be expected. It is of relevance that 
the CNS of Periplaneta, a nicotine sensitive insect was also shown to metabolise 
nicotine, although to a lesser extent than Manduca (Morris, 1983a) indicating that this 
metabolic process was not unique to Manduca.
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These preliminary results also suggested that the binding of nicotine to the a-btx 
sensitive nAChR in Manduca was not especially different from that in nicotine sensitive 
insects (see Comparison with other insects below), implying that other mechanisms are 
essential for the insensitivity to nicotine seen in Manduca (discussed in Chapter 4).
Pharmacological specificity
Inhibition of [125l]a-btx binding in Manduca resulted in a similar pharmacological profile for 
both adults and larvae with the antagonists tested, binding with nanomolar affinities and 
the agonists tested, binding with micromolar affinities.
Statistical analysis between adults and larvae indicated that there were differences in 
binding affinities for the ligands ACh and (±)epibatidine only (Table 3.5). For 
(±)epibatidine binding, the statistical difference obtained may be due to the lower number 
of binding assays for larvae compared with adults, as this error is taken into account in 
the calculation. The difference between adults and larvae for ACh is more difficult, if not 
impossible to explain. Adults exhibit lower binding affinity for the site and why this is so 
remains unclear. Despite the inclusion of the AChE inhibitor, neostigmine in all ACh 
assays, it is possible that ACh was partially metabolised in the adult preparations and 
therefore resulted in lower binding affinity.
Previously, it has been hypothesised that a different nAChR may exist for adults and 
larvae (see Chapter 1, section 1.1.3 and section 3.1.2). To recap, as larvae feed on 
tobacco without suffering any detrimental effects from nicotine poisoning, they may 
possess a nAChR that is altered within its agonist binding site (in comparison with other 
insects and / or vertebrates) such that nicotine fails to bind. Adults on the other hand, 
feed on nectar. Thus, the adult diet is devoid of nicotine and consequently a nAChR that 
does not bind nicotine is not necessary. If this were the case, it could be argued that 
there should be a statistical difference between adults and larvae for the binding affinity 
of nicotine. As the larvae nAChR would be nicotine insensitive, a low binding affinity 
would be observed whereas a nicotine sensitive nAChR in adults would result in a higher 
binding affinity. Predictably, a large evolutionary selection pressure would be needed to 
change a nicotine insensitive receptor to a nicotine sensitive receptor as this would be 
maladaptive. It is not surprising therefore, that the nicotine binding affinities for adults 
and larvae are almost identical (2.0|xM and 1.6pM respectively). These results suggest 
that the same a-btx binding site is maintained throughout the lifecycle of Manduca.
155
Nevertheless, it could be argued that as the larvae were fed on an artificial diet, they did 
not have any nicotine resistance and so have the same apparent binding affinity as the 
adults. However, Manduca larvae from the University of Bath Manduca colony have 
previously demonstrated nicotine resistance from their ability to feed and grow normally 
on tobacco plants (Reynolds et al., 1986). Moreover, Trimmer and Weeks (1989) have 
proven that resistance to nicotine is an intrinsic rather than an inducible trait, as larvae in 
their Manduca colony do not show increased resistance when raised on tobacco plants 
or nicotine-laced diets.
Comparison with other insects
Although it appears that adults and larvae share the same a-btx binding site, it is 
necessary to compare the binding affinities obtained with those from other insects to 
deduce the presence of nicotine or other cholinergic ligand resistance. Table 3.8 shows 
Kj values for insects covered in the literature. As these literature values use adult 
tissues, Manduca adult data is shown for comparison in the table. In fact studies on 
larval forms are rare (Osbome, 1996).
The nicotinoids - nicotine and anabasine
It is pertinent here to address the question of nicotine insensitivity among other insects. 
With the exception of Manduca, the insects shown in Table 3.8 are not considered to be 
nicotine insensitive. Studies on Apis and Periplaneta, the two insects with the closest 
nicotine binding affinity to Manduca, show that nicotine is acutely toxic. In Apis, nicotine 
poisoning begins with stupefaction and staggering followed by paralysis of legs, wings, 
antennae and mandibles, suggesting that nicotine causes ascending motor paralysis of 
the nerve cord (reviewed in M.E. Eldefrawi, 1985). In Periplaneta, high concentrations of 
nicotine appear to cause complete depression and paralysis of the heart (reviewed in 
M.E. Eldefrawi, 1985). In contrast, injection of nicotine into the haemolymph of Manduca 
does not cause toxic effects - indeed Manduca resumes normal feeding habits after 
30min (Self et al., 1964a). Comparison with other lepidopterans shows that this is not a 
lepidopteran specific effect as Pieris brassicae is killed by nicotine in its diet (David and 
Gardiner, 1953). As reviewed in Chapter 1 (section 1.1.1), these toxic effects are 
primarily caused by the interaction of nicotine with nAChRs. Therefore, it is clear that the 
nicotine binding affinity seen in Manduca is comparable with those from other insects 





Drosophila Musca Apis Periplaneta Schistocerca Locusta
a-Btx 1.3 x 10 '^ 1.5 x 10'y 10y 5.5 x 10 y 8.5 x 10'*10 8 .9 x 10"y 1.8 x 10 ^
ACh 5.6 x 10'5 1.2 x10® 1.8 x 10"5 ND 1.8 x10’5 ****2.7x1 O'® 1.1 x 10-4
Anabasine 3.6x1 O'5 ND ND 1.6 x 10-® ND ND ND
Epibatidine 8 .4 x 10'7 ND ND ND ND ND ND
Imidacloprid 1.7x10® ND ND 1.5x10® **2x1 O'7 ND ND
MLA 1.2x1 O'10 ND *2.5 x 10"1° ND ***1.4 x 10'9 1.8 x 10-® ND
(-)Nicotine 2.0 x 10 ® 1.4 x10'7 9.0x1 O'7 1.2x10® 3.5x1 O'6 5.1 x10’7 1.1 x 10-®
**9.8x10-®
Table 3.8. Comparison of Manduca Kj values with those from Drosophila (Schmidt-Nielsen 
et al., 1977: Kj values calculated from IC50 values quoted, using Kd value of 1.1 nM and various 
[[125l]a-btx] also quoted), Musca (Cattell et al., 1980a: IC50 values quoted; *Jennings et al., 1986), 
Apis (Tomizawa et al., 1995a: Kj values calculated from IC50 values quoted, using Kd value of 
7.5nM and [[125l]a-btx] of 2nM also quoted), Periplaneta (Lummis and Sattelle, 1985; **Bai et al., 
1991: IC50 values quoted; ***Sattelle et al., 1989), Schistocerca (MacAllan et al., 1988; ****Filbin 
et al., 1983: Kj value calculated from IC50 value quoted, using Kd value of 1.38nM and [[125l]a-btx] 
of 2nM also quoted), and Locusta (Breer, 1981: Kj values calculated from IC50 values quoted, 
using Kd value of 1.1 nM and [[125l]a-btx] of 3.1 nM also quoted).
Naturally occurring nicotine analogues, termed nicotinoids, include anabasine - another 
alkaloid found in tobacco. It is conceivable therefore, that the nicotine insensitivity seen 
in Manduca is just part of a spectrum encompassing insensitivity to many alkaloids. As 
Manduca can feed on a wide range of solanaceous plants, it is more likely that a general 
mechanism exists that prevents alkaloid toxicity.
It has been established that the nicotine insensitivity seen in Manduca is probably not 
due to a mutated nAChR containing an a-btx binding site, as similar binding affinities are 
seen with nicotine sensitive insects. Comparison with anabasine binding affinities 
however, are not as convincing. Although comparison is limited to one insect, Apis 
(Tomizawa et al., 1995a), it appears that anabasine has ~20-fold higher binding affinity 
for the a-btx binding site in Apis than Manduca adults (increasing further with comparison 
of Manduca larvae). Taken as a single result, out of context, this could suggest that 
anabasine binding is reduced due to a receptor that does not form tight bonds with 
anabasine. Considering that nicotine, the primary alkaloidal target of this investigation 
does bind with a similar extent as other insects, another explanation is warranted.
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Nicotine and anabasine are exceedingly similar in structure, as shown below and thus 
might be expected to exhibit similar binding affinities. However, in Manduca adults, 
anabasine is ~20-fold less potent than nicotine and in Manduca larvae is ~100-fold less 
potent than nicotine. This is surprising as Campbell et al. (1933) demonstrated that 
nicotine was only 2.6-fold more toxic than anabasine on larvae from the mosquito Culex 
pipiens and in Apis is only 1.3-fold more potent than anabasine. Vertebrate comparison 
using rat gives Kj values of 0.82|iM and 0.34jaM for nicotine and anabasine respectively 
at the [125l]a-btx binding site (Marks et al., 1986) demonstrating in this instance that 
anabasine is slightly more potent than nicotine. This suggests that there is an element of 
experimental error within the Manduca binding data. It has already been noted that the 
standard errors of the larvae assays are large due to the lower purity of the membrane 
preparation and for the anabasine assay only, this results in a 3-fold disparity between 
IC5o values obtained from the individual experiments and the curve fit data. Furthermore, 
the anabasine obtained from Sigma was the last of the Company’s existing stocks and 
no alternative sources were available. This supply appeared to have been synthesised 
some years earlier and quite possibly had gone off. The solution was yellow and 
previous experience with nicotine had shown that a discoloured nicotine solution resulted 
in lower binding affinity than usual. These observations may account for the differences 
seen between anabasine and nicotine in Manduca. However, it remains possible that in 
Manduca anabasine is less potent than nicotine, suggesting that different residues are 
involved in the binding of nicotine and anabasine.
Nicotine Anabasine
Although detailed structure-activity relationships for nicotinic agonists on the nAChR 
have been carried out on vertebrates (Holladay etal.t 1995), corresponding relationships 
in insects are scarce. Studies relating insecticidal activity to structural features (reviewed 
in Yamamoto, 1966) have shown that both nicotine and anabasine are highly toxic and 
that this is due to several structural features of the nicotinoids. The pyridine ring plays 
an important role in toxicity but alone is not sufficient, in addition an amino nitrogen in the 
side chain group must be separated from the pyridine ring by a definite distance. This is
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achieved by the attachment of the 3-position of the pyridine ring to the 2-position of the 
pyrrolidine ring in nicotine or the 2-position of the piperidine ring in anabasine, resulting 
in a minimum distance between the pyridyl nitrogen and the pyrrolidyl or piperidyl 
nitrogen of the two rings of 4.2A. It appears that the stereochemical arrangement of the 
pyridine and the pyrrolidyl or piperidyl nitrogen moieties is necessary for exerting the 
action on the receptor. Furthermore, it is necessary for the amino nitrogen to be of high 
basicity (pKai\ 7.4-9.0) as this results in the monocationic form of the nicotinoid (ionised 
at the pyrollidine or piperidine nitrogen) acting at the receptor binding site and appears to 
have higher toxicity than the free base.
These features are in general agreement with the requirements of a nicotinic 
pharmacophore as described by Beers and Reich (1970). In this model, it is proposed 
that nicotine requires the alkylammonium moiety for an electrostatic charge-charge 
interaction with the nAChR and an hydrogen bond acceptor group (the nitrogen on the 
pyridine ring) which is ~5.9A from the centre of positive charge on the alkylammonium 
moiety (compared with the minimum distance of 4.2A calculated by Yamamoto). 
Furthermore, it is proposed that the carbon skeleton provides the correct stereochemical 
localisation of the functional groups determining specificity.
Neonicotinoids - imidacloprid
Recent binding studies have revealed that nicotine and the nitroguanidine analogue, 1- 
(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine (imidacloprid) have differing 
selective toxicity in vertebrates and insects (Yamamoto et al., 1995). As imidacloprid is a 
cholinergic acting insecticide (Abbink, 1991) it was used in Manduca binding studies. 
Data presented in this chapter (Table 3.8) show that the binding affinity of imidacloprid is 
similar for Manduca adults (and larvae) and Apis (Tomizawa et al., 1995a). Furthermore, 
the binding affinities of imidacloprid and nicotine are almost equal in both species. In 
contrast, inhibition of [125l]a-btx binding in Periplaneta showed approximately a 50-fold 
increase in binding affinity of imidacloprid compared with nicotine (Bai et al., 1991). 
Imidacloprid binding at the vertebrate site in Torpedo (equivalent to the muscle type 
nAChR) however, shows a marked lack of affinity for the a-btx binding site (Tomizawa et 
al., 1995b) demonstrating ~15-fold lower binding affinity than nicotine, and ~500-fold 
lower binding affinity than imidacloprid in Apis (Tomizawa et al., 1995a).
Yamamoto et al. (1995) have therefore suggested that imidacloprid is one of the few 
cholinergic ligands that can distinguish between vertebrate and invertebrate targets and 
hence is ideal as an insecticide. They have postulated the following mechanism of 
action. Imidacloprid, shown below, possesses an electron-withdrawing nitroimine group
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and this delocalises the unshared electron pair on the nitrogen atom corresponding to 
the amino nitrogen atom of nicotine and becomes partially positive. This partially positive 
nitrogen atom is sufficient to interact strongly with the insect nAChR but not with the 
vertebrate nAChR which requires a fully positive charge.
Nicotine is not an especially useful insecticide, as at physiological pH (generally above 
pH6.5) it is highly ionised and therefore cannot penetrate either the insect body or 
through an ion or blood-brain barrier into the synapse. Imidacloprid, on the other hand, 
is not highly ionised and thus can penetrate to the CNS and interact with the nAChR 
causing insecticidal activity. In vertebrates, it is not easy for ionised nicotine to cross the 
blood-brain barrier and interact with the receptors of the CNS (in contrast to lipophilic 
nicotine). However, nicotine can interact with the peripheral nAChRs whereas, 
imidacloprid, due to its lack of total positive charge is less capable of interaction with 
receptors either in the PNS or when it has crossed the blood-brain barrier to the 
receptors in the CNS.
Given that Manduca appear to survive the ingestion of vast quantities of nicotinoids, it 
would be highly applicable to test for the ‘Manducacidal’ activity of imidacloprid. The 
evidence so far obtained does not suggest a cholinergic receptor with properties different 
from other susceptible insects. It would therefore be important to show that a cholinergic 
compound such as imidacloprid could bind to the nAChRs in Manduca without being 
eliminated in the same manner as nicotine.
Interestingly, imidacloprid possesses a chloropyridine group similar to epibatidine, which 
in Manduca is twice as potent as imidacloprid. In structure-activity studies using 
epibatidine analogues, replacement of the chloro moiety with hydrogen did not affect the 
binding affinity for fHJnicotine sites in rat brain membranes whereas replacement with a 
methyl or iodo moiety resulted in lower binding affinity (Badio and Daly, 1994). It is 
possible that the same substitutions could affect binding affinity in imidacloprid. 




Acetylcholine and acetylcholinesterase inhibitors
It was important to test the binding affinity of ACh to make sure that the a-btx binding site 
was cholinergic in nature. If nicotine had not bound as well as these experiments 
suggest, ACh would have been used as a reference point. It can be seen that in adult 
tissues, the binding affinity of ACh is consistently an order of magnitude lower than (-) 
nicotine (except for Locusta migratoria where excessive discrimination is observed; 
Breer, 1981). It appears therefore, that as a quaternary amine, ACh is not as effective 
as nicotine - a tertiary amine.
It was necessary to supplement ACh assays with AChE inhibitors, thus preventing 
breakdown of ACh from the AChE present in the membrane preparations. A preliminary 
experiment evaluated several AChE inhibitors for their lack of ability in binding to the a- 
btx binding site, at a concentration (10pM) high enough to stop degradation of ACh. 
Neostigmine was the least effective in inhibiting binding of [125l]a-btx whilst BW284c51, 
THA and physostigmine had an increasing tendency to bind to the a-btx binding site.
AChE inhibitors have been used as insecticides for many years and thus the finding that 
they can also bind to a-btx binding sites in insects may make some contribution to their 
insecticidal activity. ACh interacts with AChE at two sites - an anionic site which attracts 
the quaternary N atom by electrostatic force and an esteratic site, comprising a basic 
nucleophilic imidazole group of histidine and an hydroxyl group of serine, the latter 
attracting the electrophilic carbonyl C atom in a two-stage reaction. Firstly, an enzyme- 
substrate complex is formed before acetylation of the enzyme and release of the choline. 
Secondly, the electronegative O atom of a water molecule attacks the electrophilic C 
atom of the acetyl group, regenerating the active enzyme and producing acetic acid.
Neostigmine and physostigmine, as shown below, are AChE inhibitors of the carbamate 
type, binding to the esteratic subsite of the AChE in a slowly reversible manner. They 
carbamylate the serine hydroxyl that ACh acetylates (A.T. Eldefrawi, 1985). Neostigmine 
possesses a quaternary ammonium group which also interacts with the anionic site of 







c h3 ch3 ch3
Neostigmine Physostigmine Nicotine
Physostigmine, has been shown to have both an agonistic and channel blocking effect 
on the nAChR in vertebrates (Shaw et al., 1 9 8 5 ) .  Studies on vertebrates have shown 
that physostigmine acts as a non-competitive agonist (Storch et al., 1 9 9 5 ) ,  binding to 
sites that are distinct from those for ACh (Schroder et al., 1 9 9 4 ) .  The carbamate group 
is not required for agonistic action on nAChRs (Okonjo et al., 1991). In the a  subunit of 
the nAChR, a conserved lysine residue ( K 1 2 5  in Torpedo; see Appendix 1 ) ,  three before 
the first cys of the cys loop is photoaffinity labelled by ^Hjphysostigmine (Schrattenholz 
et al., 1 9 9 3 )  but has not been shown to be involved in ACh binding (see Chapter 1, 
section 1 . 2 . 7 ) .  Schroder et al. (1994) report that the region a 1 1 8 - 1 3 7  in Torpedo 
contains the physostigmine binding site. This overlaps with one of several regions 
thought to bind a-btx, namely Torpedo a 1 2 2 - 1 5 0  (Mulac-Jericevic and Atassi, 1987a,b; 
see Chapter 1, section 1 . 2 . 7 ) ,  and may explain why physostigmine binds to the a-btx 
binding site, although it has been shown that activation of the nAChR by physostigmine 
is insensitive to a-btx (Okonjo et al., 1991).
Comparison of physostigmine with nicotine, as shown above, indicates that the presence 
of an N-methyl group attached to a pyrrolidine ring in both structures may serve an 
important function in binding to the a-btx binding site. In comparison, neostigmine, which 
binds with much lower binding affinity than either nicotine or physostigmine does not 
possess this group. In fact, Schmidt-Nielsen et al. (1977) showed that neostigmine was 
approximately 1000-fold less potent than physostigmine, which had nearly identical 
binding affinity with ACh at the a-btx binding site in solubilised Drosophila membranes. 
Similarly, in Manduca membranes at the 10pM concentration used, neostigmine had a 
negligible effect on the inhibition of [125l]a-btx binding whereas physostigmine was very
effective.
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Thus, the capacity for neostigmine as an insecticide may lie exclusively in its ability to 
inhibit AChE. However, if the agonistic action of physostigmine in vertebrates is 
cautiously extrapolated to insects, the similar potential for insecticidal activity by 
physostigmine may be offset by its enhancing activity as a non-competitive agonist. 
Nevertheless, physostigmine is known to be at least as potent an insecticide as 
neostigmine and this may be due to its ability to block the nAChR ion channel at 
micromolar concentrations as shown in vertebrates (Shaw et al., 1985).
THA is an important inhibitor of AChE, being the only anticholinesterase licensed for the 
treatment of Alzheimer’s Disease (Kellar and Wonnacott, 1990). Perry et al. (1988) 
suggested that the success of THA was related to its interactions with the nAChR (and 
possibly the mAChR) rather than its properties as an AChE inhibitor. It was shown that 
THA was 1000-fold more potent than physostigmine in inhibiting [3H]nicotine binding in 
human brain. THA clearly does not have the same potency in Manduca where it is less 
potent than physostigmine (Table 3.3). Moreover, in Manduca, the AChE inhibitor 
BW284c51 had lower potency than THA but was more potent than neostigmine. This 
difference in potency may be related to their differences in structure. THA and 
Bw284c51 are unlike each other and also differ from neostigmine and physostigmine. 
Indeed, THA does not even possess a carbamate moiety.
Binding of antagonists
The two antagonists studied were by far the most potent ligands in inhibiting the binding 
of radiolabelled a-btx, with MLA being more potent than a-btx in both Manduca adults 
and larvae. As all agonists are small in size, it is presumed that competitive antagonists 
overlap the agonist site of action. Indeed, there are a number of regions that appear to 
be important in a-btx binding, those that are discriminatory being found in the muscle 
type nAChR and the neuronal a 7  and a 8  (and maybe a 9 )  subunits (see Chapter 1 ,  
section 1 . 2 . 7 ) .
MLA is found in seeds of Delphinium brownii (Nambi-Aiyar et al., 1979) and has come to 
prominence as an a 7  selective ligand. In vertebrates, it shows ~1000-fold selectivity for 
the neuronal [125l]a-btx binding site compared with neuronal fHJnicotine binding sites and 
neuromuscular [125l]a-btx binding sites (MacAllan et al., 1988; Ward et al., 1990). 
Furthermore, expression in Xenopus oocytes has shown has shown that MLA blocks 
a 3 p 2  and a 4 p 2  receptors with low micromolar affinity but a 7  receptors with picomolar 
affinity, reinforcing the hypothesis that the [125l]a-btx binding site is a property of the a 7  
subunit (Wonnacott et al., 1993; Palma etal., 1996).
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From Table 3.8, it can be seen that MLA and a-btx show very similar high affinity binding 
for a-btx binding sites in insects. The MLA binding affinity for Manduca (Kj = 0.12nM) is 
very comparable with the most evolutionarily related species shown, Musca (Kj = 0.25nM; 
Jennings et al., 1986) although MLA is less potent in Periplaneta (Sattelle et al., 1989) 
and Schistocerca (MacAllan et al., 1988). These results imply that the a-btx binding site 
in insects must have similar properties to that defining the vertebrate a7 subunit.
Structure-activity relationships using rat brain have suggested that the ester-linked 2- 
(methylsuccinimido)benzoyl group is necessary for nicotinic potency (corresponding to 
the basic structure of nicotinoids) but that the [125l]a-btx binding and a7 selectivity reside 
in the norditerpenoid core (Hardick et al., 1995).
Is there a [*H](±)epibatidine binding site in Manduca ?
Having established that an a-btx binding site consistent with an a-btx sensitive receptor 
(but not proving it) was present in Manduca adults and larvae, the presence or absence 
of putative a-btx insensitive receptors was determined. Epibatidine (exo-2-(6-chloro-3- 
pyridyl)-7-azabicyclo-[2.2.1]heptane), from the skin of the Ecuadorian poison frog, 
Epipedobates tricolour, is the most potent nicotinic agonist discovered to date. Several 
studies have shown that epibatidine has extremely high picomolar affinity for the a4p2 
receptor as determined by displacement of the radioligands fHJnicotine (Badio and Daly, 
1994) and fHJcytisine (Sullivan et al., 1994). Contrastingly, epibatidine displays ~5000- 
fold lower binding affinity for the a7 receptor, as detemined by displacement of [125l]a-btx 
(Sullivan et al., 1994). It appears therefore, that epibatidine shows selectivity toward the 
a4p2 subtype of nAChR, in contrast to MLA. However, some nAChR subtypes present 
in the brain and ganglia may have affinities for [3H]nicotine and [3H]cytisine too low to be 
reliably labelled by these radioligands in a binding assay. Hence, the possibility of other 
receptor subtypes that bind epibatidine with high affinity arises (Kellar, 1995). 
Fortunately, [3H](±)epibatidine is now commercially available and as expected has high 
affinity for nAChRs. Houghtling et al. (1995) have demonstrated that [3H](±)epibatidine 
appears to bind to two classes of nAChR sites in rat and human brain, both with 
picomolar affinity. One of these is the a4p2 receptor while the other is thought to be a 
site containing the a3 subunit.
It is possible that Manduca nervous tissue contained nAChR subtypes other than those 
labelled by a-btx. Previously, MacAllan et al. (1988) had demonstrated that fHJnicotine 
bound with low affinity to Schistocerca brain preparations and did not fully saturate over 
the concentration range used. Moreover, it was displaced by cholinergic ligands other
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than (-)nicotine with extremely poor affinity suggesting that the binding was non-specific 
and that the [3H]nicotine binding site was not a physiological nAChR. Consequently, 
[3H](±)epibatidine was the radioligand of choice in the search for other Manduca 
neuronal subunits such as a3- and a4 -like receptors.
As seen from Figure 3.7, (±)epibatidine inhibited [125l]a-btx binding with slightly higher 
affinity than (-) nicotine, indicating that it did have pharmacological properties consistent 
with a cholinergic ligand. However, [3H](±)epibatidine binding in Manduca was low and 
probably non-specific (Figure 3.9), as determined by statistical significance using the 
Student’s t-test. It appears therefore, that Manduca does not have a [3H](±)epibatidine 
binding site and consequently neither the equivalent of an a4p2 nAChR nor an a3 
containing nAChR. As yet, no data for [3H](±)epibatidine binding to insects have been 
published.
Interpretation of Hill numbers
It is noticeable that with the exception of unlabelled a-btx, all the dose response curves 
obtained for cholinergic ligand displacement of [125l]a-btx binding were shallow and this 
resulted in low Hill numbers (see Table 3.6). The shallow curves obtained may be part of 
a wide ranging insect phenomenon, as similarly shaped curves are obtained for some 
other insects (see Sattelle et al., 1989; Tomizawa et al., 1995a). These papers do not 
quote Hill numbers for the inhibition of [125l]a-btx binding. The Hill number for binding of 
a-btx in Manduca adults was close to unity suggesting that a-btx bound to one site with 
high affinity or more than one site but with equal affinity. In addition, the Scatchard plot 
obtained from saturation binding of [125l]a-btx was linear (see Figure 3.3), implying that 
the existence of two different classes of a-btx binding sites was unlikely. The same 
appears to hold for a-btx in larvae. Conversely, the other cholinergic ligands tested have 
Hill numbers at or below 0.5. This could be as a result of any of the following 
suggestions;
1) The cholinergic ligand tested could be distinguishing between two or more [125l]a-btx 
binding sites. These could represent either a second nAChR or a second site on the 
same receptor. It has previously been mentioned that the [125l]a-btx binding site 
correlates to the a7 subtype of nAChR in vertebrates. There is no conclusive evidence 
of the existence of an homomeric a7 receptor in vivo although there is little doubt that it 
functions successfully in vitro (see Chapter 1, section 1.2.5). A cautious extrapolation 
from vertebrates to Manduca suggests that an a7-like nAChR may well be present, either 
as an homomer, an heteromer, or both in Manduca. An homomeric a7-like receptor
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would contain identical a-like subunits, suggesting that each would have the same 
affinity for cholinergic ligands and thus a second site on the same receptor in this case, 
seems unlikely. Alternatively, an heteromeric a7-like receptor, if assumed to have the 
postulated structure of other vertebrate neuronal receptors in vitro, could have either two 
identical a-like and three identical p-like subunits or non-identical a-like and non-identical 
(3-like subunits such as the a4a5p2 receptor (Ramirez-Latorre et a/., 1996) or even the 
muscle receptor. In the case of an heteromeric receptor with identical a-like and identical 
p-like subunits, the two a-like subunits would be expected to have identical binding 
affinity as they would have identical flanking subunits due to the 2:3 stoichiometry. 
However, in the case of an heteromeric receptor with non-identical a-like and non­
identical p-like subunits, differing a-like or p-like subunits would be expected to result in 
different binding affinities as is the case with the muscle receptor which possesses an 
high affinity site at the a-y interface and a low affinity site at the a-5 interface (Pederson 
and Cohen, 1990; see Chapter 1, sections 1.2.5 and 1.2.7). A further possibility is that 
of cholinergic ligands binding to sites on two different a-btx binding receptors. If this 
were so, it would be expected that a-btx would bind with two differing affinities as 
postulated for Schistocerca (Filbin et al., 1983) and in one Drosophila study (Schloss et 
al., 1988). In Manduca this does not appear to happen and thus it is unlikely that there 
are two different a-btx binding receptors. Furthermore, all the cholinergic ligands tested 
fitted a one site model.
2) Negative co-operativity, where the binding of one molecule to a subunit makes it more 
difficult for subsequent molecules to bind to other subunits, is known to give Hill numbers 
lower than one. This would explain the binding of the cholinergic ligands giving shallow 
curves but does not account for the difference obtained with a-btx, which due to its large 
size would be more likely to cause negative co-operativity through steric hindrance, than 
the other ligands. a-Btx, as a polypeptide is by far the largest ligand tested and its 
binding site extends beyond that of the smaller ligands (see Chapter 1, section 1.2.7).
3) Ligand heterogeneity is a possibility for some of the ligands used. For example, the 
epibatidine used was racemic, presumably having equal amounts of (+) and (-). It has 
been shown that the naturally occurring (+) enantiomer is ~1.3-fold more potent than the 
(-) enantiomer in rat brain membranes (Badio and Daly, 1994), so a slight lowering of the 
Hill number from unity, consistent with the slightly different binding affinities could be 
expected. The same argument could apply to anabasine, again the racemic form of the 
ligand used. However, this for instance, does not explain why (-)nicotine has a low Hill 
number.
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4) Despite the inclusion of protease inhibitors in the isolation buffer to protect against 
protein degradation, it is possible that the membrane fractions were broken down as the 
experiments progressed. Leupeptin, pepstatin A and PMSF are well documentated as 
inhibitors of mammalian proteases (see Merck Index). However, little is known regarding 
the nature and specificity of proteases in the insect nervous system. Indeed Lunt (1986) 
suspects that little effect is gained from the inclusion of anti-proteases in insect 
preparations. It is therefore possible that there was partial breakdown of the Manduca 
membrane preparations.
Muscarinic and mixed receptors in Manduca
Although, it has been established that the a-btx binding site in Manduca shows 
characteristic nicotinic pharmacology when compared with other insects, it was 
necessary to demonstrate that muscarinic compounds did not bind with high affinity. At 
100^M concentrations, the majority of nicotinic ligands displaced nearly all specific [125l]a- 
btx binding. In particular, nicotine, the definitive agonist of nAChRs inhibited ~85% of 
specific binding (Figure 3.7). In contrast, muscarine, the definitive agonist of mAChRs 
inhibited ~25% of specific binding in adults and -65% of specific binding in larvae (Figure 
3.8). These results agree with the conclusions previously made, that the a-btx binding 
site in Manduca is nicotinic, not muscarinic in nature, disputing Sanes et al. (1977) who 
suggested that it may be a mixed receptor. This does not refute the idea that there may 
be a mixed receptor of nicotinic and muscarinic pharmacology in the Manduca nervous 
system. Interestingly, Trimmer et al. (1993) have identified two fHjQNB binding sites, 
consistent with the presence of mAChRs in Manduca. The high affinity ^HjQNB binding 
site has fewer binding sites (Bmax = 23fmol/mg protein) than the number of nicotinic 
binding sites obtained in this study, thus correlating with data from Drosophila.
In summary, these binding experiments demonstrate the presence of an a-btx sensitive 
nicotinic-like AChR in Manduca which is able to bind a variety of cholinergic ligands. 
Most importantly, nicotine binds with similar affinity in both adults and larvae as in other, 
nicotine sensitive insects, indicating that a naturally mutated binding site is improbable. 
Moreover, there do not appear to be a-btx insensitive binding sites that can be 
radiolabelled with [3H](±)epibatidine. Although it is apparent that nicotine can bind to 
receptors in Manduca, without testing functional ability, it is impossible to tell whether 
binding of nicotine elicits an agonistic action on the receptor. An appropriate example is 
the effect of cytisine on rat a4p2 receptors. Cytisine can bind with high affinity but acts 
only as a partial agonist at the ACh site (Papke and Heinemann, 1993; see Chapter 1,
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section 1.2.5). The relationship between the binding data obtained in this chapter and 





4.1 Relating sequence and binding data
This study has resulted in the isolation of two overlapping clones encoding a putative a- 
like subunit of the nAChR (Chapter 2), and the characterisation of a membrane bound a- 
btx binding component from Manduca larvae and adults with a profile typical of a nAChR 
(Chapter 3). The affinity of nicotine for this a-btx binding site was comparable with 
values described in the literature for other nicotine sensitive insects, indicating that the 
nicotine resistance intrinsic to Manduca was not as a result of a modified a-btx binding 
receptor (see Chapter 3). This was compatible with the sequence data obtained from the 
two overlapping clones, analysis of which implied that all the residues known to be 
essential for ligand binding, and in particular nicotine binding, were present, suggesting 
that nicotine resistance in Manduca was not due to a modified a-like subunit of the 
nAChR (see Chapter 2). This does not prevent the possibility that nicotine acts as a 
partial agonist (see Chapter 3, section 3.5) where nicotine binds with high affinity to the 
nAChR but has low efficacy in evoking responses.
Although a modified nAChR may not be responsible for Manduca's nicotine resistance, 
there remains the possibility that fewer binding sites are available with which nicotine can 
interact compared with other nicotine sensitive insects. This hypothesis is hampered by 
lack of evidence from the larval forms of other insects, so although the number of a-btx 
binding sites (and therefore potential nicotine binding sites) appears low (119 fmol/mg 
protein) in comparison with adults (815 fmol/mg protein) (see Chapter 3), this may be the 
case for all larval forms from other related species.
Interestingly, data obtained from the inhibition of specific radiolabelled a-btx binding by 
various cholinergic ligands fitted a single binding site model, suggesting that there was 
only one class of binding site. Furthermore, the use of a radioligand (radiolabelled 
epibatidine) that in vertebrates has been shown to label sites distinct from those labelled 
by a-btx (see Chapter 3), hinted at the sole presence of a-btx binding receptors. Again, 
this is consistent with the isolation of a single a-like subunit. Despite numerous attempts, 
further a-like subunits were not isolated, tentatively suggesting that only one a-like 
subunit exists in Manduca. Moreover, this agrees with the fact that only one (partial 
length) cDNA clone encoding a putative p-like subunit has been isolated from Manduca, 
MARB1 (J. Eastlake, University of Bath). It can therefore be speculated that the 
presence of a single a-like subunit and the presence of a single p-like subunit is in 
accord with an heteromeric receptor, comprising two identical a-like subunits and three 
identical p-like subunits, assuming a stoichiometry equivalent to that postulated for
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vertebrates (Anand et al., 1991; Cooper et al., 1991). As the 'ligand binding' subunits 
would be surrounded by identical 'structural' subunits only one high affinity binding site 
might be expected, consistent with the data obtained on Manduca membranes.
This single high affinity binding site model caused by identical a-like and identical p-like 
subunits may be similar to the native a7 receptor that binds a-btx and is postulated to be 
heteromeric (Couturier et al., 1990b; Anand et al., 1993). This model however, does not 
compare well with other insect data. For example, the Drosophila subunit ALS formed 
functional receptors in Xenopus oocytes only when it was expressed with the chick p2 
subunit (Bertrand et al., 1994), ACh evoked responses being blocked by low 
concentrations of a-btx. However, ARD was known to be associated with ALS in vivo 
(Schloss et al., 1991) but did not form functional receptors with ALS in Xenopus oocytes 
(Bertrand et al., 1994) suggesting that another non-identical subunit was necessary for 
the formation of the native receptor. This would probably mean the presence of more 
than one binding site for this receptor, consistent with data obtained by Schloss et al. 
(1988) which indicated the presence of two [125l]a-btx binding sites. On the other hand, 
Sgard et al. (1993) found evidence of only one a-like subunit for the lepidopterans, Chilo 
suppresalis, Heliothis virescens and Spodoptera frugiperda (see Chapter 1, section 
1.3.2). However, there is neither a-btx binding data nor data concerning the search for 
p-like subunits available to support this finding.
Binding data using radiolabelled a-btx was obtained for two developmental stages, 
larvae and adults in the life cycle of Manduca. Statistical analysis suggested that there 
was no difference in the binding of nicotine between these two developmental stages. 
This implied that the same class of a-btx binding site was present in both developmental 
stages. It was vital to establish this point, as larvae and adults have different feeding 
habits (see Chapter 1, section 1.1.2): tobacco chewing larvae would require mandatory 
protective mechanisms against nicotine poisoning whereas in adults this is not necessary 
due to feeding on nectar. The presence of equivalent a-btx binding sites is once again 
consistent with the analysis of sequence data. The two overlapping clones were isolated 
from embryo and adults and would therefore develop into nicotine ingesting larvae and 
non-nicotine ingesting adults respectively. The presence of two different a-like subunits 
corresponding to the two stages of the life cycle would result in two different sequences. 
However, the overlapping region (within the extracellular region of the subunit) of the two 
clones was identical in both nucleotide and amino acid sequence, consistent with the 
presence of a single type of receptor. Interestingly, electrophysiological studies on the 
PPR motoneuron in the prepupal stage of Manduca development demonstrated
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resistance to nicotine (Trimmer and Weeks, 1989). The authors suggested that further 
investigations on the accessory planta retractor motoneuron, which receives a mono­
synaptic afferent input, is cholinoreceptive, and unlike the larval PPR, survives to adult 
eclosion could be used for developmental studies of nicotine resistance. This would 
therefore be an ideal system for demonstrating resistance to nicotine in both nicotine 
ingesting larvae and adults at the individual neuron level.
4.2 Future directions
Sequence comparison with other sequences encoding insect a-like subunits of the 
nAChR strongly suggests that MARA1 would also form an a-like subunit of the nAChR. 
However ultimate proof will only be attained through expression of the full-length MARA1 
and functional analysis, for example, in Xenopus oocytes. Two options are possible: 1) 
alone MARA1 can form functional receptors, indicating that it has the ability to form 
homomers or 2) alone MARA1 cannot form functional receptors, indicating that other 
subunits are imperative for correct assembly. In the latter case, co-injection of the cDNA 
encoding MARA1 with the cDNA encoding the putative p-like subunit from Manduca, 
MARB1 (once obtained in its full-length form) would indicate whether a functional 
heteromeric receptor is formed. However, as previously shown with the Drosophila 
subunits ALS and ARD, co-expression of two subunits in Xenopus oocytes is not always 
definitive of their ability to combine in the same receptor (Bertrand et al., 1994).
Although it is apparent that nicotine can bind to receptors in Manduca and that residues 
involved in nicotine binding are present in MARA1, without testing functional ability, it is 
impossible to tell whether binding of nicotine elicits an agonistic action on the receptor. 
An appropriate example is the effect of cytisine on rat a4p2 receptors. Cytisine can bind 
with high affinity but acts only as a partial agonist at the ACh site (Papke and 
Heinemann, 1993) and the same may be true of nicotine at nAChRs in the Manduca 
nervous system. Even so, nicotine may still be toxic, by acting as an antagonist and 
preventing access of ACh to the nAChR.
The possible co-expression of MARA1 and MARB1 could also be investigated using 
immunoprecipitation experiments in a similar manner to that for the Drosophila ALS and 
ARD subunits (Schloss et al., 1991). Moreover, such experiments could relate to the a- 
btx binding sites present in Manduca nervous system membranes. Antisera against 
bacterially expressed fusion proteins that included the sequence of the cytoplasmic loop 
for each putative subunit and hence were subunit specific could be raised and used to
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immunoprecipitate [125l]a-btx binding sites solubilised from Manduca membrane 
preparations. If antisera to both MARA1 and MARB1 precipitated all the a-btx binding 
sites, it would be further indication that both subunits formed part of the same receptor 
and that there was only one class of a-btx binding site. Alternatively, if either one 
precipitated a different proportion of sites than the other, it would imply that additional 
combinations of subunits existed in the Manduca nervous system rather than the single 
combination postulated by this study.
In the same vein, subunit specific antibodies directed against the cytoplasmic loops of 
MARA1 and MARB1 or fluorescein isothiocyanate labelled a-btx in conjunction with 
confocal laser scanning microscopy (Wheeler et al., 1994) could be used to localise 
receptors within the Manduca nervous system. Moreover, in situ hybridisation 
experiments could show where transcripts of these putative subunits were expressed. 
These studies would be ideal for observing the presence of MARA1 and MARB1 
throughout the different stages of development and could be correlated with the 
autoradiographic localisation of a-btx binding sites presented by Hildebrand etal. (1979).
4.3 Why is Manduca resistant to nicotine?
Having virtually eliminated the possibility of a modified nAChR as being the mechanism 
of nicotine resistance in Manduca, it is necessary to ask again, why is Manduca resistant 
to nicotine, when nicotine if eaten by other insects proves so fatal? Once again, it is 
necessary to allude to Manduca's ability to ingest not only nicotine but other alkaloids 
(see Chapter 1, section 1.1.2) that would be deadly for other insects. This suggests at 
the very least, a basic common mechanism for protection against harmful 
allelochemicals.
The following mechanism of protection against the toxic effects of nicotine and other 
alkaloids is an amalgamation of hypotheses from various sources. However, 
comprehensive comparison with another lepidopteran that is susceptible to nicotine (and 
other alkaloid) poisoning is necessary to ensure that the biological machinery used in 
Manduca is not commonplace to all lepidopterans.
Rapid metabolism of nicotine in the midgut of the larvae to more polar metabolites aids 
excretion and thus is the first protective mechanism against nicotine toxicity (Snyder et 
al., 1994). Moreover, nicotine induces its own metabolism in the midgut (Snyder et al., 
1993) by switching on various cytochrome P-450 mono-oxygenase activities. It is
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possible that different alkaloids activate different subsets of these enzymes and 
therefore offer a protective mechanism unique to a particular alkaloid (see Chapter 1, 
section 1.1.3, Metabolism and excretion in Manduca).
Although this accounts for most of the absorbed nicotine, it does not explain why the 
CNS of Manduca is intrinsically insensitive to nicotine while remaining sensitive to other 
cholinergic agents (Morris, 1984; Trimmer and Weeks, 1989). The rapid metabolism of 
nicotine by the CNS has been observed (Morris, 1983a, Snyder et al., 1993) in contrast 
to results obtained in this study using inhibition of an a-btx binding site (presumably an 
nAChR) by nicotine (see Chapter 3). Considering that the CNS of Periplaneta, a nicotine 
sensitive insect, was also shown to metabolise nicotine (Moms, 1983a) it is unlikely that 
metabolism in the CNS is the sole protective mechanism of the CNS.
It has been postulated that the blood-brain barrier is an effective mechanism against 
nicotine penetration to nAChRs in the neuropile (Morris and Harrison, 1984). This is due 
to the lack of cell to cell contacts in the basal perineurial layer which preclude the 
penetration of protonated nicotine, in contrast to the many cell to cell contacts seen in 
the basal perineurial layer of the nicotine sensitive insect, Periplaneta. These 
observations would explain the global electrophysiological recordings obtained on 
Manduca and Periplaneta by Moms (1984) which demonstrated that the intact nerve cord 
of Manduca was less sensitive to nicotine than the intact nerve cord of Periplaneta.
However, studies on desheathed nerve cords (Morris, 1984) and on a desheathed 
isolated motoneuron (Trimmer and Weeks, 1989) from Manduca exhibited a similar result 
with nicotine: although sensitivity had increased, it was not as equally responsive as 
Periplaneta nerve cords (David and Sattelle, 1984). Other cholinergic ligands induced 
neural activity of similar effectiveness in both species, indicating that this phenomenon 
was peculiar to nicotine (of the ligands tested; see Chapter 1, Table 1.1).
Ultrastructural studies on the nerve cords of Manduca have revealed that desheathing 
causes only localised damage (Morris and Harrison, 1984). It was demonstrated that 
despite the removal of the neural lamella and outer perineurial cells, the interface of the 
perineurium with the underlying glial/neuronal mass was intact and the areas adjacent to 
the desheathed perineurium retained their integrity. Furthermore, ionic lanthanum (a 
cation, presumed to penetrate the blood-brain barrier to the same extent as cationic 
nicotine) was only partly successful in penetrating the desheathed nerve cords. It 
appeared that lanthanum gained access to the cytoplasm of damaged cells and also the 
intercellular clefts where perineurial cells were relatively intact but did not penetrate even
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the most peripheral regions of the subperineurial extracellular space. As nAChRs would 
be located at the junction of the inner regions of the extracellular space with the 
neuropile, it is likely that desheathing of the nerve cords does not grant access to the 
nAChRs and thus results in the low sensitivity seen with nicotine, as in its protonated 
form it is unable to interact in a sufficient amount with the receptor. In this context, it is 
interesting that Trimmer and Weeks (1989) "took great care in removing as much of the 
sheath as possible", however, as they did not perform ultrastructural studies to assess 
the damage caused by desheathing, the probability of nicotine reaching the neuropile 
and thus interacting with the nAChR is not known.
In insects, generally nicotine can reach the synapse and interact with the nAChR if the 
lipophilic form can penetrate the integument and the ion and blood-brain barriers to 
establish an equilibrium where protonated nicotine is formed at the synapse (Figure 4.1; 
see Chapter 1, section 1.1.3, Barriers to nicotine penetration).
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Figure 4.1. The route taken by nicotine to nAChRs in the CNS of insects when used as an 
insecticide. Dashed lines indicate interaction of nicotine with the nAChR. Dashed arrows 
represent minor routes. Re-drawn from Yamamoto et al. (1995).
Considering that the pH of the haemolymph in Manduca larvae is 6.6, there is little 
nicotine present in the lipophilic form (Self et a/., 1964a) to penetrate any barriers and as 
the blood-brain barrier has few cell-to-cell contacts, there are few access points left for 
the penetration of protonated nicotine. Furthermore, lipophilic nicotine entering the cells 
of the blood-brain barrier may be metabolised by the local detoxification system of the 
cells. Consequently, it is possible that hardly any nicotine reaches the synapse in either 
lipophilic or protonated form and therefore Manduca is not poisoned by the nicotine 
entering its system.
In summary, a combination of factors may account for Manduca’s resistance towards 
nicotine:
• Metabolism of nicotine in the midgut to more polar metabolites.
• Rapid excretion of the metabolic products by an active transport system.
• Possible metabolism in the CNS of the remaining lipophilic form of nicotine.
• Effective blood-brain barrier preventing access to the synapse of the protonated form 
of nicotine.
The end result: very little nicotine reaches the synapse and interacts with the nAChRs. 
Consequently, a depolarising blockade is not reached and Manduca is not killed. A 
combination of experiments would be necessary to test this hypothesis: the specific 
cytochrome P450 mono-oxygenase activities could be inhibited to test for lack of 
metabolism in the midgut and CNS while comparison of nicotine penetration into intact 
and completely desheathed neurons (as determined by ultrastructural studies) could test 
for penetration through the blood-brain barrier.
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CHAPTER 5 
Two electrode voltage clamp 
recording from Xenopus oocytes
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5.1 Introduction
The Xenopus oocyte expression system in conjunction with two electrode voltage clamp 
recording was used primarily as a training exercise with a view to expressing the 
Manduca a-like subunit if a full length clone was isolated. Mouse muscle nAChR was 
characterised using the nicotinic agonist anatoxin (together with three of its analogues) 
and the nicotinic antagonist methyllycaconitine.
5.1.1 Two electrode voltage clamp
Voltage clamp is a means of controlling the potential across a membrane. In a voltage 
clamp experiment, a voltage is applied across the membrane and the current across the 
membrane that is required to maintain that particular voltage is measured. Early studies 
used the squid giant axon to develop this technique (Hodgkin and Huxley, 1952). 
Voltage clamp is more commonly used than the alternative current clamp (in which the 
current is clamped and the voltage recorded) as firstly, it eliminates capacitive current so 
that only ionic current is measured; secondly, the currents that flow are proportional to 
the membrane conductance, i.e. the number of open channels, and thirdly, it offers tight 
control over opening and closing of ion channels if they are voltage gated.
Xenopus oocytes offer a convenient lipid membrane in which ion channels can be 
expressed and their characteristics determined by voltage clamp. In single electrode 
voltage clamp, the same electrode clamps the voltage and records the current. This 
study however, utilises two electrode voltage clamp whereby one electrode maintains the 
voltage at a set potential and the other measures the current across the membrane. 
Macroscopic currents from the whole cell (which is expressing hundreds of ion channels 
correlating with the exogenous genetic material injected - see section 5.1.2) are 
recorded; This is somewhat different from the recording of single channel currents by 
patch clamping.
In the case of currents elicited by LGICs, such as those of the nAChR, ion flux is only 
observed on application of the appropriate agonist to the oocyte, once any leakage has 
been eliminated. Thus, in a voltage clamp experiment, once the nAChRs of an oocyte 
resting in a bath of physiological buffer and clamped at a negative holding potential have 
been activated by the perfusion of agonist into the bath, cations such as Na+ flow inward 
through the ion channels, causing the current to change in order to maintain the voltage 
at its holding potential and this is seen, by convention, as a downward deflection of the 
current trace.
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5.1.2 The Xenopus oocyte expression system
Oocytes (germ cells) from the South African clawed frog, Xenopus laevis are commonly 
used as a model system for the expression of ion channels as they are able to 
synthesise exogenous proteins when injected with foreign mRNA into the cytoplasm 
(Gurdon et al., 1971) or cDNA into the nucleus (Ballivet et al., 1988). Moreover, they are 
capable of post-translational modifications such as phosphorylation and glycosylation, as 
well as the correct assembly and insertion of subunits into the surface membrane 
(reviewed in Kushnereta!., 1989).
Generally, ion channel expression studies use fully grown immature oocytes which due 
to their large size can be easily manipulated. The fully grown oocyte (stage 6) is 
between 1 and 1.3mm in diameter and has a characteristic appearance, being divided 
into hemispheres of the animal (dark brown) and vegetal (yellow) poles, as shown in 
Figure 5.1. The darker colour of the former is due to the higher concentration of melanin 
containing granules. The oocyte is surrounded by several layers: a vitelline membrane 
which is non-cellular and fibrous; a follicle cell layer which possesses numerous gap 
junctions forming contacts with the oocyte; the theca which is a connective tissue layer 
and finally an epithelial cell layer which is a continuation of the ovary wall. The outer 
layers contain the oocyte’s endogenous p-adrenergic, muscarinic and purinergic 
receptors and therefore are removed either mechanically or enzymatically with 
collagenase (reviewed in Dascal, 1987). The innermost vitelline membrane is removed 







Figure 5.1. Schematic of a Xenopus oocyte. Adapted from The Axon Guide for 
Electrophysiology and Biophysics Laboratory Techniques (1993).
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Following the injection of foreign genetic material, the oocyte expression system aids 
studies of ion channels due to the following reasons: a) the high proportion of injected 
cells expressing the functional protein, b) the ease of manipulation of the environment 
surrounding the oocyte by bath perfusion of drugs or ions and c) the control of the 
membrane potential of the oocyte by voltage clamp. However, there are some 
disadvantages to the oocyte expression system. These include the short expression 
period compared with stably transfected cell lines (at most, two weeks of expression 
before oocyte deterioration); the small number of oocytes that can be assessed for 
function during one experiment (resulting in the necessity for a normalised reponse for 
each oocyte) and the seasonal variation in the quality of the oocytes. In addition, if in 
vitro transcription of cDNA is used to produce mRNA for injection into the oocyte, 
extreme care is required to prevent degradation by RNases (Sigel, 1990).
5.1.3 The muscle nAChR
The ability of oocytes to form functional nAChRs was originally demonstrated by the 
presence of specific [125l]a-btx binding sites following injection of mRNA from Torpedo 
electroplax (Sumikawa et al., 1981) whose ion channels were later shown to be gated by 
ACh (Barnard et al., 1982). cDNA clones encoding putative a ,  p ,  y  and 5  subunits of the 
Torpedo califomica nAChR (Noda et al., 1982, 1983a,b) were shown to form a functional 
receptor when expressed together in Xenopus oocytes (Mishina et al., 1984). Results 
from the deletion of each subunit suggested that all four subunits were required to elicit 
an ACh response characteristic of a nAChR whereas only the a  subunit was imperative 
for a-btx binding activity. Moreover, it was found that fetal and adult nAChRs in calf 
muscle express ion channels that differed in their conductance and gating properties due 
to the replacement of the y  subunit in the fetal receptor with the e  subunit in the adult 
receptor (Mishina eta!., 1986). The expressed receptors had properties that were similar 
to in situ receptors. Homology of the individual subunits among a range of organisms 
was high and it was demonstrated that chimeric receptors consisting of mRNA encoding 
mixed subunits from Torpedo and either calf or cat formed functional receptors in 
oocytes, the properties of which depended on the particular subunits chosen for 
expression (Sakmann eta!., 1985; Sumikawa and Miledi, 1989).
It was later demonstrated that oligomerisation and functional nAChR formation in oocytes 
did not require injection of all four subunit RNAs (White et al., 1985; Kurosaki et al., 
1987) although nAChRs that were devoid of a subunit functioned to a lesser extent than 
those comprising all four subunits. However, Buller and White (1990a) discovered that
180
Xenopus oocytes express low levels of nAChR a subunit mRNA that, when translated 
could lead to the formation of functional Xenopus-Torpedo nAChR hybrids.
5.1.4 Anatoxin and methyllycaconitine
Anatoxin-a
Anatoxin-a (AnTx) is a potent nicotinic agonist produced by the freshwater filamentous 
cyanobacterium, Anabaena flos aquae. Surface blooms of Anabaena have killed 
livestock and waterfowl by the creation of a depolarising blockade at muscle-type 
nAChRs (as described in Chapter 1, section 1.1.1) and subsequent respiratory paralysis 
(Carmichael et al., 1975). The physiological effects of AnTx are very similar to those of 
ACh. Single channel patch clamp recordings on frog muscle fibres have shown that both 
agonists activate channels with virtually identical conductances ((+)AnTx: 28pS; ACh: 
27pS) although (+)AnTx binds with higher affinity at the [125l]a-btx binding site on 
Torpedo electroplax membranes than ACh and elicits contracture of frog muscles at 
lower concentrations than ACh (after AChE inhibition), indicating that it is a more potent 
agonist than ACh (Swanson et al., 1986). In contrast, (-)AnTx is less potent than ACh 
(Swanson et al., 1986) indicating that AnTx is stereospecific in its agonistic effects. The 
(+) isomer is the natural form of AnTx.
In rat brain, competition binding assays have shown that AnTx binds to the high affinity 
[3H]nicotine binding site (MacAllan et al., 1988), which correlates with the a4p2 subtype 
(Whiting and Lindstrom, 1986b; Flores et al., 1992; see Chapter 3, section 3.1.1) and to 
the [125l]a-btx binding site (MacAllan et al., 1988) which correlates with the a7 subtype in 
chick (and presumably in rat also) (Schoepfer et al., 1990; see Chapter 3, section 3.1.1) 
although selectivity is shown toward the [3H]nicotine binding site. Furthermore, Thomas 
et al. (1993) have shown that (+)AnTx is approximately 200-fold more potent than ACh in 
functional assays of a7 receptors expressed in Xenopus oocytes, making it, along with 
epibatidine (Badio and Daly, 1994), one of the most effective nicotinic agonists known.
Anatoxin-a analogues
AnTx is a secondary amine (with the nitrogen in a bicyclic ring system) complete with a 
conjugated enone as shown in Figure 5.3. The rigid structure of the azabicyclononene 
ring of AnTx, its small size (molecular weight 166), the high stereoselectivity for the (+) 
enantiomer and the available synthetic chemistry make AnTx an ideal parent compound 
for structure activity studies. Analogues based on AnTx can help to define the agonist 
recognition site and thus have been synthesised with systematic modifications and 
assayed for agonist potency using binding assays and electrophysiological recordings.
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Using a series of AnTx analogues with modifications of the acetyl side chain, Swanson et 
al. (1991) and Wonnacott et al. (1991) found that all additions to the acetyl side chain 
resulted in a loss of agonist potency for the muscle nAChR as determined by frog muscle 
contracture assays and [125l]a-btx binding assays and the neuronal nAChR as 
determined by [3H]nicotine and [125l]a-btx binding assays to rat brain membranes. In the 
latter case, all the analogues had higher affinity for the [3H]nicotine binding site than the 
[125l]a-btx binding site but the rank order of potency remained the same at both sites and 
furthermore, agreed with the rank order of potency at the muscle [125l]a-btx binding site 
(Wonnacott et al., 1991). More recently, three new analogues which have an increasing 
number of methine or methylene units added to the acetyl side chain of AnTx have been 
synthesised (Thomas et al., 1994). These are homoanatoxin (HAnTx), propylanatoxin 
(PAnTx) and isopropylanatoxin (IPAnTx) and are shown in Figure 5.3. Competition 
binding assays using [3H]nicotine and [125l]a-btx at the neuronal nAChR indicated that the 
analogues retained or exceeded the potency of (±)AnTx, although PAnTx showed 
marked preference for the [125l]a-btx binding site (Thomas et al., 1994). Similarly, [125l]a- 
btx binding assays on mouse skeletal muscle showed that the analogues exceeded the 
potency of the parent compound (Thomas, 1996). However, another study 
demonstrated that HAnTx possessed one tenth of the activity of (+)AnTx in frog muscle 
contracture assays (Wonnacott et al., 1992) and functional potency values for a7 
receptors expressed in Xenopus oocytes showed that (±)AnTx was more potent than 
either (±)HAnTx or (±)IPAnTX (PAnTx not tested) (Thomas et al., 1994).
Methyllycaconitine
Methyllycaconitine (MLA) is a nicotinic antagonist found in the seeds of Delphinium 
brownii. Initial studies demonstrated that MLA blocked the neuromuscular junction in the 
rat phrenic nerve-diaphragm preparation with an ED50 in the micromolar range (Nambi- 
Aiyar et al., 1979) which agreed with binding affinities obtained from MLA displacement 
of [125l]a-btx binding in Torpedo electroplax and frog and human muscle preparations 
(MacAllan et al., 1988; Ward et al., 1990). In the rat brain, MLA was more effective at 
inhibiting binding to the [125l]a-btx binding site than to the [3H]nicotine binding site 
(MacAllan et al., 1988) and in addition was more effective at the [125l]a-btx site in brain 
than in muscle (MacAllan et al., 1988; Ward et al., 1990), suggesting that MLA is a 
selective toxin for the former site. This finding was reinforced by expression of neuronal 
nAChRs in Xenopus oocytes. Although ACh evoked responses were blocked by MLA in 
a3p2, a4p2 and a7 receptors, MLA displayed a 3000-fold preference for the a7 receptor 
over the a3p2 receptor and a 26000-fold preference for the a7 receptor over the a4p2 
receptor (Drasdo etal., 1992; Wonnacott et al., 1993; Palma etaI., 1996).
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5.1.5 Aims
The aims of this study therefore, were to prepare mRNA encoding mouse muscle nAChR 
subunits by in vitro transcription, to micro-inject this mRNA into denuded oocytes and to 
characterise the functional receptors formed by analysis of two electrode voltage clamp 
recording when the receptors were activated by AnTx and analogues using ACh as a 
standard or when ACh evoked responses were blocked by MLA.
These ligands were chosen as their effects on muscle nAChR as expressed in Xenopus 
oocytes had not been previously characterised. Furthermore, this study was performed 
with a view to expressing the Manduca a-like subunit MARA1, if a full length clone was 
isolated. In this case, a range of ligands would be studied in order to analyse their 
effects on the agonist binding site. The inclusion of AnTx, its analogues and MLA would 
be appropriate as AnTx shows selectivity for the [3H]nicotine binding site (which in 
Manduca may not be present; see Chapter 3) whereas MLA shows high selectivity for 
the [125l]a-btx binding site which is present in Manduca and is displaced by low 
concentrations of MLA (see Chapter 3).
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5.2 Materials
AnTx, HAnTx, PAnTx and IPAnTx were synthesised by Professor T. Gallagher (School of 
Chemistry, University of Bristol, Bristol, U.K.) as described in Thomas et a/. (1994). MLA 
was isolated from Delphinium Garden Hybrid seeds according to the method of Coates 
et al. (1994) by Dr I S Blagborough and Professor B V L Potter (School of Pharmacy and 
Pharmacology, University of Bath, Bath, U.K.). cDNAs encoding mouse muscle subunits 
were provided by Dr J Boulter (Salk Institute, California, U.S.A.). Mature female 
Xenopus were purchased from Blades Biologicals, Edenbridge, U.K.
DNA restriction enzymes and RNA modifying enzymes were supplied by New England 
BioLabs, Hitchin, U.K. and Boehringer Mannheim U.K. Ltd., Lewes, U.K. respectively. All 
other reagents were from the Sigma-Aldrich Chemical Company Ltd., Poole, U.K. and 
were of Analar grade.
Drummond glass capillaries were obtained from Laser Laboratory Systems Ltd., 
Southampton, U.K. while borosilicate glass capillaries were obtained from Clark 
Electromedical Instruments, Reading, U.K. Falcon plasticware was purchased from 
Becton Dickinson and Company, Plymouth, U.K.
AnTx and analogues were made up as 20mM stock solutions in 19% ethanol whereas 
MLA was made up as a 20mM stock solution in 100% ethanol. Subsequent 
concentrations of drugs were prepared in standard oocyte saline (see section 5.3).
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5.3 Methods
5.3.1 In vitro transcription
Plasmid DNA encoding mouse muscle nAChR subunits was prepared from glycerol 
stocks as described in section 2.3.1. The DNA encoding each subunit (10|xg) was 
linearised with the appropriate restriction enzyme (a, p and 5 with H/ndlll, y with EcoRI) at 
37°C overnight as described in section 2.3.4. The resulting linearised template was 
extracted once with phenol:chloroform:isoamyl alcohol (25:24:1) before being 
precipitated with 0.1 volumes sterile 3M sodium acetate and 3 volumes sterile absolute 
ethanol at -20°C overnight. Linearised template was centrifuged at high speed for 
30min, washed with sterile 70% ethanol, dried and resuspended in 20[i\ RNase free 
DEPC treated sterile water.
Maintaining RNase free conditions, 5|xl 10x transcription buffer (0.4M Tris-HCI pH8.0, 
60mM MgCI2) 100mM DTT, 20mM spermidine), 5|al each of 100mM DTT, 5mM ATP, 5mM 
CTP and 5mM UTP, 5jxl 0.5mM GTP, 0.5^1 10mg/ml BSA, 2.5jxl cap analogue 
(m7G(5’)ppp(5’)G), 10|xl linearised template DNA, 2|il 40U/^il RNase inhibitor and 2|ul SP6 
polymerase in a total volume of 50^1 were mixed and incubated at 40°C for 1h. The 
resulting transcripts were precipitated with 0.1 volumes 10M ammonium acetate and 3 
volumes absolute ethanol at -70°C until required for injection. At this point, appropriate 
volumes (approximately 10-20^1) of transcript from each subunit were mixed, centrifuged 
at high speed for 20min, washed in 70% ethanol, dried and resuspended in 5-10(xl 
(depending on average concentration of transcripts) of sterile RNase free water.
To assess the quality and quantity of the transcripts, a parallel but smaller transcription 
was set up incorporating [a-32P]UTP. In this, all reagents were scaled down, 1^ il of [a- 
32P]UTP was added and a 20fxl total volume was obtained.
The quality of RNA produced from in vitro transcription of RNA was analysed on a 
denaturing gel as described in section 2.3.3. The quantity of RNA was analysed by a 
DE-81 filter binding assay. In this, 2pil of the radioactive transcription mixture was mixed 
with 18|J of RNase free water. To each of two DE-81 filters was added 8^ il of the diluted 
transcription mixture. One filter only was washed 4 times in 30ml 0.5M dibasic sodium 
phosphate buffer and then twice in water and once in absolute ethanol. Both filters were 
air dried, added to 5ml ‘Optiphase Safe’ scintillant and counted on a Packard Tricarb
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1600 TR scintillation spectrometer. The amount of transcript was then calculated using 
the amount of radioactivity incorporated into the synthesised transcript.
5.3.2 Xenopus and Xenopus oocytes
Xenopus maintenance
Female Xenopus laevis were maintained in colonies of 18 animals in chlorine free water 
under conditions of 18-22°C and 14:10 h light:dark ratio. Each colony was fed with 
minced heart twice weekly and each tank was cleaned out twice weekly.
Preparation of oocytes
Technical assistance was provided by members of the Animal House at the University of 
Bath who held a Home Office licence for the following procedure. Xenopus laevis were 
anaesthetised by submersion in 0.15% Tricaine (3-aminobenzoic acid ethyl ester) at 
room temperature for approximately 40min until leg retraction ceased. Ovarian lobes 
were extracted through an incision made in the skin and abdominal body wall in the 
posterior ventral side of the frog. The incision was sutured using Mersilk™ 4.0 (Ethicon 
Ltd., U.K.) and the frog was left to recover in water before returning to its original colony. 
The ovarian lobes were sliced into smaller clumps of approximately 50 oocytes and the 
follicle cell and thecal layers removed from the oocytes by incubation with collagenase 
(type 1A; 2mg/ml) in sterile standard oocyte saline (SOS: 100mM NaCI, 2mM KCI, 1.8mM 
CaCI2, 1mM MgCI2l 5mM HEPES, pH7.6) at 18°C with rotation for 1.5-2h. Separated 
oocytes were rinsed in several washes of SOS and stored for up to 3 days at 4°C. 
Oocytes of the appropriate size and with well defined poles were selected from 
microscopic viewing.
Injection needles were pulled from 3.5” Drummond glass capillary tubing on a moving coil 
microelectrode puller (Campden Instruments Ltd.) to produce a tip of approximately 1|im 
which was then gently broken to give a tip with a slightly larger diameter. Needles were 
sterilised by baking at 200°C for at least 2h before being back filled with sterile mineral 
oil and attached to the plunger of a Drummond micropipettor (Laser Laboratory Sytems 
Ltd.). The needles were filled with samples by manual control of the micromanipulator 
that was attached to the micropipettor. With the aid of a binocular microscope and an 
automatic ‘Nanoject’ microinjector, oocytes were co-injected with at least 50ng of 
combined in vitro transcripts in a total volume of 50nl. Oocytes were incubated at 18°C 
for 1 to 7 days in changes of SOS supplemented with 10U/ml penicillin, 10pg/ml 
streptomycin and 50pg/ml gentamycin. Control oocytes were injected with sterile water 
and incubated under the same conditions.
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5.3.3 Two electrode voltage clamp
Microelectrodes were pulled from borosilicate glass capillaries on a moving coil 
microelectrode puller (Campden Instruments Ltd.), slightly bent in a bunsen flame and 
back filled with 3M KC1 (pH 7.8). Each oocyte was positioned in the recording chamber 
and impaled with two microelectrodes, each with a resistance less than 1 mQ. 
Electrophysiological recording was performed using a CA 100 clamp amplifier (Biologic, 
France) on oocytes with a resting membrane potential of greater than -20mV. Oocytes 
were perfused with SOS supplemented with 1pM atropine (to prevent activation of any 
remaining endogenous mAChRs) at a rate of 12ml/min and voltage clamped at -80mV 
unless otherwise stated. The desired dose of agonist was applied for 5s by perfusion 
through a pinch valve system. For antagonist experiments, oocytes were incubated in 
MLA for 5min before application of ACh in the presence of MLA. Control perfusions 
used the highest dose of ethanol that would be found in a drug application. In each 
case, the change in current (or lack of) across the membrane of the oocyte required to 
keep the oocyte clamped at -80mV was recorded on an oscilloscope and chart recorder.
Data was stored on a digital-to-analogue DAT converter (Biologic) for later analysis. 
Data was acquired using an AT-MI0-16D expansion board (National Instruments) and 
analysed using the program Daqware. Data was plotted using the program Sigmaplot 
(Jandel Scientific). Dose response curves for the agonists were fitted to the non-linear 
Hill equation, y = 1 0 0 %/[1 +(EC5o/[ligand])nH] where y is the normalised current (%), EC50 
is the concentration of ligand that evokes 50% of the normal response, [ligand] is the 
agonist concentration and nH is the Hill number. Dose response curves for MLA were 
fitted to the non-linear Hill equation, y = 100%/[1+([ligand]/IC50)nH] where y is the 
normalised current (%), [ligand] is the antagonist concentration, IC50 is the concentration 




In vitro transcriptions of the mouse muscle subunits were generally successful, as shown 
in Figure 5.2. Measurement of the amount of transcript resulted in concentrations of 
approximately 200ng/pl for each transcript.
Two electrode voltage clamp recording was used to assess the effects of agonist and 
antagonist application on mouse muscle nAChRs expressed in Xenopus oocytes. 
Preliminary experiments demonstrated that application of ACh for 5s, 10s or 20s resulted 
in currents with the same amplitude as the nAChRs desensitised within the first 5s of the 
drug application (data not shown). An assessment of the agonist potencies of AnTx, 
HAnTx, PAnTx and IPAnTx as compared with ACh used increasing drug concentrations 
over the range 0.1 pM to 100pM. Application of agonist resulted in a large inward current 
of up to 2.5pA which began to desensitise within 5s of agonist application. The greater 
the drug concentration, the greater the size of the current. At the highest concentration 
tested, ACh and AnTx appeared to be equi-effacacious whereas the three AnTx 
analogues gave somewhat smaller currents (Figure 5.3).
Dose response curves (Figure 5.4) generated the following EC5o values: AnTx 8.2 ± 
2.7pM, HAnTx 71 ± 6.9pM, PAnTx 80 ± 4pM and IPAnTx 72 ± 17pM. In comparison, 
ACh gave an EC5o value of 33 ± 4.3pM. This resulted in a rank order of potency AnTx > 
ACh > HAnTx = IPAnTx > PAnTx. The three analogues did not attain peak currents 
corresponding to an 100% response as the concentrations necessary to achieve this 
were too high.
Neither water injected controls nor perfusion of ethanol corresponding to the highest 
concentration found in drug solutions resulted in change of current.
Current-voltage relationships were determined for AnTx (50pM) and ACh (50 i^M) (Figure
5.4). ACh evoked responses decreased in size as the membrane potential was 
increased step-wise from -100mV to OmV and then increased in size and direction 
corresponding to a change to positive potentials. However, AnTx evoked responses 
appeared to show a non-linear decrease with increasingly positive potentials, until no 
responses were observed at positive potentials appearing to exhibit inward rectification.
ACh evoked responses were fully blocked by 10pM MLA. Application of MLA to the 
oocyte for 5min before application of ACh (100pM) resulted in blockade of the ACh
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evoked response that was concentration dependent (Figure 5.5). The dose response 
curve for MLA resulted in an IC50 value of 0.24 ± 0.08|iM.
Current-voltage relationships were determined for ACh (50|xM) in the absence and 
presence of 100nM MLA (approximately 50% inhibition). A linear relationship was 
obtained in the absence of MLA while there was a tendency toward a curvi-linear 
relationship in the presence of MLA (Figure 5.5). For clarity, no line through the points 
determining ACh response in the presence of MLA has been drawn.
Recovery from MLA inhibition at a concentration of 100nM was also investigated by 
challenging with ACh (100fiM) every minute during MLA washout. Inhibition by MLA was 
readily reversible, with 85% recovery after washing for 5min (Figure 5.5) and total 
recovery of responsiveness to ACh within 10min.
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Figure 5.2. In vitro transcriptions of mouse muscle nAChR subunits. Radiolabelled 
transcripts were synthesised as described in section 5.3.1 and analysed on a denaturing 








Figure 5.3. Activation of mouse muscle nAChRs expressed in Xenopus oocytes by ACh, AnTx and AnTx analogues, a) Representative traces of 


































Figure 5.4. Experimental 
analysis of activation of 
mouse muscle nAChR 
expressed in Xenopus 
oocytes by ACh, AnTx 
and analogues.
a) Dose response curves. 
Responses to agonist 
(AnTx (■), HAnTx (♦ ), 
PAnTx ( • )  and IPAnTx 
(■)) were normalised to 
the ACh ( • )  maximum 
peak height and values 
from at least three oocytes 
have been averaged, with 
sem indicated by vertical 
bars.














b) Current - voltage 
relationship for ACh (• )  
and AnTx (■) at 50pM 
concentrations. Holding 
potential was stepped 
from -100mV to +20mV. 
Current responses were 
normalised with respect to 
the response observed at 
-100mV and values from 
at least three oocytes 
have been averaged, with 




Figure 5.5 Inhibition of mouse 
muscle nAChRs expressed in 
Xenopus oocytes by MLA. Oocytes 
were incubated in MLA for 5min and 
then challenged with a 5s application of 
ACh with MLA.
a) Dose response curve for antagonism 
by MLA of ACh-evoked currents 
(100pM). Responses were normalised to 
maximum peak height and values from 
at least three oocytes have been 















b) Current-voltage relationship for ACh 
(50pM) in the absence (•) and presence 
(■) of MLA (100nM). Holding potential 
was stepped from -100mV to +20mV. 
Current responses were normalised with 
respect to the response observed at - 
100mV.
c) Recovery of the ACh response from 
MLA block. MLA (100nM) was applied 
to the oocyte for 5min to ensure 
maximum inhibition. During washout, 











ACh, AnTx and AnTx analogues were assessed over a range of concentrations on 
mouse muscle nAChR expressed in Xenopus oocytes using two electrode voltage clamp 
electrophysiology. The EC50 value of 33pM obtained for ACh is in agreement with 
published figures (Labarca et al., 1995). In comparison, AnTx gave an EC50 value of 
8.2pM, which gives a relative potency of AnTx to ACh of 4 to 1. Swanson et al. (1986) 
found that AnTx was 8 times more potent than ACh when measured by muscle 
contracture in frog skeletal muscle. As Swanson et al. used the active enantiomer 
(+)AnTx, in contrast to the racemic mixture used in the present study, these data are in 
accord: there is a 150-fold difference in the potency between the (+) and (-) enantiomers 
(Swanson et al., 1986) and thus, the EC50 values derived in the present study 
underestimate the potency of the active, (+) enantiomer by 2-fold. Taking this into 
account, there is excellent agreement between the present and previous study with 
respect to the relative potency of AnTx, despite the use of frog muscle in Swanson’s 
study and mouse muscle in this study.
In contrast to the muscle nAChR, the a7 subtype of the nAChR is more sensitive to 
AnTx, giving an EC50 value of 0.58pM (Thomas et al., 1993). On the other hand, ACh 
was far less potent at the a7 nAChR, giving an EC50 value of 130pM. Thus the relative 
potency of AnTx to ACh is 225 to 1 on the a7 nAChR. This order of potency agrees with 
data from whole cell patch clamp of hippocampal neurons exhibiting type 1A currents, 
which correspond to a7-like nAChR (Alkondon and Albuquerque, 1993; Thomas et al., 
1993). Hence, while ACh has a 4-fold greater potency on muscle nAChR than a7 
nAChR, AnTx is 14-fold more potent on a7 nAChRs than muscle nAChRs. In other 
preparations that express different neuronal nAChR (namely, M10 cells that express the 
chick a4p2 combination and presynaptic nAChR mediating ACh release from 
hippocampal synaptosomes) AnTx was even more potent (Thomas et al., 1993). From 
this, it is clear that different nAChR subtypes display a wide range of sensitivities to AnTx 
but in each case it is more potent than ACh. The potency ratio varies with different 
subtypes indicative of differences at the agonist binding site.
Studies on AnTx analogues by Swanson et al. (1991) and Wonnacott et al. (1991) 
determined that the secondary amine and carbonyl functions of AnTx were crucial for 
activity. Subsequently, a set of analogues that conserved these features but altered the 
acetyl side chain by the addition of one or more methine or methylene units was 
synthesised. Wonnacott et al. (1992) demonstrated that the most simple analogue,
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HAntx had one tenth of the activity of AnTx in frog muscle contracture assays. The 
functional potencies of this set of analogues were assessed on the a 7  nAChR (Thomas 
et al., 1994) and showed less potency than the parent compound. EC50 values for 
HAnTx and IPAnTx were 0.72|aM and 0.66|xM respectively. This gives a rank order of 
potency for a 7  of AnTx > IPAnTx > HAnTx and relative potency values of 1 : 0.88 : 0.80. 
The data obtained here (see Figure 5.4), on the muscle nAChR gave the following EC5o 
values: HAnTx 71 piM, PAnTx 80pM and IPAnTx 72pM and a rank order of potency of 
AnTx > HAnTx = IPAnTx > PAnTx. In this case, the analogues are significantly less 
potent than the parent compound, AnTx, as shown with relative potency values of 1 : 
0.12 : 0.10, i.e. AnTx is approximately 10-fold more potent on muscle nAChRs than any 
of these alkyl modified analogues, agreeing with the frog muscle contracture data 
(Wonnacott et al., 1992). These data are summarised in Table 5.1.






3.3 ± 0.43 x10 '& 
8.2 ± 2.7 x 10'6
7.1 ± 0.69 x 10‘5
8.2 ± 0.4 x 10‘5
7.2 ± 1.7 x 10‘5
1.3 ±0.1 x104# 
5.8 ± 0.9 x 10‘7# 
7.2 ± 5.5 x 10‘7* 
ND
6.6 ± 2 . 0 x 1  O'7*
Table 5.1. EC50 values for mouse muscle and chick a7 nAChRs. Data are mean ± sem. ND, 
not determined. * data from Thomas et al., 1993; * data from Thomas et al., 1994.
Molecular modelling studies have shown that the extension of the acetyl side chain does 
not distort the conformation of the AnTx skeleton (Thomas et al., 1994), thus agreeing 
with the conservation of biological activity by these analogues at a 7  nAChR. However, 
the comparison detailed above, between the muscle and a 7  subtypes shows that while 
the a 7  receptor can evidently accommodate the increased hydrocarbon bulk of the side 
chain within its binding site, the muscle receptor cannot. Clearly, the binding site of the 
muscle receptor must differ from the a 7  receptor in such a way that the binding of AnTx 
is preferred over its analogues. Furthermore, it appears that PAnTx, with the most 
extended side chain has the least affinity for the binding pocket, although there is no 
significant difference between any of the analogues.
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Interestingly, [125l]a-btx binding assays on rat brain and mouse skeletal muscle have 
demonstrated that the three analogues bind with higher affinity than AnTx in both tissues 
(Thomas et al., 1994; Thomas, 1996). In mouse muscle, the rank order of potency 
according to the measure of [125l]a-btx binding affinity is IPAnTx > HAnTx > PAnTx > 
AnTx (Thomas, 1996), while in rat brain it is PAnTx > IPAnTx > HAnTx > AnTx (Thomas 
et al., 1994). In contrast [3H]nicotine binding on rat brain gives the rank order of potency 
as HAnTx > IPAnTx > AnTx > PAnTx (Thomas et al., 1994) suggesting that PAnTx 
showed a marked preference for the a7 receptor as indicated by [125l]a-btx binding, being 
more potent than AnTx and the other analogues and correspondingly less selective for 
the <x4p2 receptor as indicated by [3H]nicotine binding. This indicated that PAnTx has a 
preference for the a7 binding site.
Thus, there appear to be discrepancies between potency as measured by binding affinity 
and as measured by functional assays in Xenopus oocytes, suggesting that there is not 
always a correlation between binding affinity and functional potency. In this study, 
HAnTx, PAnTx and IPAnTx all bind with high affinity to the a-btx binding site on mouse 
skeletal muscle but act as weaker agonists at the agonist binding site. It is possible that 
there may be a difference between organisms as this study used mouse muscle nAChRs 
whereas Thomas et al. (1994) used rat brain nAChRs and/or between developmental 
stages as mouse muscle binding studies used adult mice (Thomas, 1996) whereas this 
this study used mouse muscle embryonic subunits. Therefore, there would have been 
replacement of the y subunit in the embryo with the s subunit in the adult. Moreover, the 
transcripts encoding the a,p,y and 8 subunits may have undergone different post- 
translational modifications than those in native mouse muscle. For example, it has been 
demonstrated that glycosylation of the Torpedo nAChR on expression in oocytes is 
somewhat different to that seen in native Torpedo electroplax (Buller and White, 1990b).
The current-voltage relationship obtained for AnTx differed from that for ACh (Figure
5.4). ACh resulted in a linear relationship that showed no signs of inward rectification. 
However, AnTx showed a distinct deviation from linearity at potentials more positive than 
-60mV, suggesting that the ion channel was inwardly rectifying. This phenomena is 
observed as the membrane potential becomes more positive and results in a decrease in 
current until the channel closes. This tendency for an ion channel to act as a valve, 
allowing entry of cations and thus inward flux but not exit of cations and thus outward 
flux is a property more commonly seen with neuronal nAChRs. Indeed, inward 
rectification is observed for HAnTx and IPAnTx evoked currents on the a7 receptor 
(Thomas et al., 1994). Muscle nAChRs are not known as inwardly rectifying channels,
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suggesting that AnTx was acting as an ion channel blocker in addition to an agonist, as 
channel blockade is seen as a deviation from linearity in current-voltage relationships 
(Rozenthal et al., 1989). Interestingly, a deviation from linearity in current-voltage 
relationships has been observed in neuronally evoked endplate currents and in the 
spontaneous minature endplate currents (EPCs) of voltage clamped frog sartorius 
muscle fibres. However, further analysis has indicated that AnTx does not produce ion 
channel block on EPCs (Spivak et al., 1980), although in these recordings, the highest 
concentration of AnTx used was 0.9pM, as above this concentration the amplitudes of 
the evoked currents were too small for reliable measurements. Given that in the present 
study, an AnTx concentration of 50pM was used, the possibility of ion channel block 
cannot be ruled out.
The antagonist MLA shows remarkable selectivity for the a 7  receptor (Wonnacott et al., 
1993). Competition binding assays on [125l]a-btx binding sites on rat brain and frog and 
mouse muscle showed that MLA had a markedly higher affinity for the rat brain receptor 
(K j 1.4 x 10'9 M) than for either the frog muscle receptor (K j 1.0 x K T 5 M) or the mouse 
muscle receptor (K j 3.0 x 10’7 M) (Ward et al., 1990; Thomas, 1996) and thus apparently 
distinguished between a 7  and muscle subtypes, unlike a-btx. Furthermore, it has been 
shown that the a-btx insensitive receptors, a3p2 and a4p2, when expressed in Xenopus 
oocytes, require micromolar concentrations of MLA for inhibition (Drasdo et al., 1992). 
IC50 values of 0.08pM for the a3p2 subtype and 0.65pM for the a4p2 subtype were 
obtained. In comparison, the data obtained in this study gave an IC50 value of 0.2pM for 
the muscle nAChR. Thus there appears to be no significant selectivity for MLA between 
the muscle and the a-btx insensitive neuronal nAChRs. In contrast, recent studies by 
Palma et al. (1996) on the a 7  receptor show that this subtype is highly sensitive to 
inhibition by MLA in the oocyte expression system, giving an IC50 value of 25pM. 
Accordingly, there is a 4000-fold difference in potency of MLA on muscle and a 7  
receptors. Therefore, functional expression of the muscle and a7 receptor has 
confirmed earlier observations by Ward et al. (1990) that MLA is highly selective for the 
a 7  receptor.
Analysis of the current-voltage relationships of ACh in the absence and presence of MLA 
(Figure 5.5) suggested that there was not a deviation from linearity over the range -100 
to -20mV. However, at more positive potentials, there appeared to be a slight deviation 
from linearity. But in view of the overlapping error bar at +20mV (in comparison with that 
for AnTx, Figure 5.4) there is no evidence to suggest that inward rectification is occurring 
or that MLA acts as a channel blocker. Furthermore, Alkondon et al. (1992) have
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demonstrated that the antagonism of ACh and AnTx-evoked currents by MLA in 
hippocampal neurons is voltage independent, supporting a competitive mode of 
antagonism. This was also reinforced by the finding that single channel open times of 
type 1A channels were not affected by MLA, indicating that MLA inhibited the nAChR in 
the closed conformation. That MLA is a competitive antagonist is also supported by 
ligand binding studies (Wonnacott et al., 1993), including those presented in Chapter 3 
on Manduca, where MLA was a potent inhibitor of a-btx binding.
In summary, this study shows that the muscle nAChR is activated by AnTx but to a lesser 
extent by its analogues, in contrast with the a7 nAChR. Furthermore, MLA has a weaker 
effect on the muscle nAChR than the a7 nAChR. Thus these compounds demonstrate 
the utility of neurotoxins as pharmacological tools for characterising nAChR subtypes 
and would therefore have been ideal ligands for characterising the a-like subunit of the 
nAChR from Manduca, MARA1. The expression of MARA1 in Xenopus oocytes 
(assuming that it was able to form a functional homomeric receptor) would have 
conclusively identified MARA1 as a modified (or not) subunit of the nAChR, on 
application of nicotine and comparison with ACh. AnTx and its analogues would have 
extended the pharmacological profile, while blockade of agonist-evoked currents by a-btx 













277 YMLFTMIFVIS S111TVWINTHHRS PSTHTMPQWVRKIFIDTIPNVMFF
TM3
327 STMKRASKEKQENKIFADDIDISDISGKQVTGEVIFQTPLIKNPDVKSAI
377 EGVKYIAEHMKS DEE S SNAAEEWKYVAMVIDHILLCVFMLIC11GTVSVF
TM4
427 AGRLIELSQEG
Underlined letters correspond to putative transmembrane domains; italic letters 
correspond to the cys loop; bold letters correspond to residues postulated to be involved 
in ligand binding.




a) Location of primers on fragment c (from Clarke, 1991).
Primer sequences in bold. Sense primers underlined, antisense primers italicised. Sequences 
that are both underlined and in italics represent overlapping sense and antisense primers. 
Location of degenerate primers used to find other a-like subunits indicated as dotted lines beneath 
amino acid sequence.
1 CGGCCGCGCGAGTACGGCGGCGTGGAAATGCTGCACGTGCCTTCCGACCACATCTGgCSgeCCGACATCgTgCTT 75
1 R P R E Y G G V E M L H V P S D H I W R P D I V L  25
7 6 TACAACAATgCTGACGGGAACTTTGAGGTGACGCTGGCGACTAAGGCGACGCTCAATTACACCGGCCGAGTGGAG 150
26 Y N N A D G N  F E V T L A T K A T L N Y T G R V E  50
151 TGGCGTCCGCCCGCCATCTACAAGTCCTCGTGCGAGATCGACGTAGAGTACTTTCCATTCGACCAGCAGACGTGC 225
51 W R P P A I Y K S S C E I D V E Y F P F D Q Q T C  75
22 6  GTCATGAAGTTTGGCTCGTGGACCTAGGACGGGTTTCAGGTAGATCTGCGACATATCGATGAAGTGCGAGGCACC 300
76 V M K  F G S W T Y  D G F Q V D L R H I  D E V R G T  100
3 01 AACGTCGTGGAGTTGGgCGTCGACCTCTCCgAGTTlTACACCTCTGTCGAGTGGGACATCCTGGAGGTGCCCGCC 37 5
101 N V V E L G V  D L S E F _ _Y_ _T_ _ S _ V _ _E_ _W _ D _ I _  L E V P A 125
376 GTCCGAAATGAAAAGTTCTACACGTGCTGCGACGAGCCCTATCTAGATATAACTTTCAACATCACGATGCGCCGC 4 50
126 V R N E K F Y T C C D E P Y L D I T F N I T M R  R 150
4 51 AAAACACTCTTCTACACCGTTAATCTGATCATTCCGTGCATGGGAATATCGTTCCTGACGGTCCTGGTATTTTAC 525
151 K T L F Y T V N L I I  P C M G I S  F L T V L V F Y  175
526  TTGCCTTCGGACAGTGGCGAGAAGGTATCGCTGTCCATATCGATCCTACTGTCGCTCACCGTGTTCTTCCTGCTG 600
176 L P S D S G E K V S L S I S I L L S L T V F F L L  200
601 TTGGCCGAGATCATTCCACCGACTTCGCTGGTGGTGCCACTGCTTGGCAAGTTTGTTCTCTTCACCATGATCCTC 67 5
201 L A E I  I  P P T S L V  V  P _ _ L _ _ L _ § _ J 5 _ _ F _ _ Y . _ L _ J _ _ T  M I  L 225
676 GATACGTTGAGCATATGCGTGACTGTGGTGGTATTGAATGTGCACTTCCGCTCGCCACAGACGCACACAATGTCG 750
226  D T F S I C V T V V V L N V H F R S P Q T H T M S  250
751 CCGTGGGTGCGGCGCGTGTTCATCCACGTGCTGCCGCGGCTCCTGGTCATGCGCCGCCCGCACTACCGACTCGAC 825
251 P W V R R V F I H V L P R L L V M R R P H Y R L D  275
826 CCGCACCGCAGTCGCTTCGCAGGACTGGTGACCGGCGCTGGCGAGACCACACTATGGGACGAGGGCTCGCCGGGC 900
2 7 6  P H R S R F A G L V T G A G E T T L W D E G S P G  300
901 GTGCCGGCTCCGCCCCGTCCGCCGCCCTGCGCACCCCCGCTGGCGCCCTGCGCCGCCTGCGCGCCCGCTGAGGCG 97 5
301 V P A P P R P P P C A P P L A P C A A C A P A E A  325
97 6 CCGGCGCTCTGCGACGCGCTGCGCCGGTGGCACCGGTGTCCCGAGCTACATAAGGCTATTGACGGCATCAATTAT 1050
326 P A L C D A L R R W H R C P E L H K A I  D G I N Y  350
1051 ATTGCCGACCAAACTAGGAAAGAGGAAGAGTCCACTAGGGTGAAAGAGGACTGGAAGTACGTAGCG A T G G T A C T C  1125
351 I A D Q T R K E E E S T R V K E D W K Y V A M V L  375
11 26  GACAGACCATTCCTGTGGATATTCACGCTAGCGGTGGTGGTGGGCTCGGCGGGCATCATCCTGCAGGCGCCGACG 1300
376  D R P F L W I F T L A V V V G S A G I I L Q A P T  400
13 01  CTGTACGACGAGCGCGCGCCCATCGACGTGCGCCTGTCGGAGATAGCGTACACGGCCGCCAAGCCGCGCCCACCG 1375
401 L Y D E R A P I  D V R L S E I A Y T A A K P R P P  425
13 7 6  CCGCCACGCTGAGCGGGTCTCGCGTCACGTGCTACGTGTCACGCGTGACGCGTCACGCATCACGCGTCACGCGTC 14 50
426 P P R 428
1451  GGCGTCTCTCGACGGGCTCCAGTGATTCTCGCTCGTATTTTCGATTCACGCAAATTCGAATTTGCAATATTGTAC 1525
15 26  ATAGTATACATAATTATTATAGTTTATACAAAGAAACACCGCGATCGATTCTAAGTCGAATTTCTTTTGATAGAG 1600
1601  A C G A A A T A A A A T G A T C G T T T G T A T  1624
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b) Location of primers on fragment a.
Primer sequences in bold. Sense primers underlined, antisense primers italicised. Sequences 
that are both underlined and in italics represent overlapping sense and antisense primers.
1 GTGCGAGGCCCAACGTGTGGAGTTGGGCGTCAACTCATGCGGAGTGTGACAAAATATTAC 60
-2 1  M R S V T K Y Y  -1 4
61 TTACATGGTGTTGTTTTGTTTGCGACAGGATGTGCCGGCAACCCCGACGCGAAGCGGCTG 120  
- 1 3  L H G V V L F A T G C A G N P D A K R L  7
121 TACGACGATCTGCTCAGCAATTACAACAAGTTGGTGCGGCCTGTACTCAACGTCAGCGAC 180  
8 Y D D L L S N Y N K L V R P V L N V S D  27
181 GCGCTCACCGTGCGCATCAAGCTCAAGCTGAGCCAGCTCATCGACflTGGTCAGCCGCCTT 24 0 
2 8 A L T V R I K L K L S Q L I D V  43
241 TAACACAAAAACGTCACAATCACTAGTTCTTACAATATCATACTGGAATCGTTGCAATAA 300
301 TAATAGCAATAGTTTAACATTGTAATATAATTGTTGCAGAATCTCAAGAArCAflATAATg 360  
44 N L K N Q I M  50
361 ACAACCAATCTATGGGTGGAACAGGTTAGTCTCATTGTGTATGTGTTTGCACGATTATTG 420  
5 1 T T N L W V E Q  58
421 CAAGTTTGCATACAGTTTTTCTAGTAGCTATTGTGTTATTCGCAGAGCTGGTACGACTAC 4 80 
59  S W Y D Y 63
4 81 AAGCTTTCGTGGGAGCCGCGCGAGTACGGCGGCGTGGAAATGCTGCACGTGCCTTCCGAC 54 0 
64 K L S W E P R E Y G G V E M L H V P S D  83
541 CACATCTGGCGGCCCGACATCGTGCTTTACAACAATGCTGAC 582
84 H I W R P D I V L Y N N A D  97
c) Schematic of MARA1 showing approximate location of primers.
S, sense primer; A, antisense primer. Numbering consistent with text in Chapter 2. TM, 
transmembrane domain; S-S, cys loop. Not to scale.
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A4 A8 A3 A2 A1 A6 A5
S2
A7
d) Calculation of annealing temperature of primer.





1.6% (w/v) bacto-tryptone 
1.0% (w/v) bacto-yeast extract 
0.5% (w/v) NaCI 
pH 7.0
NZY medium
1.0% (w/v) NZ amine 
0.5% (w/v) NaCI 
0.5% (w/v) bacto-yeast extract 
0.2% (w/v) MgS04.7H20  
pH 7.0
For agar plates, 1.5% (w/v) bacto-agar added. For top agarose, 0.7% (w/v) agarose 
added.
SM
0.58% (w/v) NaCI 
0.2% (w/v) MgS04.7H20  
5% (v/v) 1M Tris-CI pH7.5 
0.5% (v/v) 2% gelatin solution
SSC (20x stock solution)
3M NaCI
0.3M sodium citrate 
pH7.0
Denhardt’s solution (50x stock solution)
1% (w/v) Ficoll (type 400)
1 % (w/v) polyvinylpyrrolidone 
1 % (w/v) BSA
TE
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